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1027-I 14 Molecular Epidemiology of LQTS in a Cohort of 267 
Probands 
Carlo Napoiitano, Elena Ronchetti, Mirella Memmi, Jannt Nastoli, Giovanna Faggiano, 
Donata Cappelletti, Peter J. Schwartz. Silvia G. Priori. A4ooiecular Cardiology: /WCS 
Fondaziane Salvatore Maugeri, Pavia, I&/L: Dept. of Cardiology, University of Pavia, 
/RCCS foliciinico S Matteo, Pavia, /t&y 
The long QT syndrome (LQTS) is an inherited arrhythmogenic disorder characterized by 
mutations in at least six genes encoding for subunits of cardiac ion channels: KCNQI, 
HERG, SCNSA, KCNEI, and KCNE2. Several LQTS mutations have been reported; 
however. the molecular epidemiology of LQTS has not been defined. Here we present 
the resUlts of genetic screening (Single Strand Conformational Polymorphism combrned 
with sequencing of abnormal conformers) performed in 267 consecutive LQTS probands 
tested against a panel of 300 control individuals (600 chromosomes). The average time 
required to process a sample was 123 t 89 days: a mutation was identified in 158 pts 
(59.2%); distribution of mutations among the five genes was: 901158 (57.0%) KCNQi, 
371158 (23.4%) HERG, 24/158 (.15.2%) SCNSA, 61158 (3.8%) KCNEl and 11158 (0.6%) 
KCNE2. Missense mutations represented the majority of the genetic defects (1341158, 
85%) but other abnormalities were also identified as follows: small deletions (7%), splice 
errors (3%), stop codons (4%) and insertions (1%). KCNQI, HERG and SCNSA muta- 
tions were frequently located in the C-terminus portion of the protein (27%, 30% and 
25%, respectively). Only 12% of the SCNSA mutations were located in the DIII-DIV linker 
responsible for channel inactivation. Most mutations differed among different families as 
only 4190 KCNQl and 1137 HERG mutaiions were found in more than one family. Based 
on the present data we conclude that: 1)Standard screening techniques allow successful 
identification of the genetic defect in approximately 60% of the clinically affected 
probands. 2) KCNQI related LQTS remains the most common form of LQTS, followed by 
HERG related LQTS. 3) Mutations of the cardiac sodium channel SCNSA are more com- 
mon than anticipated and account for 15% of all LQTS and only a minority of SCNSA 
mutation are located in the inactivation domain. 4) genotyping of LQTS patients should 
start from the C-terminus of all genes where approximately one third of the mutations is 
located. 5) Since most genetic defects are limrted to a single family, screening for the 
identtficatton of known mutations does not represent a cost-effective approach. 
1027-I 15 Demonstration of a Molecular Basis for Unexplained 
Cardiac Arrest in Young Individuals 
Silvia G. Priori, Carlo Napolitano, Peter J. Schwartz, Elena Ronchetti, Pedro Brugada, 
Raffaella Bloise, Tiziana Giovannini, Mark Hiser, John Camm, Paul Touboul, Carlo 
Menozzi. ~oolecular Cardiology: IRCCS Fondazione S Maauger!, Pavia, /t&y 
Acute myocardial ischemia and infarction represent the most common substrate for ven- 
tricular fibrillatipn, while most of the remaining cases are due to diseases such as hyper- 
trophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, long QT 
syndrome, myocarditis and vaivular defects. In approximately 1.5% of individuals suc- 
cessfully resuscitated form VF, even after extensive clinical evaluation, it is not possible to 
identify the presence of a substrate to account for the arrhythmrc episode, that is there- 
fore defined as “idiopathic ventricular fibrrllation” (IVF). Even post mortem evaluation fails 
to identify the p:esence of a structural heart disease in 5.8% of the victrms of cardiac 
arrest. Despite the lack of evidences of either EGG or structural cardiac abnormalities, 
available data suggest that these indivtduals have 2530% chance of recurrence of ven- 
tricular fibrillation. In the present study we tested the hypothesis that survivors of idio- 
pathic ventricular fibrillation may harbor silent genetic defects of cardiac ion channels, i.e. 
they may be affected by concealed forms of Long QT or of Brugada Syndrome. We per- 
formed molecular screening on 20 survivors of IVF The coding region of five ion channel 
genes KCNQl, HERG, SCNBA, KCNEI, KCNEZ, was analyzed by SSCP and DNA 
sequencing. Among the 20 patients we were successful in identrfying three mutations, 
one in KCNQ1 and two in SCN5A, in three patients. Clinical and genetic analysrs of fam- 
ily members identified 12 silent carriers of the genetic abnormalities among family mem- 
bers with an apparently normal heart. Our data show that mutations in the cardrac ion 
channel genes which are known to cause long QT syndrome and Brugada syndrome, are 
also associated with IVF Moreover, they strongly suggest that these genetic defects are 
able to create a vulnerable substrate that may predispose to electrical instability and car- 
diac arrest. identification of the genetic substrate among IVF survivors and in their family 
members is important in order to establish preventive and therapeutic strategies and to 
adwse patients on lifestyle recommendations to reduce the probability of recurrences of 
ilfe threatening arrhythmias and sudden death. 
1027-l 16 A National Survey of Sudden Death Syndrome (SDS): 
Results From Cardiological Evaluation of First Degree 
Relatives 
Elijah R. Behr, Anne Casey, Ann O’Donoghue, Maurice Greenberg, Maureen Sheppard, 
Melissa Wright, Michael Davies, Wilfiam J. McKenna, Tim Bowker, David Wood. SI. 
George’s Hospifal Medical School, London, United Kingdom, Royal Brompton Hospital, 
National Heart & Lung Institute, Imperial Cokge School of Medicine, London. United 
Kingdom 
Background: About one in twenty of all sudden cardiac deaths c 65 years rn the popula- 
tion are unexplained, with normal cardiac pathology and negative toxicology - Sudden 
Death Syndrome (SDS). In this study first degree relatives of these SDS victims were 
assessed for structural and electrophysiologtcal ewdence of cardiac disease. 
Method: SDS cas?s were identified prospectively through HM Coroners throughout 
England over a twelve-month period. Inclusion criteria were: (1) 4 - 64 years old; (2) no 
known cardiac disease; (3) last seen alive within twelve hours of death; (4) coroner’s post 
mortem required to issue death certificate; (5) no identifiable cause by a cardiac patholo- 
gist and negative toxicology. For confirmed SDS cases as defined the deceased’s GP 
was approached for permission to contact first degree relatives for cardiovascular evalua- 
tion: clinical examination, electrocardiogram, echocardiogram and 24 hour Halter moni- 
toring. 
Results: 1171122 (96 %) Coroners participated. 54 SDS cases were identified. 32 (59%) 
families of SDS cases attended for evaluation. 108/151 (72%) first degree relatives from 
these families were seen. In 7 (22%)families. one first degree relative in each family was 
diagnosed with cardiac disease: 5 were diagnosed with long QT syndrome, one with dys- 
trophica myotonica and one with hypertrophic cardiomyopathy. 
Conclusions: Sudden Death Syndrome is associated with inherited cardiac disease, 
previously unsuspected, in about a quarter of all families evaluated. Simple clinical tools 
can readily identify, and where possible treat, some of the causes of unexplained prema- 
ture sudden cardiac deaths in the population. 
1027-I 17 Sensitivity and Specificity of Sodium Channel Blockers in 
Patients With Right Bundle Branch Block (RBBB) and ST- 
Segment (STE) Syndrome Not Linked to SCN5A Mutation 
Raul Weiss, Doris Cavlovich, Tuduy Nguyen, Maninder Bedi, Dennis McNamara, 
Vladimir Shusterman, Barry London Cardiovascular /nstifute/UPHS, PJttsburgh, PA 
Introduction. Genetic heterogeneity between families affected with RBBB-STE syndrome 
has been well established. Unmasking ECG abnormalities with sodium channel blockers 
agents has recently been shown to have a high sensitivity and specificity tn family mem- 
bers affected with the SCN5A mutation. The effect of sodium channel blockers in patients 
with genetic abnormalities not linked to SCN5A loci is less well known. We evaluated the 
sensttivity and specificity of a sodium channel blocker agent in a single family with RBBB- 
STE not linked to SCN5A mutation. Methods: Fourteen members of an affected family 
underwent procainamide (Proc) infusion and frequent ECG recordings. Family members 
(FM) also underwent genetic mapping using highly polymorphtc markers and linkage to 
the novel locus on chromosone 3 was determined. Results: Fourteen males age 52 I 19. 
There were 7 gene-carrier FM (Grl) and 7 unaffected FM (GR). After proc 5 FMs in Gil 
have significant ECG changes compare to two FM in group 2. The sensitivity and speci- 
frcity of proc is 71% and 71% respectively. Conclusion: Sodium channel blocking agents 
have a modest sensitivity and specificity in RBBB-STE syndrome not related to SCN5A 
mutatron. 
1027-l 18 Torsade de Pointes Associated With Arsenic Trioxide 
Treatment for Hematological Malignancies 
Dillp Unnikrishnan, Nikita Varshneya, Richard Lucariello, Janice P Dutcher, Peter H. 
Wiernik, Salvatore Chtaramida. Our Lady oi Mercy Medical Center, Bronx, MY 
Background: Arsenic trioxide is used in clinical trials for resistant leukemia and some 
solid tumors. Arsenic causes QT interval prolongation and T wave changes, but life 
threatening arrhythmias have not been reported with therapy. Methods: 19 patients (13 
males, 6 females) enrolled for Phase II study of arsenic trioxide were evaluated. Patients 
received IO-20 mg arsenic trioxide per day for up to 60 days of treatment per protocol. 
Full cardiac evaluations were performed in 8 patients including serial electrocardiograms, 
echocardiography, hotter monitoring, stress testing and radionuclide imaging. Results: 
12 of the 19 patients had evidence of capillary leak syndrome during treatment with 
arsenic and required therapy. 8 patients underwent comprehensive cardiac evaluation, all 
had normal left ventricular ejection fraction, QTc in normal range, no ventricular arrhyth- 
mia other than ventricular premature contractions, and no evidence of ischemia on radio- 
nuclide stress testing at baseline. 6 patrents had prolongation of corrected QT interval 
(QTc) while receiving arsenic. 3 patients (2 males, 1 female) developed polymorphic ven- 
tricular tachycardia (torsade de pointes) associated with prolongation of OTC interval. 
Onset of torsades occurred at cumulative arsenic doses of 840, 320 and 70 mgs respec- 
tively; at days 42, 16 and 12 respectively of starttng treatment with arsenic. Serum potas- 
sium and magnesium levels were normal. No patlent was on drugs known to cause 
torsades. 16 of the 19 patients expired on follow up. In 11 patrents for whom limited data 
is avarIable, death was sudden out of hospital in one. from congestive cardiac failure in 
another, and from progressive disease in the rest. Conclusion: Patients on treaiment 
with arsenic should be monitored for QTc prolongation. In patients with prolonged inter- 
vals from baseline, other factors (electrolyte disturbances, drugs) should be actively 
sought and corrected. This is important since arsenic induced arrhythmias are known to 
be resistant to chemical and electrical cardioversion. At least a subgroup of patients with 
severe Intercurrent illness should be considered for continuous monrtoring if they have 
increasing QTc intervals. 
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1028-121 Effects of Atrial Electrical Disconnection in a Porcine Model 
of Chronic Atrial Fibrillation 
David Schwartzman, W David Fischer, Eduardo Warman, Rahul Mehra. Atria/Arrhythmia 
Center, University of Pittsburgh, Pittsburgh, PA, Medtronic, Inc., Minneapolis, MN 
Background: recent reports have suggested a “codependence” of right (RA) and left 
(LA) atria for sustenance of atrial fibrillation (AF). We have previously described a percu- 
taneous endocardial catheter-based technique for complete RA-LA electrical disconnec- 
tion (ED) using radiofrequency ablation, with lesions targeting sites of interatrial 
conduction on the RA septum. The objective of the present study was to evaluate the 
effect of ED on sustainability of AF in a porcine chronic AF model. Methods: In 9 pigs, 
chronic AFwas established using prolonged (>5 months) high frequency RA pacing. Pigs 
were returned to the laboratory, where the following data were collected in both RA and 
LA at baseline: 1 effective refractory period (ERP), Zability to sustain AF following pro- 
grammed stimulation (sustain). 7 pigs then underwent the ED procedure (ED pigs), and 2 
oias underwent an eouivalent volume of ablation in the smooth aosterior RA free wall 
(c&trol pigs). Data collection was repeated after.ablation. Results (table): 
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1028-I 19 Counter Intuitive Relations Between In Viva RF Lesion Size, 
Power, and Tip Temperature 
Rupak Mukherjee, Preecha Laohakunakorn, M. Charles Welzig, Kdhryn S. Cowart, J. 
Philip Saul. Medical University of South Carolina, Charleston, SC 
Background: Radiofrequency (RF) 
remains unclear. We hypothesized 
that due to in viva flow effects, 
endocardium of 16 pigs using 5, 6, 
and 7 Fr catheters with standard 4 
mm tip lengths. The ablation gener- 
ator was set to achieve a maximum 
temperature of 70°C. The RF 
TS;MP (0:) 
lesions were created in different 
regions of the heart so as to encompass a wide range of blood flow and catheter move- 
ment conditions. RF lesions were measured acutely (DIMEN, mm) and correlated with 
average power applied (POWER, W), and average tip temperature (TEMP, “C) achieved 
during the creation of the lesion. The relation between POWER and TEMP was also 
examined (FIGURE). Results: At TEMPs above 55’C, POWER decreased hyperbolically 
with increasing TEMP. Further, DIMEN was inversely related to TEMP (r= -0.38, p=O.lO): 
but, was slightly positively related to POWER (r= 0.28, ~~0.23; statistically, no relation). 
Conclusion: In viva, variable tissue contact and flow yield DIMEN-POWER-TEMP rela- 
tions opposite to those found in vitro. These counter intuitive results suggest that maxi- 
mum in viva RF lesion size is achieved when power is maximized at tip temperatures 
between 50 and 60°C (FIGURE). 
1028-120 Pulsed Radiofrequency Energy and Multi-Electrode 
Catheters: Comparison of Two Different Monitoring Modes 
for Ablation of Porcine Right Atrium 
Erik Kongsgaard, Peter O‘Callaghan, Nidal Maarouf, Edward Rowland.. St. George’s 
Hospital Medical School, London, United Kingdom 
Background: Catheter ablation of atrial flutter and non-focal atrial fibrillation consists of 
inducing long lesions. The purposes of this study were to assess the feasibility of a new 
RF generator system using pulsed energy, a multi-electrode ablation catheter and imped- 
ance or temperature monitoring during the ablation procedure in order to induce trans- 
mural, long continues lesions. 
Methods: Fourteen pigs were randomised to temperature (65°C) or impedance guided 
ablation (power was increased slowly for the first 30 seconds until an impedance 
decrease of <15 ohms was observed). Pulse duration was 60s and max. power was 6OW 
- 50% duty cycle was used. The 7F ablation catheter has four 4 mm band electrodes 
each with its own thermocouple (Sidewinder, BARD). Power was delivered to two elec- 
trodes “simultaneously” (50% duty cycle). RF energy was delivered via a Quadrapulse 
controller (BARD) connected to a 1OOW RF generator. Three lines were induced in the 
right atrium (RA) and one lesion across the IVC / TA istmus (ISTM). The animals were 
sacrificed after 4 hours. 
Results: All lesions were transmural and contiguous. There was significantly less car- 
bonisation on the tip (p=O.O074) and endocardial charring in the impedance guided 
group (p=O,OO16). The frequency of collateral tissue damage (aortic wall and lung tissue) 
was similar. Damage to the right coronary artery was not observed. There was a 79% 
decrease in the atrial signal amplitude pra- vs. postablation (2.9mV vs 0.6mV) and the 
post ablation A signals ware fractionated. 
The lesion sizes were similar 
Energy delivery mode Length/mm width/mm 
RA / ISTM RA / ISTM 
Temperature guided 25~3 / 2125 5.8+1 / 6.2+1 
impedance guided 24i4 / 19+5 6.2+1 / 6.1+1 
p-value 0.38 / 0.48 0.19 / 
Conclusion: These results show that transmural, contiguous lesions can be induced 
with a multi-electrode ablation catheter system and that impedance guided ablation cre- 
ates lesions with a smoother surface. 
SUSTAIN-LA SUSTAIN-RA SUSTAIN-LA SUSTAIN-RA 
(ED Pigs) (ED Pigs) (control pigs) (control pigs) 
BASELINE 7 of 7 7 of 7 2 of 2 2 Of 2 
POST-ABLATION 2 of 7 1 of7 2 of 2 2 Of 2 
EFiPs were not significantly different between baseline and ablation in both ED and con- 
trol pigs. Conclusions: In most animals, after ED AF would not sustain in either atrium. 
This was not associated with changes in ERP. The mechanism for this did not appear to 
be atrial “debulking.” 
1028-122 Microwave Radiometric Thermometry Predicts Tissue 
Temperature During Ablation 
Eugene Bak, Wei Zhu, James Regan, Kenneth Can, Brian VanderBrink, Mark S. Link, 
Munther K. Homoud, N. A. Mark Estes, Ill, Paul J. Wang. New EnglandMedical Center, 
Boston, MA, Microwave Medical Systems, Acton, MA 
Background: Current techniques for measuring catheter tip temperatures in ablative 
therapy for cardiac arrhythmias employ thermocouples or thermistors embedded in the 
tip electrode. Electrode cooling, however, may interfere with these methods. Because 
microwave radiometry is capable of detecting microwave radiation from the molecular 
motion of molecules, we propose microwave radiometric thermometry as a new tech- 
nique to monitor temperature away from the electrode tip during ablative therapy. 
Methods: A microwave radiometer helical antenna was positioned adjacent to the site of 
cooled radiofrequency ablation in a section of excised ovine heart positioned in a circulat- 
ing saline bath maintained at 37 degrees C. Temperature-sensing fiber optic probes 
monitored tissue temperature at depths of 1 mm, 3 mm, 5 mm, and 7 mm, before, during, 
and after cooled radiofrequency ablation. The first set of experiments was used to create 
a linear regression equation to describe the relationship between radiometer voltage and 
temperature. This equation was used to predict the tissue temperature observed in a 
second set of experiments. 
Results: The radiometer voltage was highly correlated with the tissue temperature 
(R=0.99). The temperature predicted using the linear regression equation correlated 
highly with the actual temperature at 1 mm (Rz0.98). 
Conclusions: Microwave radiometric thermometry can estimate tissue temperatures 
consistently even in the presence of cooled radiofrequency ablation. The microwave 
radiometer serves as a promising instrument for monitoring temperature away from the 
catheter electrode tip during ablative therapy for cardiac arrhythmias. 
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1028-123 Fiberoptic Balloon Catheter Ablation of Pulmonary Vein 
Ostia in Pigs Using Photonic Energy Delivery With Diode 
Laser 
Robert Lemery, John Veinot, Anthony Tang, Martin Green, Norman Fan, Lincoln Baxter, 
Jon McIntyre, Ed Sinofsky. Ottawri Heart Institute, Ottawa, ON. Canada 
Background: In patients with atrial fibrillation who have arrhythmogenic foci within the 
pulmonary veins (PV), radiofrequency ablation can be curative. However, the technique 
remains complex and unsatisfactory because of either difficulties in mapping, number of 
PV involved, risk of PV stenosis, and high recurrence rates. We studied the effects of 
creating circumferential lesions to the ostium of the PV to cause conduction block at the 
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junction of the PV and left atrium. Diode laser can deliver energy through dtffusing or 
rtng fiber tips (CardioFocus Inc, Norton, MA) which has been shown experimentally to 
caue.e volumetric heating both below and at the surface of tissue. 
Methods: In 3 pigs weighing between 60.65Kg, transseptal puncture was performed and 
a fiberoptic balloon catheter with a collapsed profile of 1OF was advanced through a 
sheath under fluoroscopic guidance to the ostium of the right and left PV’s. The balloon 
was inflated with a mixture of 3cc of D20 (Deuferium Dioxide) and contrast, to deliver cir- 
cumferential lesions with a 15mm diameter x 3mm ring of light. Applications consisted of 
3.2 to 3.8 watts/cm for 120 seconds. The animals were sacrificed three hours after abla- 
tion for pathologic examination. 
Results: Photonic energy was delivered successfully to the ostium of 516 targeted Pv’s, 
and was well tolerated in each animal without ectopy. Gross inspection revealed 
endocardial lesions at the ostium of 415 PV’s, confined to the atrium in each, circumferen- 
tial in 3/5, without any charring; all PV’s were patent wrthout intraluminal thrombus. 
Microscopically, transmural coagulation necrosis of the atrium was present at the ostium 
of 315 PV, and extended into the myocardial sleeves of 2 Pv’s. 
Conclusion: Photonic energy delivery to PV ostia using a fiberoptic balloon catheter is 
feasible, well tolerated and not associated with acute PV stenosis. Circumferential trans- 
mural atrial necrosis at the ostium of the PV occurred in 60% of lesions during this pre- 
liminary set of experiments, suggesting that this new form of energy delivery may be 
therapeutically advantageous for PV ablation, with need to pursue chronic studies. 
1028-124 Photonic Energy Delivery Using Diode Laser to Create 
Circumferential and Linear Lesions to the Coronary Sinus in 
Pigs 
Robert Lemery, John Veinot, Anthony Tang, Martin Green, Norman Fan, Lincoln Baxter, 
Jon McIntyre. Ed Sinofsky. Offawa Heart Insfifufe, Otfawa, ON, Canada 
Background: The use of lasers to treat arrhythmias has generally consisted of complex 
devices that deliver a narrow beam of light to vaporize tissue, with risk of cardiac 
perforation. The advent of diode lasers, a simple set up energy source that can be deltv- 
wed through a small generator, offers the possibility of delivering energy through diffus- 
ing or ring fiber tips (CardioFocus, Norton, MA), experimentally shown to cause 
volumetric heating both below and at the surface of tissue. 
Methods: In 10 animals (9 pigs, I dog), a fiberoptic balloon catheter with a collapsed 
profile of 1OF was positioned under fluoroscopic guidance at the ostium of the coronary 
sinus (CS), and inflated with a mixture of 3cc of Deuterium Dioxide and contrast, to 
deliver circumferential lesions with a 15mm diameter x 3mm ring of kght. Applications 
consisted of 3.2 to 3.8 watts/cm delivered for 100 to 220 seconds. Thereafter, the cathe- 
ter was removed and another 6F laser catheter with a 4 cm linear diffuser was advanced 
to the distal CS. This catheter has gold foil to cover the outer aspect and prevent epicar- 
dial energy delivery; applications consisted of 3.2 to 4.3 watts/cm for 95 to 200 seconds. 
In the last 3 pigs, non-contact mapping of the right atrium pre and poet ablation was 
obtained with the Endocardial Solutions system. The animals were sacrificed three 
hours after ablation for pathologic examination. 
Results: Photonic energy delivery to both the ostium and distal CS never resulted in 
charring or significant thrombus formation, and tn 7120 lesions delivered, there were no 
grossly evident superficial lesions. Microscopically, however, coagulation necrosis was 
observed in l&l/20 lesions. Usrng the Ensite mapping data, endocardial activation pre 
and post ablation revealed conductron block without any gaps in 213 animals. 
Conclusions: 1) Photonrc energy can be delivered safely to the proximal CS, and the 
observed pathologic findings to this ostial vein may be clinically relevant regarding its 
safety and application to pulmonary veins, and 2) Successful elimtnation of interatrial 
conduction at the level of the low right atrium - CS. may offer a new strategy that uses a 
right sided approach for ablation of atrial fibrillation. 
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1029-125 Are Enhanced Dual Chamber Detection Algorithm Superior 
to Single Chamber Algorithm First Results of the 
Multicenter DETECT Study 
Katrin Ziegenbalg, Burkhard Hijgl, Nice Doll, Angelika Bucco, Mathias Benthin, Petra 
Schirdewan, Hans Kottkamp, Gerhard Hindricks, Rainer Hambrecht, Gerhard Schuler. 
Heart Center Leipzig, Leipzig, Germany 
Background. Inappropriate Schock-Therapies are a common problem in patrents with 
implantable cardioverter Defibrillators.The discrimination of fast supraventricular tachy- 
card& or arrhythmias (SVT) from ventricular tachycardias (VT) is difficult The develop- 
ment of dual chamber devices with enhanced detection criterias should reduce this 
problem. Nevertheless the superiority of a dual chamber detection algorithm to a single 
chamber algorithm is not proven. 
Method: In a prospectrve multicenter trial (Detect) we compared the single chamber cri- 
teria (SCC)stability and width criteria (Medtronic Inc. 7223/7227/7229) with the new dual 
chamber criteria(DCC) PR logic (Medtronic Inc 72710’7273). All patients met the Classlill 
(AHA/ACC) for ICD implantation and had no indication for bradycardia pacing therapies. 
Patients with perststend atnal ftbrillation were excluded. The patients (pts) were ran- 
dom&d to a dual or a single Chamber ICD and the detection zones were programmed 
equal.. 
Results: 47 patients ( age 62,‘2+10,6 years, underlying heart disease: 37 pts coronary 
artery disease, 5 pts dilated cardiomyopathie, 5 pts other; mean ejection fractton 
35,4+15,7%) were included since 1/1999,21pts with a dual chamber device and 26 
patients with a single chamber device. In the follow up time 232 VT episodes and 255 
supraventricular episodes occurred and were analyzed by the stored ECG. The SCC 
detected 143 VT episodes correct and 8 episodes false with no delivered therapie. The 
DCC detected 81 VT episodes correct and no VT-Episode false. 156 SVT Episodes were 
correct detected by the SCC with 8 false detections. 19 episodes were correct detected 
by the DCC and 64 false ( 60 episodes in one patient). There was no statistical significant 
difference between DCC and SCC. 
Conclusion: 
The first results of the DETECT Study show that the DCC is not superior in reducing 
inappropriate therapies. The advantage is a high specificity No VT was false classifted. 
Nevertheless further investigattons are necessary. 
1029-126 Incidence of Oversensing Resulting in Inappropriate 
Shocks in Transvenous Implantable Cardioverter- 
Defibrillators 
Yongkeun Cho, Andrew Corsello, Dionyssios Robotis, Andrezej Okreglicki, Spencer Z. 
Rosero, James R Daubert, David T. Huang. University of Rochester. Rochester, NY 
Background: Oversensing complications in transvenous implantable cardioverter- 
defibrillators (ICD) can lead to inappropriate shocks in the absence of a life-threatening 
arrhythmia. Limited data exist on the incidence and risk factors of oversensing as an 
adverse event in ICD. 
Methods: We reviewed data on all patients who underwent transvenous ICD implant or 
revision from 1995 to 1999. Patients with lead dislodgment, epicardial lead, and follow-up 
of less than 4 weeks were excluded. Events of inappropriate shocks were reviewed and 
confirmed by 6 electrophysiologists. Variables were analyzed by Chi-square and t-tests 
with univariate and multivariate analyses. 
Results: 322 patients [148(46.0%) Guidant leads, 141(43.8%) Medtronic leads, and 
33(10.2%) St. Jude leads] were included in this study. Ventricular sensitivity was pro- 
grammed at nominal setting in all patients. During a mean follow-up of 23.4k17.0 months, 
15 (4.7%) patients experienced oversewing requiring lead revision. 13 integrated bipolar 
leads from Guidant failed at a median of 12 months after implantation and 2 true bipolar 
leads from Medtronic failed at a mean of 65 months after implantation. No St. Jude lead 
was associated with oversensing. No statistically significant difference in follow-up exists 
between the three lead manufacturers. Univariate analysis revealed Guidant leads (p = 
O.OOZ), integrated bipolar lead type (p = 0.019) abdominal implantation site (p < O.OOl), 
and Guidant generators (p < 0.001) to be associated with a significantly higher incidence 
of oversensing. Dual chamber pacing ICD, active fixation leads, subclavian access, and 
presence of atrial fibrillation at implantation were not related to a higher incidence of 
oversensing. In time dependent analysis based on univariate Kaplan-M&r curve, 
Guidant leads were associated with a higher incidence of oversensing (p = 0.008) but 
generator manufacturers were not. 
Conclusions: The overall incidence of ICD lead oversensing requiring intervention is 
low. However, integrated bipolar leads exhibited manufacturer-specific frequent and early 
oversensing at nominal sensitivtty settings. 
1029-127 Symptomatic Deterioration Postdual Chamber Cardioverter- 
Defibrillator Implantation: A Retrospective, Observational 
Study 
Stephen V. Pawa, Alejandro Perez-Lugones, Cathy Lam, Thomas Dresing, Christopher 
Cole, Miguel Abreu, Bruce L. Wilkoff, Walid Saliba, Mina Chung, Patrick Tchou, Mark 
Niebauer, Robert Schweikert, Andrea Natale. Cleveland Clinic Foundation, Cleveland, 
OH 
Background: Implantation of dual chamber implantable cardioverter-defibrillators (CDs) 
is more frequently employed. Anecdotal evidence exists that an exacerbation of symp- 
tomatic cardiac dysfunction may occur in certain patients with thus approach, presumably 
due to right ventricular apical pacing and associated dyssynchronous ventricular contrac- 
tion. Method: We analyzed post implant outcomes in 142 patients who under went dual 
chamber ICD implantation at a single institution. Information utilizing a questionnaire was 
obtained in 48 of these patients. Symptom deterioration and a need for an increase in 
heart failure medication in the 1st month post implant were evaluated. Results: Post 
implant, 27/48(56%) patients were paced in the right ventricle (RV) on resting 12 lead 
ECG, 12/48(25%) had a worsening in exertional symptoms and g/48(19%) required an 
increase in heart failure medication. A comparison of roost imulantation RV uaced and RV 
non-paced parameters are tabulated. 
Symptom Increased Preimplant Prelm- Preim- LVEF 
worsening medication normal QRS plant plant W) 
post implant post implant (~120 msec) RBBB LBBB/ 
lVCD 
RV paced 1 O/27 (37%)’ 5127 (19%) 14127 (41%) 6113 7113 30+/- 
(27148) (46%) (54%) 13 
FiV not paced Z/21 (9%) 4/21 (19%) l4/21 (67%) 2/7 517 32+/- 
(21/48) (29%) (71%) 13 
A significant worsening of symptoms post implant was noted in the RV paced patients 
compared to those not paced post implant (p<O.O02)*. In addition, 4 out of the total 142 
patients (2.8%) suffered a severe worsening of symptoms requiring hospitalization. This 
symptomatic deterioration was reversed after reprogramming the ICD to back-up VVI 
pacing mode to allow intrinsic QRS conduction. Conclusion: RV pacing in patients with 
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LV dysfunction may be deleterious. Despite this uncommon scenario, if an atrial lead is to 
be incorporated into the ICD system, post implant AV delay programming to allow intrin- 
sic QRS conduction, when possible, appears to be important. 
1029-128 Reduced Interelectrode Spacing improves Far Field 
Ventricular Electrogram Rejection in Chronic Canine Study 
Mark L. Brown, Rahul Mehra. Medtronic, Inc., Minneapolis, MN 
were EP physicians (81%). Almost half (47%) of the respondents indicated that the post 
shock evaluation was performed by an EP associated professional and not the EP physi- 
cian. 
Frequently Performed Activities Always Sometimes NWW 
Interrogate ICD and Review Data 99% 1% 0% 
Background: In dual chamber implantable pacemakers and defibrillators, inadequate 
discrimination between near field atrial electrogram (A-EGM) and far field ventricular 
electrogram (FF-VEGM) can lead to misdetection and inappropriate device operation. 
Shorter interelectrode spacing has been shown to reduce FF-VEGM amplitude while the 
near field atrial electrogram (A-EGM) is relatively unattenuated in acute human studies. 
The effect of lead maturation on A-EGM for closely spaced atrial electrodes has not been 
well studied. This canine study compared acute and chronic A-EGM and FF-VEGM 
amplitudes at two interelectrode spacings. 
Methods: A custom tripolar active fixation pace/sense lead with a fixed screw tip and two 
ring electrodes at 4 and 9.5 mm proximal to the tip was implanted in the right atrial 
appendage (RAA) of six canines. Pacing and sensing data were collected on the day of 
implant and again at 1,2, 3, 4, 8 and 12 weeks post-implant. The electrogram was band- 
pass filtered (0.5 Hz - 1 kHz) and peak to peak amplitude of A-EGMs and FF-VEGMs 
were measured. 
Evaluate Intracardiac Electrogra ms 99% 
Review Real-time Electrogram 90% 
U-Wave Measurement 77% 
Pacing Lead lmpedence 73% 
Physical Examination 56% 
Pacing Threshold Test 53% 
12 Lead ECG 25% 
Electrolyte Assessment 12% 
1% 
9% 
22% 
26% 
43% 
46% 
74% 
81% 
0% 
cl% 
cl% 
<l% 
<I% 
<l% 
cl% 
7% 
Conclusions: There is significant diversity in the extent of “routine” evaluation and in the 
medical personnel performing the evaluation after ICD shock. These results have impli- 
Cations re: cost and cost effecweness of activities pelfarmed at the time of post shock 
evaluation. Further study is required to define optimum evaluation strategy, maximize 
diagnostic yield and minimize cost. 
Results: The FF-VEGM was smaller at 4 mm interelectrode spacing than at 9.5 mm at 
all follow-ups and overall (1.3 & 0.7 mV vs 2.0 ? 1 .O mV, p < 0.05) and did not change 
significantly over time. The A-EGM amplitude was not significantly different between 4 
and 9.5 mm at any fOllowup or overall (4.3 + 2.2 mV vs 4.2 * 1.9 mV, p > 0.05), but the A- 
EGM at both spacings were significantly attenuated in the first week post-implant. The 
ratio of the A-EGM/FF-VEGM was significantly greater at 4 mm as compared to 9.5 mm 
(5.3 i 5.3 vs 2.9 * 2.0, p < 0.05). Pacing thresholds were not significantly different 
between 4 mm and 9.5 mm at any time. 
We& 
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1030-l 11 Effects of Hypoglycemia on Cardiac Autonomic Regulation 
in Type 1 Diabetes Mellitus 
FF-EGM 1.8+0.9m” 2.3 + 1 .o Ill” w+l.om” ,.7ilOnl” 1SiWrn” 
Conclusions: Chronic atrial leads with 4 mm interelectrode spacinq in canines reduce _ 
the amplitude of the FF-VEGM without compromising A-EGM. Such leads can result in 
improved atrial detection in implantable devices. 
1029-129 Improved Survival With Cardioverter-Defibrillator Therapy in 
Patients With Non lschemic Dilated Cardiomyopathy and 
Syncope 
Robert M. Sangrigoli, Alan Katz, Hope B. Helfeld, Steven A. Rothman. Temple University 
Philadelphia, PA 
Background: Patients (pts) with syn- 
cope and non ischemic dilated cardi- 
omyopathy (DCM) have a high 
mortality and are often treated with 
cardioverter-defibrillator (ICD) implan- 
tation. In ICD treated pts there is a 
high frequency of ICD shocks, but sur- 
viva1 benefit is unproven. The purpose 
of our study was to determine the all 
cause mortality in pts with DCM 
(EF<40%) and syncope who were 
treated with an ICD compared to simi- 
lar pts who were not treated with an 
ICD. Methods: The study group consisted of 61 consecutive pts with DCM and syncope. 
30 pts received ICDs (ICD group) and 31 pts did not receive ICDs (no ICD group). In the 
no ICD group, 8 pts received antiarrhythmic drug therapy, 5 pts received non pharmaco- 
logic therapy (ablation, pacemaker implantation), and 18 pts received no specific therapy, 
most refusing ICD therapy. Results: Mean follow-up was 30~28 months in the ICD group 
and 26+25 months in the no ICD group (p = NS). There was no statistically significant dif- 
ference with respect to age (54~13 vs 54+16 years) or ejection fraction (17+8% vs 
20*10%) between the ICD and no ICD groups, respectively. 17% of the pts in the ICD 
group were inducible at electrophysiologic study compared to 21% in the no ICD group 
(p=NS). Shown below are the Kaplan-Meir cumulative survival curves for the ICD and no 
ICD groups (p = 0.06 by Log Rank test). 
Conclusions: 1) ICD therapy provides long-term survival benefit in patients with dilated 
cardiomyopathy and syncope. 2) Early survival (~24 months), however, is unaffected by 
ICD implantation. 
1029-130 Standard of Care for Evaluation of Patients After 
Implantable Cardioverter Defibrillator Shocks 
Erica S. &do, Megan P. Deely, Andrea M. Russo, Ralph J. Verdino, Henry H. Hsia, 
Francis E. Marchlinski. University of Pennsylvania Health System, Philadelphia, Pfi 
Background: The standard of care for evaluation of patients after ICD shock has not 
been defined. Methods: We surveyed 957 electrophysiologistslpractices listed in the 
NASPE directory to attempt to identify activities performed routinely after ICD shock and 
to determine if EP physicians versus EP associated professionals performed post shock 
evaluation. Only survey questions that had a completion response rate of >90% from 
those surveys returned are noted. Results (Table): Of the 232 respondents, the majority 
Minna-Liisa Koivikko, Pasi I. Salmela, Juhani K. E. Airaksinen, Juha S. Tapanainen, Aimo 
Ruokonen, Heikki V. Huikuri. University of Oulu, Department of Internal Medicine, Oulu, 
Finland 
Background: There is evidence that hypoglycemia may cause various untoward cardiac 
events in both type 1 and type 2 diabetic patients. In particular, the role of hypoglycemia 
and its effect on cardiac autonomic regulation in the pathogen&s of the sudden over- 
night death of young diabetic patients with type 1 diabetes mellitus has been discussed. 
This investigation was designed to assess the effects of controlled hypoglycemia on tonic 
and reflex cardiovascular autonomic regulation. Methods: The study group consisted of 
16 (7 males, 9 females) non-obese, normotensive type 1 diabetic subjects (mean age 
32.4+9.0 years) with no evidence of autonomic dysfunction on conventional laboratory 
autonomic testing. The duration of diabetes varied from 1.9 to 29.0 years (mean 13.2r9.0 
years) and the glycemic control was fairly strict (mean HbAlc 6.91-0.9%). The hyperin- 
sulinemic glucose clamp techmque was used to produce gradual, controlled glucose 
decline from 5 mmolll to 2 mmolll. Heart rate variability (HRV) was measured from conti- 
nous ECG recordings by power spectral analysis method and baroreflex sensitivity (BRS) 
by phenylephrine test at three different glucose levels (4.5-5.5, 3.0-3.5 and 2.0-2.5 mmol/ 
I). Results: Controlled hypoglycemia resulted in a progressive reduction of the high-fre- 
quency (HF) spectral component of HRV, e.g (In)HF power 5.53+1.34 ms2 at the normal 
, 5.2&l .56 ms2 at the middle, and 4.77t1.32 ms2 at the lowest glucose level (p<O.O5). 
Reduction of HF spectral power was not related to age, glycemic control or duration of 
diabetes. A progressive increase of heart rate (HR) was also observed during the 
hypoglycemia (p<O.Oi). However, no consistent changes were observed in the BRS dur- 
ing the various glucose levels. Conclusions: Hypoglycemia in type 1 diabetic patients 
results in a reduction of tonic cardiac wage.1 outflow but no prominent changes occur in 
reflex autonomic regulation. Reduced vagal outflow may have importance as a trigger of 
cardiac events caused by hypoglycemia. 
1030-I 12 Circadian Variation in Human Atrlal and Ventricular 
Refractoriness. Relation to Autonomic Nervous System 
Activity 
Emmanouel N. Simantirakis, Stavros I. Chrysostomakis, Maria E. Marketou, George E. 
Kochiadakis, Konstantinos E. Vardakis, Hercules E. Mavrakis, Panes E. Vardas. 
Cardiology Department, Heraklion University Hospital, Her&/ion, Greece 
Background: The aim of this study was to examine if there is circadian variation in atria 
and ventricular refractory periods and if this is related with the 24.hour fluctuations of the 
autonomic nervous system in chronically paced patients. 
Methods: We studied 24 patients aged 67.159.6 years. Eleven of them had been paced 
for complete heart block and 13 for sick sinus syndrome. The atrial and ventricular effec- 
tive refractory periods were measured bihourly, over a 24-hour period, by means of the 
pacemaker programming capabilities, using basic cycle lengths of 600ms and 500ms. 
During the same time period we evaluated the autonomic nervous system activity in 
patients paced for complete heart block, as expressed by spectral power indexes of heart 
rate variability. 
Results: Atrial and ventricular effective refractory periods showed significant circadian 
variation in both basic cycle lengths and the highest values of both occurred between 
2200 and 06:OO whereas diurnal values were clearly lower. Although the circadian pat- 
tern of both subgroups was the same, the nocturnal values of ventricular effective refrac- 
tory periods were significantly higher in the patients with complete heart block than in 
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those with sick sinus syndrome (p c 0.05), in witch, the diurnal values of atriai effective 
refractory periods were significantly higher (p < 0.05). We also found a significant nega- 
tive correlation between the atrial and ventricular effective refractory periods, at both 
basic cycle lengths, and the low to high frequency ratio in the subgroup of patients with 
complete heart block (pcO.01 and r<-0.8, for all correlations). 
Conclusion: Atrial and ventricular effective refractory period in chronically dual chamber 
paced patients have a significant circadian variation that is strongly correlated with the 
night to daytime variations in autonomic nervous system activity. During certain periods 
of the 24.hour observation, the atrial and ventricular effective refractory periods of the 
patients with sick sinus syndrome differed significantly from those of the patients with 
complete heart block. 
1030-131 Human Atrial Muscarinic Potassium Current is Inhibited by 
Sphingosine 
Bodo Brandts, Frank Tuettelmann, Marc van Bracht, Lutz Pott. Hans-Joachim Trappe. 
Dep. of Cardio/ogy and Angiology, University of Sochum, Herne, Germany 
Background: Sphingosine-l-phosphate (SPP) has been described to exert regulative 
actions on cardiac electrophysiology and to be a C&+-mobilizing second messenger in 
different cell lines. Some actions can be mimicked by sphingosine (Sp) which is sup- 
posed to be converted by an intracellular Sp-kinase to SPP. Method: We used the whole 
cell voltage calmp technique in human atrial myocytes. Results: we found Sp in concen- 
trations ziOnM to inhibit muscarinic potassium current (IK(ACh)) measured by using the 
whole-cell voltage clamp method. The same effect was observed with t-dihydro-sphin- 
gosine (T-d-Sp) a putative Sp-kinase inhibitor. InhibItion was independent of the Gi-cou- 
pled receptor by which the system had been activated (Al-. M2-receptor). Receptor 
independent basal and GTP-g-S stimulated IK(ACh) were also inhibited by the two sphln- 
gollpids, suggesting Inhibition being active after GDPiGTP exchange occured (fig: 
Pipette solution containing 5OpM GTP-g-S. EK=-5OmV: Eh=-9OmV). Ventricular IKI was 
not affected by the compounds (10yM). This excludes an unspecific block of K+-channels 
as underlying mechanism. The PKC inhibitor H7 did not antagonise the Sp effect indicat- 
ing that PKC activation due to Sp Is not involved in IK(ACh) inhibition. Conclusions: The 
physiological role of these observations remains unclear. Sp is the most frequent basic 
component of sphingollpids in mammalian membranes. Release of Sp from dying cells 
(e.g. during ischemia), and a subsequent suppression of IK(ACh) may be an arrhyth- 
mogeniclantiarrhythmic mechanism in human supraventncular tissue. 
IOOnMSp 
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1060-I 14 Early Onset of Qf Interval Prolongation and IKr 
Downregulation in Rabbits With Compensated Complete 
Heart Block 
Fumiaki Suto, Sean A. Cahill, llana Greenwald, Gil J. Gross. Hospital for Sick Children, 
Toronto, ON, Canada 
Background: Ventricular repolarization delay, evidenced by ECG QT interval prolonga- 
tion, is associated with complete heart block (CHB), and can trigger tachydysrhythmias 
such as tom&s de potntes. Ventricular repolarization changes, including QT prolonga- 
tion and downregulation of outward K+ currents, have been noted several weeks after 
chemical CHB induction in a canine surgical model. Methods: CHB was induced in New 
Zealand White rabbits (3.0-3.5 kg) by transcatheter radiofrequency AV node ablation, 
and the resulting ventricular bradycardia was partially compensated with permanent 
endocardial ventricular pacing at 140imin. QT intervals were measured on &lead surface 
ECG recordings obtained under anesthesia on post-ablation day 0, and again on day 8 or 
15. Ventricular myocytes were enzymatically isolated for whole cell patch clamp study on 
day 8 or 15. Rapidly activating delayed rectifier current (IKr) was defined as E-4031 sensi- 
tive and chromanol 2938 insensitive outward tail current elicited by repolarization to -30 
mV after 3 s depolarizing voltage steps. Results: ECG QT intervals at a constant paced 
ventricular rate of ldO/min showed significant prolongation relative to baseline (Z&8 
ms, mean&E; n=5) at both day 8 (257*4 ms, pcO.05 vs baseline; n=3) and day 15 
(302+18 ms, pcO.001 vs baseline; n=Z). Left ventricular IKr tail current density was 
already markedly reduced at post-ablation day 8 vs control (0.79-cO.09 vs 1.38+0.13 pA/ 
pF, ~~0.05; n=15 for each group). Conclusion: Progressive QT interval prolongation is 
apparent as early as 8 days post-induction of CHf3 by transcatheter radiofrequency AV 
node ablation in rabbits, and is likely due, at least in part, to a marked early reduction in 
left ventricular myocyte IKp 
1030-132 No Single Formula for Heart Rate Correction of the QT 
Interval is Suitable for All Individuals 
Velislav N. Batchvarov. Patrik F&born, Polychronis Dilaveris, A John Camm, Marek Malik. 
St George’s Hospital Medical School, London, Unifed Kingdom 
Background: All formulae for heart rate-correc- 
tion of the QT interval are based on the assump- *= 
tion that the QT/RR relation is the same in all a= . m.. ..‘& 
individuals. This has never been proven. Meth- f”* 
LlmIIl 
.’ .C .; :: :y.* : 
ods: Twenty-four hour 12.lead digital EGGS (one i “’ ’ .‘_. . 
.&.:*: . 
. 
10-s ECG every 2 min, 250 Hz, 12 bit A/D, SEER 1:~ 
MC, Marquette GE) were recorded in 49 healthy ~1 o= 01 .;L =a *a 01 
subjects (25 men, 34ilO years). The QT interval 
was measured automatically (downslope inflex 
tangent method, QT Guard, Marquette). The maxmum QT/RR relation was best-fitted by 
a power model (QT=P(RR)q and the slope (p) and the curvature (r) were estimated indl- 
vidually in each subject on the basis of the 24.hour QTiAR series. Results: The slope (p) 
(range 0.37-0.45, mean+SD 0.41+0.02) and the curvature (7) (0.22-0.48, 0.35kO.065) of 
the QTIRR relationship varied substantially between different subjects. Conclusion: The 
QTIRR relationship varies between individuals. Instead of using single formula this rela- 
tionship should be estimated individually in each subject on the basis of continuous ECG 
recordings. 
1060-I 15 Mechanism and Arrhythmogenicity of Discordant QTlT 
Alternans 
Masaomi Chinushi, Dmitry 0. Kozhevnikov, Edward B. Caref, Mark Restive, Nabil El- 
Sherif. VA NY Harbor Health Care System, Brooklyn, NI: Nigata Medical School, Nigata, 
Japan 
Background: We have recently shown that concordant (C) QTR alternans (A) induced 
by abrupt decrease of paced (P) cycle length (CL) in canine Anthopleurin-A model of 
LQT3 is associated with increased dispersion of repolarization (DR) between epicardium 
(E) and mid-myocardium (M) calculated as activation-recovery intervals (ARI) (Circ Res, 
1998). CA was induced by abrupt shortening of cycle length (CL), resulting in C short- 
long (S-L) sequence of ARI at both E and M (Fig A). 
Methods: We investigated the mechanism of discordant (D) A in the same model by 
stepwise decrease of CL (Fig 6). 
Results: DA developed when ARI at E shortened progressively in 2 or more consecutive 
cycles before beginning a S-L sequence. The shorter diastolic interval (DI) preceding P1 
in Fig A resulted in a grater abbreviation of ARI at E and M. The longer DI that followed 
perpetuated C-L-S sequence. In Fig 6, a longer DI preceding PI resulted in less shorten- 
ing of ARI at E and M. The following DI preceding P, was relatively short, compared to 
Fig A and compared with the difference in restitution kinetics between E and M (longer 
AARI at M). This resulted in further shortening of ARI at E but lengthening at M, thus initi- 
ating DA. In 5 dogs, both CA and DA could be induced. ARI dispersion and reentrant 
rhythms were greater during DA (~~0.01) 
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Conclusions: Gradual “physiologic” shortening of cycle length induces discordant alter- 1060-l 18 A Novel Index of Ventricular Repolarization Predicts 
nans with greater dispersion of repolarization and more arrhythmogenic potential. Initiation of Torsade de Pointes 
T. David Gbadebo, Robert W. Trimble, Dan M. Roden, Mark E. Anderson. Vanderbilt 
University Medical Center, Nashville, TN 
Epi 
Background: Ca*+ and calmodulin-dependent (CaM).cellular signaling is linked to after- 
depolarizations that are important for initiation of Torsade de Pointes (TdP). Previous 
studies showed that initiation of TdP is prevented by the CaM inhibitor W-7. TdP is also 
thought to be generated by dispersion of repolarization that underlies functional reentry 
circuits. We therefore studied the effects of W-7 on repolarization indices. 
Methods: W-7 (50 umolelkglmin) or vehicle control was administered to rabbits treated 
with methoxamine (70 nmolelkgimin) and clofilium (100 nmole/kg/min), an established 
model model of TdP. 
1060-116 Mechanism of Enhanced Susceptibility of Hypertrophied 
Heart to Acquired Torsade de Pointes Arrhythmias 
Keiji Yamamoto, Dmitry 0. Kozhevnikov, Dionyssios Robotis, Mark Restive, Nabil El- 
Sherif. VA NY Harbor Healthacre System. Brooklyn, NK SUNY Health Science Center, 
Brookfyn, NY 
Results: W-7 significantly reduced TdP induction @=3/i 1) compared to vehicle-treated 
controls (n=l2/14, p=O.O05). Two indices of repofarization were evaluated: QT interval 
dispersion (QTd) and the U wave to T wave amplitude ratio (UTAr). QTd was not predic- 
tive of TdP initiation or suppression, because QTd increased significantly, but equally in 
both control and W-7 treated animals. In contrast, UTAr, a unitless metric, increased sig- 
nificantly immediately preceding TcfP onset (0.65t.019 at baseline to 2.10+0.56 prior to 
TdP, ~~0.05) in control animals, while a U wave was absent in 9/l 1 W-7 treated animals. 
Conclusions: These findings indicate that UTAr, but not QTd, may be an important index 
of disordered repolarization for predicting TdP onset. Ca”+ and &M-dependent signal- 
ing appears to modulate changes in cardiac repolarization that favor TdP 
Background: Previous reports have shown increased susceptibility of hypertrophied 
heart to class III drugs-induced Torsade de Pointes (TdP). However, the in viva electro- 
physiologic mechanism of the arrhythmia has not been investigated in detail. 
Methods: We compared susceptibility to TdP by the class Ill drug, dofetilide (D) (3,10, 
and 30 pg/kg) in control dogs (C) and in dogs 6 weeks following induction of complete AV 
block (AVB) that results in ventricular hypertrophy, which was verified by echocardio- 
graphy. Tridimensional activation/repolarization patterns were simultaneously analyzed 
from 256 unipolar extracellular electrograms. Repolarization was measured from activa- 
tion-recovery intervals (ARI). 
Results: None of C dogs developed TdP at 30mg/kg, while 5/5 dogs with AVB developed 
TdP at a dose of 3 pg/kg (n=2) or 10 pg/kg (n=3). TdP was due to subendocardial focal 
activity that infringed on transmural dispersion of repolarization (TDR) primarily between 
epicardial (Epi) and mid-myocardiat leff ventricular zones resulting in functional conduc- 
tion block and reentrant arrhythmia. Analysis of mean ARI and TDR at a cycle length of 
1000 ms is shown in the table and revealed: 1) baseline ARI and TDR were significantly 
higher in AVB vs. C (P<.Ol). 2) the increase in mean ARI and TDR following D was signif- 
icantly higher in AVB vs. C (P<.Ol). 
ARI Baseline WWW D(lOmg/kg) D(30mgIkg) 
CCln- End/Mid 260*3 278~4 306+5 3llr6 
trol 
(nei) Epi 255+3 27324 298r5 303+6 
TDR 18.5+1.1 lr3.1+1.1 25.1+1.8 24.&f .7 
AVB End/Mid 318+6* 372&” 395*10*, 416&g** 
(n=5) Epi 306*6* 357*6** 372+10** 39Ocl o** 
TDR 30.9+3.3 37.1*3** 42.4*4.4** 54.1+5.3’* 
* PcO.05 ** P<O.Ol 
Conclusions: Enhanced susceptibility of hypertrophied heart to class Ill drugs is due to 
baseline increase of TDR and a greater dose-related increase of TDR compared to non- 
hypertrophied heart which provides the substrate for TdP. 
1060-l 17 The Role of Structural Complexities of the Septal Tissue in 
Maintaining Ventricular Fibrillation in Isolated, Perfused 
Canine Ventricle 
Takanori Ikeda, Kazuo Nakazawa, Ayaka Kawase, Takashi Ashihars., Tsunetotyo Namba, 
Kaoru Sugi, Tetsu Yamaguchi. Toho University Ohashi Hospital, Tokyo, Japan, National 
Cardiovascular Center, Suita, Japan 
Introduction: It is unclear how the patterns of wavelet propagation during ventricular fibril- 
lation (VF) vary between structurally different tissues. We hypothesized that the structural 
complexities of the septal tissue influence the maintenance of reentrant wavelets in the 
ventricle. Methods: Endocardial activation patterns during VF ware analyzed in the iso- 
lated, perfused canine right ventricular (RV) free wall (n=9), interventricular septum 
(n=5), and leff ventricular (LV) free wall (n=6) using a computerized mapping system (2. 
mm resolution) with 120-ms consecutive windows. Each tissue sample was cut progres- 
sively to reduce the tissue mass until the VF was terminated. Results: More wavelets 
were seen in the septa than in the RV and LV free walls at baseline (P=O.O04), and VF in 
the septa displayed a shorter cycle length than in the RV and LV free walls (P=O.O17). As 
the tissue mass decreased, VF became successively more organized in all regions: the 
number of wavelets decreased and the cycle length of VF lengthened. Single and “figure- 
eight” stationary, reentrant wavelets were often mapped after tissue mass reduction in 
the RV free walls and rarely in the LV free walls, but they were not observed in the septa. 
Less critical mass was required to maintain VF in the septa than ;n the RV and LV free 
walls (P=O.OOOS). Gross anatomic and histologic examinations indicated that the tissue 
structure of the septa is more complex than that of the RV and LV free walls. Conclusion: 
VF activation patterns with progressive reduction of tissue mass differ for the septum and 
the ventricular free walls. The structural complexities of the septal tissue influence the 
maintenance of fibrillation in the ventricle. 
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1061-119 Amiodarone Versus a Beta Blocker to Prevent Atrial 
Fibrillation Following Cardiovascular Surgery 
Allen J. Solomon, Michael 0. Greenberg, Michael J. Kilborn, Nevin M. Katz. Georgefown 
University Hospital, Washington, DC 
Background: Both amiodarone and beta blockers have been shown to decrease the 
incidence of atrial fibrillation (AF) following cardiovascular surgery. However, the superior 
agent has not been identified. Methods: Following cardiac surgery, patients were ran- 
domized to amiodarone (1 gmlday IV X 48 hours, then 400 mg po QD until discharge) or 
to propranolol (1 mg IV q 6 hours X 48 hours, then 20 mg po QID until discharge). AF 
was defined as lasting longer than one hour or for any length of time requiring treatment. 
Results: We evaluated 102 patients (68 men, mean age = 65 * 10 years, mean LVEF = 
0.53 + 0.12) undergoing cardiovascular surgery (93 CABG, 5 valve surgery, and 4 CABG 
+ valve surgery). Patients were well matched in each group. The incidence of postopera- 
tive AF was 16.0 % (E/50) in the amiodarone group and 32.7% (17/52) in the propranolol 
group (p=O.O5). When AF did occur, its duration was longer in amiodarone-treated 
patients compared to propranolol-treated patients. As a result, the mean length of hospi- 
tal stay was 8.8 c 3.5 days in amiodarone-treated patients and 8.4 t 2.7 days in propra- 
nolol-treated patients (p=NS). Adverse events were uncommon and similar in each 
group. Conclusion: Early intravenous amiodarone, followed by oral amiodarone, 
reduces the incidence of postoperative AF compared to propranolol. However, this reduc- 
tion in incidence did not result in a reduction in the length of hospitalization. Further stud- 
ies will be needed to assess the cost effectiveness of this strategy. 
1061-120 Prevention and Reversal of Electrical Remodeling in Atrial ___. 
Fibrillation by TH1177, a Novel Calcium Channel Antagonist 
Joseph G. Akar, Thomas H. Everett, IV, Lai Chow Kok, Timothy Macdonald, Gabor 
Szabo, David E. Haines. University of Virginia Health Sciences Center, Chadottesville, 
VA 
Background: Prevention of electrical remodeling in atrial fibrillation (AF) remains chal- 
lenging. While L-type calcium channel antagonists prevent remodeling in short duration 
AF, they seam ineffective in the long term. However T-type calcium channel antagonists 
seem to be effective in longer periods of AF. We have synthesized a novel calcium chan- 
nel antagonist, TH1177, which has both T- and L-type channel blocking activity. We 
hypothesized that this agent may be effective in preventing electrical remodeling. 
Methods: AF was induced via rapid atrial pacing in 11 dogs. Six dogs received THl177 
(study group) while 5 served as controls. THl177was administered as a 50mg slow IV 
bolus followed by 1OOmg IM. The dogs were paced for 8 hours. Right and left AF cycle 
lengths (AFCL) were measured at baseline, 5 minutes post IV bolus, and then every 
hour. Atrial effective refractory periods (ERP) were measured at baseline then every two 
hours in 5 sites: anterior RA, posterior RA, RA appendage, anterior LA, and posterior LA. 
ERP’s were measured after drive CCs of 350, 300, and 250ms. 
Results: In the control group, ERP’s were significantly shorter at the 5 different sites after 
8 hours of pacing compared to baseline. Average RA ERP’s decreased from 116.7 to 
101.6 ms (p<O.O03) and average LA ERP’s decreased from 129.5 to 106.1 ms (~~0.004). 
In the study group, all RA and LA ERP’s were either unchanged or increased after pac- 
ing. Average RA ERP’s increased from 104.5 to 113.5 ms (p=O.O5) and average LA 
ERP’s increased from 102.2 to 109.1 ms (~~0.04). Baseline RA and LA AFCL were simi- 
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lar in both groups. Study group RA and LA AFCL significantly increased immediately 
after the IV injection of TH1177 (122.2 to 162.8 ms, p=O.O5 and 126.1 to 154.2 ms, 
p=O.O3). After pacing, RA and LA AFCL were not significantly different than baseline in 
either group. However after pacing, study group RA and LA AFCL ((136.5 and 127.6 ms) 
were significantly higher than control (111.3 and 111.6) (p<O.O3). 
Conclusion: TH1177 is a novel calcium antagonist that prevents electrical remodeling in 
AF. It also increases atrial refractoriness thus potentially preventing further arrhythmia 
propagation. 
Beta-blockers can be safely used in pts receiving amiodarone for maintenance of sinus 
rhythm after AF cardioversion; concomitant use of beta-blockers and amiodarone has no 
synergistic effect in prevention of recurrence of AF. 
Number of pts 
Adverse effects causing discontinuation of therapy 
Bradyarrhythmias causing discontinuation of therapy 
Symptomatic bradycardia 
Group 1 Group 2 P value 
34 162 - 
26.5% 33.3% 0.43 
2.9% 4.3% 0.70 
2.9% 2.5% 0.87 
1061-121 The Efficacy of Multimodal Therapy With Pacing, 
Cardioverson and Amiodarone to Maintain Sinus Rhythm in 
Patients With “Chronic” Atrial Fibrillation and Congestive 
Heart Failure 
Scott R. Kirby, Florin T. Degeratu, Eric J. Rashba, Siephen I?. Shorcfsky, Robert W. 
Peters, Michael R. Gold. Universify ofMwy/and, Baltimore, MD 
1061-124 Frequency of Symptomatic Recurrence of Atrial Fibrillation 
After Successful Electrical Cardioversion of Atrial 
Fibrillation in Patients Treated With Metoprolol in 
Comparison to Sotalol 
Background: Atrial fibrillation (AF) is an independent predictor of mortality in patients 
(pts) with left ventricular systolic dysfunction and congestive heart failure (CHF). Unfcrtu- 
nately, the treatment of AF is difficult in this population, because of the low efficacy and 
proarrhythmia associated with drug therapy. We hypothesized that an aggressive, multi- 
modal approach of internal cardioversion, amicdarone, and dual chamber pacing would 
help maintain sinus rhythm. 
Methods: This prospective study included 19 consecutive pts with life-threatening ven- 
tricular arrhythmias, AF, CHF and planned defibrillator (ICD) implantation. All patients 
were previously diagnosed with “chronic” atrial fibrillation, due to failed attempts at car- 
dioversion or early recurrence of AF. At the time of evaluation, internal or external cardio- 
version was performed, and if sinus rhythm was maintained for at least 24 hours, a dual 
chamber ICD was implanted and amiodarone therapy was initiated (Sinus Rhythm 
Group). Otherwise, a single chamber ICD was used (AF Group). 
Results: Cardicversion was successful in 15 patients (79%). The Sinus Rhythm Group 
had a mean age of 69f9 years and ejection fraction of 24+8%. The AF duration in this 
cohort prior to cardioversion was 38t47months and the left atrial size was 5.0i0.5cm. 
All surviving pts are currently in sinus rhythm with an average follow-up of 286 days, 
although 2 required repeat cardioversion. CHFfunctional status improved in sinus rhythm 
(NYHA class 2.8+0.4 to 2.2r0.4, p&01). Mortality at 6 months was 25% in the sinus 
rhythm group and 100% in the AF group (~~0.05). 
Conclusions: The presence ‘of CHF, AF and ventricular arrhythmias identifies a high 
mortality group despite ICD implantdion.This multimodal approach is successful, despite 
poor clinical predictors for sustaining sinus rhythm, and may improve functional status 
and reduce mortality. 
Frank Fischer, Harald Schwacke, Monika Rameken, Margit Vater, Karlheinz Seidl. 
Herzentrum Ludwigshafen, Ludwigshafen, Germany 
Background: Little is known about frequency of symptomatic recurrence of atrial fibrilla- 
tion (AF) in patients treated with metoprclol after successful electrical cardioversion of 
persistent AF. 
Methods: Between 01/97 and 07199, 178 consecutive patients (pts) with first episode of 
AF of our atrial fibrillation registry ware treated with metcprolol (84 pts) or sotalol (94 pts) 
as long term therapy after successful electrical cardioversion (CV). 
Follow-up was performed at median of 8 months (5,12) for symptomatic recurrence of AF. 
RfSUltS: 
1061-122 Reproducible Efficacy of Loading Oral Propafenone to 
Restore Sinus Rhythm in Paroxysmal Atrial Fibrillation 
Metoprclol Sotalol p-value 
Age [mean i SD] (years) 64ill 64k9 ns 
Men (%) 73 80 “s 
Left atrial diamter [mean f SD] (mm) 47 + 4.7 45+5.1 ns 
Duration of AF [mean f SD] (hours) 32+69 45+96 ns 
No organic heart disease (%) 50 44 ns 
During follow up of 8 months 36 of 84 pts (43 %) treated with metoprolol and 58 of 94 pts 
(62 %) with sctalol suffered from symptomatic recurrence of AF. In a multivariate analy- 
sis pts treated with metoprolol had a significant better outcome than pts with sotalol in 
maintaining sinus rhythm [OR = 2.1 (95 % Cl 1.1 - 4.1), adjusted for age > 70 years, gen- 
der, left atrial diameter > 45 mm, duration of AF and organic heart disease. 
Conclusion: During follow up of 8 months patients treated with metoprolol had a better 
outcome than pts with sotalol in maintaining sinus rhythm after successful electrical car- 
dioversion of atrial fibrillation. About 60 % of patients treated with metoprolol were free of 
symptomatic recurrence of atrial fibrillation. 
Alessandro Capucci, Natale Marrazzo, Giovanni Quinto Villani, Alessandrc Rosi. 
Department of Cardiology CJspedale Civiie di Piacenza, Piacenza, /tab POSTER SESSION 
Background: Safety and efficacy of oral loading dose of propafenone in converting par- 
oxysmal atrial fibrillation of recent onset 1’1 patients without left ventricular dysfunction 
has been demonstrated. Aim of this study was to outline the reproducibility of this favcur- 
able effect in the same patient over the time. Methods: 212 patients with paroxysmal 
atrial fibrillation of recent onset successfully in-hospital treated with a single oral loading 
dose of prcpafenone (600 mg cr 450 mg in patients c 70 Kg, respectively) were followed- 
up for at least one year. 62 of them (41 males and 21 females) had at least one other epi- 
sode of paroxysmal atrial fibrillation and were treated again with the Same pharmacologi- 
cal scheme in order to restore sinus rhythm. Results: Mean age was 61+/-13 years, 
mean follow-up period was 15+/-7 months: 27 had hypertension, 6 coronary artery dis- 
ease, 7 valvulopathy and 22 had ‘lone” atrial fibrillation. 87 episodes of paroxysmal atrial 
fibrillation were treated; time from the onset of symptoms was 3.2+/-2.7 hours; 81 (93%) 
converted to sinus rhythm within 2.8+/-2.2 hours. No new side effects nor proarrhythmic 
events were recorded. Conclusion: An oral loading dose of propafenone for paroxysmal 
atria! fibrillation of recent onset treatment has a reproducible efficacy over the time in the 
same patient, so that a self-treatment strategy can be advised for recurrences of parox- 
ysmal atrial fibrillation in the patients in which safety, efficacy and reproducibility of the 
effect have already been established in-hospital. 
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1062-125 Assessment of Ventricular Rate in Patients With Chronic 
Atrial Fibrillation 
Kristina Wasmer, Hakan Oral, Christian Sticherling, Steven P. Chough, Robert L. Baker, 
Hiroshi Tada, Frank Pelosi, Jr., Bradley P. Knight, S. Adam Strickberger, Fred Morady. 
University of Michigan, Ann Arbor, MI 
1061-123 Safety and Efficacy of Concomitant Use of Amiodarone and 
Beta-Blockers in Patients with Atrial Fibrillation 
Justyna Watkowska, Mario Talajic, Denis Roy, Marc Dubuc, Bernard Thibault, Peter 
Guerra. Montreal Heart Inslifute, Montrea/, PQ, Canada 
Sackground: The Canadian Trial of Atrial Fibrillation (CTAF) found amiodarcne to be 
superior to sctalol or propafenone in preventing atrial fibrillation (AF) recurrence. Fre- 
quently, pts receiving amiodarone require beta-blockers for preexisting cardiovascular 
disease. The purpose of this study was to determine the safety and efficacy of CCnCOmi- 
tant use of amiodarcne and beta-blockers. Methods: Using the CTAF database, 2 
groups of pts were analyzed: Group 1; 34 pts receiving amiodarone and beta-blockers 
and Group 2; 162 pts receiving amiodarcne only. Both groups were matched with respect 
tc age, gender, duration of AF, noncardiovascular diseases and use of other medications. 
Prevalence of cardiovascular disease, ischemic heart disease and systemic hypertension 
were significantly higher in group 1 (88.2% YS 60.5%, p=O.OOZ; 41.2% vs 16.7%, 
p=O.O014; 76.5% vs 37.7%, p<O.OOOl respectively). Results: There were no StatiStiCally 
significant differences in serious adverse effects between the 2 groups. Kaplan-Meler 
survival analysis of ftrst recurrence of AF in 1st year showed no statistical difference 
between the 2 groups (sinus rhythm maintenance 71% vs 70%, p=O.92). ConclUsiOn: 
Background: Control of the ventricular(V) rate in patients with chronic atrial fibrillation is 
usually assessed with a 24-hour Halter monitor. The purpose of this study was to deter- 
mine whether simple maneuvers performed during a clinic visit can be used to predict the 
V rate during activities of daily life in patients with chronic atrial fibrillation. Methods: In 
12 men and 6 women with chronic atrial fibrillation (mean age*SD=61+14, left VentriCUlar 
ejection fraction=0.52+0.06), V rate was determined after 5 minutes of rest, after walking 
50 yards, and after stair-stepping for 1 minute during a clinic visit. Each patient also had a 
Halter monitor for 24 hours within 3 days of the clinic visit, with no changes in medica- 
tions. Minimum, mean and average hourly maximum V rates during 24 hours were deter- 
mined from the Halter recordings. Results: V rate at rest during the clinic visit, 81*18 
bpm, was significantly less than the average Helter V rate, 92rt17 bpm (~~0.01). How- 
ever, the mean of the V rates at rest and after a 50-yrd walk, 93*17 bpm, was similar to 
the average V rate recorded from a 24 hour Halter monitor, 92+17 bpm (p=O.B). Minimum 
V rate recorded from the Halter monitor, 59*17 bpm, was very similar to the V rate at rest 
during the clinic visit minus 20 bpm, 60*17 bpm (peO.7). V rate after l-minute stair-step- 
ping, 123*17 bpm, was similar to the average maximum V rate recorded from the Halter 
monitor, 118~t28 bpm (~~0.5). Conclusions: In patients with chronic atrial fibrillation, V 
rate control during activities of daily life can be accurately assessed with simple clinical 
maneuvers. Mean of V rates at rest and a 50.yrd walk can accurately predict average 
daily V rate; V rate at rest minus 20 bpm reflects minimum daily V rate whereas V rate 
after 1 -minute stair-stepping is vary similar to the average maximum daily V rate. 
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1062-126 Ectopic Beats Originating in the Superior Vena Cava in 
Patients with History of Atrial fibrillation 
Walid Saliba, Stephen Pavia, Mina K. Chung, Patrick Tchou, Lon Castle, Cathy Lam, 
Mark Niebauer, Logan Kanagaratnam, Robert Schweikert, Bruce Wilkoff, Alejandro 
Perez-Lugones, Andrea Natale. Cleveland Clinic Foundation, Cleveland 
Ectopic activity in the superior vena cava as a possible triggering mechanism of atrial 
fibrillation has been recently described. We report our experience in 30 consecutive 
patients undergoing catheter ablation for atrial fibrillation and showing multiple spontane- 
ous initiation of atrial fibrillation during the procedure. All patients had multiple spontane- 
ous initiation and termination of atrial fibrillation during the procedure allowing mapping. 
Initial mapping was performed using floating electrodes in the superior vena cava, right 
atrium, and coronary sinus combined with a transesophageal recording. More detailed 
mapping was subsequently achieved by placement of multielectrode catheters either in 
the pulmonary vein or superior vena cava. Ablation was performed using a nonfluoro- 
scopic mapping system. Twenty-eight of the 30 patients included in this series showed 
evidence of muscle sleeves in the superior vena cava extending 1 to 4 cm from the junc- 
tion with the right atrium. Premature atrial contractions originating in the superior vena 
cava were observed in xv?.” of the 30 patients (23%). However, only in one patient atrial 
fibrillation appeared to originate from the superior vena cava (3%). In the remaining six 
patients, isolated premature atrial contractions were s?en in four of them and atrial tachy- 
cardia with a rate of 145 and 150 beats per minute was seen in the remaining two 
patients. In six of the seven patients showing activity from the superior vena cava, atrial 
fibrillation consistently originated from one of the pulmonary vein. Ablation in the superior 
vt?na cava at the site of early activation was performed in all patients with suppression of 
the local activity. The patients initially showing atrial fibrillation from the superior vena 
cava experienced recurrence of tachypalpitation but appeared to have evidence of inap- 
propriate sinus tachycardia when restudied in the electrophysiology laboratory. In conclu- 
sion, isolated initiation of atrial fibrillation from the superior vena cava appears a rare 
finding. However, ectopic beats and atriai tachycardia are more frequently observed. 
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p<O.OOl). PVA correlates with atrial ejection force in both group of patients. Systolic and 
diastolic flows of PV were increased after cardioversion in both group of pts. Conclu- 
sions. We observed that a depressed atrial mechanical function after cardioversion is 
associated with a persistent LA dilatation, and is more frequent after DC shock. 
1062-127 Immediate Hemodynamic Effects of Sinus Rhythm 
Restoration by Internal Cardioversion in Chronic Persistent 
Atrial Fibrillation 
Giuseppe Boriani, M. Biffi, P. Mancuso, L. Bacchi, C. Martignani, C. Rapezzi, R. Zannoli, 
A. Branzi. hstifub of Cardiology - University of Bologna, Bologna, Italy 
The aim of this study was to assess the hemodynamic effects of sinus rhythm (SR) resto- 
ration by transvenous internal atria cardioversion (CV) in chronic persistent atrial fibrilla- 
tion (AF). Fifty patients with chronic persistent AF (mean arrhythmia duration= 8.9k9.0 
month?., range i-48) were enrolled and in 12 of them no underlying structural heart dis- 
ease (HD) was detectable. Internal CV was performed after a wash out from antiarrhyth- 
mic drugs. Before CV and 15 min following restoration of stable SR, hemodynamic 
parameters were obtained using a Swan-Ganz thermodilution catheter. Results: SR was 
restored by internal CV in all the patients, with a mean delivered energy of 5.8+3.2 joule 
(range 1.2-15.7). In patients with strudtural HD (n=38) restoration of SR was associated 
to a significant reduction in heart rate (HR) (from 92+19 to 72+14 bpm, p<O.OOl), to a 
significant increase in cardiac index (Cl)(from 2.09+0.51 to 2.2220.55 l/ml m2, ~~0.03) 
and to a significant increase in stroke work index (SWI) (from 24+10 to 32+12 g.m/ m2, 
p<O.OOl), with a reduction in pulmonary capillary wedge pressure (PCWP) of borderline 
significance. In patients without structural HD (n=12) restoration of SR was associated to 
a significant reduction in HR (from 103&23 to 74+9 bpm, pcO.005) and to a significant 
increase in SWI (from 27r8 to 36+9 g.mlm2, ~~0.02); no significant changes occurred in 
Cl (from 2.42+0.48 to 2.43t0.45 I/m/ m2, n.s.) and PCWP In conclusion, restoration of 
SR in patients with chronic persistent AF results in an immediate improvement of systolic 
function in patients with structural heart disease. In patients without structural heart dis- 
ease this improvement is less evident. 
1062-128 Left Atrial Size and Function After Conversion from Atrial 
Fibrillation: An Echo-Doppler Study of Transmitral and 
Pulmonary Vein Flows 
Anna Vittoria Mattioli, Stefania Sansoni, Silvia Bonatti, Giorgio Mattioli. University Of 
Modena and Reggio Emilia, MODENA. k/y 
Background. Atrial fibrillation (AF) impaired left atriai (LA) function and anatomy. The 
present study compared changes in LA size after cardioversion, and the relation between 
LA size and atrial function. Methods. One-hundred consecutive patients (pts) who were 
successfully cardioverted with drugs, propafenone or procainamlde (50 pts) or DC shock 
(50 pts)underwent echocardiogtaphic evaluations of LA sze and volumes. LA passive 
and active emptying volumes were calculated. LA function was assessed by Doppler 
echocardiography: from the transmitral flow we measured peak A wave velocity and atrial 
ejection force, from the pulmonary vein flow we measured systolic, diastolic and reversal 
A wave (PVA). Results. The left atrium was dilated rn all pts during AF. The LA anteropos- 
terior diameter decreased after the restoration of sinus rhythm in pts reverted with drugs 
(from 44 + 4 to 41.8 k 3 mm, p trend to 0.05), while in pts reverted with DC shock do not 
change (44 + 2 to 43 i 3 mm). In pts treated with drugs the maximal and the minimal vol- 
umfs of LA decreased (V max 37 f 5 to 30 c 6 cm3, p<O.Oi: V min 20 c 3 to 12 i 3 mm: 
~~0.01). In pts treated with DC shock we did not observe significant changes in volumes. 
Atrial stunning (peak A wave velocity <0.50 misec and atrial ejection force c7 dynes) was 
observed in 12 pts reverted with drugs and in 25 pts reverted with DC shock. The com- 
parison between pts with a normal atrial function (n=63) and pts with reduced atrial func- 
tlon (n=37) showed that a higher atrial ejection force was associated with a more marked 
reduction in LA size after cardioversion. A relationship between LA volumes and atrial 
ejection force was observed in pts with depressed atrial mechanical function (r=-0.79; 
pcO.001). The active emptying fraction was lower, although not significantly, in this group 
(0.23 f 0.08 vs 0.38 f 0.13), while the conduit volume was increased (39 + 6 vs 26 k 5 
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1063-I 11 Progression to Permanent Atrial Fibrillation Following AV 
Node Ablation and DDD-R Pacemaker Implantation Is 
Affected by the Atrial Pacing Site 
Luigi Padeletti, Maurizio Gasparini, Alessandro Proclemer, Gian Luca Botto, Tiziana 
Marotta, Andrea Grammatico, Francesco de Seta, Andrea Colella, Massimo Mantica, 
Nicola Musilli, Sergio Terrazzini, Antonio Michelucci, Cristina Ciapetti. Internal Medicine 
and Cardiology Department - University Hospital, Florence, /ta/ji Cardiology Department 
- Humanitas hsfitute, Mhno, /taJy 
Background: New techniques of atrial pacing (AP) have been proposed for atrial fibrilla- 
tion (AF) prevention, lnteratrial septum pacing (IASP) at the Koch’s triangle is safe and 
feasible. Aim of the study is to determlne if the site of AP can affect the progression to 
permanent AF (PeAF) following AVN ablation (Abl) and DDD-R pacemaker implant. 
Methods: 62 patients (pts) (30 M, 32 F, 70r8 yrs) with sinus bradycardia and paroxysmal 
AF (PxAF) were enrolled in the study. In 23 pts a screw-in lead was placed in the IAS, 
while in 39 pts a tined or screw-in lead was placed in the right atrial appendage @AA). 
The mean number of PxAF episodeslmo in the 3 mos period before the AVNAbl was 
5.3i8.3 in the IASP group and 7.0r7.7 in the RAAP group (NS). The implanted pace- 
makers were Medtronic Them 7940 (37 pts) and Vltatron Diamond II (25 pts) and were 
programmed in DDD-R mode. Pts were routinely controlled every 3 mos. PeAF was con- 
firmed by ECG at 2 consecutive controls and documentation of permanent mode switch- 
ing from DDD-R to ventricular P (VVI-R). Results: During a mean follow up period of 
19~7 mos (range 12.24) no AV conduction recurrences were observed in all patients. 
PeAF was observed in 7123 (30%) IASP pts and in 16/39 (41%) RAAP pts. Sinus Rhythm 
survival curves are reported in the graph. Conclusions: IASP significantly decreases the 
progression to PeAF (p c 0.03) when compared to RAAP following AVNAbl and DDD-R 
1063-I 12 Propagation of Right and Left Atrial Premature Beats Using 
Three-Dimensional Mapping During Standard and Novel 
Pacing Modes 
Atul Prakash, Sanjeev Saksena, Ryszard Krol, George Philip. CV Institute, Atlantic 
He&h System, Passaic, NJ 
We examined 3-D propagation of high RA [HRA] & coronary sinus [CS] premature extra- 
stimuli [ES] in the lateral RA, posterior RA, septal RA & tricuspid valve isthmus during 
HRA pacing & dual site RA pacing [DAP]. Using > 3000 virtual electrograms from a non- 
contact high density balloon electrode, total RA activation times, regional activation 
wavefronts and terminal electrical activation in the RA for fixed coupled ES from both 
sites were analyzed. Results: 8 pts with AF or atrial flutter were included. During HRA 
pacing, HRA ES coupled at 350 & 250 ms would commonly divide into two wavefronts, a 
septal & an anterolateral crania-caudal wavefront with either becoming dominant & acti- 
vating entire RA. Isthmus activation would be secondary to the dominant RA wavefront 
starting medially or laterally respectively. Terminal RA activation for HRA ES varied 
among pts between low lateral RA (n=Z), septum (n=3), CS (n=i ) & inferior vena cava 
(n=Z). In contrast, CS ES would propagate either laterally across the TVI to the lateral 
RA, or caudo-cranially in the septum with subsequent activation of the lateral RA. During 
HRA pacing, mean total RA activation time was 144517 ms for CS ES & 117+19 ms for 
HRA ES (pz.09). With DAP, activation time for HRA ES further abbreviated to 104~12 ms 
(p=.O4 vs HRA) but DAP did not alter activation wavefront pattern for HRA ES in 5 of 6 
pts. Conclusions: 1) During HRA pacing, 3-D regional RA activation differs with origin of 
triggering premature beat but isthmus & lateral RA regional activation is also determined 
by the dominant RA wavefront in individual pts.2) DAP does not alter regional propaga- 
tion of HRA ES but permits more rapid RA activation. 
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1063-129 Atrial Assessment of Short-Term Heart Rate Variability 
Before Onset of Paroxysmal Atrial Fibrillation 
Hendrik Bonnemeier, Uwe K. H. Wiegand, Werner Peters, Frank Bode, Hugo A. Katus. 
Medical University Luebeck, Medical Clinic I/, Luebeck, Germany 
was similar (Figure). Conclusions: 1) DAP is effective in rhythm control in AF pts with & 
without IACD. 2) AF recurrence rates with DAP are comparable in these two populations. 
3) The degree of IACD may not influence mechanisms underlying efficacy of AF preven- 
tion with DAP 
auionomic nervous imbal- a 
ante are discussed. Heart 0 30 O40 10s 30 a 10 8 
rate variability (HRV) is ar: 
adequate measure for these 
autonomic nervous iluctuations. By using dual chamber pacemakers (DCP) with an auto- 
matic storage function it IS possible to determine changes of autonomic activity in the 
atrium before onset of paroxysmal atrIal fibrillation (PAF). Methods: In 6 Patients with a 
history of sinuatrial block and PAF, a DCP (Vitatron Selection AF 1 .O) was Implanted. This 
DCP has the ability to store up to 2 mmutes of atrial intervals before PAF To ensure spon- 
taneous conduction the DCP was programmed with a lower rate limit of 40 bmp and an 
AV-delay of 300 ms. Results: During the 3 month follow-up 28 episodes were valid for 
short-term-HRV-analysis. SDAAIO (standard deviation of atrial intervals) and rMSSDl0 
(root mean square of successive differences of atrlal intervals) were determined from 
consecutive IO-second-periods. Both, SDAAlO and rMSSDl0 significantly increased in 
the last period before PAF. Conclusion: A slgnlficant elevation of HRV indicates an 
immediate change of autonomic activity before PAF. In Patients with DCP and PAF these 
findings may be useful for further developement of preventive antitachycardic pacing 
algorithms. 
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1063-131 Better Understanding of the Onset Mechanisms of Atrial 
Fibrillation: Optimizing Selection of Patients Who May 
Benefit From Preventive Pacing 
1103-l 15 The Efficacy of Pacing Therapies for Treating Atrial 
Tachyarrhythmias in Patients With Ventricular Arrhythmias 
Receiving a Dual-Chamber Implantable Cardioverter- 
Defibrillator 
Stuart W. Adler, II, Christian Wolpert, Eduardo N. Warman, Shailesh K. Musiey, Jodl L. 
Koehler, David E. Euler. Medfronic, Inc., Minneapolis, MN 
Andre A. Queiroga, Howard J Marshall, Faizel Osman, Michael D. Gammage. University 
Hospital Birmingham, Birmingham, Umfed Kingdom 
Background: Atrial Fibrillatlan (AF) is the most common sustained cardiac arrhythmia, 
leading to heart failure, stroke and peripheral embolism. A better understanding of AF 
onset mechanisms is likely to improve therapy. Methods: We studied 155 episodes of AF 
from a cohort of 23 patients who received the Vitatron SELECTION 900 pacemaker as 
part of the AF Therapy Study. Inclusion criteria were at least 2 previous drug therapies 
and paroxysmal atrial fibrillation (PAF) > 6 months. Using the trend tables and arrhythmia 
diary within ihe pacemaker diagnostics. the underlying effects associated with the Initla- 
tlon of AF were classified as bradycardia, tachycardia. early restart (within 1 minute of 
previous episode of AF), premature atrial contraction (PAC) trend increase and no effect. 
Using the rate profile dragrams, the potential onset triggers were classified as post PAC, 
multiple preceding PA&, short runs of AF, sudden rate drop and sudden onset. Results: 
Early restart was the most common underiymg effect (57%): followed by PAC trend 
increase (22%) and bradycardia/PAC trend increase (10%). Tachycardla induced AF was 
extremely rare (1%). Sudden onset was the most prevalent trigger (63%), indicating no 
immediate rhythm change preceding the onset of AF in the rate proflle diagrams. This 
was followed by short runs of AF (18%) and PACs in 16% (post PAC IO%, multiple pre- 
ceding PACs 6%). A mean of 2.65iO.70 (meamSD) underlying effects and 2.88?1.11 
triggers per patient was found in our population. Conclusion: New pacing systems with 
enhanced diagnostics have enabled us to develop a greater insight into the onset mech- 
an~sms of AF. Completion of the AF Therapy trial will allow assessment of specific pre- 
ventive pacing algorithms for PAF and identification of subgroups of patients who will 
benefit most. 
Background: The efficacy of overdrive pacing for treating atnal flutter is well established, 
but wcces~ rates for device-based atrial pacing therapy of spontaneous atrial tach- 
yarrhythmias (TA) in patients with significant ventricular TA is unknown. This study evalu- 
ated the efficacy of novel pacing therapies for treating atrial TA in patients receiving a 
new dual chamber implantable cardioverter defibrillator (ICD) to treat ventricular TA. 
Methods:Patients ware Implanted with a Jewel AF 7250 ICD (n=551) and followed for 
342 -? 245 days. A history of documented atrial TA was present in 74%. The device dls- 
criminated atrial tachycardia (AT) from atrial fibrillation (AF) based on cycle length and 
regularity. Three different methods of overdrive atrial pacing (Burst plus 2 extrastimuli, 
Ramp. and 50 Hz Burst) were used to treat AT episodes (AF was treated with 50 Hz 
Burst). The rhythm (AT or AF) detected at the time of the first pacing therapy was used to 
classify the entire episode, regardless of rhythm transitions (AT or AF) thereafter. 
Results: Pacing therapy successfully terminated 74.6% of 1103 spontaneous AT ep!- 
sodes, and 24.6% of 1277 spontaneous AF episodes in 167 patients (P<O.OOi). With AT 
and AF episodes combined, pacing efficacy was 47.8%. For AT cycle lengths 5 220 ms, 
the SUCCESS rate was significantly less (57.1%)(P<O.O01) compared to the swxess rate 
for AT cycle lengths Z 230 ms (77.2%). Cycle length did not significantly influence pacing 
efficacy in episodes classified’as AF. The time from the first pacing therapy to episode 
termination was analyzed to determine the effect of the atrial pacing therapies on ATIAF 
duration. The median time from the first pacing therapy to termination was 3.0 min for the 
pacing accesses and 63.2 min for failures (P<O.OOl). Conclusion: In patients wth a 
history of ventricular arrhythmias Implanted with the Jewel AF ICD, atrlal pacing therapies 
successfully terminated 47.8% of all atrial tachyarrhythmias (both AT and AF). Pacing 
efficacy was much higher for device-classified AT compared to device-classified AF AT 
cycle length significantly influenced the outcome for pacing therapy, wheras AF cycle 
length did not influence pacing therapy outcome. 
1103-I 16 The Impact of Atrial Defibrillators on the Natural History of 
Persistent Atrial Fibrillation. Does Sinus Rhythm Beget 
More Sinus Rhythm? 
Philip A. R. Spurrell. Andrew R. J. Mitchell, Kayvan Kamalvand, Ann Topham, Neil Sulke. 
Easfbourne General Hospital, Eastbourne, United Kingdom 
Multiple PACs preceding AF onset Background: To determine whether repeated atrial defibrillation of AF recurrences pro- 
motes the maintenance of sinus rhythm. Does sinus rhythm beget sinus rhythm? 
1063-132 Dual Site Atrial Pacing Is Effective for Atrial Fibrillation 
Methods: 15 patients, mean age 63214 years 80% male, were implanted with the 
Prevention in Patients With and Without Atrial Conduction 
Medtronlc Jewel AF device for the treatment of persistent atrial fibrillation. Patients per- 
Delay 
formed out-of-hospital patlent-activated atrial defibrillation shocks following self-adminis- 
tration of sedation. Data was collected from device Halters and patient diaries. 
Atul Prakash, Sanjeev Saksena, Ryszard Krol. Wlnsfitute, Atlantic Heaifh System, 
Passaic, NJ 
Results: Mean follow-up duration 13.3~6 months. 112 episodes of AF were treated by 
patient-activated atriai defibrillation. All patients are currently in SR. Comparison of the 
1” and pnd 3.month period following implant showed a non-significant reduction in AF 
Dual site overdrive atrial pacing [DAP] reduces intra-atrIal conduction delay [IACD] & can 
suppress atrial triggers. It has been used in refractory atria fibrillation [AF] patients [pts] 
with & without IACD but its efficacy for AF prevention in these populations has not been 
compared. We performed DAP in 85 pt.5 with drug-refractory AF Pts with either P wave 
duration of >120 ms &/or PA interval of xl5 ms were categorized as having IACD (Group 
1, n=35). Pts without IACD (Group 2, “~52) concurrently receiving DAP systems were 
compared to Group 1. Results: Rhythm control was feasible in 31 of 35 pts (89%) in 
Group 1 & 47 of 52 pts (90%) in Group 2 (p=NS). Actuarial freedom from any AF event 
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burden (93hrw210 vs 61 hrsc127 p=NS). 2/i 5 patients had a decreased frequency of AF 
recurrence (patients 3 and 8). The majority continued to have regular recurrences of AF 
interspersed with periods of increased atrial activity ‘atrial storms’ (eg patient 6). 
Conclusion: Atrial defibrillators are an effective means of maintaining SR in patients with 
persistent AF. Serial increases in the duration of SR between shocks were seen in some 
patients however, this did not occur in the majority. These findings may have been as a 
consequence of the longer duration between AF onset and subsequent atrial defibrilla- 
tion that occurs with patient-activated rather than automatic shocks. This increased time 
may adversely affect the atrial electrical remodelling process. 
1103-I 17 Clinical Predictors of Atrial Defibrillation Thresholds With a 
Dual Coil Active Can Lead System 
Laura Murphy, Rachida Bourouch, Eric J. Rashba, Stephen R. Shorofsky, Michael R. 
Gold. University of Mary/and, Baltimore, MJ 
Background: Dual chamber implantable defibrillators (ICDs) are now capable of treating 
both atrial and ventricular arrhythmias. Although the clinical predictors and effects of 
antiarrhythmic drugs on ventricular defibrillation thresholds (DFTs) are well studied, little 
is known about the predictors of atrial DFTs. 
Methods: This was a prospective study of 100 consecutive patients (pts) undergoing 
ICD implantation with a dual coil transvenous lead. All shocks were delivered from the 
distal coil to the proximal coil and a left pectoral emulator (RV+SVC+Can). Atrial fibrilla- 
tion (AF) was induced with ramp pacing and DFTs were measured with a step-up proto- 
col starting at 0.5 J. The biphasic waveform had 60/50% tilts and a 150 pF capacitance. 
To assess the predictors of the atrial DFT, multivariate analysis of 14 clinical parameters 
was performed with a Cox proportional Hazards model. Included were demographic, 
echocardiographic and electrocardographic features as well as electrical parameters. 
Results: The pts had a mean age of 62+12 yrs and 85% were male. The mean ejection 
fraction was 31ill% and 70% had congestive heart failure (NYHA II or Ill). There was a 
history of AF in 35% of pts and 15% were receiving amiodarone. A total of 908 R-wave 
synchronized shocks were delivered in AF with no ventricular arrhythmias induced. The 
mean atrial DFT was 4.7k4.0 J with a shock impedance of 43f7W. A high DFT (2 10 J) 
was noted in 15% of pts. Univariate analysis of the clinical factors identified only the left 
atrial size (LA) and shock impedance as predictors of the atrial DFT. Multivariate analysis 
identified LA (Rz0.24, ~~0.01) as the only independent predictor of DFTs. A high DFT 
was observed in 30% of pts with LA 2 5.0 cm, but only 10% with LA < 5.0 (p<O.O5). 
Conclusions: Atrial defibrillation can be ‘achieved safely with acceptable DFTs using a 
simple dual coil lead and no additional coronary sinus leads. LA is the only independent 
predictor of DFTs. An LA > 5.0 cm identifies pts at increased risk of high atrial DFTs. 
1103-l 18 Effect of Manual Pressure on Transthoracic impedance 
During Cardioversion for Atrial Fibrillation 
Sanjay Dixit, Henry Hsia, Francis E. Marchlinski, Dusan 2. Kocovic, Behzad B. Pavri. 
Hospital of The University of Pennsylvania, Philadelphia, PA 
Background: External cardioversion (CV) is frequently used to restore normal sinus 
rhythm in patients (pts) with atrial fibrillation (AF). We prospectively analyzed the effects 
of manual mid sternal pressure on the different electrical parameters involved in transtho- 
rack? CV. Methods: We enrolled 20 consecutive pts referred for CV of AF. All pts were 
administered general anesthesia and 100 Joules (J) of R-wave synchronized energy was 
delivered twice through two precordial (midsternal and posterior) cutaneous adhesive 
pads connected to a conventional monophasic external defibrillator system. Pts were 
randomized at the outset to two arms: a) First shock with manual pressure followed by 
second shock without or b) First shock without manual pressure and the second shock 
with. Both the shocks were delivered regardless of the rhythm outcome following the ini- 
tial shock. Trans-thoracic impedance (TTI; ohms), current delivered (i; amperes) and 
actual energy delivered (J) were measured for each shock. Changes in these parameters 
with application of pressure ware correlated to each pts body mass index (BMI) and ven- 
tricular function (EF).Results: The mean age of the study population was 67.5+/-18.2 yrs 
with 12 males, and the mean BMI was 28.7+/-6.5 kgIm2. All patients had a recent 2D 
echocardiogram and 50% demonstrated moderate to severe left ventricular dysfunction 
(EF<45%). Manual pressure deployed during the protocol averaged 50.1+/-8.1 Ibs. Use 
of manual pressure resulted in a nonsignificant decrease in the TTI (5.6+/-3.8; ~~0.13) 
associated with augmentation of 1.5+/-l .l amperes in current and 2.1+/-l .7 J in energy 
delivered. These changes did not correlate with BMI and/or EF. In 7 pts, manual pressure 
resulted in successful CV following failure at the same energy without pressure. Mean 
TTI drop in this group was 6.4+/-3.2 and was not significantly different from that of the 
whole cohort as well as pts who failed both attempts at CV. Conclusion: Manual pressure 
deployed during low energy synchronized external CV for AF appears to favorably effect 
the electrical parameters during defibrillation, and allowed successful CV of AF after a 
failed shock in 35% pts. 
1103-l 19 Differential Effects of DI-Sotalol vs. Propafenone on Global 
Spatiotemporal Complexity of Local Excitations in Chronic 
Atrial Fibrillation: A Determinant of Defibrillation 
Efficiency? 
Jiunn-Lee Lin, Ling-Ping Lai, tian-Yu tin, Chao-Cheng Du, Yung-Zu Tseng, Wen-Pin 
Lien, Shoei K. S. Huang. National Taiwan University Hospital, Taipei, kiwan,ROC 
Background. Electrical cardioversion (EC) of chronic atrial fibrillation (AF) can be facili- 
tated by the addition of dl-sotalol (STL) but not propafenone (PPF). However, the electro- 
physiologic mechanism remains obscure. Materials & Methods. To test the hypothesis 
that global spatiotemporal complexity of local excitations in AF determine the efficiency of 
EC, we investigated 28 pts (13 M, 15 F, 64+/-7 yrs) with chronic AF (> 3 mo) by bi-atrial 
basket electrode mapping before and after iv STL (1.5 mg/kg, 12 pts) or iv PPF (2 mgikg, 
16 pts). External DC shock was titrated to determine the energy requirement. Bipolar 
local electrogram from each basket electrode was sampled in 1 KHz and recorded con- 
tinuously for 5 min in each event. Power spectra for local frequency analysis were derived 
in 10.set segment for each 5.min data by Fourier transform (FT). Dominant frequency 
(DF) from FT, defined as the frequency appearing for > 60 set in a 5.min data, was 
selected at each of 64 atrial sites and mapped for its spatial distribution. The spatiotem- 
poral complexity of local excitation frequencies in the whole atria was evaluated by the 
total number of DF (DF #), standard deviation of all DF (DFSD, Hz), maximal domain 
area for all DF (MaxA, %, of 64 sites), sum of domain areas by all DF (Sum.A, %), DF 
with maximal domain area (DFA, Hz) and maximal duration of DF (Max. D, set) for all DF 
pre and post PPF (P) 01 STL (S). Resuks: 
PreP 229+,-126 11+,-s 0.7+,-o 2 33+,-s 60+/-l 1  6.9+/.0.6 2*5+,-158 
PPF 27, ii-85 II+,-2 t.t+,-0.4 25+,-8 49+,-l 0’ 4.7+/-0.4 195+,-1-141 
PES 2%3+,-t 12 11 t/-2 cm+,-, .s 36+,-S m+,-13 a,+,-0.5 15s+,-100 
STL 192+,-112 11 r- i-3 ‘I,+,-0.3 34+,-t 3  60+/-17 5.4+,-0.8 x0+,-134 
EC, in Joules. ‘, p < 0.05, post- vs. pra- PPF or STL. Conclusions. Propafenone, but not 
dl-sot&l, worsened the spatiotemporal complexity of local excitations in atrial fibrillation. 
This may contribute to the different energy requirement for EC of chronic AF. 
1103-120 Plasma Catecholamines During Low Energy internal Atrial 
Cardioversion and During Electrophysiological Study for 
Induction of Ventricular Tachyarrhythmias 
Giuseppe Boriani, Mauro Biffi,Francesco Pergolini,Cristian Martignani,Alberto 
Bargossi,Romano Zannoli,Angelo Branzi. lnsfitute of Cardiology- University of Bologna, 
Bologna, k/y 
Aim of the study was to evaluate the extent of plasma catecholamines changes induced 
by low energy internal atrial cardioversion (CV) and by electrophysiological study (EPS) 
for ventricular tachyarrhythmias (VT) induction. Plasma levels of epinephrine (E) and 
norepinephrine (NE) were measured in blood samples taken at baseline (at rest) in 9 
control subjects, in 26 pts with chronic atrial fibrillation (AF) submitted to internal CV and 
in 22 pts submitted to EPS for VT During internal CV for AF, blood samples ware taken 
following each delivered shock (step up protocol beginning at a leading voltage of 180V) 
and sedation or anaesthesia were administered only at patients’ request. During EPS for 
VT, blood samples were taken following induction of VT, either in cases terminated by 
pacing or in cases requiring termination by DC shock. Results: In basal conditions no sig- 
nificant differences were found in E or NE levels (pg/ml) comparing controls (E= 32+19, 
NE= 214*100) to CV pts (E= 37*29, NE= 180+_85) while basal levels in EPS pts (E= 
59+39, NE= 281+156) were significantly higher (~~0.05) than in CV pts. During CV and 
during EPS a significant rise in E and NE levels occurred and the pealdbaseline value 
ratio was 4.25a4.06 for E and 1.85kO.64 for NE in CV and 3.28k2.84 for E and 1.82iO.83 
for NE in EPS. In EPS patients requiring DC shock for terminating VT (n=8), significantly 
higher levels of E and NE were found in comparison to pts with VT interrupted by pacing 
(1~14) (E= 355+164 vs 49+37, pcO.001; NE= 686r187 vs 342i147, pcO.001). In internal 
CV pts,‘no differences were found in peak E or NE le@s comparing pts requiring or not 
sedation. In conclusions, a significant rise in E and NE occurs during low energy internal 
CV and following VT induction in EPS (especially if DC shock is required for VT termina- 
tion). This finding is important because the rise in catecholamines may modify the elec- 
trophysiological substrate and may favour arrhythmia recurrences immediately after this 
kind of procedures. 
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established. At least 4 PV were identified and thetr locations were tagged when the cath- 
eter tip was passed into PV beyond the endocardial shell to the most distal site where an 
Egm could be recorded. Egms were recorded from 10 pole catheters placed in CS and 
PRA. Pacing was performed in each of the 52 PVs at capture threshold and 50 mA at the 
PV ostium and at the most distal site where an Egm could be recorded. The conduction 
time between the PRA and CS and the AS in these catheters were analyzed. A change in 
AS and/or a difference >lO ms in CS-PRA time was considered significant. Results: AS 
in the CS and PRA was identical in all but 1 of the 104 PV site (RSPV-deep) at different 
Current output. Only 1 of the 104 sites (left inferior PV-deep) paced had > 10 ms differ- 
ence in CS-PRA times with different current outputs. The mean capture threshold of all 
PV pacing sites were: &urn: 7.9+9.6 mA, deep PV: 22.1+9.1 mA. Conclusion: Due to 
clinical importance of pace activation sequence mapping in localizing PV triggers of par- 
oxysmal atrial fibrillation, the absence of significant influence in activation sequence in 
CS and PRA, and in CS-PRA conduction times eliminates need for current output titra- 
tion to obtain PV pacemaps. 
1104-124 Prevalence of Ligament of Marshall Potentials Recording in 
Patients with Paroxysmal Atrial Fibrillation 
Demosthenes Katritsis, Eleftherios Giazitzoglou, Socrates Korovesis, John Parissis, 
Pericles Kalivas, John loannidis, George Sarris, A John Camm. ATHENS EUROCLINIC, 
ATHENS, GREECE, Greece, UNIVERSITY OF IOANNINA, IOANNINA, Greece 
Background Potentials representing activity of the ligament of Marshall can be recorded 
in man through the coronary sinus and the left atrial endocardium. The prevalence of 
these potentials in patients with and without paroxysmal atnal fibrillation is not known. 
Methods and Results Forty nine patients, 25 with with lone, paroxysmal AF (group A), 
and 24 with other arrhythmias (group B) were subjected to catheter mapping for intended 
recording of ligament of Marshall tissue. Catheterization of the distal superoposterior cor- 
onary sinus was feasible in 14 patients of group A; in 10 of them a discrete electrogram 
(Marshall potential) was recorded epicardially at the distal superoposterior coronary 
sinus, and/or endocardially at the left atrtal wall just inferiorly to the ostium of the left 
superior pulmonary vein. This potential followed the atria electrogram during sinus 
rhythm by 40+9 msec, and preceded it during atrial ectopy by 31+5 msec. Catheteriza- 
tion of the distal superoposterior coronary sinus was feasible in 11 patients of group B 
and in 4 of them a discrete electrogram was recorded from the Marshall area. Conclu- 
sions Cannulation of the ligament of Marshall area through the distal superoposteriorcor- 
onary sinus is feasible in approximately 50% of patients with conventional ablation 
catheters. Recording of specific potentials from this area is more frequent in patients with 
PAF than with other arrhythmias. 
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1104-121 Pulmonary Veins Show Decreased Effective Refractory 
Periods Under Acute Dilatation in Langendorff-Perfused 
Rabbit Hearts 
Markus Parse, Jens Robert, Patrick Schauerte, Peter Hanrath, Stellbrink Christoph. 
Department of cardiology and pulmonolog~ University of Technology Aachen, Aachen, 
Germany 
Background: Ectopic beats originating in the pulmonary veins (PV) can initiate paroxys- 
mal atrial fibrillation (PAF). Recently significant dilatation of the superior PV has been 
demonstrated in patients with PAF. The effects of acute dilatation (D) on refractory peri- 
ods (RP) in PV, however, have not yet been investigated. Methods: In 7 Langendodf-per- 
fused rabbit hearts confluens of left PV was stripped of lung-tissue. Pacing and sensing 
electrodes ware located within <5 mm to each other on left PV and free wall of the left 
atrium (LA). RPs were measured by incremental extraetimulus (52) technique at a basic 
cycle length (Si Si) of 250 ms under double and 10 fold diastolic threshold under 
increasing pressure (IP) [cm HZO]. The shortest SiS2 interval resulting in a propagated 
response at the adjacent sensing electrode was defined as effective RP, the minimum 
Interval between two consecutively conducted impulses from PV to LA was defined as 
functional Rl? Results: PV sensing and pacing was possible in all experiments. Thresh- 
olds were higher in PV than LA (4.3118 mA vs, 1.2iO.4 mA, p<O.Ol). PV and LA showed 
comparable decrease in effective RP under IP, which was enhanced by increased stimu- 
Ius strength. Functional RP decreased under IP. 
[cm HZ01 0 4 8 12 
PVZxT 118+16 104+16 ioot17 86313’ 
LAZxT 122*22 116+26 92+14 91rlY 
PVlOxT 100*17 92i26 82*16 67k26 ’ 
LAlOxT 111t25 89r24 9oi-20 76c8* 
*p<O.O5, all values in ms. Conclusions: Physiological pressure changes decrease ERP 
in PV substantially and might trigger the activity of ectopic foci. IP does not increase het- 
erogeneity in RP between LA and PV. Decreased FRP under IP makes the occurence of 
conduction blocks at the PV ostium due to IP unlikely. 
1104-122 Elimination of Pulmonary Vein Potential for Catheter 
Ablation of Atrial Fibrillation: Results of Short-Time Clinical 
Follow-Up 
Feifan Ouyang, Sabine I. S. Ernst, Masahito Goya, Marius Volkmer, Karl-Heinz Ku& St. 
Georg General Hospital, Hamburg, Germany 
Primary catheter ablation of triggering foci within the pulmonary veins (PV) is often ham- 
pered by the inappearence of the trigger during the ablation procedure. Ablation of spike 
potentials within the PV is risking PV stenosis. In 21 pts (2 f, 3 pts with chronic AFib) with 
symptomatic atrial fibrillation (AFib) a left atrial (LA) ablation procedure aiming at a PV 
isolation was performed. The individual anatomy was reconstructed using the electroana- 
tomical mapping system CARTO, after dual transseptal access was gained to the LA. 
After placement of a multipolar recording electrode in the targeted PV, RFC ablation was 
deployed at the PV-LA junction to selectively interrupt muscle fibers entering the PV, until 
the PV potential disappeared as monitored by the PV electrode. Results: In 21 pts (24 
procedures) a total of 30*13 RFC was needed (fluoroscopy 22,2*8,1 min, procedure 
time 47Ok99 min). During a mean follow up period of 41Qi days, 17/21 (81%) pts ware 
in stable SR with occasionally AES in bolter recordings (15117 still with antiarrhythmic 
medication). The remaining 4 pts experienced recurrences of AFib. The 213 pts with 
chronic AFib are in SR, 1 pt in intermittent AFib with 2-4 weekly episodes. Complication: 
significant pericardial effusion in 1 pt and an false aneurysm in 1 pt. Conclusion:Trigger 
elimination by sequential RFC application to interrupt muscle strains entering the PVs is 
feasible and can be online validated by a recording electrode within the target pulmonary 
vein. The clinical follow-up demonstrates AFib recurrence only in 19% of pts. Even in pts 
with chronic AFib, stable SR could be re-established. 
1104-123 Influence of Current Strength During Pulmonary Vein 
Pacing on Intracardiac Electrograms in Coronary Sinus and 
Posteromedial Right Atrium for Pacemapping Triggers of 
Atrial Fibrillation Originating in Pulmonary Veins 
Manisha S. Ashar, Ralph J. Verdino, David J. Callans, Henry H. Hsia, Francis E. 
Marchlinski. Universfty of Pennsylvania Health Systems, Philadelphia, PA 
The pattern of activation of intracardrac electrograms (Egms) in the coronary sinus (CS) 
and along the posteromedial right atrium (PRA) helps rapidly regionalize pulmonary vein 
(PV) sate of origin of focal triggers of atrial fibrillation to right versus left PV. During PV 
pacemapping, the pacing threshold and current output may vary. We sought to determine 
the influence of pacing current output on the pattern of CS and PRA activation sequence 
(AS) and in CS-PRA conduction time that might influence the ability to predict right ver- 
sus left PV sites of origin. Methods: In 13 patients, detailed left atrial magnetic electroan- 
atomic mapping (112-190 points) was performed and a left atrial endocardial shell was 
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1105-125 Complex AV-Nodal Dynamics During Ventricular-Triggered 
Atrial Pacing in Humans 
David J. Christini, Kenneth M. Stein, Steven M. Markowitz, Suneet Mittal, David J. 
Slotwiner, Marc A. Scheiner, Sei Iwai, Bruce B. Lerman. The New York Hospital - Cornell 
University Medical Center, New York, NY 
Background: In animal models, AH interval alternans (period-2 doubling) can occur dur- 
ing His-triggered atrial pacing. We investigated whether similar dynamics result from “en’ 
tricular-triggered atrial pacing in humans. 
Methods: During diagnostic EP testing, 38 patients (18 male, 20 female; 57f16 yr.) with 
normal AV conduction underwent rapid atrial pacing at an adjustable interval (VA) after 
ventricular depolarization. VA was gradually decreased until AV block or alternans 
occurred. 
Results: AV-interval 
alternans occurred in 19 375 
~;~o;CFi;va);o~;: A\I 
tions occurred in 16 (Ins) 
patients (Fig. b); 3 300 
patients had both altern- 
ans and oscillations (not 
concurrently); 6 patients 
had neither. Oscillations were approximately periodic, with mean period 55+18 s (0.02 
Hz). There were no significant correlations between type of AV dynamics and existence 
of dual AV-nodal pathways (18 patients) or antiarrhythmic medications (23 patients). 
Alternans always developed via a bifurcation (typical of nonlinear-dynamical function) 
instead of a discrete jump (dual-pathway function). 12 patients underwent a second trial 
after autonomic blockade (0.2 mgikg propranolol and 0.04 mglkg atropine). Blockade 
facilitated alternans but inhibited oscillations: 5 patients had alternans before and after 
blockade: 3 patients had alternans after blockade but not before; 3 patients had oscilla- 
tions before blockade but not after. 
Conclusions: In humans, rapid atrial excitation, such as observed in orthodromic reen- 
trant tachycardia, can result in AV-nodal alternans or oscillations. Because autonomic 
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blockade facilitated alternans but abolished oscillations, we conclude that oscillations are 
autonomically mediated whereas alternans is a function of the Inherent dynamical prop- 
erties of AV-nodal tissue. 
1105-127 Rate-Dependent Changes in Conduction Velocity in the 
Cave-Tricuspid Isthmus and Septum: Comparison of 
Patients With Atrial Flutter Versus AV Nodal Reentrant 
Tachycardia 
Pihua Fang, Nancy L. Radtke, Wesley K. Haisty, Jr., Tony W. Simmons, David M. 
Fitzgerald. Wake Forest Universify School of Medicine, Winston-Salem, NC 
Electra-anatomic maps (CARTO, Biosense) allow evaluation of both the anatomy and 
conduction characteristics of the mapped chamber. Electto-anatomic maps (EAMs) of 
the right atrium (RA) in patients with atrial flutter (AF) show a larger atrial volume and an 
increase in both length and width of the cave-tricuspid isthmus (CTI) compared to 
patients with AV nodal reentry (AVNRT). MethodsUsing EAMs obtained during coronary 
sinus pacing at pacing cycle lengths (PCL) 600, 400 and 300 msec, we evaluated con- 
duction velocities in the RA septum and CTI in 10 patients with AF (age= 53 + IO; 3 
females) and compared EAMs to 13 patients with AVNRT(age= 52 f 11; 8 females) to 
determine whether the conduction slowing required to maintain AF was related to 
changes in volume alone or to altered RA electrophysiology. Results: A summary of the 
results are listed in Table 1. Conduction velocities in CTI and septum were significantly 
slower at all PCL when the AF group was compared to the AVNRT group ( ’ ~~0.05). 
Additionally, in the AF group, conduction velocity was slower on the septum at PCL 600 
and 400 but not at 300 compared to CTI (# pc .05). In AF,during PCL 300, conduction in 
CTI slowed significantly compared to conduction in CTI at PCL 600 and 400 ($ p< 0.05) 
such that there was no difference between CTI and septum at PCL 300. Conclusions: 
Conduction is slower in the septum compared to the CTI in all patients. However, in 
patients with AF, there is significantly greater slowing of conduction in the CTI and sap- 
turn compared to patients with AVNRT as well as decremental rate-dependent slowing of 
conduction in the CTI. These findings indicate that in addition to RA enlargement, altered 
atrial electrophysiology is found in AF patients. 
Table 1. Effect of PCL on Conduction Velocity 
Conduction Veloc- PCL PCL PCL PCL 600 PCL 400 PCL 300 
ity (M/set) 600 CTI 400CTI 300 CTI Septum Septum Septum 
AF .79 * .84 * .67*$ .68’# .65 * # .68 * 
AVNRT 1.0 1.0 .99 .83 .84 .80 
patients with SVT, in whom adenosine was administered during sinus rhythm before elec- 
trophysiology study (EPS) and ablation. A single rapid bolus of 12 mg IV adenosine fol- 
lowed by 20 ml saline flush was given during sinus rhythm in a peripheral vein and a 
continuous electrocardiogram was recorded at 50 mmisec. dAVNP on the surface ECG 
was defined as an increase in the PR interval of >50 ms in two consecutive QRS com- 
plexes or by an AV nodal echo. Results. There were 40 males and 57 females, mean age 
43+/-12 yr. (range 12 to 62 yrs). EPS demonstration of dAVNP (as defined by > 50 ms 
AH jump with a IO ms decrement in the extra-stimulus) was studied by programmed elec- 
tncal stimulation (PES). Adenosine demonstrated dAVNP in 48/62 (74%) patients with 
atrioventricular nodal reentry tachycardia (AVNRT) (group A) and in 2135 (6%) patients 
with atrioventricular reciprocating tachycardia (AVRT) (group 8). EPS demonstrated 
dAVNP in all patients with AVNRT (group A). A reverse PR jump (sudden shortening of 
PR interval as the adenosine effect starts weaning off) was seen in 10 patients in group 
A. Of these 10 patlents, 2 had no PR jump. In group A, 3 patients demonstrated AV nodal 
echo & 3 had induction of AVNRT. In group B, latent preexcitation was unmasked by ade- 
nosine in 4 patients & AVRT induction occurred in 2 patients. Conclusion. Adenosine can 
demonstrate dual AV node physiology with a sensitivity of 74% and specificity of 94%. A 
positive finding of dAVNP has a positive predictive value of 96% that the tachycardia 
mechanism is AV nodal reentry. Adenosine challenge may demonstrate other phenom- 
ena, which may offer a clue regarding SVT mechanism. 
1105-130 Septal Right Atrial Activation Expedites Conduction 
Between the Sinus and Atrioventricular Nodes 
Mario D. Gonzalez, Farahnaz R. Angella, Jamie B. Conti, Anne 8. Curtis. University of 
Norida, Gainesville, FL 
1105-I 28 Quantitative Assessment of the Recovery Property in 
Mahaim Fiber 
Pi-Chang Lee, Ming-Lon Young, Ronald Kanter, Shih-Ann Chen, Grace S. Wolff. 
University of Miami, Miami, FL, National Yang-Ming University, Taipei, Taiwan, ROC 
Background: Although most investigators do not accept the existence of internodal 
tracts, preferential conduction along regions of the right atrium may facilitate conduction 
between the sinus and atrioventricular nodes. Methods: The sequence and characteris- 
tics of endocardial atrial actwation were studied in 15 patients (age 52 + 14: 6 females) 
using a noncontact mapping system (Endowdial Solutions) after introducing a multiar- 
ray electrode catheter into the right atrium. Antegrade and retrograde conduction were 
analyzed during sinus rhythm and during coronary sinus pacing, respectively. Results: In 
7 patients the sinus origin occurred high in the crista terminalis close to the right atrial- 
superior vena cava junction. In eight patients the onset of atrial activation was displaced 
inferiorly 9-29 (17 + 4) mm from the right atrial-superior vena cava junction. Atrial activa- 
tion advanced initially inferiorly, lateral to the crista terminalis, but then crossed the crista 
terminalis and proceeded over the lateral and medial aspect of the right atrium. In all 
patients, antegrade conduction along the septum advanced as a broad band inferiorly 
and anteriorly and reached the atrioventricular node before the lateral wavefront. Retro- 
grade conduction along the septum also proceeded as a broad band towards the upper 
portion of the crista terminalis and was faster than antegrade conduction (19 ? 5 vs 30 i 
9 msec; pcO.05). Conclusions: 1. Septal activation provides the main approach to the 
atrioventricular node. 2. There is preferential conduction along the septum, probably due 
to fiber orientation (broad band) and not due to defined pathways. 
Background: Mahaim 
fiber possesses a de& 140 
remental vwrty n ,20 
related to the slow rate 5 
of recovery of its excit- CJ 100 
ability similar to that of Q 
the atrioventricular (AV) 
node. This recovery 
z So 
property has not been 5 Bo 
well studied before. Our 40 
objective is to evaluate 
this functional recovery 
property in Mahaim 
fiber. Methods: In 
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- Mahaim cuw 
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- - AVN curve 
patients with preexcitation syndrome admitted for electrophysiologic study, 8 had marked 
preexcitation with prolonged atrial-to-delta interval by decremental atrial pacing, i.e., 
Mahaim fiber (male: female: 53: age: IO-32 (19r 7)). By premature atrial extrastimuli 
(AtA2) coupled to basic driven atrial beats (A,A,) or sinus rhythm, the recovery proper- 
ties of Mahaim fiber and AV node were simultaneously evaluated with (AAc, AH) and 
(AAc, AD) plots. These plots were fitted to the equation of: ApD,= AoDo+ exp(a- AAc /z) 
for Mahaim fiber; A,H*= Ar,Ho+ exp(u- AAc /T) for AV node, in which, AAc is the corrected 
coupling interval (AAc= A1A2- (A,D,- AoDo) for Mahaim fiber; AAc= A,A,- (A,H,-AoH,) 
for AV node). A,D, is Mahaim fiber conduction time, APH, is AV nodal conduction time; 
A,Da is the shortest AD and A,H, is the shortest AH obtainable at the longest cycle 
length during sinus rhythm; ais a positive constant; T is the recovery time constant: 6 is 
the minimum AAc for which conduction occurs. Paired t-test is used for comparison. 
Results: In 7 out of 8 patients the simultaneously obtained Mahaim and AV nodal recov- 
ery curves are similar (see Figure). There are no significant differences for all the recov- 
ery curve parameters between them (Mahaim fiber: CY= 6.71f 1.18, T= 129i 52 ms, and 8= 
2855 69 ms; AV node: a= 6.16’r 0.86, ?= 177f 46 ms, and 8= 257+ 67 ms). Conclusions: 
We prove that Mahaim fiber has quantitatively similar conduction characteristics as that 
of the AV node. We speculate that it might be able to function as a secondary AV node. 
1105-129 Adenosine Challenge: A Diagnostic Test for Demonstrating 
Dual Atrio Ventricular Nodal Physiology 
Anoop K. Gupta, Satish C. Toal, Alok Maheshwari, Amit M. Vera, Yash Y. Lokhandwala. 
KEM Hospital, Mum/xi, India, Michigan State University. East Lansing, MI 
Background. Several small studies have suggested that adenosine can be helpful in dif- 
ferentiating the mechanism of narrow QRS complex tachycardias. We tested the diag- 
nostic usefulness of demonstrating dual AV nodal physiology (dAVNP) in unselected 
patients presenting with supraventricular tachycardia (S/T). Methods. We analyzed 97 
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1106-I 11 Inflammatory Left Ventricular Microaneurysms Associated 
With Apparently Idiopathic Ventricular Tachyarrhythmias 
Cristina Chimenti, Fiorella Calabrese, Gaetano Thiene, Maurizio Pieroni, Attilio Maseri, 
Andrea Frustaci. Catholic University-Department of Cardiology, Rome, /ta/y, University of 
Pa&a-Department of Pathology, Padua, /ta/y 
Background. Ventricular arrhythmias may occur in pts with apparently normal heart. 
Whether inflammatory lefl ventricular (LV) microaneurysms constitute a cause of idio- 
pathic ventricular tachycardia remains to be determined. Methods. We studied 146 
patients with severe ventricular arrhythmias and normal cardiac function at PD-echo, by 
coronary and ventricular angiography, biventricular endomyocardial biopsy and electro- 
physiologic study with biventricular mapping. Polimerase-chain reaction (PCR) was uti- 
lized to ascertain the presence of cardiotropic viruses. Results. Angiography revealed 
normal coronary arteries and absence of vasospasm following ergonovine administra- 
tion. Fifteen pts (IO%, 7 M, 8 F, mean age 37.6+16.4 ys) showed angiographic evidence 
of single or multiple LV microaneurysms (length 10.6+3.1 mm, width 7.4+4.2 mm) which 
were not visible at echo. A lymphocytic myocarditis was observed in LV biopsies of all 15 
patients. Lymphocytic myocarditis in the right ventricle was restricted to 3 pts. All 15 
patients had recurrent episodes of ventricular tachycardia with right bundle branch block 
morphology and electrophysiologically the arrhyhmias originated within or in proximity of 
the aneurysms. PCR analysis in 12 patients was found to be positive in 5 (42%): hepatitis 
C virus in 2 cases, enterovirus in 2 and influenza virus A in 1. The pts ware treated with 
antiarrhythmics and cardiac function was preserved in the next 47+31 months of follow- 
up while no major clinical events nor need for an implantable cardioverter defibrillator 
were registered. Conclusion. Myocarditis, frequently of viral origin, can cause LV 
microaneurysms resulting in severe ventricular arrhythmias in apparently normal hearts. 
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1106-l 12 Simultaneous Endocardial and Epicardial Microelectrode 
Catheter Mapping in Patients With Non lschemic 
Cardiomyopathy and Refractory Sustained Ventricular 
Tachycardia 
Angelo A. V. de Paola, Gebrgia G. Siiva, Luiz R. Leite, Roberto L. Farias, Almino Rocha 
Neto. Federal University of SZo PEW/O Paul&a School of Medicine, SBo Paula, Brazil 
Background: Sustained ventricular tachycardia (SVT) is a common complication of 
nonischemic cardiomyopathy. Results of radiofrequency catheter ablation (RFCA) in 
these patients (pt) are less effective than those with ischemic cardiomyopathy, possibly 
due to nonendocardial reentry circuits. Methods: We studied 19 pt (23 procedures) with 
refractory SVT, 11 women and 8 men, ages ranging from 41 to 73 years, mean left ven- 
tricular ejection fraction of 0.41. Two pt had rigth ventricular (RV) dysplasia and 17 
chronic chagasic cardiomyopathy. Epicardial approach was performed subxyphoid punc- 
ture guided by RV angiography in LAO projection, and two octapolar microelectrode cath- 
eters were introduced in the anterior and inferior wall of left ventricle (LV). Endocardial 
catheter was placed in the LV through retrograde arterial approach. All pt were heparin- 
ized and stable SVT was induced by RV programmed ventricular stimulation and simulta- 
neous endocardial-epicardial mapping was obtained. Coronary angiography was 
performed before epicardial RF energy delivery. Results: Concealed entrainment tech- 
niques indentified in the epicardium 313 RV and 7/20 LV circuits (p<O.O5). Two RV and 7 
LV SVT were successfully ablated. Spontaneous changes of QRS morphologies were 
observed in 9 SVT with no major changes m the pattern of endocardial or epicardial acti- 
vation. Ablation was not performed in 3 pt (1 RV, 2 LV) because risk of coronary injury. 
There were no complications. Conclusion: l-in this study population, simultaneous 
endocardial and epicardial ablation was feasible and safe. P-Epicardial ablation could be 
achieved in 47% of pt. 3.Epicardium mapping was more effective in pt with RV SVT. 4. 
Changes in QRS morphologies were not associated with different epicardial or endocar- 
dial breakthrough of the circuit. 
1106-I 13 Catheter Ablation of Idiopathic Left Ventricular Tachycardia: 
Identification of Target Sites With and Without Late 
Diastolic Potential by Entrainment Mapping Technique 
Tomoo Harada, Kazutaka Aonuma, Yasushi Tomita, Yasuhiro Yokoyama, Kiyoshi 
Nakazawa. Fumihiko Miyake. Fumio Suzuki. Stmafianna University Toy&o Hospital, 
Kawasaki, Japan, Tokyo Medical and Dental University Tokyo, Japan 
Background: Purkinje potential or late diastolic potential can be a useful marker for abla- 
tion of idiopathic left ventricular tachycardia. However, identification of exact reentry cir- 
cuit has not been well defined. Objectives: To investigate appropriate target sites for 
radlofrequency(RF) catheter ablation of idiopathic left ventricular tachycardia by entrain- 
ment mapping. Methods and Results: Entrainment mapping and RF ablation of seven- 
teen ventricular tachycardias was pertormed in seventeen patients (15 man and 2 
women; mean age, 36 years). RF ablation was applied at 52 reentry circuit sites (25 exit 
sites and 27 no exit sites including proximal and outer loop reentry circuit sites) that were 
classified based on findings during entrainment. RF ablation terminated ventricular tachy- 
cardia at 28 of 52 sites: 12 of 25 exit sites (48 %) and 16 of 27 no exit sites (59%, 
p=O.25). The incidence of ventricular tachycardia termination during RF ablation at sites 
wth and without LDP’s as follows. 
incidence of ventricular tachycardia termination at sites with and without LDP’s 
(pc0.05) 
Reentry circuit(N=52) Exit(N=25) No Exit(N=27) 
Presence of LDP LDP+ LDP- LDP+ LDP- 
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demographics, procedure and fluoroscopy times and number of lesions applied. There 
was no signrficant difference in the ablation suwess rate (100% for group A, 50% for 
group B; p=O.O6). 
Group A N=4 Group B N=36 P-Value 
Age (years) 62e-10 67+9 NS 
Study Duration (min) 299 * 77 1962 103 NS (P=O.O6) 
Fluoro Time (min) 41 t 16 34 * 29 NS 
Ablation Success 414 1 o/20 NS (P=O.O6) 
# RF Applications iii14 14r20 NS 
Conclusions: VT unrelated to MI was found in 10% of our post-MI patients referred for 
EP study and catheter ablation. No demographic feature identified this important subset 
whose VT characteristics, and ablation techniques an? very different. This finding should 
alert the physician for non-MI related VT in patient with sustained VT post MI. 
1106-132 Quality of Life is Improved After Radiofrequency Energy 
Catheter Ablation of Frequent and Symptomatic Ventricular 
Ectopics 
Kathy L. Lee, Katherine Fan, Peter Lee, Hung-Fat Tse, Chu-Pak La”. Queen Mary 
Hospifal, Hong Kong, Hong Kong, Grantham Hospit& Hong Kong, Hong Kong 
Background: Frequent premature ventricular ectopics in patients with no structural heart 
disease can be very symptomatic. 
Methods: We randomized 40 such patients with >loO premature ventricular ectopics par 
hour and moderate to severe symptoms to receive radiofrequency catheter ablation or 
conventional P-blocker therapy. Quality of life was assessed by Beck anxiety scale, Beck 
depression scale, and Nottingham Health Profile before, 2 weeks and 3 months after 
treatment. The radiofrequency catheter ablation group (n=20) and P-blocker group (n=20) 
had similar clinical characteristics, ectopic counts and quality of life scores at baseline. 
RadIofrequency catheter ablation was guided by pace-mapping of the premature ventric- 
ular ectopic beats. P-blocker was taken regularly or when required in pts who received 
conventional treatment. 
Results: In the radiofrequency catheter ablation group, 19 (95%) patients had successful 
ablation. Premature ventricular ectopic count was significantly decreased in the radiofre- 
quency catheter ablation group but not the b-blocker group. There was significant reduc- 
tion in Beck anxiety and depression scores both at 2 weeks and 3 months but no 
significant change in the Nottingham Health Profile scores after radiofrequency catheter 
ablation. In the P-blocker group, all 3 sets of scores were not changed significantly. 
Conclusions: This result suggests that radiofrequency catheter ablation is associated 
with a high rate of cure and improvement in the quality of life by relieving feelings of anxi- 
ety and depression in patients with frequent and symptomatic premature ventricular 
ectopics. 
Table 1: Improvement in premature ventricular beat count and quality of life 
Radiofrequency ablation P-blocker group 
*P<O.O5 when compared to pm-treatment value 
Termination(N=28) 6 6 12 4 
No terminatian(N=24) 1 12 4 7 ORAL CONTRIBUTIONS 
% termination 86 33 75 36 
Conclusion: RF ablation often failed to terminate idiopathic left ventricular tachycardia at 
exit sites that were shown to be concealed entrainment, At exit sites, however, the pras- 813 Atrial Defibrillators 
ence of a LDP increased the likelihood of ventricular tachycardia termination by RF abla- 
tion. LDP’s are useful guide for successful RF ablation of idiopathic left ventricular 
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1106-131 Ablation of Non-Infarct Related Ventricular Tachycardia in 
Patients With Prior Myocardial Infarction 
Luis Ft. F? Scott, Giselle Gervacio-Domingo, Gregory T. Alternose, Mark A. Coppess. 
Jeffrey E. Olgin, Douglas P. Zipes, John M. Miller. Krannert institute of Cardiobgx 
Indiana Universify School of Medicine, Indianapolis, IN 
Post-Ml Vl is typified by reentry in the subendocardial border zone surrounding prior MI. 
Preferred ablation sites have low amplitude mid-diastolic multicomponent eiectrograms 
@GM). The prevalence of VT unrelated to ihe previous M/ in patients with CAD is 
unknown. Methods: From 40 consecutives patients referred over a period of 2 years for 
post-MI VT ablation, we report a group of 4 patients (group A), whose sustained VT did 
not appear to be related to their previous Ml. Three were man, 1 woman, aged 62ctlO 
years; 2 had prior infercor MI, 1 anterior and one a non-Q Ml. All had at least moderate LV 
dysfunction (EF < 40%), 3 had previous CABG and 2 had an ICD. Common features 
were: region of ongin (judged by endocardial catheter mapping and successful ablation) 
remote from MI location; facilitation of VT initiation by Isoproterenol; mmimally presys- 
tolic, large amplitude EGM at site of successful ablation; lack of abnormal EGM during 
sinus rhythm in the winity of ablation site. In each case isoproterenol facilitated VT 
induction or sustenance and an automatic mechanism was suspected. These were com- 
pared to a group of 36 patients with prior Ml whose VT was typical of post-Ml patients 
(group 5). All 4 had successful catheter ablation, whereas IO/20 who underwent ablation 
in group B had elimination of VT. No statistical difference was found between group 
813-I 
9:15 a.m. 
Pace Termination of Atrial Tachyarrhythmias First Results of 
the Multicenter Study AT500 
Burkhard Hiigl, Katrin Ziegenbalg, Christina Unterberg-Buchwald, Carsten Israel, 
Thomas Lawo, Gerhard Schuler, lngrid Kennis, Benno van Veen. Heart Center Leipzig, 
Leipzig, Germany 
Background: Painless pacing therapies may be successful in terminating spontaneous 
atrial tachyarrhythmias as prior studies have demonstrated. The Medtronic AT500 is a 
DDDRP stimulator with the ability to continuously detect and monitor atrial episodes 
using PR-Logic’” pattern and rate recognition algorithm together with sophisticated diag- 
nostics. The AT500 contains novel prevention pacing algorithms (PPA) to prevent atrial 
tachyarrhythmias and antitachycardia pacing (ATP) to terminate atrial tachyarrhythmias. 
Methods: In a prospective worldwide multicenter study the safety and efficacy was eval- 
uated in patients (pts) with Class I or II (AHAIACC) indication for pacemaker implantation. 
During the first month post-implant, all PPAs and ATP therapies were disabled par the 
study design. Results: At the cut-off date of March 10, 205 pts (54.2% male, mean age 
67.9&l 1.6yrs, AF history in 89.7%) ware enrolled wth a mean follow-up time of 3.2h1.8 
months. Stored data, including electrograms were available for 199/205 (97.1%) pts. In 
146/199 pts (73.4%) 68,263 ATiAF episodes were detected during 19,225 days. 83/199 
pts (41.7%) had 12,483 treated AT/AF episodes of which 6,832 were successfully termi- 
nated, yielding a crude ATP efficacy rate of 54.7%. After adjustmg for multiple episodes in 
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the same pt, the efficacy rate for the average pt is 38.3% (95%Cl: 32.7%.44.2%). Electro- 
gram information is available for 962 episodes, showing an average atrial cycle length 
(prior to therapy delivery) of 239.51t47.9 ms. Conclusions: The first data demonstrate 
that painless ATP therapy is effective in terminating atrial tachyarrhythmias. Further 
investigation is necessary to improve therapy efficacy by optimizing the parameter set- 
tings of ATP therapies. 
813-2 
9:30 a.m. 
Atrial Fibrillatory Frequency Predicts Atrial Defibrillation 
Threshold and Early Arrhythmia Recurrence in Patients 
Undergoing Internal Cardioversion of Persistent AF 
Andreas Bollmann, Maika Mende, Annerose Neugebauer, Dietrich Pfeiffer. University 
Hospital, Department of Cardiology, Leipzig, Germany University Hospital, Deparhnent 
of Cardiology Magdeburg, Germany 
Results: Mean follow-up 
duration 13.3*6 months. 
All patients are currently 
in SR. 112 episodes of 
persistent AF were suc- 
cessfully treated by 
patient-activated atrial 
defibrillation. The 
median duration of these 
episodes was 7.3-c27 
hours. 217 spontane- 
ously terminating AF epi- 
sodes occurred in 80% 
of patients (paroxysmal 
This study was conducted to analyze the meaning of atrial fibrillatory frequency obtained 
from the surface EGG for prediction of energy requirements and early arrhythmia relapse 
in patients undergoing internal cardioversion of persistent atrial fibrillation (AF). Nineteen 
consecutive patients (mean age 5&l 1 years, 11 male, 8 female) with persistent AF (> 7 
days) underwent internal cardioversion. A biphasic shock synchronized to the R wave 
was delivered between two catheters positioned in the high right atrium (HRA) and the 
coronary sinus (CS). Atrial fibrillatory frequency was estimated prior to cardioversion 
from surface ECG lead Vl. After filtering, QRST complexes were subtracted using a tem- 
plate matching and averaging algorithm. The resulting fibrillatory baseline signal was 
subjected to Fourier transformation, displayed as a frequency power spectrum and the 
peak frequency was determined in the 3 to 12 Hz frequency band. Atrial defibrillation 
threshold (ADFT) was determined using a step-up-protocol, All patients were cardio- 
verted successfully with a mean ADFT of 7.6 + 6.5 Joule (range 0.5 to 25). There was a 
strong positive correlation between fibrillatory frequency and ADFT (R=.71, p=.OOi). AF 
recurrence within 30 days after successful cardioversion occurred in 11 patients (58 %). 
Receiver operating characteristic analysis (ROC) revealed a fibrillatory frequency > 7 Hz 
to be 64 % sensitive and 88 % specific to predict AF recurrence. It was observed in 4111 
cases (36 %) with a fibrillatory frequency < 7 Hz, as opposed to 7/8 cases (88 %) with a 
fibrillatory frequency > 7 Hz (pz.02). No other variable affected ADFT or AF recurrence. 
In conclusion, fibrillatory frequency obtained from the surface ECG predicts both ADFT 
and early AF recurrence in patients with persistent AF undergoing internal cardioversion. 
AF - PAF). The median duration of these episodes was 46 seconds +I4 hours. The onset 
patterns of paroxysmal and persistent AF differed, with PAF episodes predominating 
from midday to midnight and persistent episodes peaking nocturnally as demonstrated in 
the onset graph below. 
Conclusion: The difference in onset patterns between per&tent and paroxysmal AF 
suggests different mechanisms of the arrhythmias. Paroxysmal AF may be adrenergic 
mediated and persistent vagally mediated. Nocturnal atrial overdrive pacing algorithms 
may be a beneficial adjunctive therapy in this subgroup of AF patients resulting in a 
reduction in the requirements for atrial defibrillation and improving patient tolerability of 
atrial defibrillators. 
813-5 
IO:15 a.m. 
Do Patients With Highly Symptomatic Atrial Fibrillation 
Always Feel Their Episodes? 
Carl Timmermans, Luz-Maria Rodriguez, Gregory M. Ayers, Suzanne Philippens, Marta 
Antonucci, Paul Barenbrug, Hein J. J. Wellens. Academic Hospital Maastricht, 
Maastricht, The Netherlands 
813-3 
9:45 a.m. 
A Prospective Randomized Comparison of Transvenous 
and Active Can Atrial Defibrillation Thresholds 
Rachida Bouhouch, Eric J. Rashba, Robert A. Joy, Scott Kirby, Stephen R. Shorofsky, 
Ahmed F. Osman, Michael R. Gold. University of Maryland, Baltimore, MD 
Background: Active left pectoral Cans are routinely used for implantable ventricular 
defibrillators (ICDs) because such lead configurations reduce defibrillation thresholds 
(DFTs). Dual chamber ICDs are now capable of treating atrial fibrillation (AF), but the 
optimal shocking vector for atrial defibrillation is unknown, To assess if an active Can 
reduces atrial DFTs, we evaluated 33 patients (pts) undergoing ICD implantation. 
Methods: Paired randomized comparisons of the atrial DFTs were made in two configu- 
rations: the dual coil transvenous lead alone (Lead: RV@SVC) and the dual coil lead with 
an active Can (Can: RV&VC+Can) configuration. AF was induced with ramp pacing 
and DFTs were measured with a step-up protocol starting at 0.5 J. The biphasic wave- 
form had 60/50% tilts and a 150 pF capacitance. 
Results: The pts had a mean age of 61+12 yrs and 85% were male. The mean ejection 
fraction was 31511% and 36% had a history of AF. A total of 274 R-wave synchronized 
shocks were delivered in AF with no ventricular arrhythmias induced. In the two configu- 
rations tested, there were no significant differences in atrial DFTs, although shock imped- 
ance decreased while peak current increased with an active Can (Table). In 16 pts (48%) 
the DFT was lower in the lead configuration, in 10 pts (30%) the DFT was lower with the 
Can and in the remaining 7 pts (21%) DFTs were the same. 
Conclusions: In contrast to ventricular defibrillation, the use of an active left pectoral 
Can does not reduce atrial DFTs. The increased current requirement at DFT with the 
Can indicates that shuntmg current away from the SVG lead does not improve the shock- 
ing vector. Progarmmable shock vector may be useful for atrial defibrillation to minimize 
DFTS. 
Background: It has been reported that patients diagnosed with symptomatic atrial fibril- 
lation (AF) do not recognize many of their AF episodes. We hypothesized that even in 
patients with highly symptomatic, drug-refractory AF, not all episodes would be recog- 
nized. Methods: Ten patients with the Metrix atrial defibrillator (Atrioverter, Guidant, Inc.) 
were followed for 15.3 (4.8-26.8) months, with the device in a rhythm monitoring mode. 
The device evaluated the patient’s rhythm every hour. Additionally, each patient was 
given a diary to record the time of onset and duration of the AF episodes they had 
noticed. At each clinical follow-up or at the time of treatment of AF episodes, the device 
was interrogated and the diary collected. From the devux memory data, the onset and 
duration of the individual episodes were determined. Results: All 10 patients had epi- 
sodes of AF either documented by the device or by the patient diary (227 episodes, aver- 
age 22.7, range Z-58). Diary data were available for 220 of 227 episodes. We excluded 1 
patient, implanted because of a tachycardia-induced cardiomyopathy and recurrent heart 
failure, who had 13 asymptomatic episodes. Of the remaining 207 episodes, 9 (4.4%) 
episodes of AF (4 patients, 1-5 episodes/patient) were perceived by the patient but not 
detected by the device. Of the 198 episodes detected by the device, 185 (93%) episodes 
were perceived and reported by the patient (6 of 9 patients had l-3 episodes not per- 
ceived). For 168/185 episodes where the patients recorded the exact onset time, 90 
(54%) were concordant within 1 hour for the device and the patient. For the remainmg 78 
of these episodes, the device recorded AF before (n= 62, mean: 4.35 hours, range: 1.06. 
22.09 hours) or after (II= 16, mean: 2.29 hours, range: 1.05-6.51 hours). Conclusion: 
Nearly all episodes of AF are perceived by patients with symptomatic, drug-refractory AF. 
Rarely do patients feel symptoms of AF when the arrhythmia is not present. This percep- 
tion may be due to symptoms associated with atrial ectopy. These findings may be useful 
for the evaluation of therapeutic results in patients with symptomatic AF. 
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823-l HERG K897T Polymorphism and QT Interval in a Random 
Middle-Aged Population 
813-4 
IO:00 a.m. 
Diurnal Pattern of Atrial Fibrillation Onsets Determined 
From Atrial Defibrillator Halters in Persistent Atrial 
Fibrillation Patients 
Eeva PietilB, Heidi Fodstad, Elmo Niskasaari, Paivi Laitinen, Heikki Swan, Markk” 
Savolainen, Antero KesBniemi, Kimmo Kontula, Heikki Huikuri. University of Oulu, Ou/u, 
Finland, University of Helsinki, Helsinki, Finland 
Philip A. R. Spurrell, Andrew R. J. Mitchell, Kayvan Kamalvand, Ann Topham, Neil Sulke. 
Eastbourne General Hospital, Eastbourne, United K;ngdom 
Background: The natural history of atrial fibrillation (AF) in patients treated with atrial 
defibrillators is unknown. The diurnal pattern of AF onsets was determined from device 
Halters. 
Methods: 15 patients, mean age 63+14 years and 80% male, were implanted with the 
Medtronic Jewel@ AF device to treat persistent AF. There was no pre-implant history of 
self-terminating paroxysms of AF. Patients performed out-of-hospital patient-activated 
atrial defibrillation shocks following self-administration of sedation. Onset times of AF 
were determined from device Halters. 
Background: Large interindividual variation occurs in the duration of the QT interval in 
subjects without apparent heart disease. This study was designed to test the hypothesis 
that a recently observed K897T polymorphism in the HERG gene coding for the alpha 
subunit of the rapidly activating delayed rectifier K+ channel may influence the QT inter- 
val duration. Methods and results: QT interval was measured by a tangent method from 
a IP-lead ECG in a randomly selected middle aged healthy population (226 men/l87 
women, mean age 50.5+5.9 years). The maximum and minimum QT interval and QT dis- 
persion were calculated and the QT intervals were corrected for heart rate using Bazett’s 
formula. DNA samples were genotyped for the HERG K897T polymorphism by poly- 
merase chain reaction. The allele frequencies were 0.84 (A) and 0.16 (C). HERG K897T 
polymorphism was associated with the duration of QT interval and QT dispersion in 
males but not in females. QTcmax was 416.0+27.2 ms in the AA genotype and 
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405.5t22.9 ms in the genotypes AC or CC (p=O.O06). QT dispersion was 46.6&!2.2 in 
the genotype AA and 38.9e15.1 in genotypes AC or CC (p=O.Ol). Conclusions: Com- 
mon polymorphism K897T in the HERG gene is associated with the length and disper- 
sion of the ventricular repolarization rn males. Duration of the QT Interval in females is 
influenced by other factors. 
823-4 
11:45 a.m. 
Short- and Long-Term Reproducibility of the QTlRR 
Relationship in Healthy Subjects 
823-2 
11:15 a.m. 
Bazett Formula Is Not Suitable for Assessment of the 
Circadian Variation of the Heart Rate-Corrected QT Interval 
Velislav N. Batchvarov, Azad Ghuran, Katerina Hnatkova, Polychronis Dilaveris, Mandy 
Graham, Patrik Wrbom, A John Camm, Marek Malik. Sf.Georg& HospitalMedical 
School, London, United Kingdom 
Velislav N. Batchvarov, Patrik F&born, Polychronis Drlaveris, A John Camm, Marek Malik. 
Cardiological Saences, St. Georgek Hospital Medical School, London, United Kingdom 
Background: Circadian variation of the heart- 
rate corrected QT interval should reveal the 
heart-rate independent (mainly autonomic) influ- 
ences on the duration of ventricular repolarisa- 
tion. We compared the circadian variation of the 
QT interval corrected for heart rate by Bazett 
formula and by a correction formula QTc=QTl 
RR? with parameters yoptimised individually for ,) ,. -r I ,: ,, 
each subject. Methods: Twenty-four hour 12. 
lead digital ECGs (one 10-s EGG every 2 min, 
250 Hz, 12 bit A/D, SEER MC, Marquette GE) were recorded in 49 healthy subjects (25 
men, 34210 years). QT interval was measured automatically (downslope inflex tangent 
method, QT Guard, Marquette). The maximum QT (QT max) was corrected by Bazett for- 
mula, and by the individual power model. The circadian variation was estimated by har- 
monic regression analysis (parameter =a +j3,cos(2nT/Z4)+p,sin(2nT/24)), where T is the 
time. Results: Circadian variation (p<O.O5, F test) was found in 24149 (49%) subjects for 
QTc (Bazett) and in 47/49 (95%) for the individually corrected QT max (p<O.OOO1,chiZ- 
test). RR and QT max showed circadian pattern in 45149 (91) and 49149 (100%) respec- 
tively. The circadian variation of QTc (Bazstt) was out of phase with RR, QT max and the 
individually corrected QT max. (Figure: circadian variation of the mean values. Open cir- 
cles - predicted values, filled circles . actual values). Conclusion: There is a circadian 
pattern of ttie heart rate-corrected QT interval. Bazett formula, however, conceals the 
extra-heart rate influences on the QT Interval and is not suitable for analysis of Its circa- 
dian variation. Heart rate-correction formula with individually calculated parameters is 
oreferable. 
Background: The short- and long-term repro- 
ducibility of the relation between the QT inter- 
val and the heart rate is not known, though 
assumed in cardiac safety studies of new 
drugs. Methods: 24.hour 12-lead digital 
EC& (SEER MC, Marquette GE) were 
recorded 4 times in each of 22 healthv sub- 
jects (11 male, age 3228 years), with periods 
between the 1 stand subsequent recordings of 
24 hours, 1 week and 1 month. One ECG was 
recorded every 30 seconds and the median QT interval was taken for analysis. A non-lin- 
ear regression analysis was used to find the best fit of the 24-hour QT/RR relationship. 
Results: The QT/RR relationship was best fitted by a power model (QT=a+b(RR)‘). 
Within each subject, the coefficients a, p and y were reproducible between the succes- 
sive recordings (~~0.78, 0.10 and 0.18 for a, p and y, respectively, repeated rnea~ures 
ANOVA). Figure: Comparison of QT/RR relations after one week and after one month in 
two patients. Conclusions: There is a high short- and long term intra-subject stability but 
a high inter-subject variability of the QT/RR relationship in normal subjects The 24-hour 
QTIRR relation from serial 24.hour recordings can be used for assessment of drug 
effects and the risk of ventricular arrhythmias. 
823-5 
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QT Variability Has Better Predictive Value Than Standard 
Methods in Identifying Arrhythmic Events in Post- 
Myocardial Infarction Patients 
Massimo lacoviello, Domenica De Laura, Pietro Guida, Brian Rizzon, Filippo 
Mastropasqua, Paolo Rizzon, Maria V PitaaIrs. lnsfifute of Cardiology-University of Sari, 
Bari, Ma/y 
Background: Standard methods have a low capability of identifying among patients with 
acute myocardial infarction those prone to develop arrhythmic events. The aim of the 
present study was to prospectively analyse the prognostic value of dynamic repolariza- 
tion measurements in patients with acute myocardial infarction. 
Methods: 171 patients with acute myocardial infarction (57+12 years, 54 females, 86 
with antenor location) underwent 24.hour ECG monitoring periods, phenylephrine test to 
analyse baroreflex sensitivity and the evaluation of ejection fraction at pre-discharge 
time. From the 24-hour ECG monitoring the following parameters were evaluated: the 
presence of non-sustained ventricular tachycardra, the mean RR interval, the standard 
deviation of RR intervals, the slope of QT-ap&RR and of QT-end/RR linear regression 
analysis by using the ELA Medical system. During follow-up (11*9 months), 6 deaths 
(3.6%) (2 of whom were sudden) and 4 spontaneous sustained ventricular tachycardia or 
ventricular fibrillation (1.8%) were observed. The sudden deaths and the malignant ven- 
tricular arrhythmia were considered as arrhythmic events. Log-rank test was used to 
analyse the prognostic value of the variables considered. 
Results: QTend slope 2 0.22 (~~0.05) QTa slope 2 0.21 (pcO.OOi), ejection fraction 5 
35% (pcO.Ol), but not baroreflex sensitivity 5 3 mmHg/ms, neither non-sustained ventric- 
ular tachycardia, netther standard deviation of RR intervals c 100 ms were related with 
arrhythmic events. QTa-slope showed the best predictive value (table). 
Conclusions: The evaluation of ventricular repolarization dinamicity is able to identify 
patients with increased arrhythmic risk and shows a better predrctive accuracy than stan- 
823-3 
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Autonomic Nervous System Influences on QT Interval in 
Normal Subjects 
Anthony R. Magnano, James A. Reiffel, Stephen F. Holleran, Daniel M. Bloomfield. 
Columbia University Co//ege of Physicians & Surgeons, New York, NY 
Background: The QT interval (QT) IS known to vary as a function of resting heart rate 
(HR). However, autonomic nervous system influences on QT during non-resting condi- 
tions require clarification. Thus, we compared the changes in QT as HR increased in 
response to isoproterenol (ISO), atropine (AT) and bicycle exercise (EX). Methods: 
Twenty-five normals (12 male / 13 female; 30 * 9 years) underwent EX, IS0 and AT infu- 
sion, Serial 12lead ECGs were recorded at steady state during each condition and QT 
intervals were analyzed using Marquette QT-Guard. The end of T wave was defined by 
the intersection between the terminal T wave slope and the isoelectric line. The HR-QT 
data for each subject during each condition were fitted using linear regression analysis. 
The HR-QT slopes, quantiving QT adaptation to HR, as well as QT at 100 bpm (derived 
from the fitted lines) were analyzed by repeated measures ANOVA. Results: As HR 
increased, QT intervals were longer for isoproterenol in comparison to EX or AT, which 
were similar. The HR-QT slope (msibpm) was less steep for IS0 (-0.83 + 0.53) than for 
AT (-1.45 + 21) or EX (-1.37 f 0.23) (p<O.OOOi). At 100 bpm, IS0 demonstrated a longer 
QT (pcO.0001) vs. EX or AT (see figure). 
Conclusion: Independent of HR, QT interval is strongly influenced by autonomic condi- 
tions. As heart rate increases, sympathomimetic stimulation is associated with less eff- 
cient QT interval shortening and, therefore, greater absolute QT intervals than states of 
predominant vagal wthdrawal. Resting HR-QT behavior cannot accurately be extrapo- 
lated to active states. 
dard methods. 
Sensitivity Specificity Positive Negative WI 
QT-apex slope 
QT-end slope 
Ejection fraction 
Non-sustained ventricular 
tachycardia 
Baroreflex sensrtivity 
Standard deviation of RR 
intervals 
predictive 
V&G? 
83 84 16 
83 80 13 
66 83 9 
17 94 8 
17 94 8 98 NS 
66 47 3 98 NS 
predictive Rank p 
value 
99 <O.OOl 
99 <0.05 
99 <O.Ol 
98 NS 
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1137-I 11 Long-Term Clinical Outcome in Patients with Spontaneous 
Early Reinitiation of Atrial Fibrillation After Internal 
Cardioversion 
Hung-Fat Tse, Lau Chu-Pak. Division of Cardiology, Department of Medicine, University 
of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong 
Background: Spontaneous early reinitiation of atriai fibrillation (ERAF) was observed in 
a significant proportion of patients (pts) after successful cardioversion using both external 
or internal method. Although previous studied have demonstrated that antiarrhythmic 
agents or atrial pacing can acutely suppress ERAF, long-term clinical outcome of patients 
with ERAF remain unclear. Methods: We studied the effect of ERAF on the clinical out- 
come in 67 pts (49M, 18F; mean age. 62r9 yrs) with persistent AF (mean AF duration: 
29+39 months), who underwent successful internal cardroversion (mean defibrillation 
threshold: 330r56V, 4.4+0.8J). Post-cardioversion, all pts received oral sotalol and were 
evaluated for AF recurrence at 1 week, 1 months and then every 3 monthly or if pts expe- 
rienced symptoms of recurrent AF. Results: ERAF was observed in 19 pts (28%) which 
was successfully treated acutely with either sotalol or atrial pacing. 17 pts (29%) had 
recurrence of AF within the first day. After 1 year, only 13 pts (19%) remained in sinus 
rhythm. Kaplan-Meier analysis revealed a significantly poorer outcome with regard to the 
recurrence of AF in pts with ERAF post-cardioversion (hazard ratio 2.15, p=O.OlZ) (left 
panel) and in those with AF > 2 years duration (hazard ratio 1.8, p=O.O09) (right panel). 
Multivariable analysis demonstrated the presence of ERAF (p<O.OOl) and longer dura- 
tion of AF (p-zO.05) were independent predictors for shorter duration of arrhythmia free 
period. Conclusions: Both the occurrence of ERAF or longer duration of AF was inde- 
pendent predictor for AF recurrence after internal cardioversion. Despite acute suppres- 
sion of ERAF with sotalol or atrial pacing, ERAF was associated with a poor long-term 
outcome. Whether long-term overdrive atrial pacing or radiofrequency ablation of focal 
source of trigger can prevent ERAF and long term AF recurrence require further investi- 
gation. 
1137-I 12 Sinus Rhythm Duration Between Episodes of Atrial 
Fibrillation 
Thomas Lawo, Burkhard Htigi, Carsten Israel, Christina Unterberg, Marcel Van den Berg, 
Benno K. Van Veen, The World-wide AT500 Investigators. University Hospitai Bochum, 
Bochum, Germany 
INTRODUCTION: Re-initiation of atrial fibrillation (AF) is a common problem after termi- 
nation of atnal arrhythmias. When the duration of sinus rhythm (SR) is very short the phe- 
nomenon is called Early Recurrence of AF (ERAF). ERAF occurs both after 
spontaneously terminated episodes as well as after cardtoverted or pace-terminated 
ones. The Medtronic AT500 is a pacemaker capable of delivering atrial anti-tachy pacing 
therapies. Furthermore, it has extensive monitoring capabilities (such as EGM storage), 
and as such re-initiations of AF, including ERAF can be studied with this device. 
METHODS: We retrospectively analysed 16397 atrial arrhythmias in 194 patients (pts) 
and calculated the time pts were in sinus rhythm (SR) between 2 consecutive episodes. If 
this time was shorter than a pre-defined threshold. the episode was counted as re-initi- 
ated. Re-initiation threshold was varied between 1 second and 320 minutes. 
RESULTS: The total number of episodes per pt varied from 1 to 685. The number of re- 
initiations per pt varied from 0 to 361. With the w-initiation threshold set to 1 minute, 152 
pts experienced one or more reinitiations of AF. On average, 34% of all atrial episodes 
was followed by a re-initiation. This percentage depends on the above threshold; the 
graph shows this function. 42 pts (22%) never experienced any re-initiation within 1 
minute. However, this highly depends on the total number of episodes (s 45 in this group; 
< 685 for the whole group). 
CONCLUSION: 78% of all pts expe- 
rienced AF re-initiations within 1 Od 
minute, the average chance for re- 
initration was 34%. The results sug- 
gest that this phenomenon, includ- 
1 
I 
ing ERAF, needs to be taken Into 
serious consideration when treating 
atrial arrhythmias. 
I, 
1 
L- 
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1137-l 13 Atrial Electrical Remodeling Following Cardioversion of 
Atrial Fibrillation in Humans 
Walter Kusumoto, Merritt H. Raitt. Portland VA Medical Center. Portland, OR, Oregon 
Health Sciences University Port/and, OR 
The reversibility of atrial electrical remodelrng after short periods of induced atnal fibrilla- 
tion (AF) has been demonstrated in human studies. However, it is less clear that atrial 
electrical remodeling is reversible following long episodes of spontaneous clinical AF. We 
examined this question by measuring the atrial effective refractory period (ERP) following 
cardioversion rn humans with persistent AF. 
Methods: Patients referred for cardioversion were eligible for the study if they had non- 
valvular AF, a left atrial size < 5 cm, an EF >35%, were not taking an antiarrhythmic med- 
Ication, were not taking dritiazem or verapamil, and had not had open heart surgery 
(OHS) in the last 3 months. The 21 patients enrolled were all men and had a mean age of 
64i5 years. Associated problems included: decreased left ventricular ejection fraction 
29%, hypertension 43%, diabetes 29% coronary artery disease 58%, prior MI 22%, and 
prior OHS 24%. Lone AF was present in 5 patients. At the time of cardioversion patients 
had been in AF for between 1.5 and 12 months. We measured the ERP during autonomic 
blockade at the high lateral rrght atrial wall, proximal coronary sinus and distal coronary 
sinus 10 minutes and 1 hour after cardioversron. The ERP was measured during continu- 
ous pacing at cycle lengths (CL) of 550 ms and 400 ms with extra stimuli introduced at 
progressively longer coupling intervals until atrial capture. The ERP measurement was 
performed twice and if the ERP values differed by x 5 ms a third measurement was per- 
formed. 
Results: The reversal of atriai electrical remodeling was demonstrated. There was an 
increase in the ERP between 10 minutes and 1 hour after cardioversion at the high lateral 
right atrium (CL 550: 225?4.8 vs. 235~t6.2 ms, p=O.O03, n=19 and CL 400: 220+5.7 vs. 
225~6.7 ms, p=O.Oi& n=l6), the proximal coronary sinus (CL 550: 230f6.3 vs. 235f6.9 
ms, p=O.lO, n=15 and CL 400: 217r5.3 vs. 223?5.6 ms, p=O.O5, n=13), and distal coro- 
nary sinus (CL 550: 231k5.6 vs. 242zL6.6 ms, p=O.O02, n=ll and CL 400: 217k6.2 vs. 
215k8.3 ms, ~~0.46, n=lO). 
Conclusion: Atrial electrical remodeling is reversible in humans after long periods of per- 
sistent AF. This finding may have important implrcations for the care of patients with AF. 
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1138-l 14 Electrocardiograms Abnormalities and Heart Block in 
Transgenic Mice That Overexpress Calreticulin 
Gang Liu, Kimitoshi Nakamura, Rashida Gulamhusein, Marek Michalak, Katherine 
Kavanagh. University of Alberta Cardiology of Medicine, Edmonton, AB, Canada 
Background: Calreticulin 
(cal) is a CaP+-bindrng multr- 
functional protein of the endo- gl 
plasmic reticulum that has se” 
been implicated in regulation :Q 
of intracellular Ca2+ and cell 0 
5ELIS ,,a rm zd,s ll i l No 
adhesion. Cal is down regu- “‘Porn wm w** 
l&d after birth but is highly 
expressed in developing 
hearts. Transgenic (Tg) mice with an 11 -fold increase in expression of cal have been doc- 
umented to develop a dilated cardiomyopathy at about 11 days of age and 80% die sud- 
denly at about 3 weeks of age. The purpose of this study is to determine if the Tg mice 
were experiencing arrhythmias that might explain their sudden death. Methods: 17 wild 
type and 17 transgenic non-sedated mice were placed in an apparatus that allowed 
access to limbs for positioning of ECG leads on the foot pads. Five ECG limb leads were 
simultaneously recorded. Results: The PR interval was significantly longer in Tg mice 
compared to Wt mice even in the first week of life. The PR rnterval prolonged with age in 
Tg animals and by the third and final week of life was more than double the PR interval of 
Wt mice. Heart rate was significantly slower in Tg mice compared to Wt mice in all age 
groups. Unlike Wt mice heart rate did not increase with age, in the final week of life it was 
about 30% slower that Wt mice. Arrhythmias were recorded in 9 (53%) of the transgenic 
mice during ECGs acquisition. Second or third degree heart block was recorded in 6 of 
the animals and atria arrhythmias including sinus pauses were recorded in 3 mrce. 5 
(29%) of the transgenic mice that died suddenly at three weeks did not have an ECG 
recording within 48 hours of death. Conclusion: Cal overexpression is associated with 
significant ECG abnormalities and arrhythmias including heart block. This is the first 
ieport indicating that cal, an endoplasmic reticulum protein, may play a role in develop- 
ment of heart block and dilated cardiomyopathy, which are common clinical entities. 
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1138-I 15 A Method of Accurate Three-Dimensional Reconstruction of 
the Atrioventricular Conduction System 
R. Kannan Muiharasan, Ashwin Nag@, Andrew J. Hamilton, David D. McPherson, 
Sarqa Bharati. Northwestern University Medical School, Chicago, IL. Hope Children’s 
Hospital, Oak Lawn, IL 
Background: The atrioventricular conduction system (AVCS) is a curved complex strut- 
ture that has not been reconstructed in three dimensions (3D) limiting accurate clinical 
and pathological correlation. The AVCS includes the AV node and Iis approaches, AV 
bundle (penetrating, branching and bifurcating parts), and the bundle branches. 
Method: To determine if 30 computer techniques could accurately reconstruct the 
AVCS, microscopic slides of every 20th serial section (cut at 7 micron level) of the AVCS 
were digitized into 600 dots/inch color images. The external outlmes of each section 
were manually segmented using commercially available 3D rendering software 
(Rhinoceros) The AVCS was traced using information gleaned from light microscopy 
and then superimposed onto the external outlines. To account for inherent errors in his- 
tological slide preparation, an optimization procedure was used to align the external out- 
lines of all sections. Using Matlab software, the color images were converted to 
monochrome, and the optimal rotation and translation of each section was establlshed by 
maximlzlng the area of overlap between adjacent sections. A sequential one-dimen- 
sional minimization algorithm was used for optimization. Rotation and translation values 
were then used to align the external outlines and the superimposed conduction system, 
reconstructmg the AVCS in 3D. To validate the method, the algorithm was applied to a 
digitized image transformed by known translations and rotations. 
Results: The validation procedure showed that each test Image aligned in translations 
and to within 0.01’ in rotations. The spatial error determined by the resolution of the dig- 
itized images was +0.5/600 Inch (t21 microns). 3D reconstruction of every 201h serial 
section clearly demonstrated the complex curved shape of the entire AVCS. 
Conclusion: We have demonstrated an accurate method of 30 reconstruction of the atri- 
oventricular conduction system. 3D reconstruction of the atrioventricular conduction sys- 
tem permits accurate pathological and electrophysialogical correlation of the conduction 
system, providing more accurate means of mapping and conduction system interven- 
t1ons. 
1138-I 16 Age-Related Changes in A-V Conduction in Connexin-40 
Deficient Mice 
Wei Zhu, Samlr Saba, Caterina Sellitto, Davtd L. Paul, Brian VanderBrink, Mark S. Link, 
Munther K. Homoud, N. A. Mark Estes, Ill, Paul J. Wang. New fnghd Medicai Center, 
Boston, MA, Harvard Medical School, Boston, MA 
Background: Previous studies have identified A-V conduction abnormalities in young 
(about 11 week) connexin 40 deficient mice. The purpose of this study was to examine 
the age-related changes in atrioventricular conduction from 11 to 36 weeks of age in con- 
nexin-40 (040) deficient mice. 
Methods: Twenty-one 11 -week-old mice (10 Cx40 -I- and 11 wild-type Cx40 +/+) and 
twenty-eight 36-week-old mice (16 6x40 -/- and 12 wild-type Cx40 +/+) underwent pro- 
spectcve blinded in viva electrophysiology study. With a 2F octapolar catheter placed from 
the right atrium to the right ventricle,recording a His bundle electrogram, standard proto- 
cols were used to obtain antearade atrioventricular conduction parameters. 
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atrial systole. MEAM measurement of LA size used the distance from the anterior wall of 
the LA to the LA posterior wall in a plane parallel to the mitral valve atinulus during atria 
end-systole by gating to the QRS complex. All values are expressed as the mean + stan- 
dard deviation. Results: 
LA Size by Echo versus MEAM 
LA Size by Echo (mm) LA Size by MEAM (mm) 
40.2 f 5.9 40.3 i 5.9 
There is a close fit between the results of echocardiography and magnetic mapping, 
Rz0.72, P=O.O2. For only seven of the 34 patients did LA size measured by MEAM differ 
from that measured by echocardiography by more than 0.5 cm. Conclusions: Magnetic 
electroanatomic catheter mapping appears to provide an accurate assessment of ana- 
tomic distance within the left atrium. The results of MEAM correlate with echocardio- 
graphic assessment of LA size, and may prove useful in tracking LA size with repeat 
mapping procedures. 
1138-l 18 Myocyte Contractility and Ouabain Toxicity in Transgenic 
Mice Which Overexpress the Alpha3 lsoform of the Na,K- 
ATPase 
Glenn T. W&al, Raphael Zahler, Shahia Jllani, Fuhua Chen. Mattel Children’s Hospital 
at UCLA, Los Angeles, CA, Kaiser Permanente, Los Angeles, CA 
The N&K-ATPase, the Na+ pump, is required to establish the transsarcolemmal Nat and 
K+ gradient needed for cell excitability. The Na,K-ATPase a3 isoform possesses a lower 
binding affinity for Na’ and has a higher binding affinity for ouabaln, a cardiac glycoslde. 
Ouabaln inhibits Na,K-ATPase activity and exerts a positive inotropic effect on the heart. 
The purpose of this study was to examine the effect of ouabain on contractility in myo- 
cytes isolated from transgenic mice (TG) which overexpress the N&K-ATPase a3 iso- 
form. As expected, perfusion with ouabain increased contraction amplitude in a dose- 
dependent fashion. In TG myocytes, contraction amplitude Increased slightly more than 
in wild type (WT) cells. Unexpectedly, perfusion with higher concentrations of ouabain 
resulted in sigmficantly less signs of toxicity (arrhythmia’s and contracture) in TG cells 
than in WT cells. After 10 minutes of perfusion with 1000 uM ouabain TG cells had a tox- 
icity score of 2.71i0.8 (mean?SE, n=6) and WT had a mean score of 4.0*0, n=4)(p<0.05, 
ANOVA with repeated measures). TG mice did not exhibit a negative staircase in peak 
[Ca”], (initial 26Oi76 nM, n=6 vs steady state 28oilOO nM, n=6, ~~0.05) as compared 
to WT (initial 430+102 nM, n=12 vs steady state 316+66, n=lZ, pe.05). TG also exhibited 
a trend toward increased resting [Na+li (TG 20.3kl.8 mM, n=4, vs WT 17.6k2.0 mM, 
n&i). In summary, myocytes which overexpress the Na,K-ATPase a3 isoform are rela- 
tively protected from the toxic effects of ouabain as compared to wild type cells, but retain 
a similar positive contractile response. However, the mechanisms underlying the protec- 
tive effect of a3 overexpression remain unclear. We speculate that gene therapy-induced 
a3 overexpression in patients treated with cardiac glycosides could result in improved 
contractility with decreased toxic cardiac side effects. 
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Results: Within each age group (11 and 36 weeks), the Cx 40 -/- mic e had longer PR. 
QRS, AH, HV, AV Wenckebach (AVW), and AVNERP compared to +/+ controls. The PR 
and AH prolonged with age in both Cx 40 *I- and +/+ groups. However, I” Cx 40 -/- Thromboembolism 
1139 Atrial Fibrillation/Flutter: 
group, the QRS, HV, and AVW also increased with age. The magnitude of change in AH 
was greatest I” the Cx 40 -i- group. Monday, March 19, 2001, Noon-2:00 p.m. 
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1139-I 19 Incidence of Cerebral Embolism in Patients With Atrial 
Fibrilation and Atrial Thrombi and/or Spontaneous Echo 
Contrast: A Prospective and Serial Study 
“P&O1 (comparison between the same age group); SP=O.O4, tPc0.01 (comparison Harald Schmidt, Heyder Omran, Torsten Sommer, Michael Steffens, Stefan Illien, Monika 
between the same genotype group). Bees, Hans Schild. Berndt LOderitz. Univewty of Bonn, Bonn, Germany 
Conclusions: Aging is associated with changes in AV nodal conduction in both Cx 40 
deficient mice and wildtype controls. Abnormalities of ventricular conduction are also 
seen with aging in Cx 40 deficient rmce, suggesting a possible role of connexins in age- 
related changes in conduction. 
Background: The presence of spontaneous echo contrast (SEC) and/or thrombl In 
patients (pts) with atrial fibrillation (AF) is associated with an elevated risk of cerebral 
embolism. The aims of this prospective study were (1) to evaluate the fate of atrial 
thrombi in anticoagulated AF pts and (2) to determine the incidence of cerebral embolism 
1138-I 17 A Comparison of Left Atrial Size by Two-Dimensional using cranial MRI- sequences during a follow up period of one year. Methods: The study 
Transthoracic Echocardiography and Magnetic Endocardial 
group consisted of 22 pts with atrial thrombi (age 65*11 years) and 40 pts with SEC (age 
C :atheter Mapping 
64+10). 19 pts with AF without thrombi or SEC served as controls (age 52*12). All pts 
underwent serial transthoracic and transesophageal echocardiographic studies, serial 
Vickas V. Pat@, Jian-Fang Ren, Erica S. &do, Dusan Z. Kocovic, Francis E. Marchlinski 
Hospital of the University of Pennsylvama, Philadelphia, PA 
Background: Magnetic electroanatomic mapplng (MEAM) IS valuable for defining the 
anatomlc lccatlon of catheter based electrophysiologic recordings by creating a detailed 
shell of the endacardiai anatomy in three-dimensional space. The MEAM system also 
allows for assessment of the distance between any two acquired points. We attempted to 
validate the accuracy of this measurement technique by comparing distance measure- 
ments using two-dimensional guided, M-mode echocardiography versus MEAM. Meth- 
ods: Thirty-four patients underwent two-dimensional echocardlography and detailed 
MEAM of the left atrium (LA). The entire LA was mapped with 47-268 distinct points 
(mean 156 i: 60 points). Careful attention was placed upon identifying the sites associ- 
ated with the mitral annulus and the posterior wall of the LA. The LA dimension was 
assessed using two-dimensional guided M-mode echocardiography cut across the LA in 
a plane parallel to the mitral valve annulus in the par&sternal long-axis view during end- 
assessment of the anticoagulation level (an INR > 2 was defined as effectively anticoagu- 
la&d) and cranial MRI including diffusion- weighted imaging to determine the presence of 
cerebral embolism at the beginning of the study, at 4 weeks, at 3 and 6 months and at 1 
year. Results: 13 pts had cerebral embolism at the index admission. 6 pts had cerebral 
embolism during the follow up period. 2 of the latter 6 pts had a neurological deficit. 1 
patient died. The other patient had repeated cerebral embolism. 2 of the 6 pts with cere- 
bral embolism had inadequate anticoagulation during the follow up. The incidence of 
cerebral embolism was similar in pts with thrombi and in pts with SEC (9% [n=2] versus 
10% [n=4], p=O.37). 10 of the 22 pts [45%] with thrombi had mobile thrombi. The average 
length and width of the thrombi was 1.4 cm x 0.8 cm. 8 of the 22 thrombi [34%] were 
echodense. 11 thrombi [50%] disappeared during the follow-up period. Those pts with 
cerebral embolism and those without cerebral embolism during the follow up did not differ 
significantly in left atrial diameter (5.2kO.9 cm versus 5.0 kl.0, p=O.69), ejection fraction 
(0.47t0.18 versus 0.55 i18, p&26), and peak emptying velocities of the left atrial 
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appendage (0.2lkO.12 m/s versus 0.31~020, p=O.24). Controls did not suffer any cera- 
bra1 embolism. Conclusions: Pts with atrial thrombi and /or SEC have an increased inci- 
dence of cerebral embolism even despite anticoagulation therapy. Our findings have 
important clinical implications for the management of pts with AF at high risk for embo- 
lism. 
1139-120 Antioxidant Therapy Can Influence the Recovery of Left 
Atrial Contraction After External Electrical Cardioversion 
Grazia Maria Costa, Carmine Pizzi, Barbara Bresciani, Luca Gabrieli, Danilo Cervellati, 
Raffaele Bugiardini. Dept Cardiology, lmola Hospital, University of Bologna, Bologna, 
My 
Recent studies have shown that in pts with atrial fibrillation (AF), external electrical car- 
dioversion (EEC) induces a state of atrial stunning that follows for several days. It is well 
known that direct current (DC Shock) generates free radicals that may contribute to atrial 
mechanical dysfunction. The aim of the study was to evaluate the effects of an antioxi- 
dant therapy on atrial function recovery in pts with non rheumatic AF. Methods. 74 con- 
secutive pts were studied in a single blind cross-over fashion who underwent successful 
EC for AF A standard medical treatment was given in 37 pts (Gl). Three days before EC 
the remaing 37 pts (G2) received an antioxidant therapy (Glucose 20% 500 cc with regu- 
lar insuline 20 UI, KCI 40 mmEq, MgS04 mMol, Vitamins C 2 gr. A single 25 mg dose of 
Captopril before EEC and Vitamine E 300 mg/die during the following 21 days was also 
given. Pulsed doppler indices of left atrial mechanical function were measured within 1 
hour (TO), at 1 day (Tl), 3 days (T2), 1 week (T3), and 3 weeks (T4) after DC shock. 
Results. At Tl and T2 G2 showed a significant increase (pcO.001) of peak A wave veloc- 
ity (PA), integrated late atrial velocities (A-VTI), atrial contribution to total transmitral flow 
(AVTIIVTI), and atrial ejection force (AEF). At T4 there was no more significant difference 
between Gl and G2: 
TO T1 T2 TS T4 
G1 G:! Gt G2 Gl G2 Gl G2 G1 GP 
PA 39+,4 as+,-1-2 a+,.3 5411.6. so+,4 6211-S so+,4 6311.5 63+/R a+,.6 
A”T, St,-* e+,-3 5.711-2 7+,x3. 5.511-4 7.111-4. 6.5+,.4 72+,-4 s.7+,-5 72+,-s 
A”T,,“T, 2911.4 2811.5 2911-8 3119’ 30+1-s 3511.4. 34+,-s 3e+,-2 36*-4 37+,.4 
AEF 4.911-3 4..3+,-2 511-z VI+,-3; e.ii-2 101,.4. 101,.4 1311.v 12+,-s 13tl.d 
Conclusions. Our findings suggest that an antioxidant therapy can accelerate atrial 
mechanical recovery from stunning after EEC. This could have a favorable impact on the 
risk of embolic complications due to atrial dysfunction following EEC. 
1139-121 Time Required to Achieve Therapeutic Anticoagulation With 
Warfarin Prior to Cardioversion for Atrial Fibrillation 
Radmira S. Greenstein, Julie Merz, William Fay, Robert L. Baker, Chi-Wo Char?, Steven 
P. Chough, Christian Sticherling, Hiroshi Tada, Kristina Wasmer, Hakan Oral, Frank 
Pelosi, Jr., Adam Strickberger, Fred Morady, Bradley F? Knight. University of Michigan, 
Ann Arbor, MI 
Background: Anticoagulation with warfarin for three weeks and transesophageal 
echocardiography are two strategies used prior to cardioversion for atrial fibrillation to 
minimize the risk of thromboembolism. The degree of post-cardioversion atrial mechani- 
cal dysfunction and atrial electrical remodeling are directly related to the duration of atrial 
fibrillation. Therefore, the purpose of this study was to determine the actual time required 
to achieve therapeutic anticoagulation with warfarin prior to cardioversion. 
Methods: Fifty-eight consecutive patients with atrial fibrillation who were started on war- 
farin therapy prior to an elective cardioversion procedure were identified. Patients were 
followed in a university anticoagulation clinic and the warfarin dose was adjusted using a 
predetermined nomogram to maintain an international normalized ratio (INR) of 2.0 to 
3.0. Patients were scheduled to undergo cardioversion after the INR was greater than 2.0 
for 3 consecutive weeks. The mean age of the patients was 63 &I 3,74% were male, and 
the mean duration of atrial fibrillation was 2.8 months. 57 % had structural heart disease 
and 28% were taking amiodarone. 
Results: The mean time required to achieve the first therapeutic INR was 2.0 ~1.7 
weeks (range 0.1-7.8 weeks). The mean time required to achieve 3 weeks of therapeutic 
anticoagulation was 5.9 ~2.4 weeks (range 3.0-12.6 weeks). Patients underwent cardio- 
version 7.6 ~2.6 weeks after initiation of warfarin (range 3.4-13.3 weeks). 
Conclusion: When initiating warfarin therapy prior to cardioversion for atrial fibrillation, at 
least 6 weeks are required to achieve 3 weeks of therapeutic anticoagulation, even when 
patients are closely monitored by an anticoagulation service. Early cardioversion using a 
transesophageal echocardiography-guided approach would reduce the overall duration 
of atrial fibrillation by almost 2 months. 
1139-122 Impaired Fibrinolytic Capacity in Rheumatic and Non- 
rheumatic Atrial Fibrillation 
Enver Atalar, Tayfun Aoil, Kudret Aytemir, ‘ibrahim Haznedaroglu, Necla Ozer, Serdar 
Aksoyek, Kenan bviinp, Syrry Kes, Ferhan Ozmen. Hacettepe University School of 
Medicine Department of Cardiology. Ankara, Turkey, Hacetfepe University School of 
Medicine Hematology Department, Ankara, Turkey 
Background: Global Fibrinolytic Capacity (GFC) is a new and innovative tecnique for 
evaluating the fibrinolytic system. GFC assay is affected by levels of t-PA, u-PA, scu-PA, 
activated protein C (APC), Factor VII, plasminogen, PAI-1, alpha-2 antiplasmin and Histi- 
din Rich Glyco-Protein (HRGP). Chronic atrial fibrillation (CAF) has often been associ- 
ated with systemic embolization, and ‘those patients with mitral stenosis have the the 
highest risk. The aim of our study was to evaluate the fibrinolytic activity in patients with 
chronic atrial fibrillation. Methods: To investigate the fibrinolytic activity, we studied GFC 
in 24 patients with nonrheumatic atrial fibrillation (11 female, mean age 55+8 years) and 
22 patients with rheumatic mitral stenosis and atrial fibrillation (16 female, 6 male, mean 
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age37+9 years). Control group comprised 30 healthy subjects in sinus rhythm. None of 
patients wars receiving anticoagulation therapy, and they did not have a history of embo- 
lization. All patients underwent transthorasic echocardiography. Results: Patients with 
CAF (rheumatic and nonrheumatic) had tower GFC than that in the controls (1.42*0,96 
mgdml vs. 2,36+1,72 mgrlml, respectively, p=O.OOl). The rheumatic atrial fibrillation 
group atso showed decreased levels of GFC compared to those with nonrheumatic atrial 
fibrillation group (0,62+0,63 mgrlml vs. I.5421 ,Ol mgrlml, respectively, p=O.Ol). Tran- 
sthorasic echocardiography revealed that none of the patients had spontaneous echo- 
contrast and left atrial thrombus. Conclusions: 1) Decreased GFC suggests hypofibrtn- 
olytic state in patients with atrial fibrillation. 2) Patients with rheumatic mitral stenosis and 
atrial fibrillation have more impairment in fibrinolytic capacity than those patients with 
nonrheumatic atrial fibrillation. Therefore mitral stenosis may contribute to an additional 
thrombotic risk in patients atrial fibrillation. 3) Hypofibrinolysis documented by decreased 
GFC may be one of the important cause of increased risk of embolism in patients with 
rheumatic and nonrheumatic atrial fibrillation. 
1139-123 Long-term Follow-Up in Patients With Atrial Fibrillation and 
Left Atrial Thrombi 
Monika Rameken, Margit Vater, Frank Fischer, Axe1 Droegemueller, Harald Schwacke, 
Caroline Bergmeier, Jochen Senges, Karlheinz Seidl. Klinikum Ludwigshafen, 
Ludwigshafen, Germany 
Aim of the present study was to determine the long-term outcome in patients (P) with 
persistent (> 48 hours) atrial fibrillation (AF) and left atrial (LA) thrombi. Methods: 
Patients with persistent AF that were referred to our AF clinic underwent transesophageal 
echocardiography (TEE) before electrical cardioversion (CV) of AF No CV was per- 
formed when TEE revealed LA thrombus. Results: Between 1994 and June 2000,560 P 
with persistent AF were referred to our AF clinic for CV of AF. In 30 P (5.4 %), TEE 
revealed LA thrombus. Mean age of these P was 6619 years, 67 % were male, and 60 % 
had an organic heart disease. After discovery of LA thrombus, all P were anticoagulated 
with an INR > 2. In 23130 P (77 %) one or more TEE were performed during follow-up 
(FU) and P underwent CV when the thrombus was no longer present. The following com- 
plications occured during FU of 20*7 months: 
TEE during FU (n = 23) No TEE during FU (n = 7) 
LA thrombus Yes No 
n 10 13 7 
cv No Yes No 
Complication during FU 1 ischemic 1 rschemic 1 hemorrhagic stroke 
stroke stroke 
Conclusion: 1. In 30/560 (5.4 %) of P with persistent AF, TEE revealed LA thrombus. 2. 
In 13123 P with LA thrombus in initial TEE, LA thrombus was no longer present after 
effective anticoagulation. 3. Stroke rate in P with LA thrombus in initial TEE was 10 % 
during long-term FU of 20~7 months. 
1139-124 Elevated Levels of Factor VIII:C in Patients With Atrial 
Flutter and Decreased Left Ventricular Function 
Bengt Herweg, Maryam Ziaie Matin, Raja’a M. Kaddaha, Frederick A. Ehlert, Margot E. 
Vloka, Alice J. Cohen, Jonathan S. Steinberg. St, Luke’s-Roosevelt Hospital Centerand 
Columbia Univefsif): New York, N’Y: Newark Beth lsrael Medical Center, Newark, NJ 
Background: Increased coagulation system activity has been demonstrated in patients 
with nonvalvular atrial fibrillation, and more recently we demonstrated similar findings in 
patients with atrial flutter. Transesophageal echocardiography in patients with atrial flutter 
has demonstrated an association between decreased left ventricular function (LVF), 
spontaneous echo contrast and left atrial thrombus. We sought to investigate the relatton- 
ship between LVF, factor VIII:C and van Willebrand AG, known markers of a predisposi- 
tion to venous thrombosis. Methods: Plasma samples ware drawn in 12 patients 
undergoing ablation of chronic atrial flutter prior to insertion of catheters. Oral warfarin 
therapy was stopped >5 days prior to admission. Results: Elevated plasma levels of fac- 
tor VIII:C were detected in 6/7 patients with decreased LVF (ejection fraction ~55%) com- 
pared to 015 patients with normal LVF (~~0.05). 
Normal Atrial Flutter, Atrial Flutter, 
Range Normal LVF (n=5) Abnormal LVF (n=7) 
Ejection Fraction (%) 55-75 56~2 2924 pco.05 
Factor VIII:C (%) 69-182 150r34 437~257 pco.05 
“on Willebrand AG (%) 54-163 136*42 241~106 p=o.o7 
Conclusion: Patients with decreased LVF and atrial flutter have elevated levels of factor 
VIII:C, and possibly van Willebrand AG, suggesting risk of thrombosis. The mechanism of 
this association, and the incremental value of these coagulation factors as predictors of 
thromboembolic risk in patients with atrial flutter, warrants further study. 
JACC February 2001 ABSTRACTS - Cardiac Arrhythmias 105A 
pacing. 3. Effects of pacing induced myocardial asynchrony between basis and apex 
seen- to be significantly amplified by reduced coronary perfusion. 4. LV basal pacing 
seems to be more effective than LV apical pacing in coronary artery disease. 
1140-127 Left Ventricular Apex is the Optimal Pacing Site for 
Hemodynamic Improvement in the Dog Heart With LBBB 
Hans De Swart, Fnts W. Prinzen, Theo Van der Nagel, Willem Ft. M. Dassen, Hein J. J. 
Wellens. Maastricht LJniversiM Maastricht, The Netherlands 
Background: Left ventricular (LV) pacing is beneficial in patients with heart failure and 
left bundle branch block (LBBB). The hemodynamic effects, however, are poorly under- 
stood. We investigated the hemodynamic effects of LBBB creation and of pacing at differ- 
ent sites Methods: Eight anesthetized, open-chest dogs were instrumented with a 
conductance catheter to assess the pressure-volume relations. LBBB was created using 
radiofrequency ablation. Pacing electrodes were attached to the right atrium, right ven- 
tricular apex (RV), LV apex (LVa) and lateral (LVlat), posterior (LVpost) and anterior wall 
(LVant). Results: The table shows that during sinus rhythm (SR) stroke volume (SV), 
dPdt max and stroke work (SW) significantly(*) decreased after LBBB creation (SR- 
LBBB) and were significantly(“)hig during LVa pacing. No differences were found for 
heart rate (HR). LV end-diastolic volume (LV Ved). LV end-diastolz pressure. svstolic 
pressure and QRS width. 
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7140.125 Biventricular Pacing and Sympathetic Nervous System in 
Heart Failure: A Randomized Trial 
Domenico Spazianl, Massimo Pagani, Gianfranco del Rosso, Stefano De Servi. 
LEGNANO HOSPITAL, LEGNANO (MILAN), k/y 
Biventricular pacing (BP) is a promising therapeutic modality for end stage heart failure 
(CHF). Emerging data support the new use of pacemakers as therapy allowing simulta- 
neous electrical stimulation of the right and the left ventricles for patients(pts) with symp- 
tomatic congestive heart failure and with intraventricular delay ( bundle branch block).. 
BP can improve cardiac function by pacing the ventricles simultaneously and then by 
more coordinate and efficient ventricular contraction .It’s moreover known that chronic 
heart failure activates the sympathetic nervous system(SNS) and increases serum level 
of the neurotrasmitter Norepinephrine (NE). This phenomenon is in direct proportion to 
severity of the disease.The aim of the study was to test if the improved cardiac perfor- 
mance, obtained with BP ,in pts with CHF and bundle branch block, was able to decrease 
the degree of the (SNS) activation .METHODS: we enrolled 13 pts with CHF(NHYA Ill- 
IV),with left bundle branch block (QRS duration 185~20mmsec) ,with normal coronary 
system at angiography ,with maximal medical therapy and without beta-blockers. We 
then randomized 7 pts to BP ( Medtronic lnsync ) (Group I) and 6 pts to medical therapy 
(Group II). In all pts we performed, at baseline( pre-implant) and after 16 weeks,a cardiac 
catheterization and an echocardiographic measurement of ejection fraction (EF) and we 
determined serum NE levels as pg/ml.All values ware expressed as mean * standard 
deviation(SD). 
BASELINE (EF) lGWEEKS(EF) 
GROUP I (7PTS) 0.22+0.05 pco.05 0.30*0.04 
GROUP II(6PTS) 0.21~0.04 NS 0.22+0.05 
BASELINE IGWEEKS(NE) 
GROUP I (7PTS) 602+ 349 pco.05 290+132 
GROUP II(6PTS) 587+302 NS 622i289 
CONCLUSIONS Our results showed that BP produce a significant improvement of 
EF,and a better hemodynamic profile in pts with CHF.The serum NE levels decreased 
significantly with a marked reduction in the degree of SNS activation This deactivation is 
in direct proportion to the best improvement of cardiac performance expressed as 
EF.Further studies with a many pts studied will be able to test our results 
1140-126 Regional Myocardial Contractility and Hemodynamic 
Depression Was Improved During Left Ventricular Basal 
Compared to Apical Pacing Under Normal and Reduced 
Coronary Perfusion Pressure 
Anil M. Sinha, Barbara Hofmann, Doroth& Sinha, Kurt Kochsiek, Georg Ertl. Medical 
Clinic, Wuerzburg. Germany, Medical Clinic /, Aachen, Germany 
Patients with left ventricular (LV) dysfunction often suffer from coronary artery disease. 
Less is known about the correlation of various LV pacing sites and myocardial contractil- 
ity and hemadynamic parameters in coronary artery disease. Therefore we studied the 
effects of LV basal and apical endocardial pacing on myocardial contractility and hemo- 
dynamic parameters in 8 anaesthetlzed open chest dogs at normal and reduced coro- 
nary perfusion pressure. Methods: LV was gradually paced (140 to 180 bpm) at basis 
and apex on normal coronary perfusion pressure of LAD (=mean aortic pressure. 65.70 
mmHg: NP) and reduced pressure creating mild (45.50mmHg; UP) and severe ischmia 
(35-40mmHg; LP). Regional myocardial contractility of the LAD supplied myocardium 
and LV systolic (LVESP) and diastolic pressure (LVEDP) were measured. Results: 
Effects were most pronounced during rapid pacing (180 bpm). The percentage of 
changes of values vs baseline values (without pacing) are given in the following table. 
Effects of rapid pacing (180 bpm) during normal and reduced coronary perfusion 
pressure 
Coronary p&u- Pacing site 
sion pressure 
NP Basis 
Regional myo- LVESP [“A] LVEDP [%] 
cardial contrac- 
tility [%I 
14.8 i 5.5 * -3.7 t 3.5 2.7 5 5.6 
Apex 2.3 f 5.2 -8.3 k 1.9 9.7 + 6.2 
MP Basis 10.4 t 3.9 -6.5 t 3.7 4.7 i 6.2 
Apex -9.8 t 3.8 * -12.1 + 3.2 11.7k5.1 
LP Basis -24.3 i 4.2 $5 -13.7 I3.0 19.8 i 3.5 
Apex -37.9 i 8.2 $5 -20.6 + 3.0 5 33.9 + 2.8 ‘$5 
Ij vs basis (p<O.O5), $ vs NP (p<O.O5), 5 vs MP (~~0.05) 
Conclusion: 1. For myocardial contractility, significant differences (~~0.05) between api- 
cal and basal pacing were only seen during reduced coronary perfusion pressure. 2. 
Hemodynamic depression of LV function during acute &hernia is lowest during LV basal 
SR SR-LBBB RV LVa LVlat Lvpost Lvant 
SV (ml) 32 25* 25 35’ 30 32 31 
SW (ml.mmHg) 2206 1405’ 1334 2472’ 1876 2037 1875 
dPdt max (mmHg/s) 1093 1020 1003 1071# 1063 1026 1067 
LV Ved (ml) 70 72 59 74 78 75 60 
QRS width (ms) 54 95 109 102 102 113 104 
Conclusion: Creation of LBBB deteriorates hemodynamics, which can be corrected by 
LVa pacing. LVa pacing changes pump function as evidenced by differences in SV, dPdt 
max and SW and not pw- and afterload. Therefore LVa pacing creates a sequence of 
activation improving LV function, not related to QRS width. 
1140-128 Non Synchronous vs Synchronous Biventricular 
Stimulation May Induce Further increase in Ventricular 
Systolic Performance 
G B. Perego, Ft. Chianca, M. Facchini, E.Balla, M.Negretto*, I.Vicini*, S.CavagliB*, 
G.Osculati.. H.S.Luca - lstitufo Auxologico Ifaliano., Milan, Italy *Medtronic ltalia 
Synchronous biventricular stimulation (BIV) can improve left ventricular (LV) systolic par- 
formance in dilated cardiomyopathy associated with intraventricular conduction delay. 
We tested the hypothesis that further improvement can be obtained by non synchronous 
BIV with optimization of both atrioventricular and interventricular delay. 
Methods: 7 biventricular implants (FE<30%, QRSd >150 msec) were associated with LV 
catheterization. LV dP/dt was acutely measured during BIV with different atrioventricu- 
lar and interventricular intervals: right atrium (RA) to right ventricle (RV) interval (AVi) 
ranged from 80 to 160 msec and RV to LV interval (VVi) from -60 to ~40 msec. 
Results: For each stimulation mode we selected the intervals which were associated 
with the maximum LV dPidt: the average AVi were similar both for VVi =0 and VVit 0. The 
values at which the LV dP/dt was maximum are presented in the table. 
VVi AVi LV dP/dt 
N=7 imsec) lmsecl 
Synch. 0 110~32 130*19 
RV to LVdelay -3O+-20” 116r29 14Oi20§ 
LVdP/dt is expressed as % of baseline. 4: p<O.Ol vs. maximum value with VVi=O; 
‘p<O.Olvs. 0. In no case maximum LV dP/dt was obtained for single ventricle LV stimula- 
tion. In no case maximum LV dP/dt was obtained at the step with the narrowest QRS. 
Conclusions: A significant increase of LV dP/dt can be obtained by non synchronous 
BIV mode of stimulation as compared to the synchronous one. The highest LV dP/dt is 
obtained when LV is stimulated before RV. The extent of this anticipation is about 30 
msec but is variable from patient to patient. 
1140-I 29 Mechanisms of Exercise Capacity Improvement Induced by 
Biventricular Pacing in Congestive Heart Failure (CHF) 
G. B. Perego, S. Blengino, G.Malfatto, M.Facchini, R.Chianca, E.Balla, M.Lunati*, 
M.Frigerio*, A. Frattola, G. Osculati. H.S.Luca lsfitufo Auxologico /talkno, Miiano, /fa/x 
*Divkione “A.De Gasperis” Ospedale Niguarda-“I% Granda’: M&no, /B/y 
In CHF one of the factors limiting exercise capacity is respiratory muscle fatigue. This has 
been attributed both to generalized muscle impairment and to the increase of lung stiff- 
ness due to increase of lung water (LW). Biventricular pacing (BIV) improves rest hemo- 
dynamics and exercise capacity. The aim of our study was to define possible 
improvements in pulmonary function and investigate about the mechanisms of increase 
of exercise capacity. 
13 Pts with CHF and QRS z 150 msec underwent rest respiratory function tests and car- 
diopulmonary stress test with arterial and femoral vein blood sampling before (pm) and 1 
month after (F.up) biventricular implantation. 
Results: 
pVO2 (ml/Kg/‘) DLCO (%pred) A Sat % FV Sat % 
Pre 10.3k2.5 53.2f18.3 93.2f6.1 2029 
F.up 12.6&2.1§ 62.1f17.6 92.8Y4.0 n.s. 21flO n.s 
l 
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pVOZ=VO2 at peak ex.; Asat and FVSat: radial artery and femoral vein Hb saturation; 
DLCO=Pulmonary diffusion of CO; $ = p < 0.01 (2.tailed paired t test - prs vs. post 
implantation). D =variation pre vs post 
Conclusions: 1) BIV was associated with a significant increase of DLCO suggesting a 
decrease of LW. 2) pVO2 increase was not due to an increase of 02 extraction. Instead, 
an increase in peak exercise blood flow to exercismg muscles (and cardiac output) must 
be hypothesised to justify our data. 3) The correlation between DLCO and pVO2 sug- 
gests that a decrease in LW can play an additional role in increasing exercise capacity. 
The improvement of pulmonary mechanics would remove one of the reason of exercise 
limitation and allow full expression of the hemodynamic reserve. 
1140-130 Delivering Current Simultaneously to Two Pacing Leads 
With Different Impedances Does Not Result in Increased 
Pacing Thresholds 
Luis G. Alvarez, David M. Gilligan, Bradley F! Knight, Regina Rogers, Deborah Cooper, 
Ross Sample, Patrick Yang, VENTAK CHF/CONTAK CD Investigators. Guidant 
Corporafion, St. Paul, MN 
Background: Ventricular resynchronization therapy (VRT) is presently performed by 
connecting an integrated bipolar right ventricular (RV)and unipolar left ventricular (LV) 
coronary venous lead in parallel to achieve a biventricular (BV) configuration with the 
pacing current split between the two leads. This analysis was performed to determine if 
connecting RV and LV leads with different impedances in parallel alters the pacing 
threshold when compared to the pacing thresholds measured with each lead individually. 
Methods: Patients studied received an implantable carcfioverter defibrillator (ICD) with 
VRT capability. Acute LV and RV pacing thresholds were measured with a pacing system 
analyzer for each lead individually and again with both leads connected in BV configura- 
tion. The unipolar LV and RV tip electrodes were the cathodes and the RV ring electrode 
was the anode. Results: RV, LV, and BV lead impedances were 589 +/- 131 ohms, 700 
+/- 227 ohms, and 362 +/- 115 ohms, respectively. LV thresholds measured alone and in 
BV configuration were 1.3 +/- 0.9V and 1.4 +/- 1 .OV, respectively. RV thresholds mea- 
sured alone and in BV configuration were 0.6 +I- 0.3 V and 0.6 +/- 0.3 V, respectively. 
Thresholds measured with lead alone had a high correlation to those measured in BV 
configuration. 
Conclusion: Delivering electrical current to two pacing leads with different impedances 
connected in parallel does not result in a clinically significant increase in pacing threshold 
when compared lo the pacing thresholds measured from each lead individually. 
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802-2 Pulmonary Vein Electrical Isolation for Control of Atrial 
Fibrillation: Can One Vein Suffice? 
David Schwartzman. Atria/ Arrhythmia Center, University of Pittsburgh, Pittsburgh, PA 
Background: there is tremendous interest in pulmonary vein (PV) electrical “isolation” 
(El) as a possible means of eradication of atrial fibrillation (AF). Although most have pro- 
posed/practiced multi-vein ablation, the necessity for this is as yet unresolved. We 
hypothesized that: l.there were patients in whom single vein El would eradicate AF, and 
PShey could be identified by characterizing AF onset invasively in the electrophysiology 
laboratory. We have previously described methodologies for: 1 .AF “trigger” (initiating 
atrial premature beat, APD) mapping using multielectrode catheters; 2.PVEI using percu- 
taneous endocardial radiofrequency catheter ablation guided by CART0 and intracardiac 
echocardiography, with lesions encircling the anatomical vein orifice. Methods: Fifteen 
consecutive patients with antlarrhythmlc drug (AAD)-refractory paroxysmal or persistent 
AF underwent AF trigger mapping. In each patient, spontaneous AF was observed to be 
caused reproducibly and solely by AP@s) eminating from deep within a single vein 
(LSPV 5; RSPV 4; LIPV 2; RIPV 4). In each patient, El of this vein was achieved. During 
followup, eradication of AF was defined as ~3 self-terminating AF episodes (cl2 hours 
each) in the AAD-free state (in each patient, this criterion represented a marked reduc- 
tion in AF burden). The first month post-ablation was censored. Each patient has been 
followed for >7 months (range 8-22 months). Result& At present, only 4 patients rernaln 
who meet the criteria for AF eradication (followup intervals of 21, 19, 18, and 8 months, 
respectively). Two other pts have been effectively suppressed on a previously ineffective 
AAD. Conclusions: Even in this selected group, eradication of AF using single vein El 
was achieved m only a minority of patients. 
802-3 
2:30 p.m. 
Preliminary Experience with Circumferential Mapping to 
Guide Isolation of the Pulmonary Veins in Patients With 
Atrial Fibrillation 
Andrea Natale, Walid Saliba, Christopher Cole, Stephen Pavia, Cathy Lam, Mark 
Niebauer, Mina K. Chung, Alejandro Perez-Lugones, Thomas Dresing, Patrick Tchou, 
Robert Schweikert. C/eve/and Clinic Foundation, Cleveland 
Recently it has been suggested that isolation of the, pulmonary vein can be achieved with 
segmental lesions targeted at sites of preferential conduction that can be identified by cir- 
cumferential mapping in sinus rhythm. To verify this concept in 11 consecutive patients 
undergoing catheter ablation for atrial fibrillation, a custom made deflectable circumferen- 
tial multielectrode mapping catheter was placed in the pulmonary veins. A second 4 mm 
tip deflectable catheter was advanced in the same vein to deliver radiofrequency energy. 
All patients included in this study had frequent premature atrial contractions (PACs) with 
multiple atrial fibrillation episodes during the procedure. The circular deflectable multi- 
electrode mapping catheter was deployed in a total of 27 veins including 11 right upper 
pulmonary veins, 11 left upper pulmonary veins and five left inferior pulmonary veins. 
Ablation lesions were delivered in 18 veins. This included none left superior pulmonary 
veins, six right superior pulmonary veins and three left inferior pulmonary veins. Ablation 
was performed 5 mm from the ostium and subsequently, energy was delivered more 
proximally should atrial fibrillation and premature contractions persist. Distal isolation tar- 
geting the site with the earliest activation on the circular mapping catheter was achieved 
with a mean lesion number of 5 + 2. However, isolation of the distal portion of the vein 
was able to prevent atrial fibrillation and PACs only in 7 of the ,18 veins (39%). In the 
remaining veins, the circular catheter was moved at the ostium where isolation required a 
mean number of lesions equal to 29 + 8. For proximal isolation, lesions had to be deliv- 
ered all around the ostium in all but two right superior pulmonary veins. In conclusion, our 
preliminary experience with circular mapping suggests that distal isolation can be 
achieved with segmental lesions. However, ostial isolation required lesion placement all 
around the circumference of the vein in the majority of cases. Distal isolation appeared to 
be an effective approach in 40% of the patients. 
802-4 
2:45 p.m. 
Linear Right Atrial Ablation for Atrial Fibrillation: Efficacy 
Decreases With Time 
David Schwartzman. University of Pittsburgh, Pittsburgh, PA 
Background: several non-pharmacologic therapies for AF are being evaluated. Some 
have demonstrated promising results early after deployment, but few have been scruti- 
nized at longer terms, which is critical for assessing their value. Our purpose was to 
assess the efficacy of right atrial (RA) linear radiofrequency catheter ablation (RFCA) in 
22 consecutive patients each of whom has been followed for >2 years. Methods: each 
patient had paroxysmal or persistent AF resistant to two or more type l/Ill drugs (AAD). 
Significant structural heart disease was present in 8 pts. Each patient underwent “linear” 
ablation limited to the RA, consisting of intercaval, isthmus, and septal lesions. Lesions 
were deployed using a combination of CART0 and intracardiac echocardiography, as 
previously reported. Each lesion was demonstrated to be complete using criteria of con- 
duction block and/or electrogram reduction. Patients were initially followed off AAD. If 
AAD was needed, a drug/dose which was previously tolerated but inefficacious was 
used. The first month after RFCA was censored. Ablation success was defined as <5 
self-terminating (~24 hours each) AF episodes during followup. Results (table): The 
dwindling success rate in pts on AAD was due to AF recurrence despite drug or after 
drug cessation secondary to Intolerance. Most pts have required other therapeutic inter- 
ventions. Conclusions: True cure of AF by RA linear ablation appears rare. Successful 
suppression of AF, when achieved, necessitates a previously ineffective AAD. The effi- 
cacy of this “strategy” wanes over time, in part due to cessation of AAD. The value of this 
strategy is questionable. 
6 mo 
12 mo 
18 rno 
24 mo 
Success without AAD 
5 (23%) 
2 (9%) 
1 (5%) 
1 (5%) 
Success with AAD 
10 (45%) 
11 (50%) 
8 (36%) 
4 (18%) 
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3:oo p.m. ber ICD (Medtronic model 7271 GEM OF?). We compared the outcome of pts without 
802-5 Circumferential Radiofrequency Ablation of Pulmonary Vein (group A: n&91) and with a history of AF (group B: n=68) to evaluate the significance of 
Ostia for Curing Atrial Fibrillation: Long-Term Results From AF as a risk factor of mortality. In addition SVT episodes as detected by the device were 
a Large, Single Center Experience analyzed. Results: Pts in group A and in group B did not differ with regard to baseline 
characteristics. In both groups medication with B-blocker and class Ill antiarrhythmics 
Carlo Pappone, Salvatore Rosanio. Monica Tocchl. Filippo Gugliotta, Gabriele was comparable (71.8% vs. 73.5%). 41 of all pts (8.7%) experienced a detected episode 
Vicedomini, Adrian0 Salvati, Simone Gulletta, Cosimo Dicandia, Patrizlo Mazzone, of AF or Atrial Flutter (AFlut). 25 pts died during the study period (group A:5.8% vs group 
Claudia Di Gioia, Anna Mognettl, Giuseppe Oreto. San Raffaele University Hospital, B:i 1.8%). Pt surival was found to be 97.9% vs 91.2% (n=279 vs 63) at 3 months after 
M/an, My imolantation, 97.5% vs 89.7% (11~244 vs 541 at 6 months and 94.4% vs 89.7% fn=t61 vs 
Background: The dominance of the left atrium (LA) in the pulmonary vein (PV) regions 41j at 9 month in group A vs g;oup 3. Pts &at died had a higher NYHA class (p=O.OOZ). 
for triggering and maintaimng atrial fibrillation (AF) is now widely recognized. We recently We found a significantly higher mortality in pts of group B (approximately 5 times higher 
developed a new technique to Isolate all 4 PVs from the LA by creating circumferential risk to die) when follow-up (FU)duration was truncated at 3 months (n=341)(p=0.005), but 
lines of block around their ostia with electroanatomical guidance (CART0 system). with complete FU (mean of 9.5 months, n=122) included no longer a significant differ- 
Methods: We report the clinical outcome of the procedure in 135 consecutive pts with ewe was seen (p=O.iO). The risk to die increased after a first episode of AF or AFlut was 
paroxysmal (81 pts) or permanent AF (54 pts) (67% male; age 5959 years; AF duration experienced during FU (Cox regression with time-varying covariate, RR=5.0, p=O.O007). 
5.8+1.5 years; 47% with structural heart disease). RF lesions were deployed transsep- A multivariate analysis shows that independent predictors of mortality are NYHA class 
taily during sinus rhythm (SR, 74 pts) or AF (61 pts) via a Navi-Star catheter at a mrni- (p=O.O02), history of AF (p=O.O09), and detected episodes of AF or AFlut during follow-up 
mum distance of 5 mm from PV ostium. Post-RF evaluation Included 48.hour telemetry, 
(p=O.OOl). Conclusion: In this study pts with a history of AF and established ICD indica- 
close clinical follow-up for >6 months. serial Halter recordings and transesophageal tion had a higher than average risk to die during the first 5 months after implantation. Pre- 
echocardiography (TEE). dictors of mortality are higher NYHA class, a history of AF and experienced episodes of 
Results: Procedural and mapping times were 284366 min and 75r27 min, respectively, AF and AFlut after ICD implantation. 
with 29i-11 mln of fluoroscopy. Complete lesions (peak-to-peak bipolar electrogram 
amplitude ~0.1 mV inside the line and no double potentials) were achieved in 83% of the 1170-l 16 Influence of Arrhythmogenic Right Ventricular Dysplasia on 
540 PVs treated. Extent of ablated area (iO.lmV) inside the lesions was 3.9iO.4 cm*, the Function of Intravenous Implantable Cardioverter 
accounting for 27+9% of the total LA map surface. Among pts in AF, SR was restored Defibrillator Leads 
during RF delivery in 40 (66%) and by DC shock in 21 (34%). Major complications (car- 
diac tamponade) occurred in 2 pts (1%). After 13i-2 months, 115 pts (85%) were AF free Emilio Garcia-Moran, Mihaela Grew, Alejandro Cuesta, Jose Rubin, August0 Ordirnez, 
without ant&rhythmic drugs. No PV stenoses were detected by TEE. By univariate Cox Guillermo Mora, Lluis Mont, Josep Brugada. Hospital Clinic, Barcelona, Spain 
regression analysis of 15 clinical and procedural variables. an increased risk of AF recur- Arrhythmogenic Right Ventricular Dysplasia (ARVD) is characterized by morphological 
rence was predicted by LA dilation (diameter 245 mm), AF duration and a low ablated and histological changes of the heart. It mainly affects the right ventricle and predisposes 
area (~15% of total LA surface). After adjustment, only the latter variable continued to be patients to ventricular arrhythmias that often require an implantable cardioverter defibril- 
significant (OR, 3.3; 95%GI, 1.7-5.2). lator (ICD). 
Conclusion: Our approach is safe and effective in either paroxysmal or permanent AF. 
Patients with enlarged LA may require wider lesions to achieve AF suppression. 
802-6 
3:15 pm 
Linear Lesion Continuity in MAZE-Oriented Catheter 
Ablation of Atrial Fibrillation: Evaluation During Ablation 
and After 6 Months With a New Noncontact-Mapping 
System 
Ali Erdogan, Joerg Carlsson, Alexander Berkowitsch, Britta Schulte, Joerg Neuzner, 
Heinz F. Pitschner. Kerckhoff Heart Center, Dept. of Cardiology: Bad Nauheim, Germany 
For maze-related radiofrequency (RF) catheter ablation of paroxysmal atrial fibrillation 
(PAF) linear lesions are necessary. To achieve and evaluate line continuity, a non-contact 
non-fluoroscopic mapping system (EnSite, Endocardial Solutions Inc., USA) was used. 
Methods and Results: RF energy was delivered in highly symptomatic patlents with drug 
refractory paroxysmal atrial fibrillation to create continuous linear lesions with multipolar 
ablation catheters: !sthmus, Tricuspid Valve and Coronary Sinus orifice, Vena Cava infe- 
rior; a lateral and a septal line. A 3.dimensional dynamic isopotential color map is created 
with a non-contact multielectrode array remotely sensing electrical potentials from the 
endocardium representing the right atrium. Guided by the non-contact mapping system. 
60 piedefined linear lesions in 20 patients (mean age 54.8 t 9.1 years) were created. 
After RF energy application, the right atrium was remapped to validate completeness of 
the block lines, demonstrated by late activation of the areas circumscribed by the lines. In 
25 of 57 cases gaps could be revealed. If a gap was observed, the energy application 
was repeated at the same place, guided by the non-contact mapping system again. In 9 
patients. non-contact mapping was repeated at 6 months follow-up (mean follow up-time 
15.5 -c 4.0 m) and 27 linear lesions were verified again. In four patients 6 gaps were 
retrieved and the observed gaps were closed in the same session. Conclusions: Creation 
of long continuous lrnear lesions, necessary to compartmentalize the atrium, is facilitated 
by a non-fluoroscopic non-contact mapping system. A second verification of linear 
lesions 6 months after ablation retrieves new gaps of linear lesions in subgroups of 
patwts demonstrating twue conductance recovery. 
Objective: We tried to assess whether abnormalities associated with ARVD may result in 
an unfavourable evolution of intravenous ICD leads function. 
Methods: We made a case-control comparison between a group of 13 patients with 
ARVD (Group A) who received an intravenous ICD and another group of ICD recipients 
with structurally normal hearts (Brugada Syndrome) (Group B). Patients were matched 
for sex, age group and model of lead. In all patients of Group A macroscopic abnormali- 
ties of the right ventricle had been documented by imaging techniques. In all patients sin- 
gle passive fixation defibrillation leads were inserted by percutaneous subclavian 
puncture. Comparisons were made between the values of pacing threshold, stimulation 
impedance and intrinsic R wave at implant, early (Imonth) and late (>6 months) follow- 
up. Defibrillation threshold at implant (DFT) was also compared between the two groups. 
Wilcoxon’s Signed Rank Test was used for comparisons. 
Results: Figures indicate mean f standard deviation. 
Pacing Threshold (V) lntrlnslc R Wa”e (nl”) Impedance (ohms, 
Gr.A G,.B p G,.A GrB p GM Gr.6 P 
Implantation 1*1 1 0.65*0.* 0.15 &4.2 10.k3.7 0.13 621t215 842*309 0.07 
h,y follow-up 1.3*1.2 m*w3 0.06 ,0.3&.7 1P.liS.Z 0.4 Sk228 m4*242 0.26 
Late follow”p I.4107 1.2t0.6 0 57 7.5k4.4 13.,*‘w 0.04 5!36i-196 688*236 0.32 
The mean values of defibrillation threshold at implant were 14.3~t4.7 J and 15.1+9.3 J for 
Group A and B, respectively; (p=O.6). None of the patients needed reintervention due to 
Intrinsic lead failure. Paired comparisons between Group A and Group l3 showed only a 
significantly smaller intrinsic R wave at late follow-up. 
ConclusiorxAFiVD does not seem to cause clinically relevant malfunction of intravenous 
ICD leads. Although some data suggest higher pacing thrashoids and smaller intrinsic R 
waves, mean values of these parameters clearly remain within safe limits. 
1170-l 17 Efficacy and Implantation Rates of Implantable Cardioverter 
Defibrillators in Olmsted County, Minnesota: 1999-1999 
Lambert A. Wu, Thomas E. Kottke, Paul A. Friedman, David M. Luria, Diane E. Grill, 
Matthew J. Maurer. Mayo Clinic, Rochester, MN 
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1170-l 15 Mortality of Patients With Implanted Cardioverter 
Defibrillator in Relation to Atrial Fibrillation 
Background: Randomized clinical trials have demonstrated that automatic implantable 
cardioverter defibrillators (ICDs) can reduce mortality in high-risk patients. The implanta- 
tion rates and survival experience for a defined community population of individuals 
meeting these criteria is unknown. 
Methods: We searched the surgical and cardiac electrophysiology registries of the Mayo 
Clinic for residents of Olmsted County, Minnesota who had their first ICD placed between 
January 1, 1989 and December 31, 1999 and abstracted age, gender, ICD implant dates 
and therapies, death and cause of death. We calculated implantation rates, survival 
rates, and rates of therapy. 
Results: Seventy devices were implanted during the study period, all for American Col- 
lege of Cardiology/ American Heart Associatron Class I indications. The ICD implantation 
rate was 6.5/100.000 over the entire oeriod. increasina from 2.5/100.000 (95% Cl 0.9 to 
4.2) in the first four years to 11.5/100,000 (95% Cl 6.7 to 16.2) in the last two years. 
Twenty-three patients (33%) received an appropriate ICD shock during the study period. 
More than 80% of these were in the first year of implantation. Patients receiving ICDs had 
a significantly increased mortality compared to the control population. However, assum- 
ina that an aoorooriate ICD theraw orevented death, the device sianificantlv reduced 
”  I I  ._ _ 
Thomas Deneke, Bernd Lemke, Thomas Lawo, Bart Gerritse, on behalf of the European mortality among these patients. Based on these data, ICDs are estimated to reduce total 
GEM DR investigators. Bergmannsheil Bochum, Sochum, Germany mortality rates in this population by 0.3% 
Atrial fibrillation (AF) seems to be a predlctor of impaired survival in patients (pts) wth 
Conclusions: Rates of ICD implantation are increasing rapidly in the general populatlOn. 
implanted cardioverter deflbrillators (ICD) Methods: We performed a retrospective analy- 
In patients drawn from a community setting with American College of Cardiology/ Ameri- 
can Heart Association class I indications for ICD implantation, implantation of ICDS 
sis of baseline characteristics, medication and endpoints in pts receiving a Dual Cham- appears to be highly efficacious in aborting potentially fatal eventS. 
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1170-l 18 Survival After Implantation of an Implantabe Cardioverter- 
Defibrillator in Elderly Patients 
Emmanouil S. Brilakis, Arturo Valve&a, David Luria, Yang-Mei Cha, Chris Scott, Robed 
Rea, Paul A. Friedman, Win K. Shen. Mayo Clinic, Rochester, MN 
Background: The effectiveness of implantable cardioverter-defibrillators (ICD) in sudden 
cardiac death (SCD) prevention and ventricular arrhythmia therapy in selected pts has 
been demonstrated by several trials. Data on the long-term survival of elderly pts foflow- 
ing ICD implantation has been lacking. In this study, we determined the long-term sur- 
vival of elderly patients following ICD implantation and predictors of increased mortality. 
Methods: All consecutive pts of age t 70 yrs who underwent ICD implantation at the 
Mayo Clinic from 1989 - August 2000 were included in the study. Pts in this cohort were 
compared with an age and gender matched mortality data, and differences between 
observed and expected survival were tested using a l-sample log-rank test. Multivariate 
predictors were identified using a stepwise Cox proportional hazards model. 
Results: Of the total 367 pts (mean age 75.4 i 3.8 yrs) included in the study, 45 (12.3%) 
were older than 80 yrs of age, 302 (82%) were male. Indications for ICD implantation 
included out of hospital cardiac arrest (19%) ventricular fibrillation (8%)ventricular tachy- 
cardia (48%) and syncope (19%). There were 91 deaths during a mean follow-up of 1.9 
* 2.0 yrs. The observed and expected survival at 1,3, and 5 yrs were 89%, 72%, 54% vs 
96%, 87%, 78%, respectively (PcO.001). Multivariate predictors of increased mortality 
ware: use of amiodarone (p=O.OOS) and lack of b-blocker use (p<O.OOl). The cumulative 
probability of the combined endpoint of survival + appropriate ICD discharges were 56%, 
28% and 15% at 1, 3 and 5 years follow, respectively. 
Conclusions: 1) The observed survival is significantly worse than the expected survival 
in the elderly compared to matched cohorts following ICD implantation emphasizing the 
importance of optimizing therapy for underlying cardiovascular diseases. 2) The differ- 
ence in observed survival and survival + appropriate ICD discharges suggests ICD may 
benefit survival in the elderly population. 
1170-l 19 Outcome of Patients With Cardiac Sarcoidosis Treated With 
an Implantable Defibrillator 
Bradley P. Knight, Radmira Greenstein, Chi-Wo Ghan, Kristina Wasmer, Christian 
Sticherling, Robert L. Baker, Steven F! Chough, Hakan Oral, Frank Pelosi, Jr., Adam 
Strickberger, Fred Morady. University of Michigan Health System, Ann Arbor, M/, 
Oakwood Hospitals, Dearborn, MI 
Background: There are limited data on the use of defibrillators in pts with cardiac sarcoi- 
dosis. The purpose of this study was to determine the presentation and outcomes of pts 
with cardiac sarcoidosis who are treated with an implantable defibrillator. 
Methods: Eight consecutive pts with cardiac sarcoidosis who received an implantable 
transvenous defibrillator since 1994 ware identified from an institutional database. Base- 
line data and the clinical outcomes of each pt were retrospectively analyzed. 
Results: The mean age of the pts was 39+6 years, 75% were male, and 63% ware Afri- 
can-American. The mean LVEF was 0.39+0.20, and 25% had congestive heart failure. 
Cardiac sarcoidosis was confirmed in each pt. Seventy-five percent had been diagnosed 
with sarcoidosis before presenting with a ventricular arrhythmia, The indications for 
defibrillator therapy were symptomatic monomorphic VT (n=5), VF arrest (n=2), and 
asymptomatic nonsustained VT +I). Among the 5 pts who underwent electrophysiol- 
ogy testing, 2 pts (40%) had inducible VT. All pts were in sinus rhythm and 3 pts had 
received a pacemaker 32+25 months before defibrillator implant. The mean defibrillation 
energy requirement was 14k6 J. Eighty-eight percent were treated with prednisone and 
63% ware treated with a mean of 1.4iO.6 antiarrhythmic drugs after implantation. During 
a mean follow-up time of 43r32 months, 4 pts (50%) received appropriate defibrillator 
therapy. All 4 pts who received therapy presented initially with symptomatic monomorphic 
VT, received defibrillator therapy within 8 months following implantation, and received a 
median of 50 therapies. Using Kaplan-Meyer analysis, the mean survival time free of 
appropriate defibrillator therapy was 33+14 months. One of the 3 pts who had no induc- 
ible VT had appropriate therapy during follow-up. One pt died of congestive heart failure 
during follow-up. 
Conclusion: Patients with cardiac sarcoidosis who undergo defibrillator implantation 
usually have longstanding sarcoidosis and present with symptomatic monomorphic VT. 
These pts appear to be protected from sudden death, but frequently experience appropri- 
ate shocks despite the use of prednisone and antiarrhythmic drugs, 
1170-120 The Role of Implantable Cardioverter-Defibrillators in 
Advanced Heart Failure Patients Awaiting Orthotopic Heart 
Transplantation 
Julie Boles, Gregg Fonarow, Jon Kobashigawa, Michele Hamilton, Hillel Laks, Zenaida 
Feliciano. UCLA School of Medicine, Los Angeles, CA 
Background: Orthotropic heart transplantation (OHT) has established itself as an 
accepted treatment for end stage CHF. Sudden cardiac death (SCD) is one of the most 
common csuses of mortality in patients (pts) with CHF awaiting OHT. The implantable 
cardioverter-defibrillator (ICD) has been effective at preventing arrhythmic SCD in 
patients with CHF. 
Methods: We retrospectively evaluated 841 consecutive patients that underwent OHT at 
UCLA Medical Center from 1989-1999. Of those, 79 patients underwent ICD implantation 
prior to OHT and we obtained data on 73 patients. 
Results: Eighty-seven percent were male, mean ejection fraction was 22 +I-7%, and 
mean New York Heart Association (NYHA) class was 3.5 +/-0.72. The CHF etiology was 
ischemic in 51 patients (70%) and non-ischemic in 22 patients (30%). The indications for 
ICD implantation were sustained VT (46%) inducible VT (28%) syncope (16%) and pro- 
phylactic (10%). Of the 73 patients with an ICD, 51% had at least one appropriate shock, 
3% had inappropriate shocks, and 46% did not receive a shock prior to OHT. The mean 
number of appropriate shocks was 4.34 +/- 11.5. We divided the patients into two groups: 
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those that received an appropriate shock (group A) prior to OHT and those that did not 
(group B). There were no significant differences in the demographics, including gender, 
substrate, ICD indication, NYHA class, time from CHF diagnosis to OHT and presence of 
comorbidities between the groups. The time between ICD implantation and OHT was sig- 
nificantly longer for the patients in Group A, 1014 vs. 486 days (p=O.O3), and they were 
more likely to have received ant&rhythmic agents, 65% vs. 33% (p=.OO7). 
Patient Demographic Total Appropriate No appropri- Pvalue 
shock ate shock 
Mean LV Ejection Fraction 22_c7% 21*8% 24+7% 0.18 
lschemic CHF Etiology 51 (70%) 27 (75%) 34 (64%) 0.71 
ICD Indication: Sustained VT 32 (46%) 20 (55%) 12 (35%) 0.13 
Days from ICD implant to OHT 1,014.3 486.3 0.004 
Conclusions: ICD implantation prior to OHT in patients with end stage CHF is associ- 
ated with a high percentage of appropriate ICD shock and it may be successfully “bridg- 
ing” them to OHT. Prospective studies are necessary to establish predictors of benefit 
from ICD in this patient population. 
POSTER SESSION 
1171 Atrial Fibrillation: Surgical and Catheter 
Ablative Techniques 
Monday, March 19, 2001, 3:00 p.m.-5:OO p.m. 
Orange County Convention Center, Hall A4 
Presentation Hour: 4:00 p.m.-5:OO p.m. 
1171-121 Final Results of a Prospective Randomized Trial to Evaluate 
the Effectiveness of the Cox-MAZE-Ill-Operation Using 
Cooled-Tip Radiofrequency Ablation in Patients With 
Chronic Atrial Fibrillation and Mitral Valve Disease 
Krishna Khargi, Thomas Deneke, Peter H. Grewe, S&fan von Dryander, Thomas Lawo, 
Ellen Schick, Jijrgen Barmeyer, Axe1 Laczkovics, Bernd Lemke. 
BerufsgenossenschaiWche Kliniken B.qrgmannsheil - University of Bochum, Bochum, 
Germany 
The Cox-MAZE-Ill-Operation is highly effective in restoring sinusrhythm (SR) in patients 
(Pts) with chronic atrial fibrillation (AF). This prospective randomized study evaluated the 
potential clinical benefit, determined by standard ergometry and Spiro-ergometry, of the 
MAZE-operation in Pts with AF and mitral valve disease (MVD). Methods: 30 Pts with 
chronic AF (-t 3.1 years) who had mitral valve surgery (MVS) ware consecutively ran- 
domized either for an additional MAZE-Operation using intraoperative cooled-tip radiofre- 
quency ablation in the left and right atrium (group A) or MVS without MAZE-Operation 
(group B). Follow-up (FU) (ECG, bolter ECG, echocardiography) was performed after 1 
and 12 days and at 3, 6, and 9 months. Functional testing (ergometry, spire-ergometry) 
was additionally performed at 6 month FU. DC-shock cardioversion was performed when 
Pts were still in AF at follow-up (+ 2). Results: Group A and B do not differ in regard to 
age (65 vs. 70 years), preoperative duration of AF (3.6 vs. 3.7 years), left atrial dimen- 
sions (60 vs. 58mm) and ejection fraction (0.64 vs. 0.61). At 9 months cumulative fre- 
quencies of SR in group A was 0.80 compared to 0.27 in group B (pcO.01). Restored 
biatrial contraction as detected in transthoracic doppler-echocardiography was 70% of 
Pts in SR in group A and 100% in group 8. At 6 months FU NYHA class (2.5 in group A, 
2.6 in group B) and maximum oxygen uptake was similar in between the two groups (9.2 
vs. 9.1 ml/min/kg) (p=O.94). 4 Pts in group A and 1 Pt in group B died in between 6 weeks 
and 12 months post surgery. Conclusions: The Cox-MAZE-Ill-operation using intraopera- 
tive cooled-tip radiofrequency ablation is a highly effective method to restore SR and 
atrial contraction in Pts with chronic AF and MVD. Functional results reveals no signifi- 
cant difference in objective parameters of cardiac capacity. Pts who will profit from the 
MAZE-operation need to be identified in a larger (multi-center) trial with longer FU. 
1171-123 Multielectrode Basket Catheter-Guided Ablation for 
Pulmonary Venous Isolation in Atrial Fibrillation 
Koichiro Kumagai, Naomichi Matsumoto, Hideaki Tojo, Hiroo Noguchi, Hideko 
Nakashima, Naoki Gondo, Keijiro Saku. Fukuoka University Hospital, Fukuoka, Japan 
Background: A major source of ectopic beats that trigger atrial fibrillation is pulmonary 
veins, and successful ablation of pulmonary vein-triggered AF requires atrio-pulmonary 
vein conduction block. Therefore, we assessed the use of a multielectrode basket cathe- 
ter for electrophysiologically based ablation. Methods: Ten patients with atrial fibrillation 
underwent catheter ablation for pulmonary venous isolation. Pulmonary veins that dis- 
played distinct and late pulmonary vein potentials were targeted for ablation. After a tar- 
geted pulmonary vein was identified, a basket catheter was positioned within the 
pulmonary vein through a transseptal sheath. Circumferential pulmonary vein electro- 
grams were acquired simultaneously, and used to guide the ablation at ostial sites with 
the earliest pulmonary vein potentials during sinus rhythm. Radiofrequency ablation was 
performed while monitoring distal pulmonary vein potentials with a set temperature of 
50°C at 20-30 W. The endpoint was determined by the elimination of pulmonary vein 
potentials and/or the creation of pulmonary venous isolation. Results: The basket cathe- 
ter was easily inserted within the pulmonary vein and left in a stable position during the 
study. The distribution and activation sequence of pulmonary vein potentials from the 
ostium to distal pulmonary vein were determined instantly. The extent of a short atrio-pul- 
monary vein potential interval varied from a limited lesion to the wide circumference of 
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the ostium. A minimal segmental ablation at the limited ostial site with the earliest pulmo- 
nary vein potentials blocked atrio-pulmonary vein conduction and eliminated all potentials 
of pulmonary vein. In cohtrast, multiple radiofrequency applications over a wide lesion 
with synchronous atrio-pulmonary vein activafion at the ostium were required to elimrnate 
distal pulmonary vein potentials. No complications were observed. Conclusion: Multi- 
electrode basket catheter-guided mapping is safe and facilitates the rapid identification of 
the distribution and activation of pulmonary vein potentials for ablation, and permits the 
continuous monitoring of distal pulmonary vein potentials during the delivery of energy. 
cedures. Results: The survival rate is 97.7 %. There were two perioperative deaths (2.3 
%) not related to the ablation procedure. The duration of intraoperative microwave abla- 
tion was 13 * 5 minutes. In the 180.days follow-up (n=35) 74.3 % of patients sustained in 
sinus rhythm. In the one-year follow-up (n=27) 67.2 % of patients were in sinus rhythm. 
Conclusion: We report about our initial experience with tntraoperative microwave appli- 
cation for treatment of chronic atrial ftbrillation. This new technique is a safe adjunct tool 
to conventional cardiac surgery. Our preliminary results suggest hrgh efficiency even in 
cases with previous long-term period of atrial fibrillation. lntraoperative application IS con- 
venient and easy. 
1171-124 Surgery for Atrial Fibrillation Using Epicardial 
Radiofrequency Catheter Ablation With and Without 
Cardiopulmonary Bypass. Results at One Year 
Joao Melo, Teresa Santiago, Pedro Adragao, Jose News, Miguel Abecasis, Manuel M. 
Ferreira. Santa Cruz Hospital, Carnaxide, Portugal, Heart /nsfitute, Carnaxide, Portugal 
Background: Until recently the treatment of atriai fibrillation has been a major challenge, 
always requiring cardiopulmonary bypass. We report the results of the treatment of atria 
fibrillation through isolation of the pulmonary veins, using epicardial radiofrequency cath- 
eter ablation, with and without extracorporeal circulation. Methods: Nine patients with 
atrial fibrillation were operated using epicardial radiofrequency ablation of the right and 
left pulmonary veins. Lone atrial fibrillation was present in 2 patient and 7 had concomi- 
tant coronary artery disease. Their mean age was 60 i: 13 years and had been in atrial 
fibriilation for 4 * 2 years. Four patients were operated under cardiopulmonary bypass 
and 5 had off-pump surgery. The ablation was performed to achieve an epicardial tem- 
perature of 8O”Celsius. Heptapolar catheters were passed around the orifices of the pul- 
monary veins in the atrium through median sternotomy. Concomitant coronary 
revascularization was performed in 4 on-pump cases and in 3 off-pump cases. Intraoper- 
atively electrophysiologic studies were performed Results: The time required for the 
radiofrequency procedure was 32 i: 10 minutes, There was no mortality or morbidity. At 6 
months all the coronary revascularizatron patrents were in sinus rhythm and free of 
arrhythmia. One lone atrial fibrillation was cured and the other remained in atrial fibrilla- 
tion. Electrophysiologic studies suggested that complete isolation was not achieved in 
most patients Conclusions: Epicardial isolation of the pulmonary veins, with or without 
cardiopulmonary bypass, is feasible and safe. A better understanding of its mechanisms 
is desirable in order to achieve total isolation. 
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1172-127 Is the Accuracy of Electrogram Reconstructions 
Independent of the Underlying Rhythm? 
Karlheinz Seidl, Monika Rameken, Harald Schwacke, Axel Droegemueller, Jochen 
Senges. Heart Center Ludwigshafen, Ludwigshafen, Germany 
1171-125 Beating MAZE Procedure Using an Infrared Coagulator: To 
Heat to Beat 
Hiroshi Kubota, Shinichi Takamoto, Katsuhide Maeda, Mikio Ninomiya, Katsuhito Ueno, 
Yutaka Kotsuka. Department of Cardiothoracic Surgery, Univ. of Tokyo, Tokyo, Japan 
Background: Maze surgery is widely used to treat atria fibrillation, but it requires car- 
diopulmonary bypass and a longer aortic cross-clamping time. Catheter maze using 
radiofrequency is time consuming and the results are still unreliable. The beating maze 
procedure using an infrared coagulator has been developed to overcome these draw- 
backs, and in this study we attempted to electrophysiologically confirm the efficacy of this 
method. With the infrared coagulator employed, light from a tungsten-halogen lamp is 
focused into a light-conducting quartz rod. The distal exit-plane of the rod is connected to 
a sapphire tip designed in our laboratory that has a rectangular edge to allow 10 mm of 
linear photocoagulation (35 W/cmP) during each application. Methods: The beating 
mazelll procedure was performed in five mongrel dogs. Two hours of burst stimulation 
and vagus nerve stimulation were done preoperatively to make an atrial fibrillation model. 
The surrounding tissue was dissected to expose the left atrium. Instead of making all of 
the incisions, except the intra-atrial septal incision, the infrared coagulator was applied 
epicardially to create a continuously overlapping linear or circular lesion. Each applica- 
tion lasted 9 s. (3x3s). The potentials of both atria were recorded wtth 11 bipolar elec- 
trodes placed in the atrial wall. The recording conditions were: 1. spontaneous beating 
and, 2. overdrive pacing from both atriai appendages (RAA, LAA) and inside the pulmo- 
nary vein encircling lesion (PVEL). Burst stimulatron was attempted again to induce atrial 
fibrillation. The heart was examined for histopathological changes. Results: 1. With 
spontaneous beating, no potentials were detectable within the RAA, LAA, PVEL. Other 
parts of the atrium showed sinus rhythm. 2. With overdrive pacing, only the area within 
the lesion was activated by the stimulus. Other parts showed sinus rhythm. Atrial fibrilla- 
tion could not be induced. Thrombi was found on the endocardium of ablated lesion. 
Ablation could be completed within 10 min. Conclusion: The beating maze procedure 
can be successfully performed with an infrared coagulator in a short time. Modification of 
the power density is required to prevent thrombosis. 
Aim of the study was to validate the non contact mapping system (NCM) in different 
arrhythmias comparing unipolar contact electrograms with calculated virtual electro- 
grams at the same recording site. Methods: The mapping system consists of a 9F multi- 
electrode array balloon catheter hat has 64 active electrodes and ring electrodes for 
emitting a locator signal. The locator signal was used to construct a 3D-map and for 
defining the recording site of contact electrograms. Virtual electrograms were calculated 
at > 3000 endocardial sites in the right atrium of left ventricle. To valrdate the accuracy of 
virtual alectrograms, a template matching algorithm was used. Analysis was performed 
on randomly selected 2 seconds windows. The algorithm was used to determine a cross- 
correlation coefficient (CC) indicating the similarity between 2 signals. Overall, 956 beats 
were evaluated in different rhythms (sinus rhythm [SRI, atrial tachycardia [AT], atria flut- 
ter [Aflutt] or ventricular tachycardia [VT], atrial fibrillation [AF]). Results: The mean CC 
between contact and virtual electrograms was 0.86 t 0.16 in all rhythms. The mean 
absolute time difference was 3.41 ? 5.57 ms. Conclusion: The accuracy of electrogram 
reconstruction was good with a CC between 0.79 in AF and 0.88 in SR. In regular 
rhythms the CC was better than in AF. The accuracy of electrogram reconstruction was 
better at sites < 40 mm from the balloon center compared to sites > 40 mm from the bal- 
loon center. 
All rhythms 
SR 
ATIAfIutVVT 
AF 
Beats cc CC<40mm CC>40mm 
956 0.86 i 0.13 0.88&0.13 0.74 * 0.17 
560 0.88 f 0.13 0.9 + 0.11 0.74 f 0.17 
119 0.88 + 0.13 0.9 * 0.13 0.76 t 0.18 
277 0.79 * 0.16 0.80 k 0.15 0.76 ? 0.18 
1172-I 28 Global Comparisons Between Contact and Noncontact 
Mapping Techniques in the Right Atrium: Role of Cavitary 
Probe Size 
Liyun Rae, Huabin Sun, Dirar S. Khoury. Baylor College of Medicine, Houston, TX 
1171-126 Curative Treatment of Chronic Atrial Fibrillation in Patients 
With Simultaneous Cardiosurgical Disease With 
lntraoperative Microwave Ablation 
Michael Knaut, Sems MalteTugtekin, Stefan G. Sprtzer, Laszlo Karolyi, Holger Boehme, 
Stephan Schueler. Cardiovascular Institute, University of Dresden, Dresden, Germane: 
institute for Cardiovascular Research, Dresden, Germany 
Background: The MAZE procedure represents the golden standard in surgrcal therapy 
of chronic atrial fibrillation, however the application is limited due to the complexity of the 
surgical procedure. Microwave ablation represents a new treatment of chronic atrial fibril- 
lation in patients with mitral valve disease and coronary artery disease. Methods: From 
1211998 - 7/2000 microwave ablation was performed in 90 patients (53 female, 37 
female, age 68.2 f 7.7 years) suffering from mttral valve disease or coronary artery dis- 
ease and chronic atrial fibrillation. Atrial fibrillation was documented for 8.0 + 8.3 (0.6 
43.4) years. A microwave device with an application frequency of 2.45 GHz was used for 
a contmuous ablation line starting at the posterior mitral valve annulus and incorporating 
the interior of ail pulmonary veins. All patients received additional mitral valve reconstruc- 
tion I replacement or coronary artery bypass grafting and concomitant cardiosurgical pro- 
Background: Endocardial electrograms were previously computed from noncontact cav- 
itary electrograms measured with large multielectrode probes. Using small probes facili- 
tates inserting diagnostic/ablation catheters in parallel and navigating them within the 
cavity. We therefore investigated properties of noncontact cavitary electrograms as well 
as computed endocardial electrograms and their dependence on probe size in the right 
atrium (!?A). 
Methods: A custom catheter was deployed in the dog RA, and contained both a cylindri- 
cal probe for measuring noncontact cavitary electrograms and a concentric basket for 
measuring contact endocardial electrograms, each carrying 64 electrodes. Two probes 
were sequentially tested in the same RA of one dog: 5.mm and lo-mm diameters (P5 
and P10, respectively). Probe and basket unipolar electrograms were simultaneously 
acquired during normal and paced rhythms (2 24 protocols per probe). Probe-basket 3-D 
geometry was determined from fluoroscopy. Endocardial etectrograms were computed at 
basket-electrode locations for comparison with contact electrograms. 
Results: Noncontact electrograms alone depicted global features of activation (e.g. 
regions of earliest and latest activation). Noncontact electrograms were however attenu- 
ated and smoothed, and this effect was exaggerated with P5 (peak-to-peak amplitude 
error: P5, 57%; Pi 0, 42%). Yet, computed endocardial electrograms more acCUrately 
reconstructed important amplitude distribution and morphological features for both 
probes (e.g. double potentials); peak-to-peak amplitude error: P5, 35%; PlO, 34%. Actr- 
vation and spatial errors for computed endocardial electrograms were 8.8 + 6.8 ms and 
5.1 f 6.1 mm for P5, respectively, and 6.0 rt 5.5 ms and 3.2 i 4.4 mm for PlO, respec- 
tively. 
Conclusion: Global RA activation features may be delmeated from noncontact cavitary 
electrograms alone, but are limited by probe size. Endocardial electrograms can however 
be successfully computed from noncontact electrograms acquired with small probes to 
reconstruct both electrogram amplitude and detalled morphology, which may ease navi- 
gating ablation catheters and monitoring ablation effects. 
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1172-129 Efficacy of a Unique System for Internal Cardioversion and 
Multipolar Electrode Recordings for Mapping Atrial 
Fibrillation Triggers 
Robert W. Rho, Vickas Pat& Manisha S. Ashar, David J. Callans, Marchlinski E. Francis. 
Hospital of the University of f’ennsylvania, Philadelphia, PA 
Background: Frequent cardioversions (CVs) are typically required when mapping trig- 
gers for atrial fibrillation (AF). In addition, multipolar recordings from the posterior right 
atrium (CRISTA) and coronary smus (CS) appear useful in localizing AF triggers. We 
evaluated a unique catheter based system to determine efficacy for 1) internal AF CV 
and 2) recording of AF initiation in 15 patients (pts). 
Methods: Ten pole catheters (Elecath) were placed in the CS (: pole) and at the CRISTA 
(+ pole) and connected by a switch box to an external defibrillator (HVSOZ, Ventritex). An 
R wave synchronous shock for AF was delivered as two 6 ms monophasic sequential 
shocks of reversed polarity separated by 0.2 ms beginning at 370 and 140V (total energy 
of 6.8.12J) afte! activating a switching system to isolate recording amplifiers. After a CV, 
the switch reversed to record activation of AF triggers. If there were two consecutive inef- 
fective CV, the energy was increased by 20.50V until the CV was successful or a total 
energy of 18.22J was achieved. 
Results: A total of 183 AF CV attempts were made ( 4.42/pt, median Sipt). Repeated 
successful CV (at least 3 of 4 shocks at designated energy) were noted in 8 pts at 6.8-12 
J, 4 pts at 12-16 J and 2 pts at 16-22 J. In 1 pt, an external CV was needed for AF termi- 
nation. One pt had VF due to inappropriate sensitivity setting and shock on T with prompt 
ventricular fibrillation termination with an external shock. No other pt had proarrhythmia, 
adverse hemodynamic effects or alteration of catheter Integrity. The switching system 
allowed for recording CS and CRISTA activation and timing of AF triggers within 2 s of 
cv. 
EMIAT study. 2 parameters of HRT, turbulence onset (TO) and turbulence slope (TS) 
were measured from Halter ECGs using a computer algorithm. Clinlcal data were pro- 
spectively collected. Cox regression ansalysis was used. Results: At a follow up period 
of 608.9+189.8 days, there were 206 deaths (174 cardiac, of which 83 were arrhythmic 
deaths). Multivariate analysis showed that among age, sex, LVEF, amiodarone treatment, 
beta-blocker, thrombolysis, ACE inhibitor, heart rate variability, VPB, TO and TS: 1) age 
(p=O.OOl), LVEF (p=O.O006), thrombolysis (p=O.O03), TS (p=O.O3) and heart rate variabil- 
ity (p=O.Ol) were predictive of all-cause mortality; 2) age (p=O.O4), LVEF (p=O.O003), 
beta-blocker (p=O.O09), thrombolysis (p=O.O04), TS (p=O.O4) and VP!3 (~~0.03) predicted 
cardiac mortality; 3) LVEF (p=O.O3) and TS (p=O.O05) were predictive of arrhythmic mor- 
tality. Conclusions: 1) Although HRT predicts all-cause and cardiac mortality less 
strongly than other risk parameters in post-Ml patients with left ventricular dysfunction, it 
is the strongest independent predictor of arrhythmic mortality despite contemporary treat- 
ment for MI; 2) The absence of the heart rate turbulence after ventricular premature 
beats is a very potent predictor of arrhythmic event independent of other known risk fac- 
tors and which is stranger than other presently available risk predictors; 3) HRT may 
potentially be used to stratify specifically patients at risk of arrhythmic death for prophy- 
lactic intervention. 
1173-l 12 Simple Risk Stratification for Sudden Cardiac Death Using 
Heart Rate Dependent Ventricular Arrhythmias in Heart 
Failure During Long-Term Follow-Up 
G Tjeerdsma, Jan Brouwer, Harry J. G. M. Crijns, Dirk Jan van Veldhuisen. University 
Hospital, Groningen, The Netherlands 
Conclusion: The described multipolar electrode catheter based internal CV, recording 
and switching system allowed for repeated effectwe termination of AF, assisted in map- 
ping of AF triggers, and was well tolerated. 
1172-130 Ablation Guided by Biatrial Catheter & Noncontact Three- 
Dimensional Mapping in Patients With Multiple Atrial 
Tachyarrhythniias 
Sanjeev Saksena, Atul Prakash, Ryszard Krol, George Philip. CVInsiitute, Atlantic 
Health System, Passaic, NJ 
We performed linear RA ablative 
lesions in 10 patients [pts] with 
refractory atrial fibrillation [AF] 
(n=3), atrial flutter [AFL] (n=3), 
atrial tachycardia [ATj & AF (n=l), 
or AF & AFL (n=3). Pts underwent 
beat-to-beat simultaneous biatrial 
contact catheter mapping [CCM] & 
3-D non-contact mapping [NCM]. 
Sustained AT, AF & AFL episodes 
Background: Ventricular arrhythmias are frequently found in patients with chronic heart 
failure (CHF). We hypothesized that a short sinus R-R interval immediately preceding a 
premature ventricular contraction (pm-PVCrr) is a strong indicator for the risk of sudden 
cardiac death in CHE Methods: We evaluated 100 patients (pts) with mild/moderate 
CHF (age 60+/-8yr [mean+/-SD], LVEF 0.29+/-0.09, NYHA class ll/lll [80/20 %I). Heart 
rate (HR) and pre-PVCrr was determined from 24.hr ambulatory EGG monitoring. A sim- 
ple risk model was developed using the three strongest predictive variables on admis- 
sion. The are under the receiver operating curve (AROC) was calculated for this model. 
Results: During 7 ‘/2 years follow-up, 30 of the CHF pts died, 26 of cardiac death (19 
sudden deaths). These pts differed sigmficantly from those without endpoint wth respect 
to HR (83+/-16 vs. 75+/-II), LVEF (0.28+/-0.09 vs. 0.31+/-0.08) and prePVCrr (461+/- 
102 vs. 534+/-136), and the number of premature ventricular beats (33[1-10911 vs. 10 [l- 
417]), all ~~0.05 between both groups. A short pre-PVCrr was strongly associated with 
an increased risk for sudden cardiac death (p<O.OOl). In addition, the combination of pre- 
PVCrr, elevated HR, low LVEF had an AROC of 0.82 (95%CI 0.71-0.91, p<O.OOOi) for the 
risk of sudden death. Conclusion: Our data indicate that CHF patients with a bradycar- 
dia- assooated PVC are at increased risk for sudden cardiac death. Furthermore, the 
combined analysis of pre-PVCrr, HR and LVEF could represent a simple model to risk 
stratify these patients. 
were mapped. RA ablation was anatomically guided by NCM or electrophysiologicaily 
guided by CCM & NCM. Linear lesion integrity was tested using pace-mapping (FIGURE 
LAO view during high RA pacing before and after RF ablation) Results: CCM immedi- 
ately localized atria origin of AT, AF & AFL while NCM identified origin & propagation in 
specific atrial region(s) in all pts. NCM guided linear AT ablation could be achieved with 
10 to14 contiguous lesions. Isthmus ablation required 6 to18 lesions for medial & lateral 
linear lesions. Focal area ablation for AF required 11 to 14 lesions & RA linear compart- 
mentalization required 24 to 38 lesions. Integrity of linear lesions was rapidly confirmed in 
a single paced cycle using NCM in all pts (Figure). After ablation there was suppression 
of AT (1 pt), AFL (6 pts) & AF (4 pts). AFL recurred in 1 pt who was successfully re- 
ablated at site where NCM demonstrated loss of linear lesion integrity. Conclusions: 1) 
Combined CCM & NCM permits rapid global localization & detailed regional analysis of 
AT, AFL & AF on a beat-to-beat basis. 2) Linear lesion confluence & integrity can be rap- 
idly established by NCM & permits sticcessful ablation. 
1173-I 13 Postextrasystolic T Wave Changes in Long QT Syndrome 
Atsunobu Nomura, Wojciech Zareba, Jennifer Robinson, Mark Andrews, Arthur J. Moss. 
University of Rochester, Rochester, NY 
Background: Augmentation of U wave after ventricular premature beats (VPB) was 
reported to be associated with ventricular tachyarrhythmias I” non-LQTS patients. The 
aim of this study was to evaluate postextrasystolic (post-VPB) changes in repolarization 
parameters in LQTS patients with and without cardiac events. 
Methods: In 48 LQTS patients (18 males and 30 females, age 32+23 years), in whom at 
least one VPB was recorded on a la-lead ECG, the following heart rate adjusted inter- 
vals were measured in beats prior to and after a VPB: QTc interval, QT peak (QTpc) 
interval, T peak- T offset (TpToc) interval and T amplitude (Tamp). The pre-VPB and 
post-VPB repolarization parameters were measured and compared between 14 patients 
with and 34 without cardiac events. 
Results: In all studied patients, the QTpc and QToc of post-VPB beats were significantly 
shorter than those of pre-VPB beats (335+61 vs. 361&O ms, and 439+91 vs. 470+91 
ms, respectively, p<O.Ol), whereas TpToc and Tamp did not show significant changes by 
VPB. When evaluating differences in repolarization parameters between post-VPB and 
pre-VPB in patients with and without cardiac events, TpToc and Tamp were significantly 
different in post-VPB beats: 
Difference (oost-VPB - we- No Cardiac Event (n=34) Cardiac Event (n=141 
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1173-I 11 Novel Heart Rate Turbulence Predicts Arrhythmic Mortality 
in Postmyocardial Infarction Patients With Left Ventricular 
Dysfunction- EMIAT Substudy 
Yee Guan Yap, A. John Camm, Georg Schmidt, Marek Malik. St. George’s Hospital 
Medical School, London, United Kingdom 
Background:Heart rate turbulence (HRT) is a phenomenon described recently to mea- 
sure the chronotropic response of sinus rhythm to VP&. However, the prognostic value 
of HRT in predicting various mode of mortality is unknown. Method: We analysed the 
prospectively collected Hotter recordings of 1486, (1254 M, age: 60.419.5) post-myocar- 
dial infarction (Ml) patients with left ventricular ejection fraction (LVEF) ~40% from the 
VPB) ” 
QTpc (ms) -30530 -2Oi-40 
QToc (ms) -40+40 -1oc50 
TpToc (ms) -12.2k25.2 9.7*2ELit 
Tamp* (irV) 20r50 90*70* 
* Absolute value of difference of Tamp between pre-VPB and post-VPB 
tPc0.05, $P<O.Ol when comparing patients with and without cardiac events 
Logistic regression analysis (including age, gender, medication of beta blocker and anti- 
arrhythmic drugs, QTc and the above parameters) showed that post-VPB change in 
Tamp is the only independent factor associated with cardiac events (odds ratio 1.20 by 10 
pV change in T wave amplitude, P=O.O08). 
Conclusion: Postextrasystolic TpToc prolongation and change of T wave amplitude are 
associated with cardiac events in LQTS patients. These postextrasystolic repolarization 
changes may reflect increased heterogeneity of ventricular repolarization predisposing to 
cardiac events in LQTS patients. 
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1173-131 Does T-Wave Alternans Predict lnducibility of Ventricular 
Tachycardia in Patients With Coronary Artery Disease and 
Depressed Left Ventricular Function? 
Jennifer D. Cohen, Kenneth M. Stem, Sun& Mittal, Sei Iwai, Mlthilesh Das, David J. 
Sldwiner, Steven M. Markowltr. Bruce B. Lerman. Cornell University Medica/ Cenfer, 
New York, NY 
Background: Implantation of defibrillatars has proven beneficial in patients with core- 
nary artery disease (CAD), depressed left ventricular function and inducible ventricular 
tachycardia during electrophysiology study (EPS). T-wave alternans (TWA) testing has 
been proposed as a nonlnvasive alternative to EPS. The purpose of this study was to 
determine whether T-wave alternans (TWA) testing could identify such pts. 
Methods: We prospectively evaluated 42 pts (28 men, mean age 64*12) referred for 
EPS. All pts underwent TWA testing during rapid atrial pacing with the Cambridge Heart 
CHZOOO system. All pts also underwent EPS “sing programmed stimulation at two ven- 
tricular sites with up to triple extrastimull with and without isoproterenol. Two physicians 
blinded to the results of EPS interpreted TWA. Positive TWA had an artifact-free interval 
of at least 1 minute with a TWA amplitude tl.9&V r either one orthogonal lead or two 
adjacent precordial leads. Positive tests had an onset heart rate 5110 beatsimin with 
persistent alternans at and above the onset heart rate. A negative test did not meet 
these criteria and required an artifact-free interval at 105 beatslmin. All other tests were 
indeterminate. Positive EPS was defined as the induction of sustained monomorphic 
ventricular tachycardia with up to triple ventricular extrastimuli or ventricular fibrillation 
with up to double ventricular extrastimull. 
Results: All pts had documented CAD and ejection fractions 540%. TWA was positive 
in 15 (35.7%) pts, negative in 17 (40.5%) pts, and indeterminate in 11 (26.2%) pts. Of 
the 15 pis with positive TWA, 11 had (+) EPS, a positive predictive value of 73%. Of the 
17 pis with negative TWA, 10 had (+) EPS, a negative predlctlve value of 41%. Of the 10 
pts with indeterminate TWA, 8 had (+) EPS. 
Conclusions: TWA does not have sufficient negative predictive value in this population 
to obviate EPS. Long-term follow-up is needed to determine the prognostic significance 
of dlscordant TWA and EPS results. 
1173-I 32 -___ Application of a Simplified Risk Assessment for Sudden 
Cardiac Death 
James A. Coman, Jr., Brian M. Ramza, P David Margolis, The Investigators of the 
Oklahoma Heart Institute. Olilahoma Heart Institute, Tulsa, OK. University of Okiahoma 
Coliege of Medicine - Tulsa, Tulsa, OK 
Background: Pa?ients with ischemic heart disease (IHD), left ventricular ejection frac- 
iions (LVEF) of 35% or less. and nonsustained ventricular tachycardia (NSVT) need eval- 
uation with electrophysiology studies (EPS) to assess risk for sudden cardiac death. 
Unfortunately, these criteria are applied variously across the country and only vague esti- 
matlons exist on the volume of patients that full application of these data would bring to 
attention. 
Methods: All outpatlents presenting to our cardiology group were evaluated for the pres- 
ence of IHD and LVEF of less than 36% Patients meeting these criteria received a 24. 
hour Halter monitor unless the physician found a ContraIndIcation to placement. Patients 
with Holters showing 3 or more beats of NSVT underwent an EPS “sing the protocol out- 
lined in the MADIT study, and ICD’s were implanted in the setting of a positive study. All 
patients were followed for overall mortality regardless of the Halter findings. The longest 
follow-up was 22 months. 
Results: Of the 6646 patients assessed, 285 (4.3%) met criteria for Halter placement. Of 
these patients, 208 completed the 24.hour monitoring period, with 133 showing normal 
Hollers. Of those with normal Halters, 14 (10.5%) deaths occurred. From the 75 (36.1%) 
patients with NSVT, 62 consented to an EPS. Eleven people declined an EPS with 1 
(9.1%) death in follow-up. Of the 62 patlents who had an EPS, 35 (56.5%) were normal 
with 1 (2.9%) death over the 22 months. The remaining 27 (43.5%) patients with a posi- 
tive EPS received ICD’s. Over the follow-up period, 2 (7.4%) patlents with ICD’s died, 17 
(63%) received no therapy, 7 (25.9%) received therapy for ventricular tachycardia, and 2 
(7.4%) for ventricular fibrillation. 
Conclusions: The percentages of patients in a large private cardiology practice who 
meet the criteria for placement of a Halter monitor, EPS, or eventual ICD implantation, 
“sing these guidelines, are low. Placement of ICD’s in this population resulted in a 33% 
rate of appropriate discharge over ihe follow-up period. The patients with risk factors but 
negative EP studies had a low mortality. The patients with IHD, depressed LVEF but neg- 
ative Halter monitors had the highest mortality of the patients studied. 
ABSTRACTS - Cardiac Arrhythmias 111A 
ORAL CONTRIBUTIONS 
839 New Concepts About Atrial Fibrillation 
Monday, March 19, 2001 I 4:00 p.m.-5:30 p.m. 
Orange County Convention Center, Room 23214 
4:00 p.m. 
839-l Gender and Age Differences in Induced Atrial Fibrillation 
Hiroshi Tada, Christian Sticherling, Steven P Chough, Robert L. Baker, Krlstina Wasmer, 
Radmira Greenstein, Chi-wo Ghan, Hakan Oral, Frank Pelosi, Jr., Bradley P. Knight, S. 
Adam Strickberger, Fred Morady. University of Michigan MedIcal Centec Ann Arbor, MI 
Background: The prevalence of atrial fibrillation (AF) appears to be higher in men than 
in women at all ages, although the absolute number of women with atrial fibrillation is 
equal to or greater than men in older age group. However, the etiology of these gender 
and age differences is still not clear. Experimental and clinical studies have shown that 
AF shortens the atrial effective refractory period (ERP) and ~ncieases the susceptibility 
towards further episodes of AF The purpose of this study was to assess whether there 
are age or gender differences in the behavior of induced AF or in the shortening of ERP 
after brief episodes of AF. Methods: Twenty-three women (41+15y; range, 20.75~) and 
15 men (39il8y; range, 19-70~) without structural heart disease were studied. None of 
the women were on hormone replacement therapy. Autonomic blockade was achieved 
with propranolol and atropine. AF then was induced by rapid atrial pacing. The ERP was 
measured at basic drive cycle lengths (BDCL) of 350 and 500 msec before AF and 
immediately after conversion of several minute episodes of AF until the ERP was back to 
baseline. Results: The duration of primary episodes of induced AF was significantly 
longer I” men than in women (65Ok242 sac vs. 398i163 sac: p<O.OOl). Electric cardio- 
version was required significantly more often in men than in women (60% vs. 13%; 
p<O.O05). The changes between pre-AF ERP and the 1st post-AF ERP at both BDCLs 
(D-ERP350 and D-ERPSOO) did not significantly differ between men and women. In 
women, but not in men, a significant positive correlation between age and D-ERP350 or 
D-ERPSOO was observed (Age and D-ERP350:r= 0.61, P=O.OO? Age and D-ERP500:r= 
0.64, P=O.OOi). There were no signilicant differences in body weight or body surface 
area between men and women. Conclusion: 1) Induced AF converts spontaneously 
within 15 men more often in women than in man. 2) In young women, attenuation of the 
shortening of the ERP in response to brief episodes of AF is observed. 
839-2 
4:15 p.m. 
The Physiologic Right to Left Atrial Gradient of Action 
Potential Duration and Refractoriness Decreases with 
Pacing Induced Atrial Fibrillation 
Bengt Herweg, Parag Chandra, Evgeny P. Anyukhovsky, Eugene A. Sosuno”, Peter 
Danilo, Jr., Michael R. Rosen. Columbia University, New York, NY 
Human and animal studies have demonstrated differences in right (RA)and left (LA)atrial 
effective refractory periods (ERP), which are longest at RA sites and shorter in Lb. We 
hypothesize that in sequentialy activated atria a reduction of the gradient of atrial action 
potential duration (APD) mcreases temporal dispersion of repolarization. that can be 
appreciated on the surface ECG. Four chronically instrumented dogs were paced for 
70t8 days from the LA appendage at a cycle length (CL) of IOOms, which resulted in 
sustained AF (>8 days duration) in 214 dogs and non-sustained AF (l-8 days) in 2 dogs. 
PTa intervals and time integrals in XYZ (Frank) leads and ERPs were measured at con- 
trol and after the last termination of AF. ERP at a CL=400 ms shortened from 13924 to 
110~10 ms in the RA (p<.O5), and from 122+4 to 107*6ms in the LAA (p=NS). Tissue 
from mid-lateral RA and LA of dogs in AF was studled using microelectrodes. Resting 
potential, AP amplitude and Vmax in RA did not differ between AF and 5 control dogs. In 
LA, AP amplitude and Vmax were higher in control (at CI=500ms 110+2 and 104+lmV, 
220115 and 153&V/s, respectively, pc.05 for both). APD to 90% repolarization (APDSO) 
at CL=500 ms was 170*7ms (RA) and 153&5ms (LAA) at control, compared to 124+3ms 
(RA) and 119+5ms (LA) in AF dogs (both pc.05). The gradient of APDSO and ERP slgnif- 
icantly diminished (see graph). XYZ PTa interval dispersion Increased from 8.3+2.6ms at 
control to 29+5.8ms during RA pacing. and from 17.7~5.2 to 32.3?4ms during LA pacing 
(both pc.05). PTa time integrals in lead X during RA pacing changed from 1.8+0.9pVs by 
1.8c.5 ~VS (pc.05) without changes in leads Y and 2. 
Conclusion: Induction of AF by rapid LAA pacing is associated with a reduction of the 
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physiologic gradient of APD and refractoriness between RA and LA. This can be appreci- 
ated in the surface ECG as a change in temporal PTa dispersion and voltage time inte- 
gral, and might increase the propensity for AF 
839-3 
4:30 p.m. 
Alteration of Atrial Electrophysiology in Patients With Heart 
Failure. An Electromagnetic Mapping Study With 
Monophasic Action Potentials 
edited manually by the investigator. Each local activation was classified as having 
between I-5 components. In each pt, fragmentation maps were constructed during 16 
seconds of continuous AF. Both the degree and total delay of fragmentation were visual- 
ized. Local interval histograms, total fragmentation and conduction delay were used to 
compare the degree of fragmentation in the whole mapping area. 
Results: 
Acute AF Chronic AF 
Juergen Schreieck, Martin R. Karch, Bernhard Zrenner, Sebastian Schmieder, Michael 
Messerschmidt, Claus Schmitt. Deutsches Herzzentrum Muenchen, Technische 
Universitaet Muenchen, Munich, Germany 
Background: Alteration of cardiac electrophysiology in the atrium due to heart failure 
has been less investigated than on the ventricular level. Methods: Therefore, we used a 
modified NaviStar catheter (Biosense Webster) for measurements of monophasic action 
potentials (MAP) with the electromagnetic mapping system of CART0 (Biosense Web- 
ster) in order to characterize three-dimensional atrial electrophysiology of patients with 
and without heart failure undergoing electrophysiological studies. Results: During steady 
state pacing from the coronary sinus ostium with a cycle length of EOOms, activation time 
and MAPS were recorded from 28 +/- 8 right atrial sites in 10 patients with heart failure 
(left ventricular ejection fraction < 45%) compared with 10 control patients without heart 
failure. Maximal MAP duration dispersion (difference between longest and shortest MAP) 
was similar in patients with heart failure compared to control patients, 80.3 +/- 6.2 ms vs. 
76.3 +I- 5.5 ms, respectively. Longitudinal and transverse conduction velocity in the pos- 
terior right atrium were also not statistically different in the two group of patients, 0.85 +I- 
0.08 m/s vs 0.99 +/- 0.08 m/s and 0.88 +/- 0.11 m/s vs 0.93 +/- 0.10 m/s. In addition, rate- 
dependent steady-state monophasic action potential duration at 90% repolarization 
(MAPDSO) in the right atrial appendage was determined in all patients. Mean values + 
SEM for the two group of patients are presented in the following table (* p’ 0.05). 
MAPDSO at a cycle length of 
total number of electrograms 5206 5341 
fractionated electrograms 4 % 19 % 
double potentials 4 % 14 % 
triples 0.1 % 4 % 
electrograms > 3 deflections 0 % 5 % 
max. % fractionated electrogramslelectrode 26 % 75 % 
fragmentation delay/ AF cycle 1 ms 7ms 
Conclusion: Acute and chronic AF in the non-dilated right atrium differ in local interval 
histograms, total fragmentation and conduction delay. Fragmentation mapping may be 
useful to distinguish different types of AF and/or to characterize the underlying substrate 
Of FC. 
839-6 
5:15 p.m. 
Impact of Hydrogen Peroxide on Human and Canine Atrial 
Calcium Current and Action Potentials: Implications for 
Postoperatlve Atrial Fibrillation 
David Ft. Van Wagoner, Michelle Lamorgese, Laurie Castel, John A. Bauer, Cynthia A. 
Carries, Mina K. Chung, Patrick M. McCarthy. Cleveland Clinic Foundation, Cleveland, 
OH, Ohio State University College of Pharmacy: Columbus, OH 
Background: Free radical injury is implicated in the initiation of repedusion arrhythmias. 
Cardiac surgery is accompanied by evidence of increased oxidative stress (free radical 
production), and is frequently (30.50% of cases) accompanied by post-operative atrial 
fibrillation (post-op AF). The mechanisms responsible for the occurrence of post-op AF 
are not understood. We hypothesize that oxidative stress may increase atrial ectopy by 
altering cellular calcium handling and/or calcium currents. Calcium overload is known to 
be an important event in the initiation of AF. The role of hydrogen peroxide (which can be 
released by activated blood cells or generated within the atrial myocyte) on atrial calcium 
currents has not previously been evaluated. Methods: We examined the impact of exog- 
enous hydrogen peroxide (0.1.1mM) on L-type CaZ+ current (IQ) and action potentials 
in canine and human atrial myocytes, recorded at 35”C, using conventional patch clamp 
techniques. Myocytes were isolated from right atrial appendage tissue (dogs, and 
patients undergoing cardiac bypass surgery) using a chunk dissociation technique. 
Results: In both canine (n=9) and human (w2) myocytes, superfusion with hydrogen 
peroxide caused a gradual and progressive increase in ICa with no shift in voltage- 
dependence or kinetics. After 12 minutes exposure, 1mM peroxide increased peak ICa 
by 106*21% in 4 canine myocytes (representative plot). 
600 ms 400 Ills 300 ms 
patients with heart failure 253+15 ms 214+18 ms 162+12ms* 
control patients 255+10 ms 244+13 Ins 194+8 ms 
Conclusions: Right atrial electraphysiologic properties concerning repolarization time, 
dispersion of repolarization and conduction velocity at a heart rate of 100 beat per minute 
is similar in patients with and without heart failure. However, rate-dependent atrial 
monophasic action potential shortening is more pronounced in patients with heart failure. 
The more steepened rate dependence of repolarization in the atria of heart failure 
patients may facilitate reentry mechanisms at high heart rates. 
839-4 
4:45 p.m. 
Fixed lntercaval Block in the Setting of Sustained 
Fibrillation Promotes Induction of Atrial Flutter 
Hanh M. Bui, Celeen M. Khrestian, Albert L. Waldo. Case Western Reserve University/ 
University Hospitals of Cleveland, Cleveland, OH 
Background: In the sterile pericarditis model: 1) the development of induced, sustained 
atrial flutter (AFL) requires a stable line of block between the venae cavae; 2) sustained 
atrial fibrillation (AF) lacks such a line of block; and 3) during AFL, if the line of block 
shortens or becomes unstable, AFL deteriorates into AF. In this model, we tested the 
hypothesis that placing a fixed line of block between the venae cavae critically alters the 
atrial substrate, enabling the induction of sustained AFL instead of AF. Methods: Five 
sterile pericarditis dogs with sustained (Z-45 min) AF induced by rapid atrial pacing 
underwent simultaneous epicardial mapping from 396 unipolar electrodes placed on the 
right and left atrium and the right atrial septum. After termination of AF, cryoablation was 
used to create a fixed line of block between the venae cavae in the area of the crista ter- 
minalis, and AF reinduction was attempted. Results: Before cryoablation, all episodes of 
AF showed a rapid, regular left atrial reentry circuit with cycle length (CL) between fOO- 
128ms (mean CL i IlclOms). Wave fronts from this circuit displayed fibrillatory conduc- 
tion and activated the right atrium via several routes. In 4/5 dogs, subsequent creation of 
the tine of block resulted in induced, sustained AFL (mean CL 167*13ms) due to figure- 
of-eight reentry (1 dog), single loop reentry involving the atrial septum and right atrial free 
wall (1 dog), or lesion reentry (2 dogs). In l/5 dogs, AFL failed to develop because the 
same left atrial reentry circuit that existed before cryoablation continued to form despite 
the presence of the line of block. This reentry circuit, which exhibited an unusually long 
CL of 128ms, traveled around the pulmonary veins and generated fibrillatory conduction 
that propagated to the rest of the atria. Conclusions: In this model of sustained AF, cre- 
ation of a fixed line of block between the venae cavae provides a substrate preferentially 
favorable for the induction of AFL. However, if the preablation reentry circuit is reengaged 
during induction, AF recurs despite the presence of a line of block. This study has poten- 
tial implications for treating AF in humans. 
839-5 
5:00 p.m. 
Distinction of Different Types of Atrial Fibrillation by 
Analysis of Fibrillation Electrograms 
Natasja M. S. de Groat, Martin J. Schalij, Joep L. R. M. Smeets, Maurits A. Allessie. 
Leiden University Medical Center, Leiden, The Netherlands 
Background: Fibrillatory conduction (FC) is associated with a different degree of frag- 
mentation in the local unipolar electrogram. In the present study, we evaluated different 
parameters to characterize degrees of fragmentation. 
Methods: Right atrial mapping (244 electrodesdiameter 0.3 mm) was performed during 
cardiac surgery in pts without a history of atrial fibrillation (AF) (acutely induced AF by 
rapid pacing) and pts with chronic AF based on mitral valve disease. All components in 
the unipolar atrial fibrillation electrograms were marked by a computer algorithm and 
Under current clamp conditions, 1 mM hydrogen peroxide enhanced the plateau and pro- 
longed action potential duration in both canine and human atrial myocytes, accompanied 
by a rapid loss of cell shortening. Conclusion: Free radical production (eg., hydrogen 
peroxide) following cardiac surgery may contribute to the development of atrial Ca2+ 
overload, mechanical stunning, and the initiation of post-operative atrial fibrillation. 
ORAL CONTRIBUTIONS 
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848-l 
8:30 a.m. 
Natural History of Lone Atrial Fibrillation in 234 Males: 
Follow-Up of 22 years 
Ants Palm-Leis, Theodore V. Arevelo, Jeb S. Pickard, William B. Kruyer. LEAFSchool of 
Medicine, Brooks AFB, TX 
Background: Little information is available regarding the long-term natural history of lone 
atrial fibrillation (AF) in a young and otherwise healthy population. 
Methods: From 1957 to 1993, 300 US Air Force male aviators were found to have AF 
and were evaluated at a central facility approximately 6 months after the initial episode. 
Two hundred thirty- four of these patients (78%) were found to have lone AF (atrial fibril- 
lation in the absence of cardiovascular disease, hypertension or precipitating factor). We 
reviewed the records of initial and serial evaluations performed on these 234 aviators 
JACC February 2001 ABSTRACTS - Cardiac Arrhythmias 113A 
with lone AF and obtained further follow-up via questionnaire surveys, telephone inter- 
views and death certificates. Arrhythmic events considered were hemodynamic symp- 
toms, cerebral ischemic events, and sudden cardiac death. 
Results: lnifial evaluation: Average age was 37 (k 8.1) years at the time of initial occur- 
rence of AF. Age ranged from 20-59 years old. One hundred eighty-six of the 234 (79%) 
had an isolated episode of AF, 30/234 (13%) had paroxysmal AF, and 18/234 (8%) had 
daily or chronic AF. Follow-up: We obtained follow-up on 2111234 (90%). Total follow-up 
time was 4,685 person years with a mean of 22.2 years (range 2-40 years), At the time 
of follow-up, 106/211 (51%) still had only an isolated episode of AF, 81/211 (38%) had 
paroxysmal AF and 24Rll (11%) had daily/chronic AF. Of those initially presenting with 
an isolated episode, 63% had no recurrence, 36% developed paroxysmal AF and 1% 
developed chronic AF. Of those presenting initially wiih paroxysmal AF, 15% subse- 
quently developed chrotxc AF. Of the 37 deaths in the study, 10 were cardiac, 21 were 
noncardw and 6 were unknown. Nine had cerebral ischemic events of unknown cause 
of which only one (chronic AF) had the event before age 60. Annual event rate prior to the 
age of 60 was 0.4% per year. 
Conclusion: Progression to chronic AF from a single episode or paroxysmal AF was 
unlikely (1% and 15%, respectively). The arrhythmic event rate prior to age 60 was low 
(0.4% per year) and the likelihood of a cerebral ischemic event before age 60 without 
chronic AF was minimal (none in this study). 
with ERAF. This finding is inconsistent with the relationship between duration of AF and 
ERAF predicted by the “AF begets AF’ hypothesis. Our data suggest that “AF beg& AF’ 
may not be the only determinant of ERAF. A prospective study is warranted. 
ERAF-1 min ERAF-1 hr ERAF-1 d 
PATIENTS 42% 59% 65% 
SHOCKS 22% 35% 48% 
Pre-shock AF duration 4 1 hour 29% 49% 59% 
Pre-shock AF duration 1-24 hours 14% 22% 37% 
Pre-shock AF duration >24 hours 6% 15% 23% 
848-4 
935 a.m. 
Von Willebrand and Tissue Factors Expressions Increased 
in the Atrial Tissue of the Fibrillating Atrium 
Naab M. Al-Saady, A J. Haven, Nidal Maarouf, Mark M. Gallagher, Peter O’Callaghan, 
Owen A. Obel, Andrew J. Murday, Michael J. Davies, A John Camm. Sf. George’s 
Hospital Medical School, London, United Kingdom 
848-Z 
8:45 a.m. 
Increased Mortality in Patients With New Onset Atrial 
Fibrillation: Significance of Noncardiovascular Medical 
Comorbidities on Long Term Survival 
Philip J. Pa&l, Bernard J. Gersh, David 0. Hedge, Stephen C. Hammill, Win K. Shen. 
Mayo Clinic, Rochester, MN 
Background: The aim of the study is to determine the clinical characteristics and prog- 
nosis in pts with new onset atrial fibrillation (AF) in an epidemiological setting. 
Methods: All Olmsted Co. residents who had new onset AF in 1996 that was docu- 
mented by ECG were included in the study. The follow up was completed in December 
1999. The cause of death was determined by reviewing the death certificates from the 
MN State Death Tape Records. The observed survival was estimated by the Kaplan 
M&r method. The expected survival was estimated from age and gender matched MN 
population data (1970-1990). The survivals were conipared using a one-sample logrank 
ts5t. 
Background:The pathogenesis of thrombus formation in atrial fibrillation (AF) has not 
been fully elucidated. Right and left atrial appendages biopsies were collected from 27 
pts with AF and 18 control pts with sinus rhythm (SR) ai the time of elective coronary 
artery bypass grafts. Methods: Double immunohistochemical staining was carried out 
using monoclonal antibodies against human TF, CD 68 to identify macrophages (M) and 
EN4 as a specific endothelial cell mark. Also an antibody to vWf was used. Immunohis- 
tochemical sections were evaluated by two investigators who were blind to the disease 
entity being investigated and the clinical characteristics of the patients. The total number 
of M as well as those expressing TF (MTF) were cowled. The percentages of M 
expressing TF (%MTF) were then calculated. The endocardial endothelium expressing 
vWf was calculated by rating each field as 1,2,3 or 4 and the mean value was expressed 
as a percentage. 1 5 25%, and 4 =lOO% expression of vWf. ResuPs: No enclothelial 
expression of TF was identified. Three pts in the SR group were excluded from the TF 
study because of diabetes mellitus. Results were presented as mean @SE) and p value 
in table. 
Results: 257 Oimsted Co. residents were included in the study. The mean age was 
73&15 yrs, M/F = 153 (60%)/104(40%). Of the total, 72 pts (28%) had no documented 
cardiovascular diseases. In this group of pts, the mean age was 69219 yrs, M/F = 45 
(63%)/27 (38%). During a mean follow up of 2.4kl.6 yrs, 26 pts died. The causes of 
death included: 5 (19%) cardiac and 21 (81%) non-cardiac deaths. Of the non-cardiac 
MTF M %MTF VWf 
SR 2.8(0.9) 28.9(3.2) 10.8(3.0) 33.3(4.4) 
AF 6.0(1.2) 47.0(3.0) 19.1(4.1) 54.1(5.1) 
P <o.oz 0.002 0.01 0.0001 
This report is the first to show an association between AF and both MTF and vWf expres- 
sions in the atrial tissue of patients with AF. Conclusion: These results suggest specific 
therapy to the prevention of atrial thrombus. 
death group, 8 pts (38%) died from malignancies; 3 pts (14%) died from cerebrovascular 
events; 3 pts (14%) died from pneumonia; 2 pts (9.5%) died from collagen vascular dis- 
9:30 a.m. 
eases; 1 pt (4.8%) died from renal failure; 1 pt (4.8%) died from a ruptured AAA; 1 pt 
848-5 Transcatheter Occlusion of the Left Atrial Appendage With a 
__ 
(4.8%) died from hepatitis; 1 pt (4.8%) died from COPD; and 1 pt (4.8%) died from other 
Novel Implanted Device: First Experience 
causes. The observed survival was significantly worse than ihe expected survival Edward P Gerstenfeld, Toshiko Nakai, Paul 6. Sparks, Yoshinaru Goseki, Clegg 
(p<O.OOl): 75% vs 94%, 69% vs 88%, 66% vs 83%. at 1, 2, and 3 years, respectively. Honeycutt, Richard Chen, Jonathan J. Langberg, Michael 0. Lesh. University of 
Conclusions: 1) Non-cardiovascular medical co-morbidities are frequently present in California, San Francisco, CA, Emory University Hospital, Atlanta, GA 
elderly pts with new onset AF. 2) Observed survival in pts with new onset AF in the 
absence of significant cardiovascular diseases is significantly worse than expected. 3) Background: Atrial fibrillation (AF) poses a risk of embolic complications. Warfarin 
These observaiions suggest a complex interaction between age, systemic illnesses, and 
reduces this risk, but problems with chronic administration result in low usage and com- 
AF, that renders the clinical management challenging and warrants further study. pliance rates. More than 90% of all emboli originate as left atrial appendage (LAA) 
thrombi. We assessed a novel. percutaneous Vanscatheter left atrial appendage occlu- 
848-3 
9:00 a.m 
Early Recurrence of Atrial Fibrillation Following Ambulatory 
Shock Conversion by an Implanted Atrial Arrhythmia 
Management Device: Incidence and Predictors 
David Schwartzman, Shaileshkumar Musley, Eduardo Warman, Charles D. Swerdlow, 
Rahul Mehra. Atria/ Arrhythmia Cenfer, University of Pittsburgh, Pittsburgh, PA, 
Medtronic Inc., Minneapolis, MN 
Background: previous reports have described the phenomenon of early recurrence of 
atrial fibrillation (ERAF) after shock termination. This abstract further characterizes 
ERAF, assessing its incidence and predictors. Methods: 144 consecutive patients with 
recurrent, antlarrhythmic drug (AAD) refractory AF underwent implantation of an atrial 
arrhythmia management device (Jewel AF. model 7250). Subsequently, ambulatory 
shocks were delivered resulting in successful cardioversion. The device was pro- 
grammed to deliver shocks either automatically or after patient activation of the device. 
ERAF was defined in three different ways: 1 .recurrence within 1 minute of cardioversion 
(ERAF-1 min); P.recurrence within 1 hour of cardioversion(ERAF-1 hr): S.recurrence 
within 1 day of cardioversion (ERAF-1 d). Multivariable assessment for factors signifi- 
cantly associated with ERAF utilized demographic, comorbidity, and cardiac structure/ 
function items as well as AAD usage, duration of AF prior to shock, automatic versus 
patient activated shock, shock energy, and time since device implantation. Results: 
(table: top segment shows incidence of ERAF for all patients and all shocks; bottom seg- 
ment shows ERAF incidence for different durations of AF prior to shock) A total of 777 
successful shocks in 83 patients (mean 9.4, median 4, range 1-91 shocks per patient) 
were delivered. Multivariate analysis identified shorter duration of AF prior to shock as 
ihe sole independent predictor of ERAF. Conclusions: ERAF is common, with an inci- 
dence that increases as the defining interval is increased. In this retrospective analysis, 
shorter duration of AF prior to shock was the sole item which was significantly associated 
sion device (LAAO) designed to seal the LAA. 
Methods: 27 mongrel dogs underwent LAAO implantation and were sacrificed after 
35+19 d (range 14 to 70) to assess acute and chronic sealing of the LAA. The device is 
delivered to the LAA through a 12Fr transseptal catheter. An initial design had two ele- 
ments, an expanding Nitinol frame and an “umbrella’‘-like biocompatible membrane fac- 
ing the left atrium (18 dogs). A second design had a single component “acorn-shaped” 
device (9 dogs), which can be collapsed and repositioned after initial deployment. Acute 
and chronic LAA sealing was determined fluoroscopically using contrast injection to 
detect leaks (graded trace, mild, moderate, or severe). Following sacrifice, the LAA was 
examined for device migration and healing. 
Results: The mean device diameter at the LAA ostium was 20+3 mm. Deployment was 
uncomplicated in all cases; location was within 4 mm of the ostium in 18127 dogs and 24 
mm distal to the ostium in 9127. No dislodgment, migration, or device fracture occurred. 
The lumen of the LAA was occluded in all cases. Contrast leaks around pectinate mus- 
cles were seen in 18/27 animals acutely (13 trace or mild; 4 moderate; 1 severe) and 131 
25 animals chronically (9 trace or mild, 4 moderate). At sacrifice, anchoring barbs on the 
perimeter of the LAAO were visible on the epicardium, with no evidence of hemopericar- 
dium, in 3118 dogs implanted with the “umbrella” design, and Oi7 dogs with the “acon? 
design. In all cases, there was endothelization of the device without macroscopic throm- 
bus. 
Conclusion: Percutaneous catheter-based delivery of an atrial appendage occlusion 
device is feasible and safe in this canine model. Longer-term studies are necessary to 
determine chronic device performance. This device may provide a non-pharmacologic, 
non-surgical treatment alternative to prevent thromboemboli in high-risk patients with AF. 
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848-6 In-Vivo Electrophysiologic Assessment of Left Atrial Muscle 
Sleeves in Pulmonary Veins With Magnetic Electroanatomic 
Mapping in Patients With Paroxysmal Atrial Fibrillation 
Manisha S. Ashar, David J. Callans, Henry H. Hsia, Andrea M. Russo, Erica S. &do, 
Francis E. Marchllnski. University of Pennsylvania Health Sjetems, Philadelphia, PA 
Although the extent of left atrial myocardial sleeve (MS) in pulmonary veins (PV) has 
been described in pathology specimens, in-viva functional assessment of MS in patients 
with atrial fibrillation (AF) has been limited. Magnetic electroanatomic (EA) catheter map- 
ping permits precise coupling of local recorded or paced events to 3-D anatomic location 
and accurate assessment of the anatomic distance between any two recorded points. We 
sought to define the length of left atrial MS in PV using EA mapping techniques in 
patients with AF. Methods: Detailed (112 to 199 points) EA mapping was performed to 
create an anatomic shell of the left atrial endocardium in 21 patients. At least 4 PV 
were identified and their location tagged when catheter tip was passed into PV beyond 
endocardial shell to the most distal site where an electrogram could be recorded. The 
catheter was then withdrawn to the ostium of the PV defined by the junction of PV tag 
and LA endocardial shell. Pacing was performed at capture threshold at the deep and 
ostial sites which were marked with location tags. Extent of left atrial MS was defined by 
the distance between the site of atrial capture deep in PV and site of atrial capture at the 
PV ostium. Results: 
Length of left atrial myocardial sleeve in PVs(mm) 
LSPV LIPV RSPV RIPV 
Mean&D 17.lzt4.0 8.9i4.4 17.0t5.9 9.9r3.4 
Range 9.5-24.9 4.7-18.2 7.525.8’* 5.6-16.7 
’ pc.001 LSPV vs LIPV, “*pc.OOi RSPV vs RIPV. 37 of 42 (88%) superior PVs had LA 
MS greater than 12mm versus only 7 of of 42 (17%) inferior PV had LA MS greater than 
12mm. Conclusion: The left atrial MS of left and right superior PVs is characteristically 
greater than 12mm and exceeds MS of right and left inferior PV. This study demonstrates 
in-viva electrophysiologic assessment of the length of left atrial MS in PVs in patients with 
paroxysmal AF with EA mapping and is consistent with previous pathology studies. 
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1202-l 12 Dronedarone Acutely Inhibits L-Type Calcium Currents and 
Alters the Channel Kinetics in Rabbit Ventricular Myocytes 
Wei Sun, Jonnalagedda S. M. Sarma, Shulan Ding, Glen T. Wetzel, Thomas S. Klitzner, 
Bramah N. Singh. WLA VA Medical Cente< Los Angeles, CA, UCLA School of Medicine, 
Los Angeles, CA 
Background: Dronedarone (DR) IS a new non-iodinated benzofuran derivative structur- 
ally related to amiodarone. Its acute effects on the L-type calcium current (ICaL) and cal- 
cium channel kinetics have not been reported. Methods: Rabbit ventricular myocytes 
were isolated by enzymatic dissociation. Whole-cell voltage clamp technique was used to 
study the effects of DR (O.l,l, 10pM) on ICaL and its kinetics. Results: DR inhiblted 
ICaL dose-dependently. At -10 mV, ICaL peak current was reversibly deceased by 
12~3%(p<O.O5), 4O_t3%(pcO.O1), and 66+12%(p<O.O01) at 0.1, 1 and i0pM of DR 
respectively(n=6). During perfusion with 1pM DR, ICaL steady-state inactivation was 
shifted to more negative membrane potentials. The half inactivation of calcium current 
occurred at a membrane potential of -31&4mV at baseline and -49+11 mV after addition 
of DR (n=4, ~~0.05). Furthermore, DR delayed calcium current recovery from previous 
inactivation; the recovery time constant prolonged from 134~13 to 247+59 msec(n=4, 
~~0.05). At an interval duration of 325 msec from the previous depolarization, ICaL cur- 
rent amplitude was 97rl4% of control compared to 75210% of control after DR (n=4, 
p<O.O5). In addition, DR inhibited ICaL at a faster stimulation rate (0.1-l Hz), suggesting 
the use-dependent block of ICaL by DR. Conclusions: These results provide evidence 
that DR not only acutely inhibited the ICaL in the rabbit ventricular myocytes, but also 
modified calcium current inactivation kinetics. This behavior is similar to that of amio- 
darone, despite the absence of iodine in DR. 
1202-I 13 Effects of Amiodarone on Wavefront Dynamics During 
Ventricular Fibrillation in Isolated Swine Right Ventricle 
Chikaya Omichi, Shengmei Zhou, Moon-Hyoung Lee, Che-Ming Chang, Alan Garfinkel, 
James N. Weiss, Shien-Fong Lin, Hrayr S. Karagueuzian, Peng-Sheng Chen. Cedars 
Sinai Medical Center, Division of Cardiology, Los Angeles, CA, UCLA School of 
Medicine, Los Angeles, CA 
Background: Intravenous amiodarone has recently gained popularity !n the emergent 
management of life-threatening ventricular arrhythmia. However, effects of acute amio- 
darone infusion on dynamics of VF are poorly understood. Methods: The epicardial sur- 
faces of 6 isolated, perfused swine right ventricles were stained with di-4 ANEPPS. 
Activation patterns during VF were mapped optically while single cell action potentials 
were simultaneously recorded with a glass microelectrode. Action potential duration 
(APD) restitution curves were constructed during VF and during pacing. Results: At 
baseline VF was associated with frequent spontaneous wavebreaks. Amiodarone infu- 
sion (2.5 pg/ml) eliminated spontaneous wavebreaks and increased an average cycle 
length of VF from 83.3 i 17.8 ms at baseline to 118.4 i 25.8 ms (p<O.O5). Short-lived 
reentrant wavefronts were observed both at baseline and during amlodarone infusion. As 
compared with baseline, amiodarone increased the reentrant wavefront cycle length 
(108.9 & 13.3 ms vs. 78.2 i 19.0 ms, ~~0.05) and central core area (4.1 r 3.8 mm’ vs. 
0.9 i 0.3 mm’, pcO.05). Amiodarone also reduced the density of VF wavelet number as 
compared with baseline (0.4lt 0.10 /cm2 vs. 0.65 i 0.08 /cm’, ~~0.05). Amiodarone flat- 
tened the APD restitution curves during VF and during pacing. Within 30 min of infusion, 
VF terminated (N=l), converted to ventricular tachycardia (VT) (N=l) or continued at a 
slower rate (N=4). Conclusions: Amiodarone infusion eliminated spontaneous wave- 
breaks and reduced the density of VF wavelets. It might terminate VF or convert VF to 
VT. These effects were associated with the flattening of APD restitution slope and 
increased core size of reentrant wavefronts. 
1202-131 Modification of HERG Channel Properties Under Conditions 
of Simulated Myocardial lschemia 
Bruce D. Walker, Hui Tie, Cameron B. Singleton, Jane A. Bursill, Ken R. Wyse, Asne R. 
Bauskin, Stella M. Valenzuela, Wan Wu, Samuel N. Breit, Terence J. Campbell. St 
Vincent’s Hospital, Sydney Australia 
Background: Acute myocardial ischemia is accompanied by a rapid reduction in action 
potential duration thought to be due mainly to activation of lKATP Since IKr is a major con- 
tributor to repolarization and action potential duration, we examined the effects of simu- 
lated &hernia (hyperkalemia, acidosis, and lysophosphatidylcholine (LPC)) on the 
human ether-a-go-go-related gene (HERG) channel which encodes IKr in the human 
heart. Methods and results: A whole cell voltage-clamp technique was used to study 
currents produced by stable transfection of HERG in CHO-Kl cells (standard solution: 
pH7.4;K4.8mM). A 0.5s linear voltage ramp from +40 to -8OmV was used to simulate a 
cardiac action potential in the following experiments. Hyperkalemia (pH7.4;KlO) aug- 
mented HERG current maximally in early repolarization (54il4% at +lOmV, n-1 l), but 
reduced outward current in late repolarization (-28 to -8OmV). Since extracellular acidosis 
inhibits HERG current, we assessed the effect of combined hyperkalemia and acidosis 
(pH6.4;KlO) using both traditional square wave as well as ramp protocols. Superfusion 
with pH6.4;KlO solution caused a 58+5% decrease in tail current amplitude following a 
step to +30mV, increased rate of deactivation, but had no significant effect on slope con- 
ductance, activation or inactivation gating &IO). During the voltage ramp, current was 
augmented in early repolarization (60fl4% at +15mV, n=9), but was reduced in late 
repolarization (-30 to -8OmV). LPC (0.1 - 3pM) increased current during a step to +2OmV 
with an EC50 of 1.7ci.3pM (n=9). This was mainly due to a concentration-dependent, 
depolarizing shift in steady state inactivation (eg. +lP mV with 3pM LPC, n=9). Current 
was augmented by 3pM LPC throughout the voltage ramp (maximum 93?22% at OmV, 
fl=5). 
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1202-I 11 Wortmannin Blocks the Carbachol-Induced Inhibition of L- 
Type Ca Current in Mouse Ventricular Myocytes: Role of 
Phosphatidylinositol3 OH-kinase/AKT/Nitric Oxide in 
Muscarinic Regulation of Ca Current 
Fuhua Chen, Meisheng Jiang, Shulan Ding, Lutz Birnbaumer. UCLA SchoolofMedicine, 
Los Angeles 
Background: Cardiac L-type Ca current is inhibited by muscarinic agonists, such as car- 
bachol (CCh). However, the mechanism for this muscarinic regulation of the current in 
heart is unclear. We have previously shown that inhibitory G proteins (Giyplay an impor- 
tant role in the muscarinic regulation of Ca current in cardiac ventricular myocytes, using 
a G protein subunit gene knockout mouse model. The purpose of the present study was 
to determine whether phosphatidylinositol 3 OH-kinase (PBK)/AKT/Nitric oxide (NO) is 
involved in muscarinic regulation of L-type Ca current by using a potent Pl3K inhibitor, 
wortmannin. Methods: Single isolated ventricular myocytes were obtained from sv129 
mouse heart using enzymatic dissociation methods. Cells were pre-incubated with 100 
nM wortmannin (wortmannin group), or incubated without wortmannin (control group) for 
20 min. Voltage clamp techniques were used to examine the effects of carbachol (CCh) 
on L-type Ca current in each group’s cells. Results: We found that extracellular perfusion 
of 100 microM CCh significantly inhibited the whole cell L-type Ca current (from 6.4i0.4, 
to 3.4kO.3 pAIpF, 11~16, ~~0.01) in the control group. On the other hand, CCh produced 
no significant decrease of L-type Ca current in the wotimannin group (from 6.220.5, to 
4.7kO.4 pA/pF, n-7, ~~0.05). This small decrease may relate to the natural run-down on 
L-type Ca current over the experimental period rather than the effects of the CCh. Wort- 
mannin seemed not to affect the Gs/cAMP/PKA signal pathways, since L-type Ca current 
was augmented by 10 microM IS0 perfusion in wortmannin-treated cells. Conclusion: 
The finding from the present study suggests that wortmannin blocks muscarinic receptor 
activation (by CCh)-induced inhibition of Ca current in mouse ventricular myocytes. For 
the first time, our data indicate that the muscarinic regulation of cardiac L-type Ca current 
may be involved in the PI3WAKTINO signal pathway. 
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Conclusions: Extracellular hyperkalemia (? acidosrs) augments HERG current during 
early repolarization, but reduces current in late repolariration LPC enhances HERG cur- 
rent (at concentrations seen during rschemra) throughout the duration of the voltage 
ramp. These effects may contribute to the shortening of action potential duratron rn acute 
myocardial ischemra. 
1202-132 Intracellular CAMP is Essential for Cardiac L-Type Ca 
Current in Both Wild Type and Inhibitory G Protein Subunit 
Gene Knockout Mice 
Fuhua Chen, Meisheng Jiang, Wei Sun, Lutz Birnbaumer, Glenn T. Wetzel. UCLA School 
of Medicine, Los Angeles 
Background: Utilizing G protein subunit gene knockout mouse model, we have previ- 
ously found that inhibitory G proteins (Gi) play an rmportant role in the muscarinic regula- 
tion of L-type Ca current (ICa-L) in cardiac ventricular myocytes. However, the 
mechanism of how Gi is involved in muscarinic regulatron of ICa-L remains unclear. The 
purpose of the present study was to determine how intracellular CAMP level is related to 
ICa-L in both weld type (WT, sv129) and Gi alpha subunit (Gi2 alpha) gene knockout (Gi2 
alpha -/-) mouse ventricular cells. Methods: Single isolated ventricular myocytes were 
obtained from both WT and Gi2 alpha -/- mice. Whole cell voltage clamp technrques were 
used to study the effect of CAMP on U-L. CAMP or protein kinase A inhibitor (PKAi) was 
added to the internal/pipette solution and allowed to dialyze into the cells for 8 minutes. 
Results: We found that in WT mouse ventricular myocytes, basal ICa-L was srgnrficantly 
greater (lO.i-cO.9 pA/pF, n=15) with intracellular addition of CAMP (500 microM), as com- 
pared to that without addition of CAMP (6.5i0.5 pAfpF, n=lO, p<O.Ol). In contrast, addr- 
tion of PKAi (1 nM, Ki=98 PM) into internal/pipette solution decreased the basal Ca 
current to 3.3kO.3 pAJpF (n=14, p<O.OOi. compared to control cells). The comparable 
effects of PKAi were also found rn G12 alpha -/- mouse ventricular myocytes. Basal ICa-L 
was 7.511.1 piVpF (w7) without the intracellular presence of PKAi, as compared to 
4.2~0.4 pA/pF (n=5. p&05) in the presence of intracellular PKAi. Conclusion: Thus find- 
ing provides important evidence that intracellular CAMP is crucial in maintaining the ICa- 
L amplitude in both WT and Gi2 alpha -/- mouse ventricular myocytes. With the prolifera- 
tion of findings suggesting that Gi may regulate ICa-L through cGMPIPKG, more expern 
merits are necessary to elucidate the precise relationship between activation of Gi and 
intracellular cellular CAMP and cGMP level in regulatron of ICa-L in heart cells. 
ABSTRACTS - Cardiac Arrhythmias 115A 
1203-l 16 The Electrocardiographic (ECG) Pattern is Frequently 
Abnormal in Professional Football Players: An Analysis in 
1282 Athletes 
Joseph K. Choo, William 8. Abemethy, Ill, Adolph M. Hut&r, Jr.. Massachusetts General 
Hosp~fal, Boston, MA 
Background: Although abnormal ECG frndings are frequent in athletes, a systematic 
analysis in professional football players has not been described 
Methods: The screening ECGs of 1282 National Football League players from 1996. 
1999 were analyzed. Echocardiographic data from 71 players with abnormal ECGs were 
reviewed for evidence of structural or functional abnormalities. 
Results: Abnormal EKG findinos were noted in 710 (55%) of olavers with the incidence 
POSTER SESSION 
1203 Electrocardiography 
Tuesday, March 20, 2001, 9:00 a.m.-l 1:OO a.m. 
orange County Convention Center, Hall A4 
Presentation Hour: 1O:OO a.m.-l 1:OO a.m. 
1203-l 15 Diagnosis of True Right Atrial Enlargement: How Useful Are 
the Classical ECG Signs? 
Elena B. Sgarbossa, Sergro L. Pinskr, Joseph Stevenson, Susan Kim, Alex Newman, 
Stuart Rich, Valerie MC Laughlin, Richard G. Trohman. Rush-Presbyterian-St. Luke’s 
Medical Center, Chicago, IL 
Background: Classic ECG criteria of right atrial enlargement (RAE) may be biased due 
to the preferential inclusion of patients with COPD or rheumatic heart disease in the pop- 
ulations analyzed. Methods: We tested all published ECG criteria of RAE in 62 patients 
with echocardiographic evidence of increased right atrial volume (age 49213, 45 women) 
with normal or near-normal left chambers in the absence of COPD. 62 age- and gender- 
matched control patients wrth normal echocardiograms acted as controls. The etiology of 
RAE was primary pulmonary hypertension (55%), connective tissue disease (15 %), infil- 
trative lung disease (13 %), ASD (IO %), other (7 %). Optimal cut-off values for continu- 
ous variables were identified with ROC curves. Results: RA volume was 111 r 64 ml vs. 
27 i 7 ml (pc.0001). Among continuous variables, P wave amplitude rn II, III, aVF, and V5 
had areas under the curve >= .70. The P wave axis did not discriminate (RAE 55 ? 28” 
vs. controls: 53 i 17”). The table presents the sensitivity and specificity of selected signs. 
Sian Sensitivitv (%I Specificrtv (%) 
P>=O.2 mV in II 61 78 
P>=O.Z5 mV in II 26 97 
P>=O.ll mV in III 35 87 
PxO.2 mV in Ill 23 97 
PxO.14 mV in aVF 54 86 
PxO.2 mV in aVF 37 98 
ST dep x0.05 mV in II 27 100 
ST dep >= 0.05 mV in aVF 37 96 
Q in Vl (Sodi-Pallares) 52 97 
R/S >= 1 in Vl 74 100 
Q or R/S >= 1 in Vi 82 97 
Conclusions: Several P wave signs have high specificity but relatively poor sensitivity to 
detect “pure” RAE (i.e., unassociated with COPD or left-heart pathology). in a population 
with low prevalence of coronary disease, associated QRS changes in lead Vl are as 
specific and much more sensitive. RAE needs to be considered in the differential dtagnc- 
sis of ST-depression in inferior leads. as it may represent a prominent atrial repolarrzation 
(Ta) wave. 
I . ,  
of specrfk abnormalities noted below: 
Total Black White p-“&E 
EARLY REPOLARIZATION 213 (16.6%) 19.4% 11.8% 0.001 
STTW ABNORMALITIES Total 
Any STTW abnormalities 199 (15.5%) 20.1% 9.4% 0.01 
Inferior STrW abnormalities 189 (14.7%) 17.7% 8.8% 0.01 
STTW abnormalities V4-V6 41 (3.2%) 4.4% 1 .O% 0.01 
Juvenile pattern 41 (3.2%) 4.3% 1 .O% 0.01 
OTHER ABNORMALITIES 
Increased voltage 219 (17.1%) 
IVCD (QRS > 0.10 set) 170 (13.3%) 
Incomplete RBBB 77 (6.0%) 
Right axis deviation 80 (6.2%) 
Increased R-wave I” V1 53 (4.1%) 
Early repolarrzation and STTW abnormalrties were significantly more frequent in black 
compared with white players. 
In all 71 players with abnormal ECGs and echocardiographic data, rest and exercise 
echocardiograms demonstrated structurally normal hearts. 
Conclusion: Abnormal ECG findings are common in professional football players with 
repolarization abnormalities significantly more common in black compared with white 
players. Echocardiographic studies excluded structural heart disease in all those tested. 
1203-I 17 Grade 3 lschemia on Presentation in Acute Myocardial 
Infarction Predicts Rapid Progression of Necrosis and Less 
Myocardial Salvage With Thrombolytic Therapy 
Yochai Brmbaum, Douglas A. Criger, Kathy 8. Gates, Alejandro Barbagelata, Peter 
Clemmensen, Elena 8. Sgarbossa, Raymond J. Gibbons, Galen S. Wagner. Rabin 
Medical Center, Petah Tiqva, Israel, Duke Clinical Research Instifute, Durham, NC 
Background: The severity of ischemia, as reflected by Grade 3 ischemia (G3) on the 
admission ECG, is associated with larger infarct size (IS) even with reperfusion. How- 
ever, the underlying mechanism is still unknown. We assessed whether G3 is associated 
with larger area at risk (AR) or more rapid progression of necrosis, and whether adenos- 
ine reduces IS in pts with grade 2 (G2) and G3 ischemia undergoing thrombolysis. Meth- 
ods: 49 myocardial infarction pts underwent Tc-99m sestamibi SPECT before (AR) and 
6+1 days after (IS) thrombolysis. Pts were divided into 2 groups based on the absence 
(G2; n=30) or presence (G3; n=19) of terminal QRS distortion in ?2 adjacent leads (J 
point/R wave 20.5 in leads with qR configuration or presence of ST elevation without S 
waves in leads with RS configuration). Data are presented as median (25, 75 percentile). 
Results: Time to therapy was similar in the 2 groups (2.67 (1.67, 3.22) h vs. 2.96 (2.33, 
4.00) h; p=.83). Among pts receiving placebo, AR was 36% (14, 49) of the left ventricle 
(LV) in the G2 and 46% (13, 69) in the G3 (p=.47), IS was 16% (5, 36) and 40% (12, 60) 
respectively (p=.O96), and the ratio IS/AR was 66% (41, 73) and 90% (83, 100) respec- 
tively (p=.OO6). Among pts receiving adenosine, AR was 21% (10, 47) of the LV in the G2 
and 26% (21, 47) in the G3 (p=.44), IS was 5% (0, 17) and 17% (7, 22) respectively 
(p=.l5), and the ratio IS/AR was 31% (0, 59) and 67% (28, 85). respectively (p=.23). Lin- 
ear regression model revealed that the IS/AR ratio is related to G3 (p=.Ol21); adenosine 
(p=.O45), but not to the time to therapy (pz.76). Conclusions: IS (indexed to AR) is 
related to the grades of ischemia and is reduced by adenosine, but was not indepen- 
dently related to trme to therapy. In the G3 group necrosis progressed rapidly over time, 
whereas in the G2 group necrosis progressed more slowly. In pts with G2 there may be 
more time for myocardial salvage wrth reperfusion. 
1203-l 18 Elevation of CK-MB Greater Than 2 Fold and Troponin 
Greater Than 3 Fold Are the Best Thresholds for Identifying 
Ml Associated With ECG Evolution 
Maria Cecilra Bahit, Douglas A. Criger, Christopher 8. Granger, E. Magnus Ohman, 
Galen S. Wagner. Duke Clinical Research Institute, Durham, NC 
Background: The definition of myocardial infarction (Ml) is increasingly dependent on 
levels of biochemical markers, including troponin. The correspondence between the level 
of these markers and electrocardiographic evidence of myocardial infarction is not well 
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established. We aimed to determine the levels of biochemical markers associated with 
definite evolutionary ECG changes in patients with ST elevation Ml. Methods: Using the 
800-patient troponin sub-study of GUSTO Ila, we selected patients with ST segment ele- 
vation at baseline, evidence of evolution of the QRS and T waveforms as well as the ST 
segment in the pre-discharge ECG, and 3 measurements of at least one of the following: 
CK-MB, troponin T (Tn T),or troponin I (Tn I).Patients with uninterpretable ECG’s, prior 
MI, or re-infarction were excluded. ECGs and biochemical markers were analyzed in a 
blinded fashion at the core laboratories. Pm-discharge ECGs were scored using the 
Selvester scoring system in order to assess the evolutionary ECG changes.. Results: 
We identified 222 patients with evolutionary ECG changes. The median QRS score for 
this population was 5: 5th percentile was 1. The table shows the median and 5th percen- 
tile of marker levels in these 222 patients. 
ULN nglmL Median 5th Percen- 5th Percentile as 
tile multiple of ULN 
CKMB (n=54) 7.0 243 15 2.1 
Tn T (n=174) 0.1 11.1 1.1 11 
Tn I (n=160) 1.5 79.2 5.8 3.8 
Conclusion: This study shows that 95% of the patients with evidence of definite electro- 
cardiographic evolution have > 2 fold increase in CK-MB , and > 3 to 11 fold increase in 
troponin. These biochemical marker thresholds may help physician to define myocardial 
infarction for clinical practice and research. 
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different electrophysiological catheters. We conclude that patients with previous cardiac 
surgery have significantly higher incidence of coronary sinus abnormalities that may 
interfere with implantation. CS stenosis may be result of manipulation during retrograde 
cardioplegia. 
1204-121 Benefit of Preimplant Coronary Sinus Venogram and 
Hemodynamic Testing in Patients Selected for Biventricular 
Pacing in Congestive Heart Failure 
Jtirgen Vogt, Barbara Lamp, Johannes Heintze, Bert Hansky, Leon Krater, Gem 
Tenderich, Reiner Kbrfer, Dieter Horstkotte. Heart Center Northrhine-Westfalia, Bad 
Oeynhaosen, Germany 
Background: In patients (pts) with congestive heart failure and left bundle branch block 
the success of biventricular (BV) pacing depends on access to the target coronary vein 
(CV) and hemodynamic response. 
Methods: Out of 47 pts planned for transvenous BV stimulation, a preoperative veno- 
gram and hemodynamic test procedure was attempted in 40 pts. 4 pts had an anomaly of 
the coronary sinus. In 5 pts preoperative testing could not be performed due to anatomi- 
cal reasons. The final study population consisted of 31 pts (age 6157 years, NYHA 
3.5kO.4, V02 max 14.2i2.7 mllkgimin, ejection fraction 20+6 %). Cycles of 10 paced 
beats and 30 seconds no pace were tested with different atrio-ventricular (AV) delay?.. 
We measured arterial pulse pressure (PP) and QRS-width (12.lead-ECG) during atric-bii 
left/ventricular pacing (VAT-mode) using electrophysiology catheters in the right atrium, 
right ventricular (RV) apex and the CV. 
Results: PP increased from 5Oi14 mm Hg at baseline to 62f15 mm Hg (+29%, 
p<O.OOl) at LV-pacing with optimal AV-delay and 64+16 mm Hg (+29%, p<O.OOl) at BV- 
pacing respectively. QRS-width decreased from 190+23 ms at baseline to 165+17 ms (- 
13%, pcO.001) at BV but not at LV pacing. The best AV-delay as compared to baseline 
was 158+34 ms (72r15%) for LV and 149+43 ms (69r18%) for BV. The best individual 
pacing mode was BV in 15 pts (PP +30%, QRS-width -16%) and LV in 16 pts (PP +31%, 
QRS unchanged). 5 pts did not show a sufficient PP-increase and were not implanted. In 
3 pts a sufficent PP increase was seen with pacing RV outflow tract and LV. In 7 pts the 
optimal LV site was identified by testing different CV. 
Conclusions: Preoperative venogram is useful for optimal implantation technique, site, 
and device. The hemodynamic improvement is related to a decrease of QRS-width at an 
optimal AV-delay in BV-pacing, whereas LV-pacing at optimal AV-delay did not lead to a 
narrowing of QRS. Maximal individual benefit could be achieved by testing different LV 
and RV sites prior to implantation. 
1204-122 A New Lead Locking Device for the Removal of Pacemaker 
and ICD Leads 
Charles Kennergren, G. Frank 0. Tyers, Charles W. Coates, Sean Coe. Sahlgrenska 
University Hospital, Gdteborg, Sweden, Vancouver General Hospital, Vancouver, BC, 
Canada 
BACKGROUND AND METHOD: Intravascular lead removal effectiveness has improved 
wer the last decade with the addition of a number of new techniques and devices: coun- 
tertraction, metal and polymer sheaths, locking stylets, various snares, and laser 
assisted lead extraction. Despite these advances, the lack of a stable, predictable lead 
extraction platform has remained a major limiting factor to successful lead removal. A fur- 
ther improvement in lead extraction success rate requires locking stylets that consistently 
reach and lock at the lead tip. A new Lead Locking DeviceTM (LLD) was developed to 
address the problem. The LLD is composed of a mandrel with an expandable metal 
mesh material. The LLD is inserted inside the lead to be removed and when deployed, 
locks along the length of the entire lead lumen. RESULTS: The LLD was used to extract 
84 leads (31 atrial, 32 ventricular and 21 other) in 51 consecutive patients from 04199 to 
11199. Implant times ranged from 6 months to 17.5 years. One-third of the leads were 
implanted in excess of 8.3 years. The indications, degree of encapsulating scar tissue 
and chronicity were very similar to previous studies. The LLD reached the tip of the lead 
91% (76184) of the time. Eighty-three leads were completely extracted and no complica- 
tions occurred as a result of the LLD. One lead had a fractured coil, which resulted in a 
partial removal. The LLD was unlocked, withdrawn and re-locked successfully in eight 
leads. The Excimer Laser was used in 77% (65184) of the leads. Traction alone was used 
in the remaining 19 (23%) of the leads. CONCLUSIONS: The new Lead Locking Device 
(LLD) reached the distal tip in leads with undamaged coils and locked firmly in all leads. 
The LLD provided a strong, stable lead extraction platform around which various dissect- 
ing sheaths can be advanced. The locking mechanism of the LLD appears to be revers- 
ible when needed. 
1204-123 Reduction of Free Radicals Production at Reoxygenation 
After Anoxia in Chronically Paced Embryonic Chick Heart 
Xavier H. Lyon, Lukas Kappenberger, Kucera Pavel, Anne C. Rochat, Eric Raddatz 
Division of Cardiology: University Hospital, Lausanne, Switzerland, Institute of 
Physiology, Lausanne, Switzerland 
It was demonstrated in animals that acute rapid ventricular pacing preceding an episode 
of coronary occlusion could markedly reduce the consequences of ischemia. We have 
tested if chronic cardiac pacing at physiological rate could induce a similar beneficial 
effect, by measuring the myocardial production of reactive oxygen species (ROS) which 
contribute to tissue injuries during an episode of anoxia-reoxygenation. The heart of 3.5. 
day-old chick embryos was stimulated at 110% of the intrinsic heart rate (HR) to follow 
the developmental changes of HR during the study period. After 24 hours of chronic 
asynchronous ventricular apical pacing hearts were submitted to 60 minutes of anoxia 
then reoxygenated with 100% 02. Peak and total ROS production was measured at reox- 
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1204-l 19 Exogenous Myocardial Tissue-Based Biosensing of 
Dynamic Chronotropic Regulation 
David J. Christini, Jeff Walden, Jay M. Edelberg. Well Medical College of CorneN 
Universify, New York, NY 
Background: Many electronic pacemakers determine pacing rate by responsive-ele- 
ment measurement of physiologic-demand surrogates (e.g., Op). Studies have shown, 
via comparison with healthy sinus rate, that such estimates are less than ideal. Pace- 
maker rate regulation might be improved by utilization of biologically-based biosensors 
for direct measurement and functional integration of the complex inputs governing heart 
rate (HR). 
Methods: Neonatal FVB murine hearts were transplanted into the pinneas of 3-month 
old FVB mice. Between 17 and 41 days post-transplantation, electrocardiographic (ECG) 
activity of the endogenous and exogenous hearts was measured simultaneously and 
compared quantitatively via polynomial curves fit to mean interbeat-interval series. To 
investigate inputs regulating the endogenous and exogenous HRs, separate pharmaco- 
logical ECG studies were performed using intraperitoneal injection (IP) of propranolol 
(100 ug) and clonidine (2.0 mg). 
Results: In 13115 transplants there was a high exogenous-endogenous HR concor- 
dance; first derivatives of the polynomial fits had a mean concordant sign of 85?11%. In 
515 IP propranolol trials, endogenous HR slowed (27?8%) as expected due to adrenergic 
receptor blockade. The exogenous rate also slowed (50r28%), indicating strong humoral 
and/or autonomic adrenergic influence. In 617 IP clonidine trials, consistent with cloni- 
dine’s sympathetic nerve activity reduction, endogenous HR rapidly decreased (48i15%) 
10-30s post-injection. In contrast, there was only a negligible reduction in exogenous HR 
during this period, suggesting that the exogenous hearts are not under significant auto- 
nomic control; thus, they are predominantly humorally regulated. 
Conclusion: Due to the inherent biosensory capacity of the exogenous tissue to inte- 
grate complex physiologic inputs, the chronotopic activity of the remote cardiac tissue 
was highly correlated to that of the endogenous heart. This offers a strong foundation for 
the development of novel electronic pacemakers that utilize tissue-based biosensors as 
rate regulatory elements. 
1204-120 Coronary Sinus Stenosis in Patients With Congestive Heart 
Failure and Previous Heart Surgery 
Dusan Z. Kocovic, Henry Hsia, Behzad B. Pavri, David Callans, Andrea Russo, Reginald 
T. Ho, Kar Lai Wong, Manisha Ashar. University of Pennsylvania Medical Center, 
Philadelphia, PA 
Biventricular pacing is a new and promising therapeutic option for patients with conges- 
tive heart failure and significant intraventricular conduction delay. Over a 18month 
period, a biventricular pacing system was successfully implanted in 61 of 67 (91%) 
patients in whom it was attempted. The patients were, on average, 67 +/- 11 years old, 
had a mean left ventricular ejection fraction (LVEF) = 20% +/- 9%, and 62% were in 
NYHA functional Class Ill and 38% were in Class IV. 32 patients had previous coronary 
by-pass grafting or other cardiac surgery (CABG group) and 35 did not (non CABG 
group). lntraoperative coronary sinus (CS) venogram with balloon occlusive catheter was 
attempted in 63 patients (31 with CABG Vs 32 non-CABG). Five CABG patients had sig- 
nificant coronary sinus abnormalities that interfered with implantation, versus 0 in non- 
CABG group (p=O.OZ ChiP test). One patient had total occlusion of the ostium of CS and 
4 had different degrees of stenosis at various sites within the CS. In all 4 patients with 
stenosis, implantation was successfully periormed after progressive dilatation of CS with 
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that occur without change in activation sequence in CS and PRA may warrant more 
detailed mapping to localize the precise site of origin of focal triggers within the regional- 
ized PV. 
1205-127 Elimination of Pulmonary Vein Potential for Catheter 
Ablation of Atrial Fibrillation Guided by Electroanatomical 
Mapping 
Sabine I. S. Ernst, Feifan Ouyang, Masahito Goya, Thomas Vogtmann, Marius Volkmer, 
Karl-Heinz Kuck. St Georg Hospital, Hamburg, Germany 
Primary catheter ablation of triggering foci within the pulmonary veins (PV) is often ham- 
pered by the inappearence of the trigger during the ablation procedure. Ablation of spike 
potentials within the PV is risking PV stenosis. We performed in 21 pts (2 f, 3 pts with 
chronic AFib) with symptomatic atrial fibrillation (AFib) a left atrial (LA) ablation procedure 
aiming at a PV isolation. After dual transseptal access was gained to the LA, the individ- 
ual anatomy was reconstructed using the electroanatomical mapping system CARTO. All 
4 PV ostia were marked on the baseline map and selective PV angiograms ware per- 
formed. After placement of a multipolar recording electrode in the targeted PV, RFC abla- 
tion was deployed at the PV-LA junction until the PV potential disappeared as monitored 
by the PV electrode. Results: In 21 pts (24 procedures) a total of 30+13 RFC was needed 
(fluoroscopy 22,2+8,1 min, procedure time 470r99 mm). In both the septal and lateral PV 
at least 2 or 3 muscle strains could be indentified with the CART0 system. In 2 /24 proce- 
dure the PV potential in the right PV persisted despite multiple RFC applications, in 7/24 
procedures left PV potential persisted. Anticoagulation was held within 200 - 250 set 
ACT by bolus heparin iv. Complications : significant pericardial effusion in 1 pt and an 
false aneurysm in 1 pt. Conclusions: Trigger elimination by sequential RFC application is 
feasible and can be online validated by a recording electrode within the target pulmonary 
vein. Complete circumferential ablation is not the endpoint, but identification and interrup- 
tion of several muscle strains into the PV is necessary to abolish the PV potential. This 
technique offers a new endpoint for primary catheter ablation of atrial fibrillation which is 
induced by triggering foci from the PVs. 
1205-128 Loss of Pulmonary Vein Potentials Following PV Isolation 
Favors Triggered Activity as the Underlying Substrate for 
PV Foci 
Sabine I. S. Ernst, Feifan Ouyang, Masahito Goya, Marius Volkmer, Karl-Heinz Kuck. St. 
Georg General Hospital, Hamburg, Germany 
The underlying mechanism for pulmonary vein (PV) foci capable of induction of atrial 
fibrillation episodes is still under debate. We report the findings of a total of 21 pts (2 
female) with atrial fibrillation that under went a left atrial ablation attempt of PV isolation. 
After dual transseptal access was gained to the LA, the ostia of the PV were recon- 
structed in great detail using the electroanatomical mapping system CARTD. A multipolar 
recording electrode was inserted into the respective PV and RFC was applied at the LA- 
PV junction to interrupt all muscular connections entering the PV. Results: In 2 I24 proce- 
dure the PV potential in the right PV persisted despite multiple RFC applications, in 7124 
procedures left PV potential persisted. In the remaining pts all PV potentials could be 
abolished with no more near-field potentials recorded in the PV electrode. No isolated 
activity was recorded after PV isolation had been achieved. A total of 30*13 RFC was 
needed (fluoroscopy 22,2+8,1 min, procedure time 470+99 min). Conclusions: After total 
PV isolation was achieved, demonstrated as a loss of all near-field potentials in multipo- 
lar electrode placed within the target PV, no further activity could be recorded from this 
catheter. This finding suggests that the underlying substrate for a firing focus within the 
PV is triggered activity rather than automaticity since no focal disharge was demon- 
strated after complete PV isolation. 
1205-129 Efficacy of Catheter Ablation in the Pulmonary Veins: 
Comparison Between Different Types of Atrial Fibrillation 
Koichiro Kumagai, Naomichi Matsumoto, Hideaki Tojo, Hiroo Noguchi, Hideko 
Nakashima, Naoki Gondo, Keijiro Saku. Fukuoka University Hospital, Fukuoka, Japan 
Background: Ablation of pulmonary venous foci can cure atrial fibrillation. However, the 
recurrence rate is relatively high and a repeated ablation is sometimes required. We 
compared the effectiveness of ablation in the pulmonary veins between different types of 
atrial fibrillation. Methods & Results: Fifty patients with paroxysmal (31), persistent (12) 
and permanent (7) atrial fibrillation underwent electrophysiological study to identify a 
focal source of atrial fibrillation initiation. Mapping was performed during spontaneous 
atrial premature beats or atrial fibrillation initiations, with isoproterenol infusion, or atrial 
premature beats after cardioversion. A pulmonary vein confirmed by the earliest atrial 
activation was targeted for ablation. If patients had no atrial premature beats or atrial 
fibrillation initiation, the pulmonary veins displaying distinct and late pulmonary vein 
potentials were targeted for ablation. After a targeted pulmonary vein was identified, a 
basket catheter was positioned within the pulmonary vein through a transseptal sheath. 
Circumferential pulmonary vein electrograms were acquired simultaneously, and used to 
guide the ablation at ostial sites with the earliest pulmonary vein potentials during sinus 
rhythm. Radiofrequency ablation was performed during monitoring distal pulmonary vein 
potentials with a set temperature of 50°C at 20s30W. The endpoint was determined by 
elimination of atrial fibrillation (32) or abolition of pulmonary vein potentials and/or creat- 
ing atrio- pulmonary vein conduction block (18). 83 foci were identified; 75 triggers (90%) 
originated from the pulmonary vein, single in 40% and multiple in 60%, and 8 from the 
atrial tissue. During a mean follow-up of 10+5 months, the clinical success rates were 
77%, 50% and 40% of the patients with paroxysmal, persistent and permanent atrial 
fibrillation without drug. No pulmonary vein stenosis was observed. Conclusions: The 
ablation in the pulmonary vein may be effective in preventing parOxysmal atria1 frbriilation, 
whereas further aggressive therapeutic approach may be necessary for the treatment of 
patients with persistent and permanent atrial fibrillation. 
ygenatfon by a photometric method. Paced hearts (PH, n=5) were compared to sham 
operated hearts (SH, n=5). All the values were corrected for heart rate and protein con- 
tent. 
Peak ROS production total ROS production n 
photons/(s*pg proteins) photonslug proteins 
Sham 0.64 + 0.13 599* 179 5 
Paced 0.48 + 0.06’ 396 i 63’ 5 
Mean * SD; *: less than in sham (p < 0.05). 
Our results show that chronic pacing at physiological rate reduces the ROS production at 
reoxygenation after anoxia in the 3.5-day-old chick embryos heart. This could be related 
to the known pacing-induced cardiac remodeling and probable alteration of myocardial 
glucose metabolism, as the degree of myocardial hypertrophy and glycogen content are 
important determinants ot the resistance of the myocytes to oxygen deprivation. These 
observations raised the hypothesis that chronic pacing at physiological rate could act as 
a preconditioning stimulus. 
1204-124 Initial US Multicenter Clinical Experience: Acute Evaluation 
of Atrial Autocapture (AAC) Capability Using Affinity@ DR 
Device 
Michael 8. Chisner, Roger A. Freedman, Seth Worley, Eric Pena, David Fitzgerald, Grant 
Simons, David Pederson, Nazam Habhab, Mark Kremers, James L. Duncan, Sandy 
Malys, Xraozheng Zhang, and Study Investigators. St. JosephB Hospital, Savannah, GA, 
University of Utah & VAMC, Salt Lake City, UT 
Background: While Ventricular AutoCapture (VAC) function has become accepted as a 
successful algorithm providing capture beat-to-beat, incorporating similar feature in A is 
desired. This prospective study was designed to evaluate the capability of AAC and pos- 
sibility of using evoked response (ER) detection feature in A. Methods: Paired data from 
A and V were collected during implant. AAC testing was conducted by connecting 
implanted A lead into V port of Affinity @ DA device. Total of 232 patients (pts), male 133 
(57.3%) age 72k12.7 years, LVEF 53.1+7 1.9% were examined by 30 centers. Fifty-eight 
(25%) pts were on antiarrhythmic drugs. Forty-one (17.7%) pts had the physiologic con- 
ditions may affect pacing threshold. Results: Current VAC algorithm (requires 
ER>2.5mV and Polarization (P) safety margin 2 1.7:1) could be activated in A in 
71(30.6%) tots. Multivariate analvsis showed A ER was sionifrcantlv related to A sensino 
threshold(p=O.OOOl), A P (p=O.d07), physiologic conditions (p=O.O604), V ER (p=O.O8).‘ 
cat’ture 
Th;eshoid ( “ )  
sensmo 
Thresh& (m”) 
E”Ok& Polarization 
Impedance Response (mV) (mV) 
mm 0.87-tO.45 3 35*1 .,I 4&3.96+145 74 2 00+1.81 0.40+0.83 
“entricuiar 0.63*0x 11 %+5.69 620.15a182.57 1375e.47 0.s3t0.55 
Conclusion: Developrng an AAC algorithm introduces new challenges to the existing 
VAC feature due to lower A ER and P safety margin. TraditIonally measured A sensing 
threshold is a strong predictor of A ER (rs0.4, p=O.OOOl). 
POSTER SESSION 
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1205-126 Influence of Pacing Sites in an Individual Pulmonary Vein 
on Intracardiac Electrograms in Coronary Sinus and 
Posteromedial Right Atrium for Pacemapping Triggers of 
Atrial Fibrillation Originating in Pulmonary Veins 
Manisha S. Ashar, David J. Callans, Erica S. &do. Francis E. Marchlinski. University of 
Pennsylvania Health Systems, Philadelphia, PA 
Activation sequence (AS) of intracardiac electrogram (Egm) and the conduction times 
between the posteromedial right atrium (PRA) and coronary sinus (CS) help regionalize 
pulmonary vein (PV) sites of origin (right versus left PV) of focal triggers of atria fibrilla- 
tion. We sought to determine the influence of different pacing sites within the same PV on 
intracardiac Egm activation in CS and PRA that might influence the ability to predict right 
versus left PV sites of origin of atrial depolarizations. Methods: Thirteen patients with 
focal atrial fibrillation had decapolar catheters placed in CS and PRA. Three dimensional 
magnetic electroanatomic left atrial endocardial maps (112-190 points) were obtained. At 
least 4 PV were identified per patient and their locations were tagged when the catheter 
tip was passed into PV beyond the endocardial shell to the most distal site where an Egm 
couid be recorded. Pacing was performed from each of the 52 PVs at capture threshold 
at the distal and the ostial sites which were tagged. The conduction time between the CS 
and PRA and the AS in these catheters were analyzed. A change in AS and/or a differ- 
ence > 10 ms in CS-PRA conduction time was considered significant. Results: The AS in 
PRA and CS remained identical despite pacing at 2 different sites within the same PV for 
all patients. Eleven of the 52 (21%) PV paced had z 10 ms in CS-PRA conduction time 
difference with pacing at the ostium versus deep in the respective PV (right superior PV- 
4, right inferior PV-1, left superior PV-3, left inferior PV-3). Conclusions: Pace map activa- 
tion sequence and CS-PRA conduction time help rapidly regionalize PV site of origin of 
atrial depolarizations to left versus right PV. Minor changes in CS-PRA conduction time 
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1205-130 Prediction of Site of Focal Atrial Fibrillation From Sequence 
of Coronary Sinus Activation and its Relationship to Right 
Atrial Electrograms 
Davendra Mehta, No& Langan, Rajeev Verma, Anthony Games. Cardiovascular 
Institute, Mount Sinai Hospitai, New York, NY 
Mapping of all 4 pulmonary veins (PV) IS performed to localize the focus for ablation of 
atrial fibrillation. Pattern of activation of coronary sinus (CS) might help in predicting the 
source of atrial premature beats so as to limit mapping of PVs. Sequence of CS activa- 
tion was evaluated by pacing the ostium of all PV. 12 pts who underwent trans-septal 
punctures for ablation of left sided accessory pathways were investigated. Following 
ablation, with CS, His and right atrial (RA) in position, ablation catheter was advanced 
into each of the 4 PVs serially. Pacing was performed at a rate of 100 bpm. Catheter was 
withdrawn until atrial capture was obtained. Pattern of CS, HRA and CS activation was 
evaluated. Results: Right Upper PV pacing was associated with atrial activation 
sequence similar to sinus rhythm. HRA activation significantly preceded His (20~13 ms) 
and proximal CS activation (26+17ms, P<O.OOl). In 1 l/l2 patients CS activation was 
proximal to distal. Right lower PV pacing was associated with relatively early activation of 
His area that preceded the HRA by lo+11 ms. Proximal CS activation was simultaneous 
with His, and CS activation was proximal to distal in all pts. Left sided PV pacing was 
associated with early activation of distal CS in all pts. However with left upper PV pacing, 
His preceded the activation of proximal CS in 10112 pts (p<O.OOl) and in 8/12 (PcO.05) 
both His and HRA preceded activation of proximal CS. In left lower PV pacing His and 
HRA activation followed activation of proximal CS in 11112 patients. Conclusion: Left 
upper and lower PV pacing was associated with early activation of distal CS. Left upper 
PV pacing was associated with HRA and His atrial activation prior to proximal CS. Pacing 
of right sided PVs was associated with proximal to distal CS activation. Right upper PV 
pacing was associated with early activation of HRA prior to His and CS activation. Right 
lower PV pacing was associated with His atrial activation prior to HRA. Thus close analy- 
sis of sequence of activation of CS activation and its relationship to His and HRA may 
help localize the origin of atrial premature beats in PVs prior to transeptal puncture for 
atrial fibrillation ablation. 
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857-2 
IO:45 a.m. 
The Value of a Preimplant Study Performed Before 
Permanent Biventricular Pacing 
David M. Giliigan, Charles A. Joyner, Dan Dan, lthiel A. Fuller, A~ay Krishen, Kenneth A. 
Ellenbogen. Veterans Affairs Medical Center, Richmond, VA, Medical College of Virginia, 
Virginia Commonwealth University, Richmond, VA 
Background: Permanent blventricular (Biv) pacing is being investigated as a therapy for 
patients (pts) with congestive heart failure (CHF) and bundle branch block (EBB). How- 
ever, the identification of pts most appropriate for pacing and the best left ventricular (LV) 
venous site at which to pace are controversial. We hypothesized that a baseline study to 
determine a) the coronary venous anatomy, b) the acute hemodynamic response to pac- 
ing in different veins and c) ventricular tachycardia (VT) inducibility, would provide valu- 
able information before implantation of a permanent Biv pacing device. 
Methods: Coronary sinus (CS) venography, acute hemodynamic testing of potential LV 
pacing sites and electrophysiology studies (EPS) were performed in 21 male pts with 
CHF and BBB (left in 19). The mean age was 69*7 years, ejection fraction 22i4%, QRS 
duration 165+17 ms and the etiology of CHF was lschemic in 14 (66%). After accessing 
the CS and defining the anatomy, LV veins were cannulated with a microelectrode cathe- 
ter. VDD pacing was performed at the right ventricular (RV) apex, and at LV sites in ran- 
dom order, with measurement of stroke volume (SV) by thermodilution. 
Results: 
a) Coronary vein anatomy was highly variable including complete mid CS occlusion in 1 
pt precluding LV “em access. In the other pts, 1 to 4 veins were accessed and tested. 
b) Overall, Biv pacing at the optimum LV site increased SV by 17*23% compared to 
sinus rhythm, p<O.Ol. However, there was marked inter-Individual variation, including 3 
pts who deteriorated with Biv pacing (SV fall by >I 0%). There was also an average differ- 
ence of 19% between Biv pacing SV at the best LV site and Biv pacing SV at the worst LV 
site. 
c) EPS was periormed in 18 pts who had not had prior EPS. Monomorphic VT was induc- 
ible in 7 (44%). 
A permanent Biv pacing device was subsequently implanted successfully in all 12 pts 
attempted, targeting a previously tested vein. 
Conclusions: A baseline study of coronary venous anatomy, the acute hemodynamic 
response to Biv pacing and VT inducibility provides valuable information before attempt- 
ing a permanent Biv implant with regard to selecting the patient, the device and the lead 
placement. 
857-3 
11 :OO a.m. 
The Effect of Atrioventricular Pacing on Ejection and Filling 
Hemodynamics in Patients With Dilated Cardiomyopathy 
With Activation Disturbances: The MUSTIC Study 
Alison M. Duncan, Thomas D. Wait, Derek G. Gibson, J C. Daub&. RoyalBrompton 
Hospital, London, United Kingdom 
Aim: To assess the effect of biventricular pacing on ejection and filling times in patients 
with dilated cardiomyopathy (DCM) and impaired ventricular activation. Methods: 34 
patients with DCM and left bundle branch block (DCM-LBBB), aged 65 +/-9 years, with a 
mean QRS duration of 168+22ms were studied before and after atrio-biventricular 
pacing. Doppler echocardiography was used to assess relative left ventricular (LV) ejec- 
tion and filling patterns (expressed in se&in). Results were compared with 17 normal 
subjects, aged 63+/-10 years, with a mean QRS duration of 9t+/-9ms, and with 16 
patients with dilated cardiomyopathy but normal activation (DCM-NA), aged 83+/-g years, 
with a mean QRS duration of 96+/-13ms. Results: In normal subjects, relative ejection 
time occupied 20+/-3 sec/min, and relative filling time was 28+//-4 secimin. In patients 
with DCM-NA (with an end diastolic dimension [EDD] of 7.l+/-0.7cm and end systolic 
dimension [ESDI of 5.9+/-0.7cm), these times did not differ from normal. LV cavity 
dimensions were similar in patients with DCM-LBBB (EDD 7.4+/-0.9cm and ESD 6.2+/- 
0.9cm), but relative ejection time (17+/-3 secimin) and filling time (23+/-5 secimin) were 
both shorter compared with controls and with patients with DCM-NA. Thus, in patients 
with DCM-LBBB before pacing, the ventricle was neither ejecting nor filling for 20+1-4 
seclmin compared with 12+/-2 seclmin in controls (all p<O.OOl). In patients with DCM- 
LBBB after atrio-biventricular pacing, relative ejection time increased (to 20 +/-3 sac/ 
min), and relative filling time Increased (to 30+1-4 secimin, both p<O.OOl). Thus, in 
patients with DCM-LBBB subsequent to atrio-biventricular pacing, the total time in the 
cardiac cycle spent neither ejecting nor filling fell to lo+/-5 seclmin, which was not signif- 
icantly different from either normal subjects or patients with DCM-NA. Conclusion: In 
patients with dilated cardiomyopathy, superadded LBBB greatly reduces the time avail- 
able for left ventricular ejection and filling, with considerable prolongation of the two iso- 
volumic periods. Atrio-biventricular pacing effectively normalizes this deleterious effect 
of abnormal activation. 
II:15 a.m. 
857-4 Effect of Chronic Cardiac Resynchronization on Left 
Ventricular Remodeling and Neurohormonal Activation 
Teresa De Marco, Elyse Foster, Jill Schafer, Kanu Chatterjee, Samer Dibs, Leslie A. 
Saxon. University of California San Francisco, San Francisco, CA 
Background: Cardiac resynchronization therapy (CRT) using biventricular stimulation is 
under investigation to determine whether it improves the clinical status and outcome of 
patients with dilated cardiomyopathy and bundle branch block. The Ventak CHFiContak 
CD trial is a randomized trial comparing cardiac resynchronization therapy to no cardiac 
resynchronization therapy (NCRT) over 6 months followed by cardiac resynchronization 
therapy in all patients. Methods: A total of 426 patients (age: 66*10 years; 85% male; 
70% ischemic etiology ejection fraction 22+7%; New York Heart Association class II/Ill/ 
ORAL CONTRIBUTIONS 
857 Resynchronization Therapy for 
Congestive Heart Failure I 
Tuesday, March 20, 2001, IO:30 a.m.-Noon 
Orange County Convention Center, Room 232A 
857-i 
IO:30 a.m. 
Reverse Remodeling of the Left Ventricle After Biventricular 
Pacing in Patients With Advanced Heart Failure is Related to 
lntraventricular Resynchronization: A Mechanistic Study by 
Tissue Doppler Imaging 
Cheuk-Man Yu, Chu-Pak Lau, Hung-Fat Tse, Man-Oi Tang, Hua Yang, Elaine M. C. 
Chau, Kathryn Fan, Kathy L. F Lee, Michael R. S. Hill. The University of Hong Kong, 
Hong Kong, Hong Kong 
Background: Biventricuiar pacing improves symptoms in patients with severe heart fail- 
ure. This study investigated the potential mechanism of benefit from biventricular pacing. 
Methods: 21 patients (64 ? 13 yrs, 14 male) with class Ill / IV heart failure and QRS 
duration >140ms who had biventricular pacemaker implanted (Medtronic. lnc) were fol- 
lowed up by serial echocardiography up to 3 months, and pacing was then withdrawn for 
4 weeks. Tissue Doppler imaging (TDI) was performed using 3 apical views by a 6 basal, 
6 mid segmental model. Results: The mean ejection fraction was 25 f 9%, which 
increased significantly over 3 months (37 -f: 13%, p<O.Oi). There was progressive 
decrease in left ventricular end-diastolic (220 + 83 Vs 174 + 62ml, ~~0.05) and end-sys- 
tolic (185 + 78 Vs 132 r 56ml, ~~0.05) volume after biventricuiar pacing. When pacing 
was withdrawn for 4 weeks, the ejection fraction decreased gradually (29 * 9%), while the 
left ventricular end-diastolic (201 + 68ml) and end-systolic (161 + 66ml) volume were 
increased (both p<O.O5 compared to pacing). By TDI, there was evidence of delay in the 
time to peak myocardial sustained systolic contraction (TSM) at the basal lateral segment 
when compared to the basal septal segment (224 ? 48 Vs 195 r 61ms, p<O.O5), which 
was abolished by biventricular pacing (188 +46 Vs 178 f 34ms, p=NS). The mean TSM 
of the 12 segments was insignificantly shortened after biventricuiar pacing (196 r 37 Vs 
184 + 15ms, p = NS). However, when the standard deviation of the mean TSM of the 12 
segments was used as an indicator of the degree of dys-synchrony, it was shortened sig- 
nificantly after biventricular pacing (43 f 15 Vs 32 + lOms, p<O.Ol), reflecting the 
improvement of systolic synchrony. In addition, there was no significant change in mean 
peak myocardial sustained systolic velocity (2.4 * 0.5 Vs 2.4 r O.llcm/s, p = NS). Conclu- 
sion: Biventricular pacing reverses left ventricular remodeling and improves cardiac 
function in heart failure. This is likely secondary to the improvement of overall left ventric- 
ular synchronization during systole and especially abolishment of the lateral wall 
mechanical delay. 
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IV: 33% 158% 19% respectively) have been enrolled. Echo volume data is available in 91 
patients and serum narepinephrine (NE) level is available in 204 patients at 3 months of 
follow-up from randomization. 
Results: - 
Conclusion: By measuring LV cavity dynamics, CK detected immediate improvement I” 
LV filling and contraction. Follow-up CK showed that in a substantial proportion of pts 
BVP benefits are underestimated at 1 week. Further studies are needed to define the 
optimal timing for evaluating BIV effects on LV function and clinical status. 
CRT 
*AESVl(ml/m2) -3.9t16.7 
*AEDVl(ml/mP) -i 6r19.3 
*ANE (pg/mi) -29.2+357.6 
(* A3 months versus baseline) 
(** CRT versus NCRT) 
NCRT P 
il 
-1 6116.0 NS 
+0.3i19.3 NS 
-51.6t653.5 NS 
POSTER SESSION 
In the NCRT group, there was a trend correlating ESV to NE level (~~0.08, 1x35) 
Three months of cardiac resynchronization therapy in dilated cardiomyopathy does not 
affect ventricular remodeling or neurohormonal activation Conclusion: Further study is 
required to determine If cardiac resynchronization therapy, with longer follow-up, can 
modulate the clinical, mechanical. and “eurohormonal progression of systolic heart fail- 
ure. 
1236 Ventricular Tachyarrhythmias: 
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1 I:30 a.m. 1236-i 11 Mortality Pattern in High Risk Patients After Acute 
Effects of &ventricular Pacing on Cardiac Myocytes Myocardial Infarction in the Thrombolytic Era: A Combined 
Apoptosis Analysis of Contemporary Survival Studies 
Cristlna TostiGuerra, Maria Cnstma Porclani, Alessandra Sabinl. Andrea Colella, Antonio 
Micheiuccl, Paolo Pleragnoli, Nicola Mwlli, Cristina Ciapetti, Gian Franca Gensini, Luigl 
Padeletti. Department of lnternai Medmne and Cardiology Florence, k/x Institute of 
Internal Medicine, Careggi Hospital, Florence, k/y 
Yee Guan Yap, Trinh Duong, Martin Bland, Marek Malik, ChristIan Tarp-Pederson, Lars 
Kober, Stuart Connolly, Robln Roberts, Bradley Marchant, A. John Camm. Sf. George’s 
Hosjxtal Medical School, London, United Kingdom 
Background: The development of dilated cardiomyopathy (DCM) involves apoptosis of 
cardiomyocytes Insulin like growth factor-l (IGF-1) is a” important cell survival factor, 
which inhibits cardiac myocytes apoptosis (CMA) in viva and its levels are reduced in 
congestive heart failure (CHF). Recently, biventricular pacing (BVP) has been demon- 
strated to improve hemodynamics in pts with CHF and left bundle branch block (LBBB). 
The aim of our study was to evaluate modifications of IGF-1 levels in pts with chronic 
CHF and BVP. Methods: Nine pts (7 m, range 59-77 yrs) with DCM and LBBB (QRS 
duration longer than 140 ms) were implanted with a permanent transvenous system 
(Medtronic InSync). Before and after 3 months implantation we evaluated IGF-1 plasma 
levels, NYHA class, and the following Echo/Doppler parameters: cardiac output (CO), 
ejection fraction (EF), interventricular delay (IVD) as the difference between aortic and 
pulmonary pre-ejection times. myocardial performance index (MPI) as the sum of iso- 
volumic contraction and relaxation time divided by ejection time. ResultsSee table 
below: 
Pre-implant 3 months P< 
QRS (ms) 184t35 138+21 0.00005 
NYHA Class 2.77+0.97 1.71+0.95 0.04 
EF (%) 281-8 39210 0.0008 
CO (l/mm) 3.6+1.02 4.2320.74 0.03 
lVD(ms) 55i29 13i16 0.03 
MPI 1.3AO.4 0.78x0 44 0.03 
IGF-1 @g/ml) 87 9k34.7 108.5+29.4 0.02 
Conclusion: In patients with CHF and LBBB, BVP significantly improves left ventricular 
function. The hemodynamic improvement induced by BVP significantly reduces CMA, as 
indicated by the significantly higher IGF-1 plasma levels 
Background: Contemporary data on the mode of death after acute myocardial infarction 
(AMI) is lacking. We examined the mode of death after AMI in a recently completed post- 
MI trials performed in the thrombolytic era. Methods: We pooled the individual data on 
3105 placebo patient (2471M, median age: 65 (23-92)) from E.M.I.A.T., C.A.M.I.A.T., 
S.W.O.R.D., T.R.A.C.E. and D.I.A.M.O.N.D-M.I. with left ventricular ejectlo” fraction 
~40% or frequent ventricular ectopic beats. Surwal at 2-year was calculated from day 45 
after index infarct to allow for different recruitment periods between studies. Survival from 
the from onset of MI was also examined for T.R.A.C.E. & D.I.A.M.O.N.D.-M.I. that 
recruited patients withln P-weeks of MI. Results: Among the 3105 patients from the com- 
bined 5 studies that survived at least 45 days from MI, there were 488 (16%) deaths 
within the first 2 years. Of these, 220 (45%) were of arrhythmic and another 172 (35%) 
were of non-arrhythmic cardiac causes. (hazard ratio: all-cause mortality: 81.6% (95% 
C.I.: 80.0%.83.0%); arrhythmic mortality’ 91.3% (95% C.I.: 90.1%92.4%); cardiac mor- 
tality: 93.1% (95% C.I.: 92.0%-94.1%); non-cardiac mortality: 96.0% (95% 6.1.: 95.1%. 
96.7%)) (figure). There were a total of 1634 patients from the D.I.A.M.0.N.D:M.I. and 
T.R.A.C.E. studies combined. Of these, 539 (33%) died from all-causes, 241 (15%) died 
from arrhythmic and 203 (12%) from cardiac caus?s (hazard ratlo: all-cause mortality: 
85.0% (95% C.I.: 83.0%-86.8%); arrhythmic mortality: 82.6% (95% 6.1.: 80.5%-84.6%); 
cardiac mortality: 64.8% (95% 6.1. 62 3%.67 2%); non-cardiac mortakty: 92.4% (95% 
6.1.: 90.8%-93.8%)) (figure). Conclusion: Despite contemporary treatment, high-risk 
post-Ml patients were still more likely to die from arrhythmic than non-arrhythmlc cardiac 
death. Risk stratification of post-Ml patients from arrhythmic death remains a worthwhile 
exercise. 
857-6 
1 I:45 a.m. 
Quantitative Assessment of Left Ventricular Contractile 
Synchrony During Biventricular Pacing Using Color Kinesis 
Echocardiography 
Carlo Pappone, Salvatore Rosanio, Monica Tocchi. Eustachio Agricola, Gabriele 
Vicedomini. Adrian0 Salvati, Simone Gullet& Patnzio Mazzone. Giovanni La Canna. 
San Raffaeie University Hospifai, Mikn, /t&y 
1236-I 12 Does Atrio-Ventricular Synchrony During Ventricular 
Tachycardia Improve Blood Pressure Response? 
Background: Biventricular pacing (BVP) is a promising therapeutic modality for heart 
failure (HF) pts with discoordinated wall motion associated with LBBB. Although BVP 
produces QRS shortening, few data are available on related changes in regional left ven- 
tricular (LV) function. New digital echocardiographic technologies, such as Color Kinesis 
(CK), allow real-time quantitative evaluation of the magnitude and timing of endocardial 
motion throughout systole and diatole, and may be useful in this setting. 
Methods: We selected 55 HF pts (age 66+8 years; 60% male: ischemic 35%; NYHA 
class 3 lr0.7: EF 18t9%) with LBBB (QRS 171+22 ms), who had adequate tracking of 
>80% of LV endocardial boundary. CK was performed at 1 week and 1, 3 and 6 months 
after BIV implantation. Digital color-coded images were acquired I” 4 views and analyzed 
by custom software using a IS-segment model. Color pixel counts were used to calculate 
regional fractional area change (RFAC), expressed as % of end-diastolic area. Systolic 
regional time curves depicting % regional ejection at any % of ejection time were used to 
derive a systolic asynchrony index (SAI), defined as the standard deviation of mea” % 
ejection for all segments at 25% of ejection time. EF was measured using the automated 
boundary detection algorithm. 
Results: During BVP, peak filling rate increased by 33t13% (P<O.O5), with decreased 
mean filling time. A 19tE% EF rise was associated with increased peak ejection rate and 
reduced mea” ejection time. RFAC improved from 15+7% to 31?9% in all segments. 
Maximal RFAC enhancement was observed in antero-septal and postero-lateral seg- 
ments depending on the LV pacing site. At 1 week, correction of contractile asynchrony 
(SAI <lo) was detected I” 27 pts (49%), and 19 of those had EF increase >10%. At 1 
month. a” additional 17 pts (31%) had a similar SAI and EF response. These patterns 
were maintained at 3 and 6 months 
Taresh Tanela. Ala” Kadlsh, Jeffrey Goldbergec Northwestern Univers~fy /&dim/ 
School, Chicago, IL 
Background: Atrio-Ventricular synchrony may be a potential mechanism contributing to 
hemadynamic tolerance of ventricular tachycardia (VT). Methods: During electrophysio- 
logic studies we compared the hemodynamic effects of VT to right ventricular apex 
(RVA): right ventricular outflow tract (RVOT), and Atno-Ventricular (A-RVA, A-RVOT) pac- 
ing at the same rate as the VT in 7 patients (6 men) with eight hemodynamically tolerated 
induced VT’s(l patient had two VT rates). Mean age was 65?9 years and mea” ejection 
fraction was 24i-4%. Four patients had coronary artery disease and three had other car- 
diac disease. Mean cycle length of the induced VT’s and pacmg was 370tiOO msec. VA 
block or dissociation was present in ail VT’s, RVA, RVOT, A-RVA, A-RVOT (AV interval 
150 msec) pacing were each instituted for 30 seconds. Blood pressure (BP) was continu- 
ously recorded for 30 seconds from a 5F femoral arterial catheter. Mean BP was mea- 
sured every 5 seconds. Data were analyzed using repeated measures ANOVA. Results: 
There were significant ~“creases in BP from 5 to 30 seconds following VT induction. 
There were similar significant increases with RVA, RVOT. A-RVA. and A-RVOT pacing 
(see Table, * p < 0.05 over time ** p< 0.01 over time). There were no significant differ- 
ences in BP among VT, RVA, RVOT, A-RVA, A-RVOT pacing at each time epoch Con- 
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elusions: In patients with decreased EF and hemodynamically tolerated VT, following 
induction of VT, there is gradual recovery of BP over 30 seconds. Atrio-Ventricular syn- 
chrony is not a significant mechanism in maintaining BP during VT in these patients. 
Mean BP response (mm Hg) with time in VT and paced rhythms. 
5 10 15 20 25 30 
seconds seconds seconds seconds seconds seconds 
VT* 66*19 69+19 71+18 75+21 77123 78~22 
RVA** 63_cl7 62+16 63il6 66*18 68+21 71+19 
RVOT** 53*15 54+15 56_tl6 62+17 63~20 65+21 
A-RVA* 58r21 60+19 60-+20 64iZl 65+21 6&21 
A-RVOT* 59+24 59*24 61+23 62r23 67r24 67+24 
infarct-related artery did not predict mode of death in the PAMI patients (p=NS). Final 
TIMI flow correlated with survival ~wO.0061. but not with SD (o=NS). Prior arrhvthmia 
correlated both with survival (p<O.O&) as well as mode of deati(p<O.bl). 
SD N=l8 NSD N=136 All N=2289 SD vs NSD SD “s All 
Killip class 21 12% 32% 1 1% NS NS 
LVEF (%) 43~12 39rl3 49*12 NS NS 
Residual IRA 23+32 25t27 171-17 NS NS 
stenosis (%) 
TIMI- 61% 67% 87% NS 0.006 
Arrhythmia 55% 33% 6% NS co.001 
VTNF 45% 16% 4% 0.003 <O.OOl 
Defibrillation 50% 1 1% 2% 0.006 <O.OOl 
Legend: NSD - non-sudden death, All - all patients in PAMI databases, IRA - infarct 
related artery 
Conclusion: Risk factors for SD in Ml patients who receive PCI may be different than 
risk factors in Ml patients who are treated with thrombolytics or in patients who do not 
receive reperfusion therapy. 
1236-l 13 Does Ventricular Triggered Atrial (AVT) Pacing Mitigate 
Hemodynamic Collapse During Ventricular 
Tachyarrhythmia? 
S. Dinakar Satti, G. Muqtada Chaudhry, Craig S. Vinch, David C&avant, Thomas F. 
Marchese, Charles I. Haffajee. St. Elizabeth’s Medical Center of Boston, Boston, MA, 
Medtmnic Inc, Minneapolis, MN 
Background: Hemodynamic col- 
lapse is frequently associated with 
monomorphic ventricular tachy- 
cardia (MVT). It has been show” 
that there is direct relationship 
between blood pressure and sinus 
rate during MVT. Reflex vasodila- 
tatio” secondary to atrial dilatation 
due to AV dyssynchrony is postu- 
lated to be one of the mecha- 
nisms. We sought to determine 
that whether AVT pacing during 
induced MVT results in better 
hemodynamic tolerability. Methods: Consecutive patients with inducible sustained MVT 
without I:1 ventriculo-atrial (VA) conduction during electrophysiology study were 
included. Continuous arterial blood pressure monitoring was performed with intra-arterial 
line. After tachycardia had persisted for 30 seconds, ventricular triggered atrial pacing 
was accomplished using a dual-channel EP stimulator. Three VA intervals, 50%, 60% 
and 70% of the VT cycle length timed from ventricular events recorded from the RV apex, 
were used in a randomized fashion. Pacing was continued for at least 30 seconds at 
each VA interval. Results: AVT was attempted in 10 paiients with sustained MVT. 
Patients were aged 74+/- 7 years and all were male; mean LVEF was 0.26+/-0.11 .Two 
patients developed atrial fibrillation dliring attempts at atrial pacing and were therefore 
excluded from the analysis. Mean arterial blood pressure (mABP) at baseline was 91.4 
mm Hg and during induced MVT was 53.2 mm Hg. Differential response was see” to 
AVT pacing at 3 VA intervals. If most favorable response to AVT pacing was selected, 
mABP during pacing was 69.1 mm Hg, which was significantly (p= 0.014) higher than 
that during VT. Conclusions: Ventricular triggered atrial pacing during induced VT can 
result in improved blood pressure and better tolerability of the tachycardia. This might be 
a useful modality to maintain hemodynamics during VT ablation or during attempts at ter- 
mination by anti-tachycardia pacing. 
1236-131 Are Risk Factors for Sudden Death in Myocardial Infarction 
Patients Treated With Percutaneous Coronary Intervention 
Different? Analysis of the PAMI Database 
Bohuslav Finta, Howard Frumin, Judy Soura, Gregg W. Stone, Bruce R. Brady, David A. 
Cox, Eulogio Garcia, Lori L. Grines, Kimberly A. Skelding, Cindy L. Grines. William 
Beaumont Hospital, Royal Oak, MI 
Background: Coronary atherosclerosis, left ventricular dysfunction and ventricular 
arrhythmias are established risk factors for sudden death (SD). Because these factors 
have been determined mostly in the pre-reperfusion and thrombolytic era, it is not known 
if they can be extrapolated to the myocardial infarction (Ml) patients treated with primary 
percutaneous coronary intervention (PCI). 
Methods: We evaluated PAMI-1, PAMI-2, Stent-PAMI and Stent-PAMI Pilot databases for 
the outcome data in Ml patients who received PCI. We then compared demographic, clin- 
ical and angiographic characteristics between the patients who died of SD on one hand 
and 1) the patients who died of other documented causes and 2) all PAMI patients a” the 
other hand. Our goal was to determine whether any of these characteristics are associ- 
ated with sudden death as opposed to death from all other causes or as opposed to sur- 
viving in MI patients treated with PCI. 
ReSUltS: l-year follow-up data were available for 2,289 of 2,760 PAMI patients who 
received PCI. In 152 (6.6%) patients who died during follow-up period the cause of death 
was as follows: 18 - SD, 77 - other cardiac causes, 2 stroke, 1 - bleeding, 38 - “on-car- 
diac, 16 -unknown. Heart failure, left ventricular dysfunction and residual stenosis of the 
1236-132 Utility of Electrophysiologic Testing in Patients with 
Nonischemic Dilated Cardiomyopathy and Syncope 
Robert M. Sangrigoli, Ala” Katz, Hope B. Helfeld, Steven A. Rothman. Temple Universi~ 
Philadelphia, PA 
Background: Electrophysiologic (EP) testing has bee” noted to have a low yield in 
patients (pts) with “on-ischemic dilated cardiomyopathy (DCM) who present with syn- 
cope. Due to a perceived increased risk of arrhythmic sudden cardiac death in these pts, 
implantation of a cardioverter-defibrillator (ICD) is often performed regardless of the EP 
test results. The purpose of this study was to determine the utility of EP testing in pts with 
DCM who present with syncope and underwent ICD placement. Methods: EP results 
and long-term follow up of 29 pts with DCM and syncope were evaluated. The study pop- 
ulation consisted of 17 me” and 12 women with a mea” age of 54rl3 years and a mea” 
ejection fraction of 17+8 %. Pts were followed for a period of 28r25 months. Appropriate 
ICD interventions (antitachycardia pacing [ATP] or shock delivery for sustained ventricu- 
lar tachycardia [VT] or ventricular fibrillation) were used to define our events in the induc- 
ible (+EP) and “on inducible (-EP) groups. Results: Event rates and the need for 
suppressive antiarrhythmic drug therapy (Drug Rx) for repetitive ICD interventions are 
show” below. 
Event Rate in Inducible and Noninducible Patients 
+EP (n = 5) -EP (n = 24) p Value 
Events 5 (100%) 8 (33%) <0.05 
Drug Rx 4 (80%) 4 (17%) <0.05 
The sensitivity and specificity for EP testing are 31% and 100% respectively with a “ega- 
tive predictive value of 67% and a positive predictive value of 100%. EP testing also 
revealed additional findings (significant His-Purkinje system disease, AV nodal disease 
and sinus nodal dysfunction) in 12 of 29 pts (41%) which were used for appropriate 
choice (single versus dual chamber) of the ICD system. Pre-EP study electrocardio- 
grams demonstrated significant AV conduction disturbance in only 2 pts. In addition, 3 pts 
had slower forms of monomorphic VT which were amenable to ATP and allowed for pro- 
gramming of the ICD algorithm to avoid shock therapy. Conclusion: 1) Despite the low 
sensitivity of EP testing in DCM pts with syncope, inducibility predicts a subset of pts with 
a high event rate and subsequent need for suppressive antiarrhythmlc drug therapy. 2) 
EP testing provides additional findings which are used for appropriate choice and pro- 
gramming of the ICD system. 
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1237-l 15 Goats in Chronic Atrial Fibrillation Show Apoptotic Atrial 
Myocytes and BCL-2 Upregulation in Ventricular.Myocytes 
Richard Ammer, David Keane, Jeremy N. Ruski”, Tom Aretz. Massachusetfs General 
Hospital, Boston, MA, German Heart Center, Munich, Germany 
Background: The extent of apoptosis in persistent atrial fibrillation (AF) over time is not 
know”. Methods: Myocardial samples from both atria and ventricles were obtained from 
the hearts of 40 goats which had undergone cardiac pacemaker (660ppm) implantation 
to induce AF in 30 goats. Goats were grouped according to AF duration, ranging from 2 
to 210 days. Cardiac samples from the other 10 goats remaining in sinus rhythm (SR) 
were used as controls. Apoptosis was evaluated biochemically and by a combination of 
histochemical analysis and confocal microscopy. Results: Persistent AF was character- 
ized morphologically by an up to g-fold increase in atrial myocyte apoptosis (TUNEL 
staining, 0.27 k 0.05% vs. 0.03% + O.Ol%, piO.001) and biochemically by agarose gel 
electrophoresis and Western blots for Bax, 6~12, Cytochrome C, Caspase-S(pP0). The 
percentage of myocytes labeled with Bcl2 was 4.times higher in the ventricles of goats in 
AF than in the control hearts (pcO.005). The percentage of apototic atria1 myocytes corre- 
lated with the duration of AF (p<O.O5), fibrosis and glycogen deposition increased over 
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time in the atrial wail (p<O.Ol). Atrial stretch, corrected by heart weight, was noted over 
time. Conclusions: In this model, programmed death of myocytes occurs and increas?s 
over time with persrstent AF, in spite of the enhanced expression of Bcl2 and prior to 
atrial stretch. This phenomenon may contribute to the progression of electrical and struc- 
tural remodeling associated with AF 
1237-I 16 Electroanatomic Characteristic of the Left Atrium in 
Patients With Atrial Fibrillation 
Vickas V. Patei, Henry H. Hsia, Francis E. Marchlinski. Hospifai of the University of 
Pennsylvania, Pennsyivania, PA 
Background: Magnetic electroanatomic mapping allows for the coupling and display of 
catheter based electrophysiologic information and detailed endocardial anatomy. We 
sought to characterize the electroanatomic substrate of the left atrium (LA) in patients 
with paroxysmal and persistent atrial fibrillation. 
Methods: During sinus rhythm, the activation and voltage characteristics of the LA were 
documented. Detailed endocardial maps of the LA (47 to 263 points) were created allow- 
ing for the assessment of LA volume and the anterior to posterior (AP) LA dimension. 
Results: A total of 39 patients were studied, 33 of which had paroxysmal and six of 
which had perristent atriai fibrillation. For all patients, the earliest site of LA activation 
during sinus rhythm was the superior medial septum and the latest activation was in the 
LA appendage or lateral wall. The distribution of electrogram amplitudes was inhomoge- 
neous with lower amplitudes surrounding the pulmonary vein orrfices and larger ampli- 
tudes in the posterior wall and LA appendage. All values are expressed as the mean + 
standard deviation. 
LA Electroanatomic Characteristics 
Voltage (rnV) 2.7 e 0.8 (range 1 .o-4.3) 
Volume (cc) 137i35 (range 91-212) 
AP Dimension (mm) 41 r 6.8 (range 31-59) 
Activation Time (ms) 92dct-15 (range 71.121) 
Conclusions: Magnetic electromagnetic mapping allows for detailed characterization of 
the LA in patients with drug refractory AF. These data may serve as a reference for com- 
parison with electroanatomic characterization of the LA in patients without AF or with 
other arrhythmias. 
1237-l 17 Viral Myocarditis in Patients with Lone Atrial Fibrillation 
Kengo F. Kusano, Kazufumi Nakamura, Yoichi Nakamura, Mikio Kakishita, Keiko Ohta, 
Hironori Sarto, Yusuke Katayama, Satoshi Nagase, Kenichi Hisamatsu, Hiromi 
Matsubara, Tetsuro Emori, Tohru Ohe. Cardiovascular Medicine, Okayama University 
Medical School, Okayama, Japan 
Background: Lone atrial fibrillation (LAF) is a common arrhythmia, but its ethiology is 
poorly understood. Recently, it is suggested that viral infection is one of the causes of 
LAF We therefore investigated the presence of viral myocarditis in human atial tissue of 
LAF patients. In addition, viral genome assessment was performed to evaluate viral infec- 
tion. Method: Atrial tissue samples ware obtarned from twelve LAF patients (10 men and 
2 women. mean 48t14 years). by endomyocardial biopsies in 10. postmortem sampele 
in 1 and surgical resection sample in 1. Clinical AF was chronic in 4 and paroxysmal in 8. 
To evaluate actrvated cells. serial sections were stained with the cell activation markers 
UCHL-1 (CD45R0, T cells), 126 (CDPOcy, i3 cells) and KPI (CD68 macrophages). In 
addition to lymphocyte staining, atrial samples were screened semiquantitatively for rela- 
trve levels of major histocompatibitity complex (MHC) class I and MHC class II antigens 
(grade 0 to 3). Furthermore. viral genome assessment for adenovirus, cytomegalovirus 
and enterovirus was performed by polymerase chain reactions (PCR). Results: Histolog- 
ical assessment showed an increased number of interstitial cells in 4 out of 12 patients 
who were defined as bordeline myocarditis. immunohistological cell marker analysis 
revealed these interstitial cells were mainly T cells (mean 6.9 * 6.0 cells, range 1 to 20 
cells per high power field). Moderate to severe expression of MHC antigens (grade 2 or 
3) were 8 out of 12 patients in class I antigen and 11 out of 12 patients in class II antigen. 
Endomyocarditis was detected in 7 out of 12 patients. Viral genome assessment 
revealed that adenovirus genome was detected in 3 out of 12 patients, whereas cytome- 
galovirus and enterovirus was identified in none of the patients. Conclusion: Adenoviral 
myocarditis should be considered as one of the causes of LAF 
1237-118 The Relation Between Transverse Conduction Capabilities 
and the Anatomy of the Crista Terminalis in Patients With 
Paroxysmal Atrial Fibrillation and Flutter: Analysis With 
Intracardiac Echocardiography 
Koichi Mizumaki, Akira Fujrki, Hidehiko Nagasawa, Kenji Sakurai, Kunihiro Nrshida, 
Masao Sakabe, Hiroshi Inoue. The Second Department of Internal Medicine. Toyama 
Medical and Pharmaceutical University Toyama, Japan 
Background: The crista terminalis (CT) has been identified as the barrier to transverse 
conduction during typical atrial flutter (AFL). However,the relation between transverse 
conduction capabilities and the anatomy of CT remains unclear. So, the aim of the study 
was to evaluate Its relation using rntracardiac echocardiography (ICE) Methods: Twelve 
patients(group AF) with paroxysmal atria) fibrillation (PAF), 10 patients with both PAF and 
typical AFL (group AF+AFL) and 16 patients without PAF or AFL (group N) were included 
in this study. The imaging catheter of ICE (9Fr) with g-MHz ultrasound transducer was 
advanced to the right atrium (RA). The maximum short axis diameter of CT in end-sys- 
tale (dCT) was measured using ICE images. To determine transverse conduction capa- 
bilities of CT, the mapprng catheter was positioned along with CT under ICE guidance. 
During extrastrmulation (basic cycle length=600 msec) from 1-2 cm anteriorly (free wall) 
or 1-2 cm posteriorly (septal) to CT, CT-ERP(t) was defined as the longest coupling inter- 
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val that resulted in a transverse conduction block at CT (occurring split potentials at the 
CT mapping catheter). Results: The dCT (mm: mean values of high RA and mid RA) 
was greater in group AF+AFL than in both groups AF and N(5.1+0.5 v.s 4.7kO.5 and 
4.0~0.6, p&O5 and p<O.OOi). CT-ERP(t)( msec) was longer in septal pacing than in free 
wall pacing (293i-47 vs 263~31 ,pcO.Ol) CT-ERP(t) in septal pacing was longer in group 
AF+AFL than in both groups AF and N(393i131 vs 282*54 and 252533, ~~0.05 and 
p<O.Ol ,respectively). CT-ERP(t) did not correlate significantly with dCT. However, the 
dCT was greater in patients with split potentials at the CT mapping catheter than in 
patients without it (5.0+0.7 vs 4.2~0.4, p<O.O5), before RA was refractory. Therefore, the 
transverse conduction block of CT was more likely to be caused in greater CT. Conctu- 
sions: In patients with PAF+AFL, CT-ERP(t) was longer and the greater CT was seen. 
Thus, rn these patients, limited transverse conduction capabilities of the crista terminalis 
in relation to its anatomy seem to contribute to the development of typical AFL 
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1238-I 19 Procainamide Facilitates Induction of Counterclockwise 
Atrial Flutter 
Mario D. Gonzalez, Farahnaz R. Angelia, Jamie B. Conti, Anne B. Curtis. University of 
Florida, Gainesville, FL 
Background: In some patients with documented atria flutter, the arrhythmia can not be 
induced in the electrophysiology laboratory. In the present study we investigated if intra- 
venous procainamide could facilitate induction of atrial flutter by altering conduction 
along the subeustachian isthmus. Methods: Thirty-six consecutive patients (age 58 t 
12; 7 females) referred for catheter ablation of documented typical atrial flutter. Results: 
Twenty-five patients were in atrial flutter at the beginning of the procedure. Programmed 
stimulation and decremental atria pacing from the right atrium and the coronary sinus 
were performed in the remaining Ii patients in an attempt to induce atrial flutter. In 5111 
patients, atrial pacing before or during isoproterenol administration failed to induce atrial 
flutter. In these patients unidirectional block in the subeustachian isthmus could not be 
obtained during decremental atrial pacing from the proximal coronary sinus at the short- 
est pacing cycle length associated with I:1 atrial activation (190-210 msec). Following 
administration of intravenous procainamide (15 mgikg), decremental pacing from the 
proximal coronary sinus resulted in unidirectional bock in the subeustachian isthmus at a 
pacing cycle length of 230-260 m.sec with counterclockwise rotation and induction of sus- 
tained typical atriai flutter (cycle length 245370 msec). Twelve-lead ECG characteristics 
of induced atrial flutter were identical to clinical atrial flutter. Concealed entrainment was 
obtained in all patients from the posterior (inferior) and lateral tricuspid annulus. Conclu- 
sions: In patients with documented typical atrial flutter in whom the arrhythmia cannot be 
induced using standard techniques, intravenous procainamide may facilitate induction of 
atrial flutter by causing unidirectional block in the subeustachian isthmus. 
1238120 Prospective Evaluation of a Simplified Approach for 
Common Atrial Flutter Radiofrequency Ablation with Only 
Two Catheters 
Didier Klug. Dominique Lacrorx, Bernard d’Hautefeuille, Max Pecheux, Stephane 
Dennetiere. Claude Kouakam, Christ& Marquie, Salem Kacet. University of Lille, Lib 
France 
lntwatrial conduction block within the inferiorvena cava-tricuspid annulus isthmus (IVCT) 
has been shown to predict successful common atrial flutter ablation. However, its demon- 
stration requires the use of several electrode catheters and to map the line of block. The 
aim of this study was to prospectively test the feasibility of a simplified ablation procedure 
using only two catheters. Methods: RF ablation of common atrial flutter was performed in 
30 patients with the sole use of a catheter for atrial pacing and a RF catheter. RF ablation 
lesions were created in the IVCT. Surface ECG criteria were used to monitor the conduc- 
tion within the IVCT. The end point during low lateral atrial pacing was an increment in 
the interval between the pacing artefact and the peak of the R wave in surface lead II > 
50 ms and a clockwise rotation of the P wave axis beyond -30” and inferiorly. Then the 
line of lesions was mapped during atrial pacing with the RF catheter. Additional RF 
lesions were applied if mapping disclosed a zone of residual conduction. Otherwise the 
procedure was stopped if mapping showed parallel double potentials all along the line. 
Finally the block was reassessed with a “Halo” catheter. Results: Surface ECG criteria 
were met in 26 patients. Mapping the line of lesions showed a complete corridor of paral- 
lel double potentials in these 26 cases and in 3 out of the 4 patients rn whom ECG Criteria 
were not met. The conduction evaluated with the Halo catheter showed a bi-directional 
complete block in these 29 patients. After a follow-up of 16 + 4 months there was no 
recurrence of atrial flutter. Conclusion. Surface ECG criteria combined with a mapping of 
the line of block allow to evidence bi-directional IVCT block. Thus simplified RF ablation of 
common atriai flutter is feasrble with a low recurrence rate. 
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1238-121 Prospective Randomized Comparison of Pulsed and 
Continuous Energy Delivery in Catheter Ablation of 
Common Atrial Flutter 
Ali Erdogan, Joerg Carlsson, Alexander Berkowitsch, Britta Schulte, Joerg Neuzner, 
Heinz F. Pitschner. Kerckhoff Heart Center, Dept. of Cardiolog)( Bad Nauheim, Germany 
Background - Radiofrequency (RF) ablation of common flutter requires the creation of a 
complete ablation line to produce bidirectional conduction block in the cavotricuspid idh- 
mus. Pulsed energy delivery has been shown to be effective in producing homogeneous 
linear lesions. This randomized study compares the efficacy and safety of this mode of 
energy delivery with those of a conventional continuous energy delivery of de nova flutter 
ablation and analyzes differences in pain perception. Methods and Results - Cavotricus- 
pid ablation was performed in patients with conventional (n =20) or with pulsed (duty 
cycle 5 ms) energy delivery (n-20). RF was applied for 2 minutes with a temperature- 
controlled mode: 55 “C up to 100 W with a standard ablation catheter (8 mm tip elec- 
trode, Sidewinder, Bard Inc., Boston, USA). The endpoint was the achievement of bidi- 
rectional isthmus block, and a crossover was performed after 15 unsuccessful 
applications (3 patients, cross-over from pulsed to continuous mode, ns.). Complete bidi- 
rectional isthmus block was achieved for all patients. Procedural ablation parameters as 
well as number of RF-applications, catheter tip temperature, X-ray exposure, total energy 
amount, procedure duration, impedance rise, clot formation, and pain perception - using 
the visual analog scale (VAS, O=no pal”, lo=insuflerable) were compared for each group. 
No analgesic medication was applicated. The VAS scows were significant lower in the 
pulsed group (2.25 +1.2 vs. 5.25+ 1.74, pcO.001). The total energy amount required for 
bidirectional block and the catheter tip temperature were significantly higher in the contin- 
uous than in the pulsed group: 62965 540939 J vs. 42068 + 240139 J and 54.7 A 1.4 “C 
vs. 51.1 f 2.9 “C. No significant side effects occurred. Conclusions- Catheter ablation of 
atrial flutter using pulsed energy delivery was found to be as effective and as safe as con- 
tinuous energy delivery for flutter ablation. With pulsed energy delivery significant less 
energy amount was required to achieve bidirectional isthmus block and the reduction of 
delivered energy was associated with significant reduction of felt pain. 
1238-122 Irrigated-Tip Versus &mm-Tip Catheters for Radiofrequency 
Ablation of Common Atrial Flutter in Patients With 
Structural Heart Disease: A Prospective Randomized Study 
Maurizio Landolina, Gaetano De Ferrari, Francesco Cant& Michela Casella, Barbara 
Petracci. SMaffeo Hospital - IRCCS, Pavia, Italy 
The occurrence of atrial flutter (AFI) may lead to severe impairment of cardiac function in 
patients with structural heart disease (SHD). Radiofrequency (RF) ablation is a curative 
therapy of common AFI that requires continuous and transmural lesion along the cavotri- 
cuspid isthmus to obtain complete and bidirectional block. This target may be difficult to 
achieve in SHD pts for anatomical abnormalities of the isthmus, enlargement of right 
atrium and tricuspid valve insufficiency. Both a-mm tip and irrigated-tip catheters have 
been proved to create deeper and wider lesions. Aim of our study was to compare the 
efficacy and safety of these catheters for AFI ablation in SHD pts. Twenty four consecu- 
tive SHD pts with AFI unresponsive to antiarrhythmic drugs were randomized to ablation 
with B-mm tip thermocouple catheter (Cordis Websterj (Group 1) or irrigated B-mm-tip 
thermocouple catheter (Cordis Webster Thermocool) (Group 2). The 2 groups were 
homogeneous in age (60 + 12 vs 61+ 13 yrs) and weight (81 + 12 vs 80 + IO kg). Abla- 
tion was performed during pacing from coronary sinus with the technique of point-by- 
point lesions. In all pts a long sheath (SRO Daig) was used to stabilize the ablation cathe- 
ter. Saline (0.9%) solution was infused through the irrigated-tip at a rate of 17 mlimin dur- 
ing RF application. 
Group 1 (n=ll) Group 2 (n=13) p value 
RF pulses [mean (SD)] 32 (22) 14 (7) p<o.o5 
Block achieved 9/l 1 13/13 NS 
Power [W, mean (SD)] 43 (7) 33 (6) p<o.o05 
lmpedence [Ohm, mean (SD)] 108 (20) 132 (15) p<o.o05 
T [CO, mean (SD)] 48 (4) 40 (1) p<o.o05 
Total energy [J, mean (SD)] 79926 (57304) 27539 (16671) p<o.o05 
Pericardial effusion 0 0 NS 
Conclusions:The irrigated-tip catheter is more effective and more rapid than the 8.mm- 
tip catheter to achieve bidirectional block in SHD pts. This is likely to be due both to 
deeper IeSiOns and to a more accurate mapping of the ablation line provided by the 
smaller tip that allows the identification of conduction gap?.. 
1238-123 Electra-Anatomic Mapping of Atrial Flutter: Prompt 
Diagnosis of Complete Block in the Cavo-Tricuspid Isthmus 
Pihua Fang, Nancy L. Radtke, Wesley K. Haisty, Jr., Tony W. Simmons, David M. 
Fitzgerald. Wake Forest University School of Medicine, Winston-Salem, NC 
Electra-anatomic mapping (CARTO, Bio- 
sense) as a guide for radiofrequency ablation Iy 
zr 
(RFA) of atrial flutter (AF) allows precise 
marking of ablation points for creation of a c,I”’ 
/6 
line of block in the cave-tricuspid isthmus NO’ 
2 
(CT& The disadvantage is the time delay ‘u 
IL 
required to generate a map to evaluate con- y 
duction post-RFA. Accordingly, we evaluated 
changes in conduction time in the CTI post- I 
RFA to establish values that would indicate .” y,“,~;p p,” i,,, 
Complete block. Methods: 20 patients with 
AF underwent ablation of the CTI using 
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CART0 for guidance. Complete block in the isthmus was documented with a multi-polar 
catheter placed near the tricuspid annulus during coronary sinus (CS) and lateral right 
atrial pacing. Maps were obtained during CS pacing at 600 msec. Parameters measured 
included conduction time (CT) and conduction velocity (CV) measured between 3 sets of 
points taken on each side of the linear ablation line both pre- and post-RFA with the aver- 
age of the 3 values reported. Distance between points was measured. Additionally, inter- 
vals between spikes of double potentials (DP) identified after RFA were measured. 
Results.Listed in Table land displayed in the graphic. CT prolonged and CV slowed sig- 
nificantly (t test) post- RFA with no overlap between pre- and post-RFA values. Widely 
spaced DPs were recorded post-RFA. Conclusions: Prolongation of CT by > 70 msec 
and decrease in CV to < .3 mlsec are consistent with complete block in the CTI post- 
RFA. Presence of double potentials along the line with DP interval > 100 rwec is also 
consistent with complete block. Using these values as a marker for complete block in CTI 
could decrease the number of points required to confirm block and shorten procedure 
time. 
Table l.Mapping Data 
Pre-Ablation 
Measured Distance 19.7+ 3.6 
(mm) 
CT (msec) 22.4 k 9.2 
cv (misec) 1 .o + 0.4 
DP Interval 
Post-Ablation 
20.8+ 5.2 
142.1 + 29.0 
0.15* 0.05 
134.2 i 34.0 
p value 
z 0.05 
< 0.001 
< 0.001 
1238-124 Use of Different Catheter Ablation Technologies for Typical 
Atrial Flutter: Acute Results and Follow-Up 
Robert Schweikert, Andrea Natale, Mina K. Chung, PatrickTchou, Walid Saliba, Lon 
Castle, Logan Kanagaratnam, Mark Niebauer, Stephen Pavia, Cathy Lam, Alejandro 
Perez-Lugones. Cleveland Clinic Foundation, Cleveland 
We report the acute success and short term follow-up in consecutive patients undergoing 
catheter ablation of typical atrial flutter with different catheter designs, and radiofre- 
quency energy delivery systems. Seventy-nine patients entered the study. Based on 
availability and the physician preference ablation was performed with a cooled tip cathe- 
ter (23 patients), with an 8 or IO mm tip catheter connected to a high power radiofre- 
quency generator (19 patients), and with a conventional 4 mm tip catheter (37 patients). 
Acute successful ablation was achieved in all 42 patients undergoing the procedure with 
either the cooled or larger size tip (group 1). Among the 37 patients undergoing ablation 
with the 4 mm tip (group 2), cross over to an 8 mm tip or a cooled tip catheter was 
required in 11 patients (30%). The mean fluoroscopic time was 26 minutes in group 1 
and 50 minutes in group 2 (p < 0.05). After a mean follow-up of 6 months no patient in 
group 1 experienced recurrence of atrial flutter, whereas 7 of the 37 patients in group 2 
(19%) had recurrence of typical atrial flutter. Conclusion: ablation technologies designed 
to obtain larger size lesions appeared more effective in achieving acute ablation of typical 
atrial flutter and in limiting recurrence rate at follow-up. 
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1239-125 The Effect of a Passive Coronary Sinus Defibrillation Lead 
on the Ventricular Defibrillation Threshold 
Michael E. Benser, Steven D. Girouard, Cheryl R. Killingsworth, Gregory P Walcott, 
Raymond E. Ideker. Guidant Corp., St. Paul, MN, University of Alabama at Birmingham, 
Birmingham, AL 
Background: While a coronary sinus (CS) electrode is efficacious for internal electrical 
atrial defibrillation, the effect of a passive CS lead on the ventricular defibrillation thresh- 
old (DFT) is not known. This is an important consideration for the atrio-ventricular defibril- 
lator. Methods: In 8 isoflurane-anesthetized dogs (3353 kg), we compared the DFTs of 3 
defibrillation configurations (RV - SVC+Can, RV Can, and RV - SVC all listed as cath- 
ode - anode(s)) with 3 CS electrode positions: proximal CS (posterior left heart), distal 
CS (lateral left heart) and removed (out of thorax). Dogs were instrumented with a two- 
electrode (RV, SVC) tlansvenous defibrillation catheter, a left-pectoral subcutaneous ICD 
Can electrode, and a CS lead. The delivered-energy DFTs of flxed-tilt, biphasic shocks 
for each of nine test configurations (see below) in each animal were determined in ran- 
dom order according to a multiple-reversal up-down protocol. Results: See table for test 
configuration DFTs (in J, mean+s.d.). By ANOVA, none of the three defibrillation configu- 
rations showed a significant difference in DFT between &her the proximal or distal CS 
positions and the lead removed (~~0.05 for each comparison). However, in the RV - 
SVC+Can and RV - Can configurations, the presence of the CS lead trended toward 
higher DFTs compared to the control (no CS) configuration. 
Test configuration DFTs (in J). 
RV SVC+Can RV Can RV SVC 
no cs prox CS dist CS no CS proxCS dist CS no CS prox CS dist CS 
14+4 14*4 16*6 19?6 21f8 20~10 24+8 24+9 2258 
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age 59+14) the 6944 lead was implanted. Implant success was 100%. Pacing and sens- 
ing values, impedances in the pace and shock lead (painless measurement) were mea- 
sured during implant, at predischarge and at each follow-up (1,3,6,12 months). 
Time Lead Thres. [V: msec.]] R wave Imped. V Shock lead 
Conclusions: The presence of a passive CS lead does not significantly increase the 
DFT in the dog. However, there may be a trend toward higher DFTs I” the presence of 
passive CS leads. Because of the relevance to atrio-ventricular defibrillators, this topic 
warrants further investigation in humans. 
1239-126 Catheterization of the Coronary Sinus for Left Ventricular 
Pacing: Challenges and Solutions 
lmran K. Niazi, MD, Helen Berrier, JoAnn Kiemen, Charles Lanzarott, James McPike. 
Wisconsin Center for Clinical Research, Mihvaukee, WI 
Left ventricular (LV) pacing using a coronary sinus (Cs) lead appears promising for the 
treatment of congestwe heart failure (CHF) in patients (pts) with asynchronous ventricu- 
lar contraction. Although catheterization of the Cs IS usually simple in pts with SVT this is 
reportedly not the case in some patients with CHF. This study was performed to investi- 
gate the anatomical hurdles to successful lead placement, and identify patients where 
difficulty is more likely. Population: In 24 pts with CHF and QRS>lZOmsac, mean 
LVEF=23, a” investigational over-the-wire lead was introduced into a branch of the Cs for 
LV pacing. Sixteen pts were male; 19 had ischemic and 5 had nonischemic cardiomyopa- 
thy. 
Methods: Anatomy was assessed by echocardiography, and by contrast injection into 
the Cs, right atrium, and into the left main coronary artery, to visualize the Cs during the 
Iwo phase. Digital cineangiographic images were recorded in multiple views. 
Results: Lead placement was significantly more difficult in females (median time 120 vs. 
65 minutes, p=.Oi, Mann-Whitney); and non-significantly greater in cardiomyopathy vs. 
coronary disease pts. (100 vs. 75 minutes, p=.OZ). There was no correlation between 
lead placement time and age, LVEF, or body surface area. Anatomic hurdles included a 
dilated right atrium, a prominent Eustachian valve, and tortuosity, acute angulation or 
hypoplasla of the Cs. Cannulation of the coronary sinus wth a deflectable-tip luminal 
catheter, followed by serial catheter and lead exchanges over a guidewire, appeared to 
be the most promising technique in dlfficulf cases. 
Conclusion: Permanent Cs lead placement is sometimes unusually difhcult in CHF pts, 
especially females. Further studies are warranted to devise appropriate equipment and 
Implant procedures. 
1239-127 Single Center Experience With Extraction of Chronic 
Implanted Transvenous ICD Leads: Methods and Results 
Winoc Fonteyne, Heidi Rottiers, Rene H. Tavernier. Department of Cardiology. Universrty 
Hospital Ghent, Ghent, Belgium 
Background: Pacing leads can be removed with good clinical results. These data can 
not be extrapolated towards extraction of lmplantable c~rdioverter deflbriliator (ICD) 
leads due to their larger size, the severity of fibrosis and the underlying heart disease. 
This study analyses the feasibility and safety of the ICD lead extraction. using a stepwise 
approach. 
Methods:lnitially simple traction on the lead with a stylet in place was performed. If this 
was unsuccessful a locking stylet (Cook, Vascomed or Spectraneticsjwas inserted to 
obtain distal traction. When the tip was free but ihe lead could not be removed due to 
obstruction of the coil, a basket catheter (Cook) was inserted from the femoral vein in 
order to remove the electrode from below. When the Spectranetlcs laser sheath became 
available, It was only used when no distal traction could be obtained with the locking 
stylet. If the lead was partially removed, surgery was only performed I” case of infection 
or mechanical irritation of the heart. 
Results: In 27 patients (pts) 8 vena cava superior (SVC) leads and 27 right ventricular 
@VA) leads were removed. The reason for removal was infection in 9 pts and lead mal- 
function in 18 pts. The ICD leads were implanted for 40 i 23 months. 
All SVC leads (100%) and 4 RVA leads could be extracted by simple traction. With a iock- 
ing stylet as the only device 13 leads could be extracted completely. The combination of a 
locking stylet and a basket was used in 5 pts, allowing a complete removal of 3 leads. A 
locking stylet and the laser sheath was used I” 5 pts: 4 leads were removed completely, 
the remnants of one lead were removed surgically, 3 days later. As a result, 25 RVA leads 
(33%) were removed completely and 2 RVA leads (7%) partially. No deaths occurred. 
Seven pts needed blood transfusion. In 3 out of these 7 patients the laser was used. One 
pi received anticoagulants because of thrombosis of the Vena Cava Superior. No other 
complications were observed. 
Conclusion: Extraction of ICD leads can be performed safely and with good clinical 
results if multiple extraction facilities are available and used in a stepwise approach. In 
our experience a laser extraction system is only needed when severe fibrosis of the coil 
limits distal traction. 
1239-128 Randomized Comparison Between a Low and a New High 
Impedance True Bipolar Defibrillation Lead 
Christina Unterberg, Jens Stevens, Dirk Vollmann. Holger Krieglstein, Dieter Zenker, for 
the worlwtrde 6944 Lead Study Group. Depratment of Cardiology, University Clinic, 
Goettingen, Germany, Deprafemnt of Cardiothoracic Surgery, University Cifnic 
Introduction: The a~rr of the study is to compare acute and long-term follow-up parame- 
ters of a low (Medtronlc Sprint 6942) and high impedance (Medtronic Sprint 6944) 
defibrillation lead The new high impedance lead is a true bipolar ICD lead which is a sili- 
cone device with a polyurethane overlay and a” lead body passing through a” 9.0 Fr 
introducer. Both electrodes are steroid-eluting. 
Method: Patients (pts) with classical ICD indications (n=34) were randomized in two 
groiips: group I pts (“=16, 11 CHD, EF 30fll %, 7 VF, 8 VT, lVF/VT, age 63fll) 
received the 6942 lead, in 18 pts of group II (14 CHD, 6 VF, 10 VT, 2 VT/VF, EF 35214 %, 
# p < 0.01 
At implant ventricular pacing threshold (VPS) and shock impedance were not different 
but significantly higher impedances were observed for the pacing part of 6944 lead corn- 
pared to the 6942 lead. During follow-up this difference remained significant. Energy 
delivery is dependant on voltage, impedance and pulse width and thus the high imped- 
ance values may translate into increases in device longevity. Though the 6944 lead is a 
true bipolar electrode sensing did not differ between groups.The surgeons had the feel- 
ing that placing was easier for the 6944 lead but this did not result in shorter position 
times (18,7*8,8 min for group I; 21,3*41,8 mi” for group II) or less repositioning. 
1239-129 One Wire or Two? The Value of Electrophysiologic Testing 
to Guide Selection of Single Versus Dual Chamber 
Defibrillators 
Jay H. Curwin, Robert F. Coyne, William Wesloske, Karen Quinlan, Etti Eckstein, Kelly 
Shea, Elizabeth Tuffiash, John S. Banas, Jr., Stephen L. Winters. Morristown Memorial 
Hospital, Morristown, NJ 
While dual chamber (DDD) implantable defibrlllators may provide advantages over single 
chamber (VVI) devices, DDD ICDs are more complex and expensive. The need for DDD 
ICDs in pts without overt sinus node or AV conduction disturbances is unclear. Thus, we 
analyzed the utility of electrophysiologic testing (EPT)in the selection process. Abnormal 
EPT results(with respect to sinus node function and AV conduction) included: HV interval 
> 80 ms; corrected SNRT > 550 ms; Wenckebach cycle length >500 ms; AV node ERP > 
440 ms. 
Results: In 113 consecutive pts (mean age 68 yrs).l4 new DDD ICDs and 99 VVI ICDs 
were implanted over a 12 month period. Excluded from analysis were 12 pts in chronic 
AF, 7 who had not undergone EPT, 4 who already had DDD pacemakers, and 6 who 
received DDD ICDs for reasons independent of EPT results. Eight of 17 pts (47%) with 
abnormal EPT fmdings received DDD ICDs. Of the 75 pts who received VVI-ICDs, 7 pts 
died or underwent cardiac transplantation within 6 months. The remaining 68 VVI ICD 
patients were followed for 14 +/- 4 months. Nine of the 75 VVI ICD pts (12%)had at least 
1 abnormal EPT parameter. Of the 66 VVI ICD patients who had no EPT abnormalities, 7 
pts (1 l%)developed problems which pacing or diagnostic features of a DDD ICD might 
have prevented: 3 pts - pacemaker syndrome: 2 pts - shocks for AF or supraventricular 
tachycardia; 2 pts - subsequent placement of a DDD pacemaker [one after AV nodal 
ablation for AF with shocks and one for pacemaker syndrome]. AV junction ablation and 
DDD pacemaker implantation were subsequently required in a pt who had a” atrial 
tachycardia at EPT, but received a VVI-ICD. Fifty-nine (89%)of the VVI ICD pts without 
abnormalities at EPT experienced no symptoms or shocks which DDD-ICDs could have 
prevented. The absence of findings at EPT had a negative predictive value of 89% with 
respect to subsequent need for DDD ICD therapy. However, the positive predictive value 
of abnormal findings at EPT was only 47% for identifying need for DDD ICD support. 
Conclusions: EPT is useful in the selection of VVI vs. DDD ICDs. A normal EPT may 
help to avoid unnecessary use of more complex and costly DDD ICDs in an era of limlted 
financial resources. 
1239-130 Complications Associated With Implantable Cardioverter 
Defibrillator Implantation: Single Chamber Versus 
Atrioventricular Devices 
Ralph J. Verdino, Andrea M. Russo, Dusan Z. Kocovic, Behzad B. Pavri, Henry H. Hsia, 
Vickas V. Patel, Manisha Ashar, David J. Callans, Francis E. Marchlinski. University of 
Pennsylvania Health System, Philadelphia, PA 
Background: Implantable defibrillators (ICDs) with dual chamber capabilities (AVICDs) 
offer increased diagnostic capabilities as well as AV synchronous pacing. However, the 
requirement for the implantation of a second lead and the slightly larger size of the gener- 
ator over single chamber ICDs have raised concerns about higher complications rates. 
Methods: We reviewed our experience with complications associated with ICD implanta- 
tion over the past 24 months in 384 patients (pts) undergoing implantation of a new ICD 
system. Implantation was performed by 7 attending electrophysiologists with 5 fellows-in- 
training electrophysiologists. AVlCDs were implanted in 123 (32%) pts. Results: Thirteen 
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ventional procedures typically use Uni EgMs to characterize ischemic rather than 
infarcted areas, accurate localization of infarct zones remains critical for both interven- 
tional and electrophysiologic procedures. 
862-4 
2:45 p.m. 
Improving the Success of Catheter Ablation of Ventricular 
Tachycardia: A Role for Ventricular Pacing During Ablation 
to Stabilize Catheter Position 
Gregory T. Alternose, Luis R. Scott, Giselle Gervacio-Domingo, Mark A. Coppess, 
Douglas P. Zipes, John M. Miller. Indiana University School of Medicine, Krannert 
Institute of Cardiology, Indianapolis, IN 
Background: Success rates of radiofrequency (RF) catheter ablation (CA) of ventricular 
tachycardia (vr) vary depending on the substrate and mechanism of the VTs targeted for 
ablation. Even when VT terminates with RF application, it often remains inducible. We 
hypothesized that sudden catheter movement at the time of VT termination may limit the 
delivery of RF energy to the desired site. We proposed that right ventricular pacing @VP) 
at or near the VT cycle length (CL) during VT while delivering RF would improve catheter 
stability upon termination of VT and thus result in more effective RF delivery and an 
improved CA result. Methods: We studied 23 patients (19 male) with a mean age of 
64+15 years who underwent electrophysiology study and CA; 15 patients (65%) had prior 
myocardial infarction, 2 (9%) had cardiomyopathy and 6 (26%) had no structural heart 
disease. All patients had easily inducible (reproducible) VT or incessant spontaneous VT. 
RVP (at VT CL or VT CL-5 msec) was begun during VT immediately prior to RF delivery 
resulting in ECG fusion. When VT ceased due to RF, the surface ECG showed pure (non- 
fused) RVP indicating efficacy of RF while preventing a sudden heart rate change that 
might shift catheter position. Pacing was continued for the duration of RF energy delivery 
(60 set). Results: A total of 57 VTs (mean CL 402+91 ms, range 254-600 ms) were ana- 
lyzed; 39 (68%) of these were post-infarct, 9 (16%) were myopathic and 9 (16%) were 
from structurally normal hearts. Nine patients (10 VTs) underwent the RVP protocol dur- 
ing VT ablation, while 14 patients (47 VTs) underwent a standard ablation procedure (RF 
during Vl without RVP). Nine out of 10 VTs (90%) ablated during RVP were immediately 
non-inducible, while only 26 out of 47 VTs (55%) were immediately non-inducible follow- 
ing a standard ablation approach. ( ~0.04) Conclusions: RF delivery during RVP at or 
near the VT CL, resulting in ECG fusion until the moment VT terminates, results in a sig- 
nificant improvement in VT ablation success compared to ablation utilizing a standard 
approach. This method may help optimize ablation results. 
862-5 
3:00 p.m. 
Complications After Radiofrequency Catheter Ablation of 
Ventricular Tachycardia 
Alida E. Borger van der Burg, Lies&t van Erven, Marianne Bootsma, Natasja M. S. De 
Groat, Martin J. Schalij. Leiden University Medical Center, Leiden, The Netherlands 
Background: Ventricular tachycardia (VT) is often associated with a poor prognosis. 
Therapy modalities include anti-arrhythmic drugs, an implantable cardioverter defibrillator 
(ICD) and radiofrequency catheter ablation (RFCA). RFCA is the only potentially curative 
therapy. This study was performed to evaluate the procedural complicaiions (~48 hrs 
after the procedure) of RFCA for VT. 
Methods: Medical files and the cardiology information system were evaluated of all pts 
who underwent RFCA for treatment of VT in our hospital. Peri-procedural complications 
were scored. SPSS 9.0 wis used for statistlcal analyses. 
ReSults: Since 1997, 123 pts (104 male, 19 female, average age 58.2 c 15.4 yrs) were 
treated with RFCA for VT. Etiology: ischemic heart disease: 67, dilated cardiomyopathy: 
7, arrhythmogenic right ventricular dysplasia: 20, others: 21. Complications registered in 
this study population are described in the table. 
Complications pts (%) Complications pts (%) 
NOW? 105 (85.5) Myocardial perforation 1 (0.8) 
Haematoma 3 (2.4) Pericardial effusion 1 (0.8) 
TIA 2 (1.6) AV block 1 (0.8) 
CVA 4 (3.3) Resp InsuWlABP 3 (2.4) 
DVT 1 10.8) Death 2 11.61 
pts. (3.4%) experienced 14 significant ICD complications. There were no significant dif- 
ferences in total comDlication rates behwen im&ntation of AVlCDs (4.9%) and the sin- 
gle chamber ICD implantations (3.1%). 
Complication AVICD Single Chamber ICD 
Pneumothorax 2 1 
Lead Dislodgement 0 5 
Pocket Hematoma Requiring Intervention 3 2 
Subendocardial Injury 1 0 
Total 6 (4.9%) 8 (3.1%) 
Conclusion: Complication rates of IX implantion are acceptably low. The addition of a 
second lead does not significantly add to the complication rates associated with implan 
tation of AVICDs. 
ORAL CONTRIBUTIONS 
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862-2 
2:15 p.m. 
Transvenous Cryoablation in Dogs With a Healed Anterior 
Myocardial Infarction: A Promising Method for Ablation of 
Ventricular Tachycardia 
Luz-Maria Rodriguez, Robert van Suylen, Marc Vos, Carl Timmermans, Jet Leunissen, 
Bart J. Korteling, Arend Hoekstra, Wilfred Heiner, Hein J. J. Wellens. Academic Hospital 
Maastricht, Maastricht, The Netherlands 
Background: Clinical practice shows that ventricular tachycardia originating intramurally 
can not be ablated from the endocardium using standard radiofrequency energy or irri- 
gated tip technology. The aim of our study was to analyze the effect of cryothermia in 
areas of a healed anterior myocardial infarction (INF), at the border zone (BZ) and in nor- 
mal ventricular myocardium (N). Methods: In 7 mongrel dogs with complete AV block, 
INF was created. The ischemic area was delineated with 3 markers. A 4th marker was 
placed at the base of the left ventricle in N. 2-3 weeks later, transveneous cryolesions (- 
7O”C, N20;Biosense/Webster) were made in the INF, BZ areas and N myocardium on the 
basis of fluoroscopy and ventricular electrograms. The dimensions of the cryolesions 
were microscopically analyzed 7-9 days post cryoablation. Results: In the INF area, cry- 
olesions could not be distinguished from infarcted tissue. Cryolesions in N and BZ 
showed well demarcated areas of coagulation necrosis with granulation tissue and pres- 
ervation of collagen skeleton. There were no signs of myocardial rupture or thrombus for- 
mation. 
Wall thickness Depth (mm) Area (mm2) % Wall thick- 
(mm) 
Border zone 14+4 
Normal rnyocar- 13+3 
dium 
7?2.1* 
4.7*1.0* 
40+24 
23r7 
ness 
50*11 
34+14 
WT=wall thickness, *= P value= 0.02. Conclusions: 1) Cryolesions at the BZ are deeper 
than in N myocardium, probably due to higher blood flow in N (table). 2) Cryolesions at 
the BZ penetrated 50% of the hypertrophied left ventricular wall. 3) Transveneous cryo- 
therm& can be safely used for ablation of ventricular tachycardia after a healed myocar- 
dial infarction. 
862-3 
2:30 p.m. 
Electroanatomic Mapping in the Chronic Porcine Infarct 
Model: Use of Bipolar Versus Unipolar Electrograms 
Compared to Intracardiac Echocardiography 
David J. Callans, John Michele, Jian-Fang Ren, Francis E. Marchlinski, Stephen M. 
Dillon. University of Pennsylvania, Philadelphia, PA 
Background: Electroanatomic mapping (EA) has proven useful in characterizing inf- 
arcted and ischemic zones during electrophysiologic and interventional procedures. We 
hypothesized that EA would be more accurate using a bipolar (Bi) compared to unipolar 
(Uni) electrograms (EgM) voltage mapping strategy. Methods: EA was performed during 
sinus rhythm with a 3.5 mm tip catheter (1 mm electrode spacing) in 10 pigs 8 weeks 
after closed-chest LAD embolization; maps were constructed with 96 ? 26 points. Signals 
were acquired at 1 kHz with filtering lo-400 Hz (Bi) and 3-240 (Uni). EA infarct area was 
measured by planimetry as the zone of contiguous EgMs < a predetermined voltage (2.0 
mV for Bi, 5.0 mV for Uni). Voltage criteria were based on previous study as well as val- 
ues < mean - 2 SD Egm voltage in normal pigs. EA infarct area and location was com- 
pared to that measured by 9 MHz LV intracardiac echocardiography (ICE; area of 
akinesis). Results: Infarct area measured by ICE, Bi and Uni were 10.7 k 6.9, 10.6 + 6.8 
and 7.2 * 7.8 cm2 (ICE vs. Bi, p = NS: ICE vs. Uni, p < 0.05). In 2 animals, Uni mapping 
did not identify any infarct zone. A linear correlation was demonstrated between ICE and 
Bi (r2 = 0.99) and ICE and Uni (r2 = 0.49) over a range of infarct areas. Bi infarct location 
correlated with ICE better than Uni (96 vs 41%, p c 0.0001). Infarcts were typically 
located by Uni mapping apical and lateral to their actual location by ICE. Conclusions: 
Using ICE imaging as a reference standard, EA mapping with Bi EgMs was more accu- 
rate than Uni EgMs for identifying infarct area and location in this model. Although inter- 
/ I > , 
TIA=transient ischemic attack, CVA=cerebrovascular accident, DVT= deep venous 
thrombosis, AV block= atrio-ventricular conduction block, Resp Insuf= respiratory insuffi- 
ciency, IABP=intra-aorta1 balloon pump 
The procedure was successful in 78% of the pts (non-inducible VT after the procedure). 
The majority (86%) of the pts did not suffer from any complication. Two pts treated 
because of ischemic incessant VT died <I2 hrs after the procedure, although the proce- 
dure was successful. The 6 pts who suffered from neurological complications (all 
ischemic heart disease pts) did not have a history of cerebrovascular accidents prior to 
RFCA. The pts with complications were slightly older than the pts without complications 
(60,Q r13.1 years “s 57.2 zk 15.9 years, NS). 
Conclusion: Treatment of VT with RFCA is effective and relatively safe. The incidence of 
complications tends to increase with age. 
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865-2 A Global Index of Cardiac Autonomic Status and Reflexes 
Azad Ghuran, Fiona Reid, lrina Savelieva, Maria Teresa La Revere, Georg Schmidt, J 
Thomas Bigger, Jr., A John Camm, Peter J Schwartz, Marek Malik. St. George* Hospital 
Medical School, London, United Kingdom, Departmenf of Cardiology Policlinico S. 
Ma&o IRCCS and University of Pavia, Pavia, /t&y 
Background: Heart Rate Turbulence (HRT), baroreflex sensitivity (BRS) and heart rate 
vanability (HRV) are parameters currently used to provide a measure of cardiac auto- 
nomic status and reflexes. Consequently, by combining these parameters a more com- 
prehensive index of cardiac sympathovagal interaction can be obtained. Methods: Using 
data available from the ATRAMI trial, HRT (characterised by turbulence onset -TO, and 
turbulence slope -TS), BRS and HRV (standard deviation of normal to normal RR inter- 
vals - SDNN) ware determined in 985, 1,i 18 and 1,093 patients, respectively. A compos- 
ite index was created by combining TO, TS, BRS and SDNN and stratified into five 
categories (table). Relative hazards for cardiac mortality ware determined using Cox’s 
univariate regression models. Results: Summarised in table below. ‘Compared to all fac- 
tars normal. 
862-6 
3:15 pm 
A Simple ECG Algorithm Derived by Pace Mapping Along 
the Border of Scared Myocardium May More Accurately 
Identify the Exit Site of Unstable Postinfarction Ventricular 
Tachycardia 
Koji Azegami, Mauricio Arruda, Martin C. Burke, Douglas E. Kopp, John G. Kall. Albert C. 
Lin, David J. Wilber. Universify of Chicago, Chicago, IL 
Background: Pace mapping studies obtained from multiple left ventricular (LV) sites, 
without precise knowledge of their relationship to scared myocardium, have been used to 
identlfy the approximate exit site of ventricular tachycardia (VT). The purpose of this 
study was to identify the myocardial scar by electroanatomicai voltage mapping and to 
evaluate the QRS configuration on the surface 1%Lead electrocardiogram (EGG) 
obtained from multiple pace map sites at the border of the scar in patients with post-inf- 
arction VT. Methods: Five patients with unstable VT (3.2~1.3 VTipt) associated with prior 
inferior myocardial infarction (MI) were studied. Localization of LV scar was achieved by 
electroanatomical voltage map (CARTO, Biosense/Cordis-Webster) created in sinus 
rhythm. Scared myocardium was defined as sites of voltage < 1.5 mV. Results: Analysis 
of LV voltage map determined a mean infarct surface area of 58226 cm2. Pacing was 
performed at 86 sites (46 along the border of the scar, mean of 923 sites/pt). Based on 
the analysis of the QRS configuration obtained during pace map at the border of the scar, 
the following ECG algorithm was derived (Figure). The sensitivity and specificity of using 
this algorithm to predict a particular pacing site at the border of the scar was 72% and 
91%, respectively. Conclusions: 1) A simple ECG algorithm guides location of pace 
mapping along the border of myocardiai scar , 2) This ECG algorithm may identify the 
exit site of unstable VT in pts with prior inferior Ml, and 3) may promptly guide ablation in 
sinus rhythm. Nevertheless it must be evaluated prospectively. 
LBBB R8E8 
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865-l 
2:oo p.m. 
EMIAT Substudy: Prediction of the Efficacy of Amiodarone 
by Heart Rate Turbulence 
Georg Schmidt, Petra Barthel. Raphael Schneider, Albert Schomig, John Camm, Marek 
Malik. Technische Universilt Mijnchen, Munich, Germany, St. George’s Hospiral 
Medical School, London, United Kingdom 
Background: In the EMIAT trial, there was a trend to an improved survival of patients 
treated with a combination of Amiodarone and betablockers. This study investigated 
whether Heart Rate Turbulence (HRT) can predict Amiodarone efficacy in post-infarction 
patients on b&blockers. 
Methods: The analyses were performed in 517 patients of EMIAT who were treated wth 
b&blockers. Primary endpoint was the all-cause mortality. HRT was quantified accord- 
ing to the published methodology by HAT Onset and HRT Slope. 
Results: On placebo, patients with an abnormal HRT Onset had a 2.year survival of 
80.3% in contrast to 92.3% in patients with a normal HRT Onset (p=O.O04, Figure la). 
On Amiodarone, the Z-year survival of these subgroups were 92.2% and 91.7%, raspec- 
tively (p=O.98, Figure lb). Thus, Amiodarone treatment normalizes the survival of 
patients with abnormal HRT Onset on betablockers. HRT slope was not a significant pre- 
dictor of amiodarone efficacy. 
Conclusion: HRT Onset allows the identification of post-infarction patients who benefit 
from a combined Amiodaronelbetablockter therapy. 
Relative Hazard (95% Cl) p value 
Combined variable < 0.0001 
Any one factor abnormal* 1.71 (0.76 - 3.85) 0.194 
Any two factors abnormal* 2.84 (0.93 8.63) 0.066 
Any three factors abnormal* 5.16 (1.86 14.33) 0.0016 
All four factors abnormal* 16.79 (6.01 - 46.89) < 0.0001 
Conclusion: A comprehensive index of cardiac autonomic status and reflexes can be 
determined by combining HRT, BRS and HRV. This index is a powerful predictor of car- 
diac mortality. 
865-3 
2:30 p.m. 
QT Dynamics as an Independent Predictor of Mortality in 
CHF Patients 
Curnier Daniel, Pathak Atul, Fourcade Joelle, Bousquet Marc, Fauvel Jean-Marie, 
Bounhoure Jean-Pierre, Montastruc Jean-Louis, Galinier Michel. CHU Rangeuil, 
Toulouse, France, NVSERM U317. Toulouse, France 
Background: QT dynamics are modified in patients with chronic heart failure (CHF) 
related to sympathovagal modifications. The autonomic nervous system can be investi- 
gated using heart rate variability (HRV) which is a marker of poor prognosis and mortality 
The aim of this study is to examine the prognostic value of QT dynamics. Methods: We 
prospectively included 88 CHF patients in sinus rhythm, with mean age of 58.9 +/- 12.2 
years, and mean leff ventricular ejection fraction of 28.6 +/- 8.6 %. Forty-six patients had 
ischaemic cardiomypathy and 42 had idiopathic dilated cardiomyopathy. HRV time and 
frequency domains measured were obtained using 24 h. Halter ECG recordings. QT 
dynamics with QT/RR slope and QT duration at a fixed heart rate (800 ms) were obtained 
for 24 h., daytime (9.00 am to 9.00 pm) and night-time (11 pm to 6 am). Periods Analyses 
were performed at the apex (QTa) and at the end of T wave (QTe). Results: During the 
follow-up of 23.7 +/- 12.2 months, 33 patients died. The 3 year mortality rate was 38.5 %. 
Qt dynamics were found to be a prognotic factor using univariate analysis with: QTe slope 
on 24 h. (RK4.11, p=O.O002), QTa slope (RR=2.71, p=O.O16) and QTe slope (RR=2.71, 
p=O.O16) during day-time and QTe at 800 ms (RR=2.92, p=O.O04) during day-time. In 
multivariate analysis, independent predictors for all-cause mortality were: NYHA classes 
(II vs. Ill-IV, RR=2.33, p=O.O39), low frequency spectra of HRV (cut off inf 4.27 In(ms2), 
RR=0.67, p=O.O08) and QTe at 800 ms in day period (cut off sup 404.5 ms, RR=2.32, 
p=O.O35). Conclusion: QT dynamics demonstrate independent prognotic value in CHF 
patients. As described previously regarding the spectral domain of HRV, prognostic infor- 
mations are available for day-time periods. Further study with a higher sample size is 
needed to evaluate QT dynamics as a predictor of sudden death. 
865-4 
2:45 p.m. 
Influence of Left Bundle Branch Block on the Prognostic 
Value of QT Dynamicity for Major Arrhythmic Events in 
Idiopathic Dilated Cardiomyopathy 
Laurent Fauchier, Dominique Babuty, David Tena-Carbi, Olivier Marie, Philippe Poret, 
Marie Laurence Autret, Pierre Cosnay, Jean Paul Fauchier. Cardiobgie 6, Centre 
Hospitalier Universitaire Trousseau, Tours, France 
QT interval dynamicity has been proposed as a tool to evaluate the risk of ventricular 
arrhythmias. The aim of this study was to evaluate the influence of bundle branch block 
(LBBB) on the prognostic value of QT dynamicity for major arrhythmic events in patients 
with idiopathic dilated cardiomyopathy (IDC). Methods. We performed 24-h ECG record- 
ing in 165 patients with IDC in sinus rhythm (WHO criteria; mean age 51 years; range 18- 
70; 130 men; left ventricular ejection fraction 32 + 12%). The QT intervals (end and apex) 
were measured automatically with a computerized Halter system (Ela medical, France). 
The rate dependence of re~olarization was evaluated over 24 hours, during daytime and 
nighttime periods with measurement of QT/RR slopes. Results. QTendiRR slopes were 
significantly increased in patients with IDC (p<O.OOl) compared to a control group of 80 
subjects. Among patients with IDC, those with LBBB (n = 47) had steeper QT/RR slopes 
compared to patients with narrow QRS (p range 0.02 to 0.001). With a follow-up of 45 e 
44 months, 26 patients suffered cardiac death (14 progressive CHF: 12 sudden deaths) 
and 10 had sustained ventricular tachycardia (VT) or resuscitated ventricular fibrillation 
(VF). In patients with narrow QRS, the only independent predictors (proportional hazards 
model) of major arrhythmic event (sudden death, sustained VT or VF) were a history of 
previous VT/VF (p = O.OOOl), late potentials on signal-averaged ECG (p=O.Oi), and an 
increased QTend/RR slope over 24h (p = 0.03). In patients with LBBB, a history of previ- 
ous VTNF (p = O.OOOl), late potentials on signal-averaged ECG (p=O.O05), nonsustained 
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ventricular tachycardia (p=O.O3), and a decreased heart rate variability (standard devia- 
tion of normal-to-normal intervals, p=O.O3) were the only independent predictors of car- 
diac death. Considering the whole population of patients with IDC, a decreased heart 
rate variability was a better predictor of cardiac death than an increased QTendiRR 
slope. Conclusion. In IDC, an increased QTendiRR slope over 24h may help to identify 
patients with narrow QRS at risk of major arrhythmic events. The presence of LBBB 
i d ecreased the prognostic value of QT dynamicity in patients with IDC. 
ROC curve were calculated and statistically compared with the area under the PCA ratio 
ROC curve. Sensitivity and specificity were calculated for predefined cutoff values. 
Results: 
865-5 
3:oo p.m. 
Is Assessment of QT Dispersion Useful for Predicting 
Sudden Cardiac Death in Patients With Hypertrophic 
Cardiomyopathy? 
Yi Gang, Jan Poloniecki, Shaughan Dickie, Perry M. Elliott, Marek Mailk, William J. 
McKenna. St. George’s Hospital Medical School, London, United Kingdom 
Areas under the ROC curves, Sensitivity, Specificity 
PCA ratio QTc QTD SDNN RMSSD pRR50 
ROC Area 0.82 0.67* 0.77 0.60’ 0.49* 0.54* 
Sensitivity 58% 38% 52% 38% 12% 31% 
Specificity 96% 83% 87% 83% 91% 87% 
* =p<O.O5 marked parameter vs. PCA ratio Conclusion: PCA ratio of the T wave as a 
marker to Identify high-risk patients is superior compared to the mean 24h QTc duration 
and the investigated HRV parameters. QT dispersion does not significantly differ in the 
ROC area analysis but has less sensitivity and is much more difficult to measure. The 
sensitivity of the PCA ratio is not high enough for a good test but it is meaningful to con- 
duct further investigations with methods that describe T wave morphology 
Background: Sudden death is a critical feature of natural history in hypertrophic cardi- 
omyopathy (HCM). QT dispersion (QTd) IS thought to reflect heterogeneity of ventricular 
repolarisation and to be associated with arrhythmic events and mortality. 
Methods: This study is to evaluate whether QTd is of cllnical use for identifying patients 
with HCM who are at risk of sudden cardiac death. QTd (difference between longest and 
shortest QT interval) was measured on initial standard 12.lead ECGs of 46 HCM patients 
(32 men). Case group (Case) consisted of 23 HCM patients who died suddenly. Control 
group (Con) consisted of 23 HCM patients who survived uneventfully during follow-up 
The 2 groups were pair-matched for age (25 years), sex and maximum left ventricular 
wall thickness (i5 mm). Of 23 Cases, 15 had their last ECGs before death available for 
this study. QT mtervals were measured manually using a high-resolution (0.1 mm to 4 
ms) digitising board. An in-house program was used for calculating QT and JT intervals. 
QTd and JT dispersion (JTd, difference between longest and shortest J point to T end 
interval). 
Results: QTd (74r28 v59+21 ms) and JTd (76+32 v59r26 ms) from Initial ECGs were 
significantly greater in Case than in Con (p=O.OZO and 0.029, respectwly) (Figure). 
Maximum corrected QT intervals (OTC) in Case were similar to Con (489ZZ9 v 479k.27 
ms, p&13). No systematic changes in QTd or QTc were found from late ECGs of Case 
compared to those from early ones (75+23 Y 76+25 ms, p=O.5; 484+34 v 485k26 ms, 
p=O.5). There was no correlation between maximum left ventricular wall thickness and 
QTd, JTd, and maximum QTc (rc0.29, p>O.O5 for all). 
Conclusion: Statistically significant differences in the measurements of QTd and JTd 
were observed between Case and Con. However, the small difference and wide overlap 
in measurements between Case and Con will limit its clinical use in predicting sudden 
cardiac death in HCM. 
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1269-l 12 Atrial Tachycardia in Dogs With Rapid Ventricular Pacing 
Induced Heart Failure is Due to Either a Focal or Reentrant 
Mechanism 
Jayakumar Sahadevan, James Golebiewski, C&en Khrestian, Kyung Ryu, Albert L. 
Waldo, Bruce S. Stambler. Case Western Reserve Universify/Univers,fy Hospifaals of 
Cleveland, Cieveland, OH 
Atrial tachyarrhythmias are common in congestive heart failure (CHF) in humans, but 
their mechanisms are poorly understood. Our prior studies in a canine rapid ventricular 
pacing induced CHF model using low density epicardial and endocardial mapping sug- 
gested that atrial tachycardia (AT) can be due to a single focus firing rapidly. Using higher 
density eplcardial mapping, we tested the hypothesis that sustained AT in this model can 
be due to 2 different mechanisms. METHODS: We studied 12 episodes of sustained AT 
(>5 “ins) induced by atrial burst pacing in 9 dogs with CHF induced by right ventricular 
pacing at 235 bpm for 18 - 50 days. Unipolar electrograms were recorded simultaneously 
from 394 sites on the epicardium of the right atrium (RA) and the left atrium (LA) and the 
right side of the atrial septum. Activation maps of 2 consecutive cycles were analyzed 
from Several time periods during each episode of sustained AT (cycle length (CL) 152 + 
12 ms and SD of 10 CCs 1.2 f 0.5 ms). RESULTS: The mechanism of AT was mac- 
roreentry in 5 episodes in 5 dogs and a single focus firing rapidly in 7 episodes in 4 dogs. 
Only one AT mechanism was found in each CHF dog. Dogs with focal vs reentrant AT did 
not differ in: 1) AT CL (148 & 13 vs 157 f 10 ms); 2) SD of CL (1.2 i 0.6 vs 1.2 i 0.3); or 
3) method of induction. Dogs with focal AT underwent rapid ventricular pacing for a 
shorter duration compared with reentrant AT dogs (29 f 9 vs 46 + 5 days, p<O.Ol). In the 
5 episodes of reentry, the circuit was constant in each episode but varied in location from 
episode to episode. In 215 episodes, the reentrant circuit traveled around a functional line 
of block in the LA free wall. In 315 episodes, the circuit was in the RA and resembled typ- 
ical canine atrial flutter with a septal circuit component. In the 7 episodes of focal AT, 2 
episodes originated from the superior or mid sulcus terminalis and 5 episodes originated 
within or around the pulmonary veins. CONCLUSIONS: In this CHF model, AT either: 1) 
has a focal origin near the sulcus terminalis ot’ pulmonary veins; or 2) is due to mac- 
roreentry with variable functional and anatomic components to the circuit; and 3) only 
one mechanism appears responsible for AT in each CHF dog and IS dependent on the 
duration of ventricular pacing. 
865-6 
3:15 p.m. 
Principal Component Analysis of the T Wave as an Index of 
Life-Threatening Arrhythmia Risk 
Thomas Hilbel, Eva vom Brocke, Marc Reiter, Patricia Kraft, Jutta Ruf-Richter, Johannes 
Brachmann. University of Heidelberg, Department of Cardiology, Heidelberg, Germany, 
Klinikum Goburg, &burg, Germany 
Meaningful noninvasive diagnostic,tools are required in order to predict risk for sudden 
cardiac death, particularly in patients with non ischemic heart disease or apparently nor- 
mal hearts. Abnormal T wave patterns can be linked to heterogeneity of ventricular repo- 
larization, an established factor in the development of lethal arrhythmias. Often, however, 
the occurrence of T wave change is variable and potentially short in duration. Methods: 
To measure repolarization abnormalities, we recorded 24h, 12 lead Halter and calculated 
the ratio of the second eigenvalue to the first after computing the principal components 
(PC) of the T wave for every normal beat. The PC ratio analysis (PCA ratio) can be used 
to describe the T wave morphology. To estimate the diagnostic value of the PCA ratio as 
a risk marker we compared it with other noninvasive repolarization measures (mean glo- 
bal QTc interval duration and mean QT dispersion, both measured af every full hour oi 
the 24-hour recording) and autonomic activity HRV Halter parameters (SDNN, RMSSD 
and pNN50). We studied 48 patients with implantable defibrillators and a history of life- 
threatening arrhythmias and 23 control subjects. Persons with ischemic heart disease or 
negative T waves at rest were not included. For validation of the measured parameters, 
ROC analysis was performed. For each investigated parameter, the areas under the 
1269-I 13 Temporal Trends of the Risk of Arrhythmic Versus Non 
Arrhythmic Deaths After Acute Myocardial Infarction: A 
Combined Analysis of Multicentre Trials 
Yee Guan Yap, Trinh Duong, Martin Bland, Marek Malik, Christian Tarp-Pederson, Lars 
Kober, Stuart Connolly, Robin Roberts, Bradley Marchant, A. John Cam”. St George’s 
Hospital Medical School, London, United Kingdom 
Background: An understanding of the temporal trends of the risk of arrhythmic death is 
crucial to decide the optimal time for risk stratification but the data IS lacking. Method: 
Individual patient data was pooled from the placebo arms of EMIAT, CAMIAT, SWORD, 
TRACE & DIAMOND-MI who had a recent Ml and LVEF<40% or frequent VPBs. Tempo- 
ral trends were exammed for all studies from day 45 after Ml to allow for different recruit- 
ment periods between trials. Rate of arrhythmic (AD) and non-arrhythmic cardiac death 
(NAD) were compared over 6.monthly interval after Ml. Kaplan-Meier, logistic & Cox 
regression were used. Results: 3104 patients (median age: 65 (23-92) yr; 2471 M) were 
pooled from ail 5 stdies with 487 deaths at 2 years F/U (220 AD & 172 NAD). There was 
no significant change in the proportion of AD vs. NAD over time from day 45 to 2 year 
after MI (AD:57%(45d-6m), 55%(-12m), 55%(-18m), 58%(-24”); p=O.4). The risks of 
both AD & NAD were highest in the first 6 months but the risk of AD was consistently 
higher than that of NAD throughout the 2 years period (rate of death/l 00 person-year at 
risk (AD/NAD): 8.09/6.07(45d-6m), 4.07/3.35(-12m), 4.34/3.60(-18m), 3.76/2.77(-24m)). 
There were significant interactions between the temporal trends of mortalities and gender 
(p=O.O3) & hypertension (p=O.O4). Similar trend was observed when mortality was mea- 
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sured from the onset of MI on TRACE & DIAMOND-MI only, which recruited patients 
wlthin 2 weeks of MI and had 536 death by 2 years (241 AD & 203 NAD). Again, there 
was no significant change in the proportion of AD vs. NAD measured from day of Ml 
(AD:56%(0d-6m), 52%(-lZm), 50%(-18m), 53%(-24m); ~~0.4). The risk of both AD & 
NAD were highest in the first 6 monthswith ihe risk of AD persistently higher than that of 
NAD during 2 year F/U (rate of death/l00 person-yearat risk (AD/NAD): 23.97/18.9l(Od- 
6m), 5.62/5.28(-12m). 5.14/5.14[~18m), 4.96/4.48(-24m)). Conclusion: In high risk post- 
MI patients. the risk of AD after AMI was persistently higher than NAD and did not 
change with time against previous speculation. The risk of both AD and NAD were high- 
est in the first 6 months after AMI and plateauing thereafter suggestive thai ihis is the 
optimal window period for risk stratification. 
1269-131 Increased Atrial Vulnerability to Tachyarrhythmias in the 
Aged Rat 
Hldekl Hayashi. Charles Wang, Toshihiko Ohara, Chikaya Omichi, Shengmel Zhou, 
Yasusht Miyauchi, Peng-Sheng Chen, Hrayr S. Karagueuzian Cedars-Sinai Medical 
Center and UCLA School of Med,cine. Los Angeles, CA 
Background: The incidence of atrial tachycardia (AT) and atrial fibrillation (AF) increases 
with age. No animal models of aging have been reported. In the present study we report 
that old rats are suiiable to test atria vulnerability hypothesis of aging. Methods: Eight 
male rats (Fisher-344) were grouped into young (N=4, 2-3 months) and old (N=4, 22.24 
months). The hearts were isolated, cannulated and perfused through the aorta with oxy- 
genated Tyrode’s solution at a rate of 5 mlimin at 37°C. Vulnerability to AT/AF was tested 
by burst atnal pacing. The epicardium of the atria was mapped by recording optical sig- 
nals with CCD camera with >3,000 pixels over an area of 1 by 1 cm? The frame to frame 
rime was 2.3 ms. The effect of the cellular uncoupler heptanol (0.002-0.01 mM) on vul- 
nerabillty was then tested in both groups. Results: Burst pacing induced short runs (-10 
s) of AT I” 1 out 4 young rats. In ccnirast, ihe .same pacing protocol induced long lasting 
(>30 s) AT in all iour old rats (P<O.Ol). Hepianol at 0.002 mM, caused reversible rate- 
dependent (300 to 50 ms CL) increase (PcO.05) in conduction bme (delay between pac- 
ing and recording electrodes -2 mm apart) from 29&6 to 34*3.1 ms (CL=200 ms) and 
conduction block inducing AT in all four young rats. In the old rats, heptanol (0 002 mM) 
converled AT to AF in 2 oui 4 rats In contrast, no AF could be induced in the young rats 
even when heptanol concentration was raised up to 0.01 mM. During AT optical mapping 
showed the presence of a periodic single activation wave front in both groups. During AF 
multiple 2 to 4 independent wavefronts were present. Histologic studies showed that the 
ratio of ihe area occupied by interstitial fibrosis to the total area was significantly larger in 
the old than in the young rats. In the RA it was 1.72+0.81 vs. 0 38+0.45% and in the LA it 
was 2.56+1.61 vs. 0.55+0.72% (PcO.05 for RA & LA). Conclusion: The old rat IS a suit- 
able model to study age-related ~ncwase in vulnerability to ATiAF. Heptanol-induced 
increase in vulnerability in the young rats suggests that partial critical cellular uncoupling 
that might be produced by the increased interstitial fibrosis seen in the old rats may be 
responsible for the greater vulnerability to ATiAF in the aged rats. 
1269-132 Loss of Spatiotemporal Organization With the Transition 
From Acute to Chronic Atrial Fibrillation In Vivo 
Joseph G. Akar, Thomas H. Everett, IV. Lai Chow Kok, J. Randall Moorman, David E. 
Haines. Universify of V;i’giflia. Charioftesviiie, VA 
Introduction: AtrIal fibrillation (AF) may originate from discrete sites of periodic activity, 
or rotors. The spatiotemporai changes in rotor activity as acute AF becomes chronic have 
not been defined. We studled this transition in viva by measuring complexity and period- 
icity of atria electrical activity in dogs with AF 
Methods: Five dogs underwent rapid atria pacing for 48 hours and developed acute AF. 
In seven other dogs mitral regurgitation was induced and the dogs were paced until 
chronic AF developed (>8 weeks) A 64.electrode basket catheter was placed wa a trans- 
septal approach into the left atrium (LA). Bipolar eiectrograms were recorded at 1 kHz. 
Electrograms with mostly ventricular activity or 60 Hz noise were excluded. To quantify 
complexity, we calculated sample entropy (SampEn) (window m=5, tolerence r=O.O75 
S.D., length N=2048), a measure similar lo approximate entropy (ApEn) but with less 
bias, especially for short data sets. To quantify penodicity, we calculated power spectra 
on filtered 60+x eleclrograms each 0.25 set on a sliding 10 set wlndow, and noted the 
frequency and power of the largest peak. 
Results: More than 4000 discrete electrograms from 283 bipoles were analyzed (aver- 
age 23.6 bipolesidog). A single dominant frequency was identified in 100% of acute AF 
bipoles and 34.9% of chronic AF bipales (p<O.OOOOl). The mean frequency of the largest 
power spectrum peak was similar in both groups (8.1 and 8.2 Hz, p=NS), reflecting the 
preservation of a single frequency rotor in the transition from acute to chronic AF. But, 
median SampEn was significantly higher in chronic AF (1.04, 0.80 - 1.43 [25-75 percen- 
tile]) versus acute (0.47, 0.23-0.79, p<O.OOi). reflecting less orgawation of the electrical 
activity. This implies that the transition from acute to chronic AF involves an increase in 
fibrillatory conducton or reentry wth the persistence of a single dnvlng rotor. 
Conclusion: We have demonstrated the loss of spatiotemporal organization in the tran- 
sltion from acute to chronic AF. In acute AF there is a single well-organized electrical 
rotor recruiting the majority of the LA. This rotor persists in chronic AF. but the majority of 
the LA activity is poorly organized. 
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1270-I 15 Recannalisation of Venous Occlusion, a New Indication for 
Permanent Pacemaker Lead Extraction Using a Femoral 
Approach 
Richard J Schiliing. Cardiology Department, St Mary’s Hospitai and Imperial College 
School of Medicine, London, United Kingdom 
Background: A subclavian approach for permanent pacemaker lead extraction provides 
access for replacement of leads, important in the presence of venous occlusion. Lead 
extraction using a femoral approach avoids the need for dissection of fibrosis in the sub- 
clavian vein (ScV) and superior vena cava (SVC). This study assessed the fe&ibility of a 
novel femoral “drag-through” technique designed to gain access for new pacing leads 
even in occluded veins. Methods: Guide wes are attached to the externalized ends of 
the leads that are to be extracted; these are then dragged behind the lead as it is drawn 
down from the femoral vein. The guide wires are used to advance a peel-away sheath 
through which new leads are passed. This was only employed III palients (pts) without 
infection. Results: Twenty nine consecuilve pts (15 male, aged 62il6 yrs mean&D) 
had 47 (1.6/pt) leads extracted with a mean implant time of 1Ot4.1 yrs. lndlcaions for 
extractron were infection and/or erosion (n=17), lead failure and replacement in 
pts&Oyears (n=5) or pts with occluded ScV/SVC (n=4), breast radotherapy (n=l) and 
requirement for implantabie defibrillator (n=2). Procedures were performed under local 
anaesthetic and sedation apart from 1 pl with septlcemic shock and 2 pts requiring 
defibrillator implantation. All leads were successfully extracted, with 3 partial successes 
(7.1%) in whom the electrode (n=l) or <2 cm of the distal coil (n=Z) was retained. The 
drag-through technique was employed in 8 pts (4 with ScViSVC occlusion) on 11 (7 ven- 
tri&ar, 4 atrial) leads and was successful in all. Mean procedure and fluoroscopy times, 
including the time required for implantation of a new system, was 152*7Omins and 3li23 
mins respectively. There were no compllcatlons and hospital stay was 4.656.9 (range 1 to 
30) days for ail pts and 1 day for pts without infection or undergoing other unrelated pro- 
cedures. Conclusion: The “drag-through” techmque allows a femoral lead extraction 
approach io be used even in pts with venous occlusion, is ai least as effectwe and 
cheaper than newer technologies and can be performed under local anaesthesia. 
Venous occlusion and pacemaker lead failure is a new indication for femoral lead extrac- 
t1on. 
1270-I 16 Efficacy of Automatic Atrial Antitachycardia Pacing for 
Termination of Atrial Flutter in Patients With a Dual 
Chamber Pacemaker 
Dirk Vollmann, Jew Stevens: Arnd Buchwaid, Georg Goertier, Christina Unterberg. 
Department of Card!oiogy, Georg-August University Goeitingen, Goetfingen, Germany 
Background: Atrial pacing has been proposed as a nonpharmacological approach for 
the prevention and treatment of atrial tachyarrhythmias. The aim of this study was to eval- 
uate the efficacy of automatic atria antitachycardia pacing (ATP) for termination of atrial 
flutter (AFlut) in patients with an AT500 dual chamber pacemaker (Medtronic Inc.). 
Methods: 28 patients with conventional pacing indication and a history of atrial tach- 
yarrhythmias received the AT500. Automatic ATP, activated one month after implant, was 
delivered for episodes (eps.) classified as AFlut and lasting >lminute Device definition of 
atrial fibrillation was a mean atrial cycle length (CL) of 100.270ms definition of AFlut a 
CL of 220.360ms wth CL variability ~25% m the overlapping zone. Programmed ATP 
therapies were BxRamp (91%, 4 initial pulses), GxBurst+ (91/84%, 8 pulses) and 
4xBursti (81/X%, 15 pulses). Counter data from all treated eps. and detailed informa- 
tion on up io 35 eps. stored with atrial electrograms (EGM) were retrieved on each fol- 
low-up visit. 
Results: Calculation of ATP efficacy was performed a) on all treated eps. according to 
device counter and automatic ATP success analysis and b) on treated eps. stored with 
EGM; these eps. were manually analysed in addition (table). 173 of 182 eps. with manu- 
ally verified successful ATP were terminated by Ramp therapy (7.2i-2.8 pulses). 111 of 
the 203 eps. with unsuccessful ATP terminated spontaneously within 1 minute after deliv- 
ery of ATP. In these eps automatic classification of ATP as successful larqely contrib- 
uted to the difference in automatic and manual ATP success rate. 
Treated episodes Total Successful ATP efficacy 
All (counter, automatic analysis) 7662 5691 74.3% 
With EGM: Automatic analysis 385 283 73.5% 
With EGM: Manual analysis 385 182 47.3% 
-atrIal CL <270ms 299 121 40.5%* 
-atrial CL >270ms 86 62 7z.l%*p<o.o1 
Conclusion: According to manual analysis, 1. ATP efficacy for the termination of AFiut 
was 47%, 2. ATP efficacy for AFlut with a CL>270ms was stgnlficantly higher than for 
AFlut with a CL s270ms and 3. the majority of treated eps. had a CL<270ms. Efficacy 
according to automatic analysts (74%) was not confirmed by manual analysis. 
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1270-l 17 The Haemodynamic Effects of Acute Right Atrial, Coronary 
Sinus, and Biatrial Pacing 
Simon A. James, Harry H. Collins. Maidstone General f&pi&l, Hermitage lane, 
Barming, Kent, United Kingdom 
Background: Atrial fibrillation is associated with various electrophysiological abnormali- 
ties.lntr.a-atrial pressure & stretch receptors have also been found to have an affect on 
the susceptibility to AF. Biatrial pacing (high right atriallcoronary sinus) has been shown 
to decrease AF episodes frequency and duration, presumed due to resynchronisation of 
the atria. To date there is no study observing the haemodynamic effects of biatrial @A), 
right atrial (RA) and coronary sinus (CS) pacing. Methods: Ii! patients with BiA pace- 
makers ware investigated. All had a htstory of drug refractory paroxysmal AF,with no his- 
tory of sick sinus syndrome or bradycardia. Each patient was paced from RA, CS and 
BiA at 10 beats par minute (bpm) above base rate, 90 and 120 bpm in random order until 
all modes had been used. After 10 minutes pacing transthoracic echo was performed. 
The following parameters were documented: Left ventricle outflow tract VTI, EA ratio, 
Diastolic filling pdriod, mitral Deceleration time, pacing to peak mitral flow interval and 
Mitral VTI. Results: BiA atrial pacing caused a 3% reduction in E/A ratio;RA/CS pacing 
caused an increase in E/A ratio. (P>O.O5).BiA pacing also resulted in the greatest dias- 
tolic filling period and the shortest deceleration time at equivalent rates, but these were 
not statistically significance (p> 0.05). Corrected LV outflow VTI was greatest for CS pac- 
ing at 90 and 120 bmp(l9.2% and 37.9% increase respectively),p c 0.05 Mitral VTI cor- 
rected for rate was greatest for CS as 90 and 120 bpm (pc 0.05) Pacing to peak flow 
interval was shortest for CS pacing at all rates Conclusions: There were changes in 
many of the echo parameters, some of which reached statistical significance; others sug- 
gested a trend towards change.This is the first study to look at haemodynamic effect of 
BiA pacing and suggests there is an effect, the exact significance of which is unclear. 
These changes may be due to resynchronisation causing more physiological contraction, 
or possibly recruitment of atrial myocardium. Haemodynamic effects may play a role in 
the AF prevention by BIA pacing, along with correction of interatrial conduction defects. 
1270-l 18 Is Right Ventricular Septal Pacing Superior to Conventional 
Right Ventricular Apical Pacing in Chronically Implanted 
Patients? A Prospective Randomized Crossover 
Comparison 
Frederic Victor, Sr., Hassan Mansour, Sr., Dominique Pavin, Sr., Christine Alonso, Sr., 
Christophe Leclercq, Sr., Philippe Mabo, Sr., Claude Daub& Sr.. Deparrement de 
Cardiologie CHU, Rennes, France 
Background : Recent studies suggested that permanent right ventricular septal (RVS) 
pacing was technically feasible and might significantly improve cardiac performance in 
comparison with conventional right ventricular apical (RVA) pacing. Objectives : To evalu- 
ate long term functionnal and hemodynamic effects of RVS pacing in comparison with 
RVA pacing. Methods : 11 patients (pts), agei 61.1 f 3.4 years with chronic atrial fibrilla- 
tion and complete AV block induced by radiofrequency catheter ablation were implanted 
with a standard DDDR pacemaker connected to two ventricular leads. A screw-in lead 
was placed at the RVS and connected to the atrial port. The second lead was posi- 
tionned at the RVA and connected to the ventricular port. RVS and RVA pacing were 
achieved by programming the pacemaker either in the AAIR mode or in the VVIR mode 
respectively. Four month after implant pts were randomized to a crossover single-blind 
comparison of RVS and RVA during two periods of 3 months each. Pacemaker program- 
ming remained unchanged throughout the study. At the end of each period, NYHA class, 
LVEF (radionuclide angiography), exercise time and maximal oxygen uptake (pVO2) 
ware assessed. Results : In comparison with RVA pacing, RVS pacing resulted in a sig- 
nificant reduction of QRS duration (152.7 * 4 ms vs 173.7 * 5 ms, p = 0.002) and normal- 
ized axis (27.3 + 12.9” vs 71.8 ? 3.2”, p < 0.0001). But no significant differences were 
observed between the two pacing sites for all other monitored parameters. Conclusion : 
Within the limitations of this study, permanent RVS pacing failed to demonstrate any sig- 
nificant benefit on sympoms, exercise tolerance and LV function in comparison with stan- 
dard RVA pacing. 
1270-I 19 Effect of Long- Versus Short-Term Ventricular Pacing on 
Left Ventricular Function 
Maher Nahlawi, Michael Waligora, Stewart Spies, Robert Bonow, Alan Kadish, Jeffrey 
Goldberger. Norfhwesfern University Medical School, Chicago, IL 
Background: To compare the effect of long term versus short term ventricular pacing on 
left ventricular systolic function. Methods: Ten patients (6 females), mean age 71+/- 6 
years, with dual chamber pacemakers, normal left ventricular function, and intact AV con- 
duction were studied. Patients were evaluated after 1 week of atrial pacing only (AP), and 
during AV pacing with an AV delay of 100 ms to ensure 100% ventricular pacing (VP). 
Short term VP (STVP) studies were done after 2 hours of VP Long term VP (LTVP) stud- 
ies ware done after 1 week of VP. All data ware acquired at a pacing rate of 80 bpm. Left 
ventricular ejection fraction (EF) was measured at each time point by gated cardiac blood 
pool imaging. ECGs were acquired at each time point. Plasma catecholamines were 
measured during AP and LTVP and assayed by liquid chromatography with electrochem- 
ical detection. Data ware analyzed with repeated measures ANOVA. Results: The table 
shows results. LVEF decreased with STVP (~~0.05) and decreased further with LTVP 
(p<O.O08 vs STVP). QT interval increased with STVP and LTVP. Plasma epinephrine 
increased in 8110 subjects with LTVP vs AP One subject had an abnormally high value 
during AP that decreased by 90% during LTVP Conclusion: STVP results in a mild 
decrease in LVEF which is likely related to changes in activation sequence, LTVP further 
depresses left ventricular function despite an activation sequence similar to SNR This 
JACC February 2001 
suggests that LTVP from the right ventricular apex results in potentially deleterious 
changes in myocardial contractile elements and/or geometry and suggests that further 
work on alternate pacing sites is justified. 
Effect of long term and short term ventricular pacing versus atrial pacing 
LVEF (%) Epinephrine Norepinephrine QT 
AP 66 +I- 5 1.4 +/- 1.2 2.2 +I- 1.3 366 +I- 38 
SNP 61 +I- 7 433 +I- 32 
LNP 52 +I- 9 1.7+1- 1.3 1.9+/-0.6 431 +I- 31 
1270-120 Influence of Overdrive Atrial Pacing on the Occurrence of 
Atrial Fibrillation After Cardiac Surgery: A Meta-Analysis 
Sergio L. Pinski, Elena B. Sgarbossa. Rush-Presbyterian-St. Luke’s Medical Center, 
Chicago, IL 
Background: Post-operative atrial fibrillation (post-op AF) occurs in up to 40% of 
patients after cardiac surgery and results in longer length of stays and increased costs. 
Prophylactic overdrive atrial pacing via temporary epicardial wires may decrease the inci- 
dence of post-op AF, but results of clinical trials have been inconsistent. Methods: We 
performed a m&-analysis of all randomized clinical trials that addressed the effect of 
prophylactic atrial pacing in reducing the incidence of post-op AF. Trials were identified by 
MEDLINE searches, manual searches of abstracts of major national and international 
cardiology and electrophysiology meetings, and direct contact with investigators. We 
used a random-effects model to perform the m&a-analysis. Results: 12 trials including 
1,407 patients were analyzed. Eight trials studied the effects of right atrial pacing, 3 the 
effects of left atrial or Bachman’s bundle pacing, and 8 the effects of simultaneous biatrial 
pacing. The incidence of post-op AF in the control groups (no pacing) was 34%. The 
overall odds ratio for right atrial pacing was 0.72 (P=O.O7; 95% Cl: 0.45 to 1.17; absolute 
risk reduction 7%). The overall odds ratio for left atrial pacing was 0.60 (P=O.O6; 95% Cl: 
0.35 to 1.02; absolute risk reduction 12%). The overall odds ratio for biatrial pacing was 
0.44 (Pc.0001; 95% Cl: 0.29 to 0.66; absolute risk reduction 16 %).To prevent one occur- 
rence of post-op AF, 6.25 patients need to be treated with biatrial pacing Conclusions: 
Temporary biatrial overdrive pacing is effective in preventing post-op AF, with a 65% odds 
reduction. The value of single-site right or left atrial pacing is less clear. 
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1271-121 Lesion imaging Characteristics Associated With Successful 
Ablation of Appropriate Sinus Tachycardia: An Intracardiac 
Echocardiographic Study 
Jian-Fang Fien, Francis E. Marchlinski, David J. Callans, Erica S. Zado. University of 
Pennsylvania, Philadelphia, PA 
Background: Radiofrequency (RF) ablation of inappropriate sinus tachycardia (IST) 
often requires multiple lesions. With the known immediately subepicardial location of the 
sinus node, we hypothesized that RF ablation of IST is successful only when the lesion 
extends to the epicardium opposite the superior lateral crista terminalis (CT), and that 
morphologiciechodensity changes observed with intracardiac echocardiography (IE) 
would detect when this endpoint was achieved. Methods: Detailed IE imaging of CT was 
performed to detect changes in wall thickness and echodensity at lesion sites at baseline, 
after each RF lesion and with lesion that produced heart rate (HR) reduction using IE 
(SMHz,SFr) imaging in 17 pts (age 32*9yrs, 15 female) with IST. RF ablation was ana- 
tomically based and targeted only the CT. RF (20-50~ for up to 120sec) was delivered 
with an 8 mm tip electrode. Results: Successful HR reduction (z-20 bpm) was achieved 
in 15117 pts and required 41?31(range 5-110) RF applications. Effective RF (reduced 
HR) was observed starting with the 32ndr24th (range 3rd-86th) lesion. Following the 
effective RF, the CT wall thickness was increased (11.4+3.lmm vs. 7.7i2.4mm baseline, 
pcO.01) and wall swelling expanded to adjacent superior vana cava (SVC), but degree of 
thickening was not associated directly with HR reduction. Echodensity changes reaching 
directly to the epicardium with the development of a trivial linear echo-free space were 
consistently observed at time of effective RF resulting in HR reduction. In 2 pts without 
effective HR reduction, echodensity changes did not reach the epicardium. No complica- 
tions of RF were identified. Six pts required repeat procedures (after 8+7 months fol- 
lowup) for initial failure (n=2) or recurrent symptoms (~4). Repeat RF ablation was 
successful in all 6, and the described IE images characteristic of success were demon- 
strated. Conclusions: IE guided anatomic approach to RF ablation of IST is safe and 
effective. A characteristic IE signature suggesting transmurali epicardium damage 
appears to be present at time of successful HR reduction and may serve as an appropri- 
ate guide for directing additional RF. 
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1271-122 New Electrocardiographic Criteria for Localization of Focal 
Atrial Tachycardia 
Joachim H. Ix, Kojr Azegami, John G. Kall, Mauricio Arruda, Albert G. Lrn, Martin C. 
Burke, Douglas E. Kopp, Amit P&l, David J. Wilber. University of Chicago, Chicago, IL 
Background: Predicting the site of origin (SOO) for focal atrial tachycardia (AT) prior to 
ablation procedures IS useful in planning mapping strategies and the need for transseptal 
catheterization. The SO0 can be estimated from the surface P wave configuration (PWC) 
during AT, but published data are limited by small sample sizes and variable methodolo- 
gies. 
Methods: We evaluated PWC in 138 distinct focal AT from 118 pts who underwent abla- 
tion. Mean pt age was 49517 yrs, and 28% had evidence of structural heart disease. 
PWC was classified as +, -, i-i-, -ii or 0 rn each lead based on P wave polarity and ampli- 
tude. Where relevant, P waves were evaluated during spontaneous or induced AV block 
to minimize the confounding influence of the preceding T wave. The SO0 (successful 
ablation site) was assigned to one of 18 predetermined regions based on biplane fluoro- 
scopic images (67 AT) or electroanatomical reconstructions (71 AT). PWC in each lead 
was analyzed for ability to discriminate SO0 in 3 different dimensions: left (LA) vs right 
atrial, periannular (mitral or triscusprd) vs nonannular (crista, pulmonary vein, other), and 
caudal vs cranial. The origin of AT was annular in 57 pts (41%), crista in 54 (39%) pul- 
monary vein in 16 (12%) and other sites in 11 (8%). AT orrginated from LA sites in 30 pts 
(22%) and caudal sites in 29 (21%). 
Results: The table indicates highly significant associations (pcO.0001) between SO0 
and specific P wave configurations, and displays the sensitivity (SEN), specificity 
(SPEC), and positwe (PPV) and negative (NPV) predictive values associated with each. 
The best criteria for LA SO0 had a high NPV, but only modest sensitivity, primarily due to 
the unpredrctable PWC of AT arising from or adjacent to the interatrial septum. 
Conclusions: The SO0 for most focal AT can be relrably approximated wth simple crite- 
ria for PWC in specific surface leads. However, accurate discrimination between left and 
right atrial SO0 remains problematic for AT arising near the septum. 
SITE LEAD PWC SENS SPEC PPV NPV 
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ablation target, both unipolar (from the tip of ablating catheter) and bipolar (from the distal 
pair of ablating catheter) recording were performed during AT. Results: The origin of AT 
was from right atrium in 12 pts, and from left atrium in the remaining 3 pts., RFCA was 
successful in all pts. except one. RFCA was delivered at a total of 37 sites. The unipolar 
electrogram displayed a “QS” pattern (LA-P: -36+/-15 ms) at all successful ablating sites, 
and a “rS’ pattern (LA-P: -30 +/- 11 ms , ~~0.05)) at the 23 failed sites. Conclusion: The 
“QS” morphology in unipolar electrogram appears to be a uesful marker for successful 
ablation of focal atrial tachycardia. 
1271-125 Catheter Ablation of Atrial Tachycardia: do we need to 
ablate anything that fires? 
Andrea Natale, Walid I. Saliba, Mina K. Chung, Patrick Tchou, Lon Castle, Mark 
Niebauer, Logan Kanagaratnam, Cathy Lam, Robert Schweikert, Alejandro Perez- 
Lugones, Stephen Pavra, Gery Tomassoni. Cleveland Clinic Foundation, Cleveland, OH 
We report the long-term follow-up in 52 patients undergorng catheter ablation for atnal 
tachycardia. In each patient the clinical tachycardia was successfully ablated and a sec- 
ond non-sustained atrial tachycardia was documented but not ablated. Of the 52 atrial 
tachycardia, 40 originated from the right atrium and 12 from the left atrium. Each patrent 
underwent post-ablation follow-up as par institutronal protocol and based on the racur- 
rance of symptoms. In addition, after a mean follow-up of 14 months each patient was 
contacted by phone and questions were asked baaed on a standard questionnaire. 26 
patients did not have any recurrence of symptoms and continued to be off of antiarrhyth- 
mic drugs. 22 patients (43%) experienced recurrence of palpitations. Of them 12 (23%) 
required re-instrtution of antiarrhythmic therapy. In 2 patients recurrence of the clinical 
tachycardia, previously ablated, was documented and ablation rescheduled. 3 of these 
22 patients were in chronic atrial fibrillation at follow-up and 3 others experienced epi- 
sodes of persistent atrial fibrillation requiring cardioversion. A total of 6 patients (12%) 
experienced atrial fibrillation at follow-up. Conclusion: in patients undergoing ablation for 
atrial tachycardia: 1) evidence of non-sustained non-clinical atrial arrhythmia is associ- 
ated with high recurrence of symptoms requiring treatment; 2) Occurrence of atrial fibril- 
lation at follow-up is observed in one fourth of the patients; 3) ablation of any induced 
arrhythmia may be appropriate to maximize cure. 
1271-126 Postoperative Ectopic Atrial Tachycardia in Chidren With 
Congenital Heart Disease 
Ana M. Resales, Edward P. Walsh, David L. Wessel, John K. Triedman. Children’s 
Hospitai, Boston, MA 
Background/Objective: The causes and significance of postoperative ectopic atrial tachy- 
cardia (EAT) remain unknown. We attempted to identify potential clinical factors associ- 
ated with postoperative EAT in children after congenital heart disease repair. Methods: A 
retrospective case control study (09/95-10/99) was used to study 17 patients identified 
with a dischare diagnosis of postoperative EAT. Preoperative, intraoperative and postop- 
erative factors were compared using Fisher’s exact test and Wilcoxon rank sum tests. 
Results: Median age for the EAT cases was 6 mo (1 day-10 yr), which was younger than 
the general postoperative ICU population (17 mo, p=O.O08). Onset of EAT occured at 
median postoperative day 10 (O-27 days). Beta-blockers or other antiarrhythmic drugs 
were used in 13117 cases. Among EAT cases, serum potassium was lower at onset of 
EAT than at immediate postoperative and discharge measurements (3.5, 3.8, 4.4 mEq/L 
respectively. ~~0.044 and p<O.OOOl). Compared to age-matched controls, cases of EAT 
had lower preoperative 02 saturation, (median 84 vs 99% p=O.OOl). Trends were noted 
to increase preoperative use of inotropes (24% vs 6% p=O.O8) and atrial septostomy 
(24% vs 6% p=O.O8). EAT cases had longer total pump times (median 115 vs 88 min 
p=O.O2) and cross clamp time (median 63 vs 46 min p=O.O3). Postoperatively, more EAT 
cases received inotropes (100 vs 58% p=O.OOl) and had prolonged ICU stay (median 10 
vs 3 days p=O.OOl). EAT resolved prior to discharge rn IO/l6 patients. 316 remaining 
cases discharged with EAT had follow-up Halter monitoring; no significant atrial ectopy 
was noted on theses studies. Deaths were recorded in 2117 EAT cases vs 0136 controls 
(p=O.iO). One death was inpatrent and attributed to other causes. The other death 
occurred as an outpatient after apparent EAT resolution by monrtoring. Conclusions: 
Young, ill, cyanotic patients are most at risk for postoperative EAT. Etiology of EAT 
appears multifactorial, and may include disruption of atrral septum, longer pump times, 
need for inotropic support and potassium depletion. Although EAT is associated with pro- 
longed intensive care, it appears to resolve in most cases over time. 
LA 
LA 
ANNULAR 
ANNULAR 
CAUDAL 
CAUDAL 
Vl + or -/+ 80% 76% 48% 93% 
aVL or 0 73% 67% 39% 90% 
Vl-V6 -or-/+,>3 88% 91% 88% 91% 
leads 
aVR + or +/- 79% 96% 94% 87% 
II 90% 88% 67% 97% 
aVF 86% 85% 61% 96% 
1271-123 A Novel Form of Focal Atrial Tachycardia Arising From the 
Tricuspid Valve Annulus: A New Ring of Fire? 
Sei lwai, Steven M. Markowitz, Kenneth M. Stein, Suneet Mittal, David J. Slotwiner, 
Mithilesh K. Das, Bruce B. Lerman. Cornell Universi~Medical Center, New York, NY 
Background: A “ring of fire”, comprising a malority of right atrial tachycardias (AT), origi- 
nates along the crista terminalis as previously described. We have demonstrated that 
these adenosine-sensitive ATs are focal and are due to either triggered activity or cal- 
cium-dependent microreentry. A unique form of focal AT arising from Koch’s triangle has 
also been described. We have identified a novel form of focal AT arising from another 
“ring of fire” around the tricuspid valve annulus (TA) which includes ATs from Koch’s trian- 
gle. 
Methods: The study population consisted of 9 consecutive patients (58 +/- 15 yrs; SF) 
with AT arising from the TA. 8 pts underwent 3-D electroanatomic mapping (CARTO, Bio- 
sense), and 8 pts were given adenosine during tachycardia. 
Results: Focal AT was inducible with rapid atrial 
pacing or atrial extrastimulus testing in all cases. . 
Entrainment could not be demonstrated in any pt. 
AT arose from the anteroseptal regron of the TA in 
2 pts, from the lateral TA in 3 pts, posterior TA in 3 His 
pts, and the posteroseptal TA in 1 pt (see figure). 8 ^’ _ (‘. 
Adenosine (5.25 +/- 1.39 mg) given to 8 pts during 
~ 
+- I-A 
3 
.: ;,’ 
AT terminated tachycardia in all cases. 3-D elec- :I, 
troanatcmic mapping in 8/8 pts confirmed a focal 
origin of the AT. Radiofrequency ablation was 
~“&@+&& $ cs 
successful in all pts.. $JVC :. 
Conclusions: This new “ring of fire” comprising 
1,“1‘;:, :, ax. 
tile circumference of the TA extends the descrip- 
tion of focal adenosine-sensrtive AT This ring also includes the previously described 
tachycardias arising from Koch’s triangle. Tachycardras arising from the TA and crista 
terminalis appear to have similar electrophysiologic mechanisms and responses 
1271-124 QS Morphology in Unipolar Electrogram to Identify the 
Ablation Target for Focal Atrial Tachycardia 
Jian Ma, Fangzheng Wang, Kuijun Zhang. Jianmin Chu, Xin Chen, Shu Zhang. Division 
of Cardiology, Beijing Fu Wai Heart Hospital, Beging, People’s Republic of China 
Background: Radiofrequency catheter ablation (RFCA) of focal atrial tachycardia (AT) is 
usually performed with mapping the earliest site of local atrial activation(LA). However, 
the value of LA-P wave intervals (LA-P interval) for successful ablation sites is variable. 
We used the unipolar recording of LA and delivered rediofrequency enegy at the site with 
a completely negative atrial deflection rQS” morphology) of electrogram to ablate AT 
Methods: Fifteen consecutive patients (9 men, 6 women age 43 +/-17 years) with AT (2 
inCessant, 13 paroxysmal) were referred to our hospital for RFCA. Tachycardias were 
induced by atrial programmed stimulation in patients with paroxysmal AT. To identify the 
POSTER SESSION 
1272 Atrial Fibrillation: Cardioversion 
Tuesday, March 20, 2001, 3:00 p.m.-500 p.m. 
Orange County Convention Center, Hall A4 
Presentation Hour: 4:00 p.m.-500 p.m. 
1272-127 Does Digoxin affect the outcome of DC cardioversion in 
Humans? 
Xiaohua Guo, Mark M. Gallagher, Yea G. Yap, Monica Harries, Marek Malik, John Camm. 
St George’s Hospital Medical School, London, United Kingdom 
Background: Digoxin is widely used to control heart rate in atrial fibrillation (AF), In ani- 
mal models Digoxin aggravates tachycardia-induced atrral electrical remodelling which 
rncreases the inducibility, duration of AF and delays the recovery of atrial function after 
restoration of sinus rhythm(SR). We assessed whether Drgoxin has an adverse clinical 
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effect on the outcome of Direct Current Cardioversion (DCC) in human subjects 
Method: 125 patents ( 90 Men, 65+lOyears old) who received DCC for persistent AF 
were investigated prospectively. ECGs were recorded during DCC and repeated 1 week 
and 1 month later to assess outcome. The Dig&n dose was not changed after DCC. The 
outcome of DCC was compared between patents who received Digoxin alone (Dig+); 
Digoxin with antiarrhythmic drugs (Dig + Anti-drug) and those did not taking Digoxin (Dig- 
). The dose-response relationship of the effect of Digoxin on the outcome of DCC was 
also calculated. Subgroup analysis was further performed by stratifying for age ( 65 and 
75 years old); AF duration (~6 and >lamonth); LA size (>44mm) as well as for a combi- 
nation of adverse factors ( patient who were age>60 years old with AF duration >6 month 
and abnormal LA size). The chi-square; Student t and NPar Kruskal-Walks tests were 
used. Results: Out of 125 patents, failed DCC, defined as uninterrupted AF or SR for 
~5s occurred in 15 (12%) patents; early recurrence of AF (Early RAF), defined as resto- 
ration of SR for 5 seconds - 7 days occurred in 46 (37%) patents. later recurrence of AF 
(Later RAF) defined as SR last for 8-30 days occurred in 27 (21%) patents, the remainder 
37(30%) were in SR for>30 days. Outcome was not influenced by Digoxin (Table) includ- 
ing analysed in each subgroup. Conclusion: Contrary to animal studies our investigation 
showed Digoxin did not have any significant adverse effect on the outcome of DCC in the 
patients studied. 
Number of Patients (%) Dig+ Dig+ Dig- P value 
form step-up protocol. At 1 hr, 42 of 58 pts (72%) were defibrillated successfully. Table 
shows association between the test variables and success of IC. There was no signifi- 
cant correlation between DFT for IC and tested variables. 
S U C C S S S  Failure P 
Age (yrs) 62k9 56+15 NS 
Gendermaleifemale 32113 1310 0.03 
Body mass index (kg/m2) 31+8.2 41+17 0.03 
AF duration: >6/<6 months 12133 815 0.02 
CHF (presentabsent) 9136 3110 NS 
HTN (present/absent) 29116 716 NS 
Prior EC 1.1+0.8 1.5-+1.4 NS 
LA diameter (mm) 45+5.9 46+5.1 NS 
LV and systolic diameter (mm) 36klO 35~13 NS 
LV and drastolic 47210 55+9.2 NS 
Conclusions: Successful IC is associated with female gender, lower body mass index and 
shorter duration of AF, simrlar to previously reported findings for EC. 
- 
1272-130 Internal Cardioversion of Atrial Fibrillation: A New Single 
Catheter Approach 
Christoph Ehlers, Michael Wiedemann, Maria T. Kofler, Thomas Briiggemann, Dietrich 
Andresen. Krankenhaus Am Urban, Dept. of Cardiology Berlin, Germany 
Background: Internal cardioversion (ICV) has been suggested as an efficient method to 
restore sinus rhythm in patients (pts) with atrial fibrillation (AFib) refractory to external 
cardioversion (ECV). However, conventional techniques with introduction of at least two 
catheters are both, time and money consuming and require interruption of oral anticoag- 
ulation. Thus we studied the feasibility of a minimal invasive single catheter approach for 
ICV. Method: We studied 28 pts with persistant AFib (19 male, mean age 59 years) after 
at least 3 unsuccessful attempts of ECV. Ail pts had oral anticoagulation with warfarin 
(INR 2-3). The CV-catheter (Rhythm Technologies, 6F) was positioned in the right ven- 
tricular outflow tract right behind the tricuspid valve. Shock-synchronization was achieved 
with bipolar sensing at the tip of the catheter, energy was delivered between a coil in the 
right atrium (cathode) and an external adhesive patch electrode (anode), positioned at 
the pts back. Under short-term anesthesia, up to three biphasic shocks with an energy of 
35 Joules were applied. Successful ICV was defined as >= 2 P-waves after shock deliv- 
ery, early recurrence of AFib was defined as relapse within 1 minute after successful ICV. 
Results: ICV was primarily successful in 24w8 pts (86%). In two further pts (7%) sinus 
rhythm could be achieved with an optimized catheter position under application of an 
additional 4F-sensing catheter. Early recurrence of AFib was observed in 5/26 pts (19%) 
after successful ICV. The mean duration of the procedure was 14.5 min. Complications 
(e.g. bleeding) did not occur. Conclusion: Internal cardioversion with a single catheter 
and an external patch electrode is feasible and efficient. In comparison to conventional 
ICV techniques this method is easy to perform and less complex with regard to time and 
cost aspects. 
Anti-drugs 
Total patients : 125 Failed DC n=15 2 (10) 7 (22) 6 (8.3) 0.14 
Total patients : 110 Early RAF: n=46 8 (42) 13 (52) 25 (38) 0.48 
Total patients : 64 Later RAF: n= 27 4 (36) 4 (33) 19 (46) 0.66 
1272-128 Reduction of Left Atrial Stretch Facilitates Internal 
Cardioversion of Chronic Atrial Fibrillation in Patients 
Undergoing Percutaneous Balloon Mitral Valvuloplasty for 
Mitral Stenosis 
Katherine Fan, Kathy L. Lee, Wing Hing Chow, Elaine Chau, On Hing Kwok, Chu Pak 
Lau. Grantham Hospital, Hong Kong, Hong Kong 
Background: 
Chronic atrial fibrillation is common in mitral valve disease, with increased incidence of 
heart failure and thromboembolism. Percutaneous balloon mitral valvuloplasty has been 
shown to have favorable outcome for patients with severe mitral stenosis. We assess the 
effect of acute reduction of left atrial pressure on internal cardioversion of atrial fibrillation 
for these patients. 
Methods: 
Internal cardioversion were carried out in 11 patients (mean age 47+ 11 years) with 
chronic atrial fibrillation (mean duration 3.2 years) and severe mitral stenosis before bal- 
iOOn mitral valvuloplasty using a single catheter system with proximal array in RA free 
wall and distal array in left pulmonary artery. A step-up protocol of 3J each starting at 
OSJ and until maximum of 15J was reached. For those who failed to convert to sinus 
rhythm, this was repeated after the procedure. Refractory periods of the regional atrium ( 
high right atrium, low right atium. proximal and distal coronary sinus) were also deter- 
mined. 
Results: 
internal cardioversion were successful in 4 out of 11 patients before PBMV while the 
another 6 pts had successful internal cardioversion after mitral valvuloplasty. The mean 
energy was 10.3?7 joules for successful cardioversion with mean impedance was 
50.3t8Q 1 patient failed to maintain sinus rhythm with early reinitiation of atrial fibrilla- 
tion. There were significant reduction of left atrial pressure (18.2 ~6.6 mmHg to 9.9 ? 4.1 
mmHg, p< 0.001) and mitral valve gradients without any rise in left ventricular diastolic 
pressure after valvuloplasty. There was no significant differences in hemodynamic pres- 
Sure, left atrial Size or atrial refractory periods between the 2 groups. Atrial fibrillation 
recurred in 2 patients by 5 and 8 weeks respectively. 
Conclusion: 
internal cardioversion of chronic atrial fibrillation in mitral valve disease is greatly facili- 
tated after reduction of left atrial stretch pressure and is associated with high success 
rate of maintenance of sinus rhythm. 
1272-129 Predictors of Successful Cardioversion of Atrial Fibrillation 
With a Balloon-Tipped Internal Cardioversion Catheter 
Margot E. Vloka, Jonathan S. Steinberg, Donna Mendelson. J. Marcus Wharton. St. 
Luke’sRooseve/f Hospital Center, New York, NL: Duke University Medical Center, 
Durham, NC 
The variables associated with successful external cardioversion (EC) of atrial fibrillation 
(AF) have been extensively studied, yet those predictive of internal cardioversion (IC) are 
not well characterized. Methods and Results: We have studied 58 patients (61&l 1 yrs, 
78% male, 9 with EF<= 40%) treated with IC using an investigational balloon-tipped pul- 
monary artery catheter (ALERT@, EP MedSystems, lnc) with distal and proximal shock 
electrodes and biphasic shocks <= 15 J. Defibrillation threshold (DFT) was tested by uni- 
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Risk Stratification and Control of Symptoms in 
Arrhythmogenic Right Ventricular Dysplasia (ARVD) 
Mihaela Grecu, Emilio Garcia-Moran, August0 Ordonez, Guillermo Mom, Jose Rubfn, 
Alejandro Cuesta, Lluis Mont, Josep Brugada. Hospital Clinic, Barcelona, Spain 
Background: Arrhythmogenic Right Ventricular Dysplasia (ARVD) is a disease whose 
management is not yet well defined. 
Objectives: To describe the evolution of a cohort of pts with ARVD according to a sys- 
tematic approach based on their clinical history and the results of electrophysiological 
study (EPS) 
Methods: Data collected prospectively op 25 pts with proven diagnosis of ARVD were 
analysed. All pts underwent EPS with programmed ventricular stimulation. Our system- 
atic approach to management indicated an implantable cardioverter-defibrillator (ICD) in 
case of inducible polymorphic VT, monomorphic poorly tolerated VT or history of cardiac 
arrest. A history of cardiac arrest was a sufficient indication by itself for ICD implantation. 
Ablation was attempted in case of monomorphic, well tolerated VT. Antiarrhyhtmic drugs 
(AAD) were prescribed in non-inducible pts with a history of syncope or early familial sud- 
den death. In inducible pts AAD were given after effective ablation or syncope caused by 
the induced tachycardia. In ICD recipients AAD were added during follow-up in case of 
multiple recurrences of VT. All pts were periodically followed up to record their clinical 
status and evidence of arrhythmia recurrence. 
Results: Of the 25 pts, 2 had a history of SD, and 11 had had syncope, 18 were inducible 
to some form of VT (16 single monomorphic VT, 1 polymorphic VT) and 7 were non 
inducible. 6 pts were placed on antiarrhythmic drugs after EPS. In 5 pts successful radiof- 
requency ablation was performed during EPS. None of these pts had clinical recurrences 
during follow-up. 14 pts received an ICD. In 7 ICD recipients an AAD was prescribed 
because of multiple recurrences of VT, After a mean follow-up of 34.3Q1.8 (range:8-96) 
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months all pts were alive. Syncope did not recur in any patient. ICD recipients had a high 
number of detected and appropriately treated episodes. The median time of survival free 
of appropriate therapy was 2 months. No complications related to ICD occurred. 
Conclusions: An strategy based on clinaal history and risk assessment by electrophys- 
iological study is effective in establishing a therapeutic approach for ARVD which 
achieves a favourable result in survival and conirol of syncope. 
873-2 
4:15 p.m. 
Regional Myocardial Response to Defibrillation Shocks is a 
Key Determinant for Shock Outcome: An Optical Mapping 
Study in Swine 
III DR allows the PR interval timing criterion to be customized (35%85% of the RR inter- 
val). The objective of this retrospective analysis was to determine if this new parameter is 
safe and effective. 
Methods: All stored spontaneous tachycardia episodes (n=31) from 6 GEM DR pts with 
LPR SVT were w-evaluated using the enhanced PR Logic algorithm. Results were com- 
pared to the PR Logic performance in the GEM DR clinical study (I:1 VT-ST boundary = 
50%). 
Results: 
Classification Result pith 1 :l VT-ST boundary set to: 
35% 50% 66% 75% 85% 
(GEM DR) 
Nipon Chattipakorn, lsabelle Banvilie, Richard A. Gray, Raymond E. Ideker. Universrfyof 
Alabama al Birmingham, Birmingham. AL 
For shocks near 50% defibrillation sUccess (DFT50) delivered from electrodes at right 
ventricular apex (RVA) and SIC, postshock activations are frequently observed arising 
repeatedly at left ventricular apex (LVA) where the shock field is weak I” both successful 
(SDF) and failed (FDF) shocks, suggesting that the myocardial response at thls particular 
region, not others, may determine shock outcome. We tested this hypothesis in 6 isolated 
swne hearts. Methods: In each heart, 10 DFT50 shocks were given and the anterior and 
posterior ventricular surfaces were optically mapped using 2 CCD cameras. The time 
from the shock onset to 75% repoiarization of the immediate postshock action potential 
(RT75), and the coupling interval between the last VF actwation immediately preceding 
ihe shock and the shock onset (Cl) were determined at 3 reglow (-4.6 cm2 each): left 
ventricular apex (LVA), base (LVB), and right ventricular apex @VA). Results: Of 60 
shocks, 31 were SDF. In all 3 regions, Cl for SDF was greater than FDF (P<O.O2) How- 
ever, only FiT75 at the LVA was longer for SDF than FDF (Table, *=p<O.O5 “s SDF). Spa- 
tial dispersions (I)) of Cl and RT75 were not different in any regions. Conclusion: For 
DFTSO shocks delivered from electrodes at RVA and SVC, myocardial response to the 
shock at the early site determines shock outcome. 
Episode Type VT SVT VT SVT VT SVT VT SVT VT SVT 
VT/VF(n=3) 3 0 3 0 3 0 3 0 2 1 
SVT(n=28) 26 2 22 6 3 25 3 25 2 26 
With the 1 :l VT-ST boundary set to 66% all 3 VTs were detected appropriately and 25/ 
28 SVTs were classified as SVT. 213 SvTs detected as VT would have been classified as 
SVT if the “Other 1:l SVT’ PR Logic criterion was enabled, and 113 SVTs required an 
85% 1:l VT-ST boundary for classification as SVT. One VT with 1 :l retrograde conduc- 
tion was classified as SVT when the .I :l VT-ST boundary was set to 85%. 
Conclusions: This retrospective analysis shows that changing the 1:l VT-ST boundary 
in PR Logic for a subset of patients can reduce the incidence of inappropriate therapy. 
Selection of this parameter should be done carefully, since patients may also have VT 
with 1:l retrograde conduction. With this enhancement, the PPV of PR Logic can be up 
to 95.2% (86.8% adjusted). 
RVA LVB LVA 
(in rns) SDF FDF SDF FDF SDF FDF 
Cl 6Oi-12 53r9* 59*10 52ilO’ 621-9 52+9* 
Cl-D 35r7 34& 34i8 34?6 35t6 32t5 
FIT75 63+15 S&6 59*12 57c7 6Oil6 50+7’ 
FiT75.D Ii*6 1 ot2 1728 16+9 19*11 15r7 
ORAL CONTRIBUTIONS 
880 Supraventricular Arrhythmias: Anatomy, 
Mapping, and Ablation 
Wednesday, March 21, 2001, 8:30 a.m.-l 0:OO a.m. 
Orange County Convkntion Center, Room 232A 
873-3 
4:30 p.m. 
Device Infections: Clinical Outcome Following Early Device 
Reimplantation 
880-l 
8:30 a.m. 
Coronary Sinus Anatomy in Patients With Epicardial 
Posteroseptal and Left Posterior Accessory Pathways 
Steven P ChoUgh, Christian Sticherling, Robert L. Baker, Kristina Wasmer, Hiroshi Tada. 
Chi-Wo Ghan, Radmlra Greenstein, Hakan Oral, Frank Pelosi, Jr., Bradley P. Knight, Fred 
Morady, Adam Strickberger. University of Michigan Medical Center, Ann Arbor, MI 
Yingxian Sun, Mauncio S. Artuda, Karen J. Beckman, Hiroshi Nakagawa, Peter Spector, 
Nayyar Shah, James C&me, Daniel Lustgarten, Arun Rae, Ralph Lazzara, Warren M. 
Jackman. University of Oklahoma, Oklahoma Cifv: OK 
Background: InfectIon is an uncommon yet serious complication of pacemaker or 
defibrillator implantation. Whi!e complete removal of the pacing or defibrillator system is 
required, there IS no consensus regarding the optimal timing for reimplantation. After 
extraction, patients are generally treated with intravenous antibiotics for 2 to 6 weeks 
pr~ar to reimplantation. Objective: The goal of this study was to determine the safety of 
reimplantation of a pacemaker or a defibrillator within 1 week after extraction for an infec- 
tlon. Methods: Beiween November 1999 and July 2000, 14 consecutive patients (10 
male, 4 female, age 66r5 yrs) who presented to our institution with a pacemaker (n=9) or 
defibrillator (n=5) infection were prospectively followed. On presentation (symptom dura- 
tion 42514 days), 100% of patients had evidence of generator pocket Infection, and 21% 
had fever or systemic illness. Lead or wound cultures were posltlve in 79% of patients 
and initial blood cultures were positive in only 7% of patients. Vegetations were seen with 
transesophageal echocardiogram in 25% of pailents. All patients underwent complete 
transvenous device extraction (21.8k6.1 months following initial implantation) using stan- 
dard techniques. Intravenous antibiotics were contmued following extraction. All patients 
were without fever, leukocytosis, or positive blood cultures at the time of reimplantation 
Results: Reimplantatmn of the device on the contralateral side was performed in all 
patients 4.2iO.5 days (median 4 days, range 1-7 days) after extraction. The duration of 
post extraction antibiotic therapy was 2.5&0.2 weeks. During 4.1r0.8 months of followup. 
recurrent device infection was not observed. Conclusions: These data suggest that in 
patients without evidence of a systemic infection, reimplantation of a pacemaker or 
deflbnllator on the contralateral side may be appropriately performed within days of the 
extraction procedure. 
Background; It is known that the coronary sinus and major proximal branches (CS-B) are 
invested with atnal myocardium in continuity with the atria. Myocardium in CS-B divertic- 
ula has been shown to connect with the ventricle to form epicardial postetoseptal and left 
postwar accessory pathways (EpiAP). The purpose of this study was to determine the 
frequency with which normal myocardium from the CS-B can produce EpiAP. Methods; 
EpiAP were defined as those with an accessory pathway potential recorded in the middle 
cardiac vein or other branches of the CS-B, and late activation (often associated with pre- 
viously unsuccessful ablation) at endocardial annular sites. Retrograde CS-8 angiogra- 
phy was performed in all pts with suspected EpiAP. Results; EpiAP were found in 154 of 
443 pts with posteroseptal and left posterior APs, 112/259 (43%) and 42/184 (23%) of 
pts with and without prior failed ablation. The location of AP potentials and CS-B anatomy 
are shown: 
Conclusions. CS-B anatomy was normal in the majority of pts (73%) with EpiAP, indicat- 
ing that like the myocardium of a CS-B diverticulum, the myocardium of normal CS-B can 
connect to the ventricle. The significance of enlarged CS-B in EpiAP is Unknown. 
873-4 
4:45 p.m. 
The Enhanced PR LogicTM Dual Chamber Tachyarrhythmia 
Detection Algorithm: Retrospective Analysis of 
Supraventricular Tachycardia With Long PR Intervals 
880-2 
%A5 a.m. 
Magnetic Navigation System for Intracardiac Pacing and 
Mapping: Safety and Equivalence Study 
Mitchell N. Faddis. Andrew F. Hall, Michael Talcott, Jennifer Dehne, John C. Rauch, Jon 
C. Sell, Bruce D. Lindsay. Washington University School of Medicine, St. Louis, MO, 
Stereotaxis, Inc, St. Louis, MO 
Bruce L. Wilkoff, Jeffrey M. Gillberg. Cynthia M. DeSouza. The C/eve/and Clinic 
Foundation, Cleveland, OH, Medtronic Inc., Minneapolis, MN 
Background: Despite advances in dual chamber tachyarrhythmia detection algorithms, 
inappropriate ICD therapy for fast supraventricular rhythms may still occur. The PR Logic 
“Sinus Tach” (ST) criterion I” GEM DR and GEM II DR ICDs (Medtronic, Inc.) discrimi- 
nates between atrial or sinus iachycardia(SVT) and VT with I:1 retrograde conduction 
based on atriai to ventricular(R) event timing. Rhythms with PR intervals < 50% RR 
interval may be considered ST, Rhythms with PR intervals t 50% RR interval, i.e. Long 
PR(LPR), may be considered VT. Early GEM DR clinical study results showed a positive 
predictive value (PPV) of 92.8% (7111766, 81.3% as adlusted for muitlpie episodes per 
patient) and 100% sensitivity for detecimg true VTNF; SVTs in 6 patients(pts) received 
inappropriate VTNF therapy due to LPR. The I:1 VT-SJboundaryparameter in the GEM 
Background: We have evaluated a Magnetic Guidance System that generates external 
magnetic fields to control the precise movement and position of a Magnetically Guided 
Catheter and eliminates the need for conventional steering mechanisms. This study com- 
pared the safety and equivalence of the Magnetically Guided Catheter to a conventional 
catheter in canines. 
Methods: The study evaluated electrogram amplitudes, pacing thresholds, signal to 
rose ratios, gross and histopathologic analysis for signs of cardiac injury, and the ability 
to navigate to specified targets in the right atrium, right ventricle, left atrium, and left “en- 
tricle. The Magnetic Guidance System is composed of biplanar fluoroscopy, a Computer 
to control the system, and an array of superconducting electromagnets that surround the 
subject’s torso and generate programmable magnetic fields to navigate a 7 Fr magnetic 
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catheter. A graphic interface was used to select the target direction on biplanar fluoro- 
scopic images, then the computer calculated the 3D magnetic field vector to navigate the 
Magnetically Guided Catheter. 
Results: There were no differences in the signal amplitudes at a total of 75 sites (3.2+1.2 
mV vs 4.5 23.4 mV), the pacing thresholds at 15 sites (1.31-0.6 vs 1.421 .O ma), or the 
mean His bundle signal to noise ratio when the Magnetically Guided Catheter and con- 
ventional catheter were compared. The Magnetically Gurded Catheter was navigated 
successfully to 46 of 51 pre-defined targets (90%) in all four cardiac chambers. The fail- 
ures were due to inability to cross the aortic valve in 1 of 6 animals. The mean fluoro- 
scoprc distance between the distal electrode of the Magnetically Guided Catheter and 5 
preselected targets in the right atrium was <l mm. In 1 animal there was a 6x2 mm ellip- 
tical superficial hemorrhage near the septal leaflet of the aortic valve caused by inciden- 
tal catheter contact during navigation in the left atrium. 
Conclusions: These results demonstrate the equivalence of the Magnetically Guided 
Catheter to the conventional catheter for pacing and recording. We have also demon- 
strated the ability to accurately navigate the Magnetically Guided Catheter to precrse tar- 
gets in all four cardiac chambers. 
880-5 
9:30 a.m. 
Effects of Circumferential Radiofrequency Ablation of 
Pulmonary Vein Ostia on Sympathovagal Balance in 
Patients With Atrial Fibrillation 
Carlo Pappone, Salvatore Rosanio, Monica Tocchi, Vrncenzo Santinelli, Stefano Nardi, 
Adriano Salvati, Simone Gulletta, Cosimo Dicandia, Gabriele Vicedominr. S. Raffaele 
University Hospital, Milan, #a/y 
880-3 
9:oo a.m. 
Differences in His to Atrial Interval in Atrioventricular Nodal 
Reentrant Tachycardia: Distinction Among Tachycardia 
Subtypes and Relationship to Heart Block With Catheter 
Ablation 
Gregory T. Altemose, John V. Jayachandran, Douglas P. Zipes, John M. Miller. Indiana 
University School of Medicine, Krameri Institute of Cardiology Indianapolis, IN 
Background: Prior studies have suggested the existence of AV nodal tissue Interposed 
between the tachycardia circuit and His bundle (the lower common pathway, [LCP]) dur- 
ing atrioventricular nodal reentrant tachycardia (AVNRT). We had observed that the dif- 
ference in His to atrial (HA) intervals during ventricular pacing (VP) and SVT (A HA = 
HAVp - HAeyT) differed among three forms of AVNRT [slow-fast (SF), slow-slow (SS) and 
fast-slow (FS)]. The purpose of this study was to further characterize these differences. 
Methods: We studied 320 patients who underwent electrophysiology study and catheter 
ablation for AVNRT. Of these, 239 patients (85 male) with a mean age of 49?19 years 
had a retrograde His visible during VP at the SVT cycle length (CL); 215 patients (90%) 
had SF, 15 (6%) had SS and 9 (4%) had FS SVT. HAvp was measured from the end of 
the His deflection to the onset of the atrial electrogram in the His lead during RV apical 
pacing at the SVT CL. HAsvT was measured from the onset of the His deflection to the 
onset of the atrial electrogram in the same recording during SVT, Results: The CL of SS 
(445+140 ms) was significantly longer than SF (366~82 ms), ( p=O.O007). There was no 
significant difference between CL of FS (392259 ms) and SS or SF The HAye was signif- 
icantly different ( pcO.0001) among the three forms of AVNRT: [FS (342i-54) > SS 
(252~83) > SF (128k39) ms]. The HAsvr was significantly different ( p<O.OOOl) among 
the three forms of AVNRT [FS (284+54) > SS (200+71) > SF (103+38) ms]. The A HA 
was significantly longer (pcO.0001) in the FS and SS forms of AVNRT than the SF form 
[FS (59+27) z SS (52+30) > SF (24r17) ms]. The A HA was not significantly different 
between the FS and SS forms of AVNRT. 9 of 45 (20%) patients with a A HA< 10 ms had 
transient or permanent AV block with ablation, compared to 131194 (7%) patients with A 
HA > 10 ms (~~0.005). Age did not influence the form of AVNRT, the A HA or the risk of 
heart block during catheter ablation. Conclusions: The A HA, reflecting the LCP, differs 
among the 3 forms of AVNRT Patients with shorter A HA intervals (5 10 ms) appear to be 
at higher risk of ablation-induced transient or permanent AV block, perhaps reflecting a 
shorter anatomic distance between the compact node and His bundle. 
Background: Focal pulmonary vein (PV) ablation for atrial fibrillation (AF) may result in 
transient alterations in heart rate variability (HRV), suggesting reversible autonomic dys- 
function. We report the effects on sympathovagal balance of circumferential RF lines of 
conduction block around all 4 PVs, a novel anatomically-based technique developed in 
our laboratory. 
Methods: We selected 75 pts with resistant paroxysmal AF (77% male; age 56+_9 years; 
AF duration 3.8i1.4 years; 39% with structural heart disease). All pts underwent 24-h 
Halter recording pre-RF and 1, 3 and 6 months post-RF. Autonomic function was 
assessed using time- and frequency-domain HRV analysis. 
Results: Using the CART0 mapping system, lesions were deployed at >5mm from PV 
ostia. Extent of ablated area inside the circular lesions (peak-to-peak bipolar efectrogram 
amplitude ~0.1 mV) was 4.1+0.5cm2, accounting for 26f8% of the total left atrial map 
surface. Transient severe bradycardia (~40 bpm), sinus arrest or systolic hypotension 
(<SOmmHg) occurred in 13 pts (17%) during RF delivery. No bradyarrhythmias were 
recorded during 48-h telemetry or subsequent Halter monitoring. Follow-up HRV mea- 
sures did not differ between pts with and without acute baroreflex responses. Compared 
with pre-RF, time-domain measures primarily modulated by parasympathetic tone 
(pNN50, RMSDD) were increased in all pts, and frequency domain analysis suggested 
decreased sympathetic tone (LF power: 4.6kO.5 vs 5.2t0.3 normalized units, P<O.Oi; LF/ 
HF ratio: 1.7M.4 vs. 2.5f0.4, P<O.Ol). Remarkably, a higher LFiHF ratio was correlated 
(P-x0.01) with AF recurrence (11 pts, 15%). 
Conclusion: Unlike focal ablation, extensive debulking in the PV regions rich in endocar- 
dial nerve terminals is associated with persistent autonomic changes. The shift of sym- 
pathovagal balance towards parasympathetic predominance may contribute to 
suppression of AF. 
880-6 
9:45 a.m. 
Prevalence and Significance of Exit Block From Multiple 
Pulmonary Veins in Patients With Paroxysmal Atrial 
Fibrillation 
Hakan Oral, Christian Sticherling, Robert L. Baker, Steven P. Chough, Kristina Wasmer, 
Hiroshi Tada, Frank Pelosi, Jr., Bradley R Knight, S. Adam Strickberger, Fred Morady. 
University of Michigan, Ann Arbor, MI 
9:15 a.m. 
880-4 Novel Fast Electroanatomical Mapping 
Gal Hayam, Assaf Govari, Aharon Turgeman, Shuki Porath, Yitzhack Schwartz., Shlomo 
A. Ben-Haim. Biosense- Websier, Jim&Hacamel, /me/ 
Background: Electroanatomical mapping (CARTO) provides accurate 3D endocardial 
electrophysiological maps but requires acquisition of multiple points. Noncontact map- 
ping offers reconstructed endocardial electrical information based on single-beat cavitary 
electrograms. Electroanatomical and noncontact mapping concepts were integrated into 
a novel CART0 fast mapping (CFM) system. Methods: A multi electrode 7F mapping 
and ablation catheter (Biosense-Webster) was equipped with 2 location sensors to pro- 
vide real-time determination of its shape, position and electrodes locations. This catheter 
allows the acquisition of both endocardial electrograms (contact) and intracavitary elec- 
trograms. An algorithm calculates the distance of each electrode from the endocardial 
surface and through an interpolation technique project the intracavitary electrograms of 
location adjacent to the endocardium. 12 local activation time (LAT) and unipolar voltage 
(UV) maps, 4 RA and 8 LV, of swine and canine during either sinus rhythm or pacing were 
acquired. Each CFM and CART0 map was compared to a complete gold standard 
CART0 map. Two parameters were calculated as a function of the number of acquired 
points: the standard deviation of differences between the map values reflecting the global 
difference between the two maps, and the percentage of area coverage. Results: In 
average, 10 and 23 LV points and 8 and 20 RA points, acquired by the CFM and CART0 
methods respectively, resulted in a map that differed by merely 25% from the gold stan- 
dard. Reaching 50% area coverage of the LV required 12+3.9 (Mean&EM) and 44e8.3 
Points, CFM and CARTO, respectively; and 50% area coverage of the RA required 
13r0.24 and 29+1.4 points, CFM and CARTO, respectively. Fuller area coverage of 80% 
Of the LV required 31t4.0 and 71+14.2 points, CFM and CARTO, respectively; and simi- 
far coverage of the RA required 2924.9 and 46i-3.7 points, CFM and CARTO, respec- 
tively. Conclusions: By allowing simultaneous acquisition of intracavitary and 
endocardial potentials, CFM allows fast and efficient mapping technique. This may 
enable a swift area of interest delineation, facilitate line of block assessment and map- 
ping for guided therapy. 
Background: Exit block from arrhythmogenic pulmonary veins (PV) during atriai fibrilla- 
tion (AF) is a common observation. However, the prevalence and significance of exit 
block from multiple PVs during AF are unclear. The purpose of this study is to determine 
the prevalence and significance of exit block from multiple PVs during AF. Methods: An 
electrophysiologic study was performed in 15 men and 5 women (mean agetSD=51~10 
years, left ventricular ejection fraction=0.54+0.05, left atriai srze=36r7mm) with paroxys- 
mal or persistent AF (duration=58+44 months). Radiofrequency energy was delivered in 
14 patients at 22 different arrhythmogenic foci (13 left superior PV, 6 right superior PV, 2 
left inferior PV, 1 right inferior PV). Pulmonary vein isolation was performed in one 
patient. Results: The acute success rate was 93%. The prevalence of exit block during 
spontaneous and induced AF was 75% vs. 86% in left superior PV (p=NS), 57% vs. 80% 
in left inferior PV (pcO.Ol), 63% vs. 72% in right superior PV (p=NS), and 64% vs. 67% in 
right inferior PV (p=NS), respectively. Exit block during the same episode of AF was 
observed in all 4 PVs rn 8 patients (40%) 3 PVs in 2 patients (12%) 2 PVs in 6 patients 
(30%) and 1 PV in 2 patients (10%). No exit block was seen in 2 patients (10%). There 
was no difference in the prevalence of exit block between spontaneous and induced epi- 
sodes of AF. Among the 14 patients in whom ablation was attempted, the effective site 
was within a PV that demonstrated exit block in 10 patients. In 8 of these patrents, there 
was at least 1 other PV with exit block which was not the trigger for spontaneous initiation 
of AF. In 3 patients, the effective site was in a PV that did not display exit block, desprte 
the presence of exit block in other PV(s). Conclusions: Exit block from a PV during AF 
does not necessarily indicate that the trigger for spontaneous AF is originating in that PV. 
Rather, during AF there may be passive activation of bystander PVs, with the initiation of 
a secondary tachycardia. The role of these secondary tachycardias in perpetuating AF 
remains to be determined. 
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Heart Rate Turbulence is Influenced by Heart Rate, Age, 
LVEF, NYHA Class, Diabetes, Drugs and Frequency of 
Ventricular Ectopics in Patients after Acute Myocardial 
Infarction- EMIAT Substudy 
JACC February 2001 
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9:oo a.m. 
1010-201 Relationship of Principal Component Analysis of the T 
Wave to Left Ventricular Hypertrophy: The Stong Heart 
Study 
Peter M. Okin, Richard B. Devereux, Richard R. Fabsitz, Ellsa T. Lee, James M. 
Galloway, Barbara V Howard. We!// Medica/ College of Cornell University, New York, NY 
Background: Echocardiographic left ventricular hypertrophy (LVH) is known to predict 
cardiovascular death (CVD) that IS frequently arrhythmic. Principal component analysis 
(PCA) of the T-wave vector loop, an ECG measure of repolarization abnormality also pre- 
dicts CVD However, ihe relation of LVH to PCA measures remains unclear. 
Methods: The relation of LVH to PCA of the T-wave was assessed in 1454 American 
Indian participants in the second Strong Heart Study examinalion with no clinical or ECG 
evidence of coronary artery disease. who ware in sinus rhythm, with no bundle branch 
block, and wiih at least 6 total and 3 precordiai leads with technically adequate QT inter- 
val measurements by computer on digitally-acquired ECGs. Abnormal T-wave loop mor- 
phology was quantified by the ratro of the Znd to 1” eigenvector of the T-wave vector loop 
by PCA (PCA ratio). An abnormal PCA ratio was defined based on gender-specific 90th 
percentile values, previously demonstraied to predict CVD death: PCA ratio >24.6% in 
men and >32.0% in women. LVH was defined by LV mass indexed to height? >49.2 gi 
mz7in men and >46.7 g/m”-’ I” women. 
Results: LVH was present in 293 participants (20%). Taking into account gender differ- 
ences using two-way ANOVA, LVH was associated with elevated PCA ratios (20.7*10.7 
vs 17.1i-8.7%, p<O.OOi) and wrth a higher prevalence of an abnormal PCA ratlo (13.7 vs 
7.6%, p=O.O02). After further adjusting for baseline differences in systolic blood pres- 
sure, creatinine and fibrrnogen levels, urine albumin to creatinine ratio, smoking, and the 
prevalence of diabetes, using multivariate ANCOVA, LVH remained strongly associated 
with a significantly increased PCA ratio (19.9+12.0 vs 16.8r9.2%, p<O.OOl). Using step- 
wise logistic regression analyses and the same cavariates, LVH remained a strong pre- 
dictor of an abnormal PCA ratio (chisquare=10.8, p=O.OOl, odds ratlo 2.07,95% Cl 1.34. 
3.20) 
Conclusions. LVH is associated with an increased PCA ratio and an increased rusk of 
an abnormal PCA ratio, independent of possible confounding variables. These findings 
suggest that repolarization-related ventricular arrhythmias may in part account for the 
increased risk of CVD with LVH. 
9:12 a.m. 
1010-202 Measurement of Microvolt T Wave Alternans During 
Standard Treadmill Exercise Protocols 
Anthony R. Magnano, Daniel M. Bloomfield. Coiumbfa University College of Physicians & 
Surgeons, New York, NY 
Background: T wave ?&mans (TWA) measured during bicycle exarcrse (BIG) is associ- 
ated with an increased susceptibility to ventricular arrhythmias. Recently, sophisticated 
noise reduction methods have made it possible to measure TWA during treadmill exer- 
cise (TM). Since most exercise tests in the U.S. utilize TM rather than BIC, we assessed 
the validrty of TWA testing during TM as compared to BIG. Methods: Patients underwent 
sequential TWA measurements during BIG and TM. TWA was measured using a spectral 
method and was considered positive (POS) if there was sustained TWA >I .9 mV for at 
least one minute at an onset heart rate < 110 bpm. A negative (NEG) TWA study required 
a heart rate 2105 bpm wiih noise ~1.8 mV and ectopics ~10% for 1 minute without sus- 
tained TWA. All other TWA tests were considered indeterminate (IND). Results: 73 sub- 
jects were enrolled including 24 healthy controls and 49 patients with heart disease 
(predominantly NYHA class 11-111 congestive heart failure). Of the 56 (77%) cases which 
had determinate results (either POS or NEG) on both tests, the agreement between bicy- 
cle and treadmill was 89% (Kappa 0.72, p<O.OOl) (see table). In the subset of patients 
with heart disease and determinate results on both tests (32 cases), the agreement 
between BIC and TM was 81% (Kappa 0.62, p<O.OOi). Fewer TM tests were indetermi- 
nate (TM 22% vs. SIC 27%). Of the Indeterminate tests, fewer treadmill tests ware mde- 
terminate because of inabilrty to achieve a target HR of 105 bpm (TM: 3/i 1 vs BIG: 7113). 
Conclusion: There IS a high level of agreement between TWA measured during BIC and 
TM. During TM, patients are more likely to achieve the target HR of 105 bpm, which will 
lower the rate of indeterminate tests. These data demonstrate that TWA can be effec- 
tively measured during TM, which should allow for more widespread use of TWA to iden- 
tify patients at risk for sudden cardiac death during standard stress testing. 
TVVA Results: Comparison of TM and BIG 
TM Pas TM Neg TM Ind 
BIC Pos 11 5 3 19 
BIC Neg 1 39 1 41 
BIG lnd 7 
Ill 
Yee Guan Yap, A. John Camm, Georg Schmidt, Marek Malik. St. George’s Hospitai 
Medical School, London, United Kingdom 
Background: Heart rate turbulence (HRT) is a phenomenon described recently to mea- 
sure the chronotropic response of sinus rhythm to ventricular premature beats (VPBs) 
and has been shown to predict mortality However, the actual mechanism of HRT and 
factors that may influence its measurement are unknown Method: We analysed the pro- 
spectively colleded Halter recordings of 1486 (1254 M, age: 60.4+9.5) post-myocardial 
infarction (Ml) patients with left ventricular ejection fraction (LVEF) ~40% from the EMIAT 
study. 2 parameters of HRT, turbulence onset (TO) and turbulence slope (TS) as well as 
time domain heart rate variability were measured from Halter ECGs using a computer 
algorithm. TO is a measure of the acceleration phase and it is the relative change of RR 
intervals immediately before and after a VPB. TS is a measure of the deceleration phase 
and it is the steepest regression line between RR interval count and duration. Clinical 
data were prospectively collected. Linear regression analysis was used. Results: TO 
and TS were significantly affected by heart rate, age, left ventricular ejection fraction, 
NYHA class, diabetes (DM) and frequency of VPBs (table). Furthermore, TO and TS are 
influenced by thrombolysis beta-blocker, ACE inhibitor but not amiodarone. TO and TS 
are not affected by gender, previous angina, systolic blood pressure. 
TS P.rl.002 pco.ooo1 p=PE p=NS 
Conclusions: HRT is affected by many variables. It is imperative that these factors are 
taken into account and adjusted for when using HRT for risk stratification of post-MI 
patien!s. 
9:36 a.m. 
1010-204 Interleukind Is Inversely Associated With Heart Rate 
Variability in Decompensated Heart Failure 
Andrew J. Burger, Darlene P. Horton, Doron Aronson 6I Deaconess Medical Center, 
Boston, MA, Harvard Medical School, Boston, MA 
Background: Heart rate variability (HRV) is depressed in patients with congestive heart 
failure (CHF) and reflects the extent of autonomic perturbations. Cytokines are overex- 
pressed in CHF and may play an important role in the pathogenesis of myocardial dys- 
function. Given that sympathetic neurons express interleukin-6 (IL-6) receptors and can 
produce and respond to cytokines such as IL-6, increased cytokine levels may contribute 
to the autonomic dysfunction that characterizes CHF. Methods: We studied 64 patients 
admitted for decompensated CHF (mean age 59+12 years, NYHA Class Ill [72%] and IV 
[28%]). Autonomic function was assessed using time and frequency domain heart rate 
variability (HRV) parameters from 24-hour bolter recordings. In addition, norepinephrine 
(NE), tumor necrosis factor-a (TNF-IX), and IL-6 were measured in all patients. Results: 
IL-6 correlated negatively with the time domain parameters of standard deviation of RR 
intervals (SDNN) (r-0.36, p=O.O04) and the standard deviation of all 5 minutes mean 
intervals (SDANN) (r=-0.39, p=O.OOi); and with the frequency domain parameters of total 
power (TP) (r=-0.37, p=O.O03) and ultra low frequency (ULF) power (r-0.43, p=O.OOl). 
No significant association was found between IL-6 and the time or frequency domain indi- 
ces of parasympathetic modulation (percentage of RR intervals >50 ms variations. 
square root of mean squared differences of successive RR intervals, and the high fre- 
quency power). Using multiple linear regression models and adjusting for clinical vari- 
ables, drug therapies, NE and TNF-a, the strong negative association between IL-6 and 
SDNN (p=O.O06), SDANN (p=O.OOl), TP (p=O.O4), and ULF (p=O.O07) persisted. TNF-a 
levels did not correlate with any time or frequency domain HRV indices. Conclusion: 
The inverse relationship between time and frequency domain HRV parameters and IL-6 
suggests that IL-6 may modulate autonomic tone and contribute to the depressed HRV in 
patients with decompensated CHF. 
9:48 a.m. 
1010-205 Abnormal Repolarization Dynamics in Patients With 
Hypertrophic Cardiomyopathy: A New Risk Factor for 
Sudden Death? 
Christopher 6. E. Lang, Saidi A. Mohiddin, Andrew D. Flapan, Lameh Fananapazir. 
University of Edinburgh, Edinburgh, United Kingdom. National Heart, Lung and Blood 
Institute, Bethesda, MD 
Background: Hypertrophic cardiomyopathy (HCM) is associated with a risk of sudden 
death (SD). It remains difficult to predict those patients at greatest risk. Abnormal QT 
interval dynamics may be related to this risk. 
Methods: Sixty patients with non-obstructive HCM on no medication (40 male) and 40 
normal control subjects (30 male) underwent 24 hour Halter recordings. Tapes were 
analysed using a Pathfinder analyser with QT and RR measurement software. Raw QT 
and RR interval data were analysed offlrne, usmg a previously reported automated math- 
ematical model for correcting the lag trme of QT adaptation to changes in heart rate (Rey- 
nolds Medical, UK). This removes the need for beat averaging over long periods and 
allows continuous estimation of the QTiRR relationship using data from a scrolling 5- 
minute window of data. The corrected data is fitted to the formula QT = QTo x RRJ where 
QTo is the corrected QT at an RR interval of 1000 msec, J the variable exponent (in 
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Bazett’s formula, J is fixed at 0.5). The goodness of fit (I) is continuously estimated by 
correlating actual with estimated data. Thus from QT/RR data, the slope, S, QTo and J 
are derived. Holters were accepted for analysis only if >20h was recorded, accurate auto- 
mated detection of Tend was present, mean 24h best-fit (r) was >0.8, and if ~20% of data 
was excluded by error correction algorithms. 37 normal subjects (26 male) and 32 HCM 
patients (23 male) had recordings suitable for inclusion in analysis. 
Results: 
(p=O.O06). Conclusion: Late potentials detected by signal-averaged EGG are a noninva- 
sive risk stratifier in patwts with Brugada syndrome. These results may support the idea 
that conduction disturbance per se is arrhythmogenic in the syndrome. 
IO:24 a.m. 
1010.208 The Prognostic Significance of Intermediate QRS 
Prolongation in Acute Myocardial Infarction Treated With 
Thrombolysis 
p”aiUe 088 coo5 COW”l coooo1 coooo1 coo5 0 06 
Conclusions: 1) 24.hour mean QT and QTo are prolonged in HCM (2) Mean 24h QT/RR 
slope is steeper, and J greater in HCM indicating that changes in RR result in larger 
changes in QT; (2) the 24 hour standard dwation of J is greater in HCM indicating a 
greater temporal varlatlon in repolarization; and (3) repolarization abnormalities may con- 
tribute to the increased risk of SD. 
Radek Pudil, Micha S. Feinberg, Hanoch Hod, Valentina Boyko, Lori Mandelzweig, 
Solomon Behar. Neufeld Cardiac Research institute, Tel Hashomer, lsraei 
IO:00 a.m. 
1010-206 Comparison of P Wave Duration Between Signal Averaged 
ECG and 12 Lead ECG in Predicting Early Recurrence of 
Atrial Fibrillation Following Direct Current Cardioversion 
Xiaohua Guo, Katerina Hnatkova, Mark M. Gallagher, Monica Harries, A. John Camm, 
Marek Malik. Sf George’s Hospital Medical School, London, United Kingdom 
Background: Complere right and left bundle branch block (WLBBB) and advanced atrio- 
veniriculat block present on admission electrocardiograms of patients with acute myo- 
cardial infarction (AMI), are associated with poor short and long-term outcome. Little is 
known about the impact of intermediate QRS prolongation (0.09-0.11 s) on the prognosis 
of AMI. Methods: The characteristics and outcome of 1100 consecutive patients with 
AMI treated with thrombolysis were correlated with manually measured QRS duration of 
admission electrocardiograms. Results: The QRS duration was CO.09 s in 536 (48%) 
patients, between 0.09-0.11 s in 496 (45%) patients and >O.ll s in 78 (7 %) patients. 
QRS duration was strongly associated with 7.day (0.6%, 6%,18%, p<O.O01), 30.day (I%, 
8%, 22% p<O.OOl) and one-year (3% ll%, 26%, p<O.OOl) all-cause mortality. Multi- 
variate regression analyses of mortality were as follows: 
MORTALITY 
Background: Prolonged: P wave duration (PD) in the signal averaged ECG (SA-ECG) 
predicts recurrence of atrial fibrillation (AF) following Direct Current Cardioversion (DCC). 
Its predictive accuracy is influenced by the filter techntque and noise level. We evaluated 
the PD in 12 Lead ECG (12L-ECG) and SA-ECG to study their relative value in predicting 
AF recurrence. Method: The SA and 12L- ECG ( Marquette MAC VU ) were recorded 1 
hour after successful DCC on 70 patients with previously persistent AF (41 M, 64.8+10.7 
years old). ECGs were repeated 1 week later to assess the outcome. The PD in the 12L- 
EGG, defined as the median value of the 12 lead P waves, was analyzed using an “in- 
house” computer program by operaiors blinded io the patients’ characteristics. The PD in 
SA-EGG was obtalned from a P wave triggered FFT filter technique. t Test, Pearson Cor- 
relation Coefficient and Multiple Regression statistics were used. Results: After 1 week 
47 (67%) patients maintained sinus rhythm (SR) and 23 (33%) patients returned to AF 
(R-AF). Although the correlation between PD of both types ECG was significant ( r:0.6, 
P<O.OOOi), the PD of SA-ECG was significant prolonged in the R-AF patients when anal- 
ysed the ECGs which noise level was reduced to 0.44 + 0.23 whereas the PD of 12 L- 
ECG was strongly significant prolonged in any patients group. Furthermore the multivari- 
ate analysis was performed using age, left atrium size (LA), AF duration, and PD of both 
ECGs, ihe PD in IPL-ECG was the only independent predictor of recurrence of AF within 
1 week of DCC (P=O.Oll). Additionally there were significant correlation between PD of 
IPL-ECG and LA ot’ AF duration (r:0.4, P=O.OOl; r:0.275, P=O.O21 respectively) but no 
correlation beiween the PD of SA-ECG and LA or AF durationConclusion: The P wave 
duration in 12L-ECG IS a sensitive predictor of early relapse of AF after DCC. Its prolon- 
gation is associated with LA dilatation and duration of AF. 
70 (100%) patients 54 (77.1%) patients 
7.day 30-day l-year 
OR (95% Cl) OR (95% Cl) OR (95% Cl) 
QRS duration;0.09-0.11 s 4.8(2:3-10.3) 3.0 (155.8) 2.2(1.3-3.8) 
QRS duration:>O.ll s 7.1(2.9-17.1) 5.3(2.4-l 1.6) 3.9(1.9-7.7) 
OR adjusted for age, female gender, diabetes mellitus, sysiemic hypertension, previous 
myocardial infarction, anterior myocardial infarction & Killip class >I-2 on admission 
Conclusion: Intermediate QRS prolongation in evolving AMI emerged as an indepen- 
dent risk predictor of short and long-term all-cause mortality. 
IO:36 a.m. 
1010-209 Prevalence of T Wave Alternans in lschemic and 
Nonischemic Cardiomyopathy 
Anthony R. Magnano, Daniel M. Bloomfield. Columbia Universify Coliege of Physicians & 
Surgeons, New York, NY 
Background: Risk slratification methods, including electrophysiologic study (EPS), have 
lower predictive accuracy in non-ischemic cardiomyopathy (NICM) as compared to 
ischemic cardiomyopathy (ICM). However, preliminary data suggests that presence of 
microvolt T-wave alternans (TWA) during exercise may be a strong predictor of arrhyth- 
mic events in both NICM and ICM. We, therefore, sought io determine the prevalence of 
TWA in NICM and ICM. Methods: TWA testing during exercise was performed in 158 
congestive heart failure patients. TWA was measured using a spectral method and was 
consldered positive if there was sustained TWA 21.9 mV for at least one minute at an 
onset heart rate c 110 bpm. A negative TWA study required a heart rate Z 105 bpm with 
noise cl.8 mV and ectopics ~10% for 1 minute without sustained TWA. All other TWA 
tests were considered indeterminate. Results: The prevalence of lWA was 41% in 
patients with ICM as compared to 46% in NICM. Aside from older age in the ischemic 
group, no slgniflcant differences in ejection fraction or NYHA class were present. 
Patient Characteristics: ICM vs NICM 
12L-ECG 
SR R-AF P 
value 
132r15 145+14 0.002 
SA-ECG Noise 147i20 156~30 0.15 
0.54t0.34 
SR R-AF P 
Value 
12L-ECG 130~1 14&l 0.001 
4 5 
SA-ECG Noise 145+1 155i-2 0.045 
0.44iO.23 8 6 
IO:12 a.m. 
1010-207 Assessment of Noninvasive Markers in Identifying Patients 
at Risk in the Brugada Syndrome: Insight Into Risk 
Stratification 
Takanori Ikeda, Harumizu Sakurada, Kolchl Sakabe, Takao Sakata, Mitsuaki Takami, 
Mahito Nom Ayaka Kawase, Kenta Kumagai, Naoki Tezuka, Takeshi Nakae, Yoshihisa 
Enjoji, Tam&u Tejima, Kaoru Sugi, Tetsu Yamaguchi. Toho University Ohashi Hospital, 
Tokyo, Japan, Tokyo Metropolitan Hiroo Hospital, Tokyo, Japan 
Background: The role of conduction disturbance in arrhythmogenesis of Brugada syn- 
drome is controversial, while It IS well established that repolarization abnormalities is 
responsible for ventricular arrhythmias. The value of noninvasive markers reflecting con- 
duction or repoiarization abnormalities in identifying patients at risk for significant arrhyth- 
mias has not been shown. The aim of this study was to compare the use of various 
noninvasive markers for detecting risk of life-threatening arrhythmic events in patients 
with Brugada syndrome. Methods: We assessed late potentials (LP) using signal-aver- 
aged electrocardiography (ECG), microvolt T-wave alternans (TWA), and corrected QT- 
interval dispersion (QTD) in 44,conseculive patients who had ECGs showing a pattern of 
righi bundle branch block and ST-segment elevation in leads Vl to V3 but structurally 
normal hearts. The patients were compared with 30 normal individuals who were 
matched for age and gender. Results: Eleven patients were excluded from data analysis 
because of an absence of EGG manifestations of Brugada syndrome at the time of the 
tests. A history of life-threatening events defined as syncope and aborted sudden death 
was present in 19 of 33 patients (58%); in 15 of the 19, electrical stimulation induced ven- 
tricular fibrillation or polymorphic ventricular tachycardia. LP were present in 24133 
patients (73%); TWA were present !n 5/31 patients (16%); and a QTD >50 ms was 
present in 9/33 patients (27%). The Incidence of LP in Brugada patients was significantly 
(p<O.OOOl) higherthan in the controls, whereas the incidence of TWA and QTD were not 
significantly different. Multivariate logistic regression analysis revealed that the presence 
of LP had the most significant correlation to the occurrence of life-threatening events 
Percent of Patients 
Age 
Ejection Fraction 
NYHA Class I 
NYHA Class II 
NYHA Class Ill 
ICM NICM 
44% 56% 
58.8 A 7.5 50.4 + 10.8 
24.7 k 7.4 21.1 t 7.1 
10% 20% 
53% 45% 
37% 35% 
TWA Positive 41% 46% 
Conclusion: The prevalence of TWA is similar in patients with ICM and NICM. These 
data suggest that TWA has the potential to identify patients with NICM who are at 
increased risk for sudden cardiac death. Further outcome studies are needed to estab- 
lish the predictive accuracy of TWA in NICM. 
IO:48 a.m. 
101 O-210 Role of Risk Stratifiers in Postinfarction Patients With Acute 
PTCAISTENTING 
Petra Barthel, Kurt Ulm, Raphael Schneider, Axel Bauer, Alexander Hierl, Albert 
Schomig, Georg Schmidt. Technische Universilt fvfiinchen, Munich, Germany 
Background: The clinical value of risk predictors in patients (pts) treated with PTCAI 
Stenting during the acute phase of myocardial infarcilon (AMI) IS not known. Aim of the 
study was to investigate the performance of risk predictors in these pts. 
Methods: 1436 consecutive patients with AMI were included. 90% of them underwent 
PTCA and/or Stenting. 91% receivedb-Blockers. 88% ACE inhibitors, 80% statins and 
99% aspirin. In the Znd week after AMI, a resting ECG, 24-hour Halter EGG, SAECG and 
left ventriculography was performed. Heart rate warlability (HRV), heart rate turbulence 
(HRT), arrhythmia count, mean heart rate (mHR), late potential, presence of atrial fibrilla- 
tion (AFib) or bundle brunch block (BBB) and left ventricular ejection fraction (LVEF) were 
assessed. A multivariate Cox regression analysis was performed including these vari- 
ables after adjustment to age, presence of diabetes mellitus and history of previous myo- 
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card~al infarction. All variables were dichotomized at predefined cut off points. The 
primary endpoint of the study was the composite rate of cardiac death and serious 
arrhythmic events. 
Results: In the univariate analysis, all predictors showed a significant association with 
the endpoint. In rhe multivariate analysis, five parameters were significantly associated 
with rhe endpoint, namely LVEF. HRT, mHR. presence of AFib and of BBB (see Table). 
Conclusion: A stat,stical model for risk stratification in patients treated by PTCAIStenting 
durmg the acute phase of myocardial infarction should include LVEF, HRT, mHR, pres- 
ence of AFib and of EBB. 
Multivariate Cox regression 
Variable Relative hazard p value 
Mean HR >75 bpm 1.9 (1.1-3.1) 405 
HRT 5.7 (2X-11.8) co.ooo1 
AFib 4.9 (2.2-11 .O) <0.0001 
BBB 2.3 (1.2-4.2) <O.Ol 
LVEF <40 % 3.6 (2.2-6.3) <0.0001 
the D and R patterns were similar Conclusion: The differences in the Fi patterns but not 
D patterns suggest that the long WCT-R of cycle 1 could have caused slow propagation 
of successive cycles which originates from the same site as cycle 1. leading to unidirec- 
tional block, reentry and eventually VF. 
1297-l 13 Upper and Lower Energy Limits of Vulnerability to Sudden 
Death With Chest Wall Impact (Commotio Cordis) 
Mark S. Link, Barry J. Maron, Brian A. VanderBrink, Wei Zhu, Natesa G. Pandian. Paul J. 
Wang, N. A. Mark Estes, Ill. Tuffs-New Engiand Medica/ Center, Boston, MA, 
Minneapolis Heart Institute Foundation, Minneapolis, MA 
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1297-I 11 Basic Fibroblast Growth Factor may Attenuate 
Susceptibility to Ventricular Tachyarrhythmias in 
Chronically lschemic Porcine Myocardium 
Background: Sudden death can occur with chest wall blows during sports activities 
(commotio cordis). Clinical events suggest that the energy of impact IS not of unusual 
force. Yet, this factor is dlfflcult to quantify. Therefore, in an experimental model of com- 
motio cordis, we examined the importance of the precise energy of impact. 
Methods: Juvenile swine (8-12 kg and 18-25 kg) were anesthetized, placed prone, and 
randomized to receive chest wall strikes with a regulation baseball thrown from 20 to 70 
mph during the vulnerable time window for the initiation of ventricular fibrillation (VF), 10 
to 30 ms prior to the peak of the T-wave. 
Results: Impacts at 20 mph failed to produce VF. The incidence of VF increased incre- 
mentally to 72% at 40 mph, but then diminished at faster velocities (to 56% at 50 mph, 
41% at 60 mph, and 36% at 70 mph). There were no significant differences between VF 
incidence in the smaller or larger animals. 
Conclusion: Baseballs impacting the precordium at 40 mph (typical speed of a little 
league pitcher) may be more deadly than baseballs delivered at higher velocities. Use of 
this model to assess safety equipment in sport (including balls and chest wall protective 
devices) may be life saving for young individuals participating in sporting activities. 
John D. Day, Mehrdad Rezaee, Sung H. Ghun, Alan C. Yeung, Paul G. Yock, Peter J. 
Fitzgerald, Andrew Carter, Abel L. Robertson. Ruey J. Sung. Stanford University Madicai 
Center, Stanford. CA 
Background: Most cases of sudden cardiac death are caused by sustained ventricular 
tachyarrhythmias that occur in the setting of myocardial infarction or ischemia and con- 
gestive heart failure. The use of fibroblast growth factor (FGF) represents a novel method 
of improving myocardial blood flow and function via induction of anglogenesis. We exam- 
ined whether local administration of FGF might have a beneficial effect in suppressing 
ventricular tachycardia (VT) in a chronically ischemic porcine heart model. Methods: 
Chronic &hernia was created I” the left anterior descending or circumflex artery territo- 
ries using an injurylischemlc model. FGF was delivered via a catheter to the myocardium 
using the anterior intraventricular vein (AIV). Electrophysiology testing for VT was per- 
formed using ventricular burst pacing and programmed stimulation of up to triple prema- 
ture stimuli at two sites in the right ventricle and at the site of focal wall motion 
abnormalltity in the left ventricle. Coronary perfusion was assessed using microsperes at 
30 days after randomization to FGF or saline infusion. Results: In FGF treated pigs, 
there was a decrease in the inducibllrty of monomorphic VT (315 positive for Inducible VT, 
60%) compared with untreated animals (8/8 positive for inducible m, 100%). Overall, a 
16% +/- 2.3% (95% Cl) improvement in ischemic zone flow was observed after FGF 
treatment. Mild to moderate focal left ventricular hypokinesis was seen in all animals 
which corresponded to an average of I-1.5 cm in diameter myocardia infarction on gross 
pathologic examination. Conclusion: Local delivery of FGF may diminish the proarrhyth- 
mia substrate of ischemic heart disease. 
1297-131 Infarct Size and Location Determines Susceptibility to 
Inducible Ventricular Tachycardia in Healed Porcine 
Infarction 
David J. Callans, John Michele, Jian-Fang Ren, Francis E. Marchlinski, Stephen M. 
Dillon. University of Pennsylvania, Philadelphia, PA 
1297-l 12 Mechanism of VF Reinitiation After Failed Defibrillation 
Shocks: An Optical Mapping Study in Isolated Swine Hearts 
Nipon Chattipakorn, lsabelle Banville, Richard A. Gray. Raymond E. Ideker. Universify of 
Alabama at Birmingham, Birmingham, AL 
Background: Infarct (Ml) size and septal location are important determinants forsuscep- 
tibility to ventricular tachycardia (VT) in man. This characterlstlc should be reproduced in 
realistic animal models of VT The relationship between MI size and location with induc- 
ible VT was determined in a porcine model of healed Ml. Methods: RV and LV pro- 
grammed stimulation was performed 58.5 i 5.1 days after anteroseptal MI was produced 
by distal LAD embolization in 8 pigs. Ml area was estimated as an ellipse, (p*max width/ 
2*max heightl2), measured with electraanatomic (EA) voltage (eiectrograms c 1 mV) 
mapping and pathologic analysis MI location was also characterwed by LV intracardiac 
echocardiography (9 MHz). Results: Fourteen distinct VT morphologies (mean cycle 
length 256 i 52 ms) were induced in 5 of 8 pigs Ml included the anterior wall and the 
septum in all 5 pigs with inducible VT; all 3 noninducible pigs had MI llmited to the ante- 
rmr wall (Chi square, p < 0.005). Correlation between EA and pathologic measurements 
was good (r = 0.80, p < 0.02); Ml size data presented IS from the EA calculation. Ml area 
was larger in pigs with inducible VT than in those wthout VT (773 + 328 vs 213 * 50 
mm2, p = 0.02). NO pig wth Ml area < 300 cm2 had inducible VT. MI size also correlated 
with the number of distinct VT morphologies induced (I = 0.82, p = 0.011). Conclusions: 
Susceptibility to inducible VT in this porcine model of healed LAD Ml is dependent on Ml 
size and septal involvement, similar to the relationship seen in human VT. A “threshold” 
Ml area (1 300 mm2) with septal involvement was a prerequisite for inducible VT in this 
study. This suggests that anatomic features of the Ml such as size and location deter- 
mine the electrophysiologic VT substrate. Further understanding of Infarct anatomy and 
its relationship to VT substrate will be helpful in design of anatomically based VT ablation 
procedures. 
Previous studies show 
that foliowing near 
defibrillation threshold 
(DFT) shocks, the acti- 
vation pattern of post- 
shock Cycle 1 
(Depolarization, D) is 
similar for successful (S) 
and failed (F) shocks, 
suggesting that shock 
outcome is not deter- 
mined by the immediate 
myocardial response to 
the shock. However, the 
repolarization (R) pat- 
Ci/cle IWmber Cycle lilurnber 
terns were not determined in those studies. We sought to investigate the R patterns of 
the immediate postshock cycle and its relationship to defibrillation success. In each of 6 
isolated swine hearts, 10 DFT shacks were delivered and the ventricular surface were 
optically mapped using 2 CCD cameras. The intercycle interval (ICI, an interval between 
the onset of 2 successive cycles) and wavefront conduction times (WCT, an interval 
between the site of earliest and latest activation of a cycle) for D and R of the first 5 post- 
shock cycles were detemined wng a 50% cutoff threshold. Results: The R patterns for 
cycle 1 were different between S and F shocks but not the D patterns. Starting at cycle 2, 
1297-132 Amiodarone Widens Excitable Gap During Ventricular 
Fibrillation 
Jian Huang, Jonathan L. Skinner, Jack M. Rogers, William L. Holman, Raymond E. 
Ideker. University of Alabama at Birmingham, Birmingham, AL 
Background: Widening the excitable gap is thought to be a mechanism for pharmaco- 
logical cardioversion of tachyarrhythmla. 
Methods: To test whether amiodarone widens the excitable gap during ventricular fibril- 
lation (VF), six dogs were given IO mgikg of amiodarone intravenously. Effective refrac- 
tory periods (ERP) and VF before and after amlodarone were compared. VF was 
quantified using computer analysis of the electrograms to identify Individual wavefronts 
and to determine which were reentrant. A flexible mapping plaque of 504 (24x21) elec- 
trodes spaced 2 mm apart was sewn to the anterior right and left ventricular epicardium. 
VF was induced using 60 Hz alternating current and unipolar electrograms were 
recorded from the plaque for 20s after VF onset. The following parameters were mea- 
sured: (1) Wavefronts (number of wavefronts in a Is interval), (2) Area (mean area acti- 
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vated by wavefronts), (3) Rate (activations/s, which has been shown to be inversely carotid hypersensitrvity in 5 (3%). The percentage of dual chamber ICDs utilization 
related to the refractory period during VF), (4) Conduction velocity, (5) Perimeter of the increased from 34% (19/56) in 1998, to 48% (71/149) in 1999 and to 61% (731120) in 
core of reentrant wavefronts, (6) Cycle length (time for reentrant wavefronts to complete a 2000. 
rotation). Conclusions: A significant proportion of patients (61%) currently receive dual chamber 
Results: 
ERP Wave- Area Rate (s- Velocity Perime- Cycle 
(ms) fronts (mm2) 1) w4 ter length 
(mm) W 
Pre-drug 170+14 86256 231+27 6.9+1.8 0.31+0.05 43el7 82+29 
Post-drug 170+7 47+25* 360~78’ 6.7rl.4 0.36*0.05 50*19* 100*29* 
‘~~0.05 compared to pre-drug. (mean&D). 
The absence of changes in ERP, Rate, and conduction velocity indicates that amio- 
darone did not change wavelength (the product of velocity and refractory period). The 
product of wavefronts and area is a measure of total area activated. The decrease of this 
product together with unchanged wavelength indicates an increased excitable gap. This 
is further supported by increases in reentry perimeter and cycle length without change in 
wavelength. 
Conclusion: Amiodarone increases the excitable gap both temporally and spatially dur- 
ing VF. 
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1298-I 14 Nonlinear-Dynamical Arrhythmia Control in Humans 
David J. Christini, Kenneth M. Stein, Steven M. Markowitz, Suneet Mittal, David J. 
Slotwiner, Marc A. Scheiner, Sei Iwai, Bruce 8. Lerman. The New York Hospital - Cornell 
University Medical Center, New York, NY 
Background: Nonlinear-dynamical control, also known as chaos control, has been used 
to control the behavior of cardiac tissue in vitro. However, the feasibility of using such 
techniques to control cardiac dynamics has not been demonstrated in humans. 
Methods: During diagnostic electrophysiological testing, 5 patients (3 male, 2 female; 
52?17 yr.) underwent rapid atrial stimulation at an adjustable interval (VA) following ven- 
tricular depolarization. VA was reduced until alternans in the atrioventricular (AV) conduc- 
tion time was observed. An adaptive chaos-control technique, which made beat-to-beat 
perturbations to VA, was then applied to suppress alternans by stabilizing the underlying 
unstable steady-state conduction. 
Results: In 52I54 control atempts, 
pacing-induced AV alternans were 
successfully suppressed. There was 325 
C - Control N . No Control 
no correlation between control suc- AV 
cess and either antiarrhythmic medi- b-4 
cations (3 patients) or the presence of 225 
dual AV-nodal pathways (2 patients). 950 beat number 1750 
The Figure shows the AV intervals for 
three successful control attempts dur- 
ing one representative trial. AV alternans occurred when the VA intervals were held con- 
stant without control (N); alternans was suppressed when the VA intervals were 
perturbed (C)via the chaos control algorithm. 
Conclusion: This proof-of-concept demonstration shows that nonlinear-dynamical con- 
trol techniques are clinically feasible, thereby providing support for future investigations 
into their clinical utility. 
ICDs. Tradrtional pacing indications (conduction system disease and sinus node dysfunc- 
tion) together form the most common indkxtion for dual chamber ICD use, followed by 
PAFldetection specificity. 
1298-l 16 Occurrence of Implantable Cardioverter Defibrillator Events 
in Patients With Syncope and a Nonischemic Dilated 
Cardiomyopathy 
Andrea M. Russo, Ralph Verdino, Christa Schorr, Maureen Nicholas, Sanjay Dixit, Vickas 
Patel, Francis Marchlinski. University of Pennsylvania Health System, Philadelphia, PA 
Background: Syncope is known to be a predictor of poor outcome in pts with nonis- 
chemic dilated cardiomyopathies. Although EP testing often reveals no inducible sus- 
tained ventricular arrhythmias, its predictive value in this population is poor. Although 
controversial, ICDs are frequently recommended. Methods: We evaluated the occur- 
rence of ICD events in 28 pts with syncope and nonischemic dilated cardiomyopathies 
over a mean follow-up period of 552+/-571 days. The mean age was 65 +I- 14 yrs, and 
mean LVEF was 26 +/- 11%. There were 18 men. All but one pt underwent baseline EP 
testing, and inducible sustained VT was noted in 11 pts. No sustained ventricular arrhyth- 
mias were inducible in 16 pts. Results: During follow-up, a total of 32 ICD events 
occurred in 14 pts with 53 shocks, 34 aborted shocks, and 5 ATP events. Appropriate 
ICD therapy for VT/VF occurred in 10 pts (36%). Symptoms included syncope or hemo- 
dynamically unstable VT/VF in 3 pts. Appropriate ICD therapy for VTivF occurred in 6 pts 
who did not have any sustained arrhythmias inducible at EPS. Inappropriate therapy for 
supraventricular arrhythmias (SVA) occurred in 6 pts (21%). Two pts died in follow-up. 
One pt had recurrent incessant VT/VF in the hospital with effective ICD shock therapy on 
the first attempt on each occasion, followed by asystole, and the other pt died from non- 
arrhythmic causes. One pt underwent heart transplantation. Conclusion:. (1) Many pts 
(36%) with nonischemic dilated cardiomyopathies and syncope receive appropriate 
defibrillator therapy in follow-up, even in the absence of inducibility at EPS. (2) Treatment 
of SVA is also commonly noted (21%) in these pts. Although the results strongly support 
the need for ICD therapy in these pts, efforts to modify ICD programming or selection of 
dual chamber systems appear necessary to optimize device function and avoid treatment 
of SVA. 
1298-l 17 One-to-One Tachycardias Do Not Endanger Safe Arrhythmia 
Detection Due to Imitation of Supraventricular 
Tachyarrhythmias: Results With Two New Dual-Chamber 
Detection Algorithms 
Christian Wolpert, Werner Jung, Susanne Herwig, Rainer Schimpf, Kyung-Mi Jeong, 
Alexander Yang, Berndt Luederitz. University of Bonn, Bonn, Germany 
Novel dual-chamber detection algorithms incorporate the atrial signal for underlying 
rhythm analysis. In the setting of 1:l tachycardia underdetection can occur challenging 
discrimination efficacy of the various dual-chamber detection algorithms. If in a PR-pat- 
tern based time window-assigned algorithm atrial signals occur in the time zone of ante- 
grade sinus activation, VT would be misdiagnosed as SVT In acceleration and AV- 
association based algorithms VT with 1 :l conduction can be misdiagnosed as SVT, if 
acceleration is determined to be of atrial origin. The aim of this prospective study was to 
assess the incidence of 1 :l tachycardias and to test the algorithms for sensitivity and 
specificity in this specific setting. METHODS: A total of 40181 patients with an Defender 
9001,9201 (ELA Medical) and and a Jewel 7250 AF or Gem DR (Medtronic Inc.) were 
included into analysis. Rhythm diagnosis was based on the stored endocardial electro- 
grams, PP,PR,RP and RR-intervals as offered by the devices. RESULTS: A total of 378 
spontaneous tachyarrhythmias could be documented during a mean follow-up of 25 
months. 32 episodes ware 1:l tachycardias during initial detection. In 4 cases there was 
a sinus tachycardia with PR> RP imitating a VT rhythm, due to time window assignment 
to the zone of retrograde activation. In one case atrial tachycardia led to inappropriate 
1298-l 15 Indications and Frequency of Dual Chamber Implantable detection of VT. In none of the patients 1:l ventricular tachycardia with constant retro- 
Defibrillator Use 
grade conduction was underdetected. This equals a sensitivity of 100% for 1:l VT. This is 
both true for the PR IooicTM and the ParadTM aloorithm. CONCLUSIONS: 1. 1:1 tachv- 
Emmanouil Brilakis, MaryJane Rasmussen, Nancy Lexvold, Win-Kuang Shen, Robert 
Rea. David Haves. Steohen Hammill. Paul FrIedman. Mavo Clinic. Rochester. MN 
cardias occur in 32/378 (8.5%) of all spontaneous tachyarrhythmia episodes. In the vast 
majority a ventricular tachycardia with constant retrograde activation is found. 2. New 
1 , .  I  
Background: Dual chamber defibrillators (ICDs) have been advocated for patients with 
dual-chamber detection algorithms using time pattern based, or association and acceler- 
AV block, sinus node dysfunction, paroxysmal atrial arrhythmias (for arrhythmia specific- 
ation features provide a sensitivity of 100% for 1 :l VT, maintaining patients safety. 
ity and prevention), heart failure (particularly in the setting of a long PR interval), syn- ___ 
cops, and hypertrophic cardiomyopathy (HCM). However, single chamber devices offer 
1298-118 Frequency of Appropriate Shocks in the Patients With 
~ 
greater simplicity and longevity, and lower cost. We sought to describe the frequency of Implanted Defibrillators for MADIT (Multicenter Automatic 
utilization and indications for dual chamber ICD use at our tertiary care center. Defibrillator Implantation Trial) or MUSTT (Multiple 
Method and Results: Data were prospectively collected on all patients who underwent Unsustained Tachycardia Trial) Criteria 
initial ICD implantation between l&98 and 8/22/2000. Device’selection was up to the 
treating physician, and indication for dual chamber device use was recorded at the time 
Gunjan J. Shukla, S. Dinakar Satti, G. Muqtada Chaudhry, Patricia E. Pacetti, Thomas F. 
of implantation. Of 325 consecutive ICD recipients with a ventricular device indication, 
Marchese, Charles I. Haffajee. St. Elizabeth’s Medical Centeer, Boston, MA. Tufts 
163 (50%) received a dual chamber ICD. Patients were 61 f 16 “ears old. and 75% were 
University School of Medicine, Boston, MA 
male. Mean ejection fraction was 0.38 t 0.19. Of the devices used, 98% incorporated Background: Patients with ischemic cardiomyopathy (EF<=35%), clrnical non-sustained 
rate response; 1% were capable of atrial defibrillation. The indication for ICD implanta- ventricular tachycardia (VT) and inducible, non-suppressible VT on electrophysiology 
tion was ventricular tachycardia or fibrillation in 108 patients (66%) out-of-hospital car- (EP) studies, who were randomized to conventional therapy in MADIT had a 27 month 
diac arrest in 18 (11%) syncope in 22 (13.5%) family history of sudden death without cardiac mortality rate of 30%. Even though 60% of the patients with an implantable 
clinical arrhythmia in 10 (6%) long QT syndrome in 2 (1.2%) and other in 3 (1.8%). The defibrillator (ICD) had a shock within 2 years, appropriateness of defibrillator discharges 
indication for dual chamber system was AV block or conduction system disease in 56 could not be assessed due to lack of electrogram storage capability in the devices used 
patients (34%), paroxysmal atrial fibrillation (PAF)/enhanced detection specificity in 48 in the trial. Cardiac mortality was 25 % in patients with cardiomyopathy (EF<=40%), non- 
(29%), HCM in 28 (17%) heart failure in 13 (8%) sinus node dysfunction in 13 (8%) and sustained VT and inducible VT on EP study who did not receive ICD in MUSTT Electro- 
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gram storage capabilities in current generation of ICDs enable us to assess the appropri- 
ateness of delivered therapy in such patients. Methods: Retrospective analysis of 
frequency and appropriateness of ICD discharges in patients who had their device 
implanted for criteria used for enrollment in MADIT or MUSTT studies. Results: Over a 
period of 3 years, 133 patients met criteria for ICD implant based on MADIT or MUSTT 
studres. Mean age was 69 +I- 10 years; 83% were males; mean LVEF was 0.24 +/- 0.08. 
Over a mean follow up of 29 +I- 25 months 481133 (36%) received at least one appropri- 
ate therapy for malrgnant ventricular tachyarrhythmia. Conclusion: Frequency of appro- 
priate ICD drscharges in patients who received their devices based on guidelines from 
MUSTT and MADIT studies closely approximates the mortality rates in control group in 
those trials over a similar follow up period. This further corroborates the recommendation 
to implant ICDs in high-risk subset of patients with non-sustained VT identified by these 
trials. 
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1298-I 19 Effect of Structural Heart Disease on the Long-Term 
Efficacy and Safety of the Metrix Implantable Atrial 
Defibrillator 
1299-121 Atrial Fibrillation Accelerates Accumulation of Age-Related 
Common Type Mitochondrial DNA Deletion Mutation in 
Human Atrial Tissue 
Hung-Fat Tse. Chu-Pak Lau, Luz-Maria Rodriguez, Carl Trmmermans, Emile G Daoud, 
Gregory M Ayers, Hein J J Wellens. University of Hong Kong, Queen Mary Hospital, 
Hong Kong, Hong Kong 
Ling-Ping Lai, Ming-Jai Su, Jiunn-Lee Lin, Shoei K Stephen Huang. Pharmacological 
Inshtute, National Taiwan University, Taipei, Taiwan,ROC, Department of Internal 
Me&me, National Taiwan University Hospital, Taipei, Taiwan,ROC 
Background: The long-term efficacy and safety of implantable atrial defibrillator (IAD) 
therapy in patients with atrial fibrillation (AF) and structural heart disease is unclear. The 
aim of this study was to evaluate the efficacy and safety of IAD therapy in patients with 
and without structural heart drsease. Methods and Results: In 115 patients implanted 
with an IAD, 85 patients had sfructural heart disease: 41 patients (48%) had one, 29 
patients (35%) had two, 13 patients (15%) had three and 2 patients (2%) had four differ- 
ent cardiovascular abnormalities. The device was programmed into a rhythm monitoring 
mode for the frrst 3 months post-implant. All defibrillation therapy was performed under 
physician supervision to monitor safety and efficacy. After this rnitiai monitoring period, 
patients were allowed to activate therr device away from the hospital or clinic. A total of 
357 spontaneous AF episodes occurred in 83 patients (72%) during observed operation 
and the mean shock efficacy was 93&20.3% (lower 95% conference interval [Cl]= 
69.8%). As of last follow-up, 58 patients (55%) had transition to receive non-physician 
observed therapy. Forty-two patients (72%) had experienced 332 episodes of AF for 
which they had received devrce therapy away from the hospital/ clinic (mean shock effr- 
cacy 90.5i39.7 %). The presence of hypertension, valvular heart disease and ischemic 
heart disease did not affect the shock efficacy of the IAD both during physician observed 
and non-observed therapy (p>O.O5). However, the presence of congestive heart failure 
was associated with a lower clinical efficacy during both observed and non-observed 
therapy (pc 0.05). Overall, 5262 shocks have been delivered with the IAD without any 
episode of proarrhythmia. The observed proarrhythmic risk was O%, with an estimated 
maximum proarrhythmic risk of 0.06 % per shock (95% upper Cl). Conclusions: A 
stand-alone IAD appears to be safe in the presence of structural heart disease. The 
lower clinical efficacy for AF associated wrth congestive heart failure might be related to a 
higher rate of early reinitiation of AF after defibrillation. 
Background: Accumulation of somatrc mutatrons of mitochondrial DNA (mtDNA) con- 
tributes to aging process and progressive organ dysfunction. We measured the amount 
of a common type 4977.base pair mtDNA deletron (mtDNA4977) in human atrial tissue 
and correlated the amount of mtDNA4977 to clinical atrial fibrillation (Af). Methods and 
Results: Atrial tissue from the right atrial appendage was obtained in 80 patients during 
open heart surgery (41 male and 39 female, 19 children and 61 adults, 25 with Af and 55 
without). Total cellular DNA from the atrial tissue was subjected to a nested polymerase 
chain reactron protocol for amplification of mtDNA4977. Primers for wild type mtDNA 
were added in the reaction for co-amplification. The mtDNA4977 amount was normalized 
to wild type mtDNA amount. We found that the mtDNA4977 was absent in all 19 pediatric 
patients. In the adult patients, the relative amount of mtDNA4977 was significantly higher 
in patients with Af than in patients without Af (0.60 5 0.24 vs 0.34 8 0.30, p<O.Ol). The 
amount of mtDNA4977 was also positively associated with age, left atrial pressure and 
right atria pressure. Further multi-variate analysis showed that only age and atrial fibnlla- 
tion were independently associated with the amount of mtDNA4977 (Table). 
The p values of correlation between clinical parameters and the amount of mtDNA 
deletion mutation 
Af Age RA pressure LA pressure 
Univariate 0.0015 0.0006 0.0017 0.0419 
Multivariate 0.0342 0.0073 0.0867 0.3732 
Conclusions: Af is associated with an increase of mtDNA4977. This change is similar to 
the aging process of atria tissue and might contribute to atriai dysfunction in Af. 
1299-122 Impact of Atrial Fibrillation on Neurohormonal Status and 
Systolic Pressure Variability 
Maria V. Pitzalis, Francesco Massari, Massimo Grimaldr, Massimo lacoviello, Fikppo 
Mastropasqua, Giovanni Luzzi, Brian Rizzon, Vito Vulpis, Paolo P&on. lnsrifute of 
Cardioiogy - Universify of Bari, Bari, lfaf~ Cardiology De@. “S. Maugeri” Foundation, 
Cassano Murge, k/y 
1298-120 Comparison of Step-Down and Binary-Search Algorithms 
for Determination of Defibrillation Thresholds in Humans 
Stephen R. Shorofsky, Eric Rashba, Michael R. Gold. Unwersily of Mary/and, Baifimore, 
MD 
Background: Defrbriflation efficacy IS typically defined clinically by a defibrillation thresh- 
old (DFT), despite the fact that defibrillation success is a continuous function of applied 
energy. Two frequently used protocols to determine DFT are 1) decreasing the energy in 
a step-wise fashion to first failure (step-down) and 2) performing three shocks in a step- 
down and step-up fashion depending on the success or failure of the previous shock 
attempt (binary search). Theoretically, the step-down protocol should estimate the 
energy at which 70% of the shocks were successful while the binary-search protocol 
should estimate the 50% success energy. Despite this difference, comparisons are often 
made be!ween data obtained with each of these protocols. This study was desrgned to 
directly compare these protocols ior determining DFT in humans. 
Methods: This was a prospective study of 34 patients to compare DFT measured with 
each of these protocols. Identical energy steps were used for each DFT determination. 
The order of testing was randomized. Step-down began at 18J and the binary search at 
9J. Each patient had a dual coil lead system and an active pulse generator. 
Results: The patients were 63% male, with a mean age of 63314 years, and ejection 
fraction of 34 ? 15%. There was no statistical difference between DFT determmed with 
either protocol (8.4 i: 5.3 for binary-search vs 7.7 + 4.0). The DFT determined with each 
protocol differed by no more than 1 step in 24 patients. The order of testing had no effect 
on the results. 
, 
minations of DFT are required. 
DFT (J)’ Resistance (ohms) 
Conclusions: Binary-search and step-down protocols yreld similar DFT, Since binary- 
search determines the DFT with fewer trials, it should be emoloved when multioie deter- 
Background: Atrial fibrillatron is a common arrhythmia assocrated with an increased risk 
of heart failure development. Neurohormonal activatron plays a key role in the pathophys- 
iology of heart failure: due to its potentially relevant hemodynamic consequences, atrial 
fibrillation may have an addrtronal effect on neurohumoral activation. This study was 
tion during atrial fibrillation. 
addressed to evaluate the impact of atrial fibrillation on plasma neurohormones and 
pressure variability, comparrng the measures before and after cardioversion to sinus 
rhythm. 
Atrial fibrillation Sinus rhythm p level 
Methods: In 17 patients (mean age 63+6 years) with heart diseases (NYHA class I-II) 
and persistent atrial fibrillation (lasting 68+60 days from the diagnosis) we evaluated 
plasma levels of norepinephrine, epinephrine, atrial natriuretic peptide and endothelin-1 
and performed time and frequency analysis on 10.minutes of systolic arterial pressure 
(Finapres) both during atrial fibrillation and the day after the efficacious electrical cardio- 
version to sinus rhythm. 
Results: Changes occurred in systolic arterial pressure, systolic arterial pressure vari- 
abrlity, and neurohormones are reported in the Table. Sinus rhythm restoration signifi- 
cantly decreased norepinephrine (by 35 %), atrial natriuretic peptide (by 41 %) and 
systolic variabilrty (by 89 %). In addition, the variablity of systolic pressure correlated wrth 
plasma norepinephrine (r-0.5; ~~0.05) during atrial fibrillation but not during sinus 
rhythm (r=0.2; p=ns). 
Conclusions: Atrial fibrillation is an important determinant of plasma norepinephrine 
levels and systolic vanablity that are two interrelated factors potentially deleterious for 
cardiovascular system. In addition, our results raise important questions regarding the 
siqnificance of ulasma atrial natriuretic DaDtide in the diaqnosis of left ventricular dysfunc- 
Binary-search 8.4 f 5.3 
Step-down 7.7 i 4.0 
*P=O 42 binary-search vs step-down DFT 
43i 12 
43ill 
Systolic pressure (mmHg) 119+14 121+22 NS 
Systolrc pressure variability (In mmHg2) 5.0+0.8 2.7*0.7 <O.OOl 
Norepinephrine (pgiml) 199+63 123t54 <O.OOl 
Epinephrine (pglml) 
Atrial natriuretic peptide (pgiml) 
Endothelin-I (pgiml) 
30rl6 21*7 NS 
59+28 35i23 <O.OOi 
6+4 5+2 NS 
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1299-123 Ventricular Rate Modulation During Atrial Fibrillation: Can 
Sinus Rate Be Achieved and Maintained by Computer 
Controlled Post ganglionic Vagal Stimulation? 
Kent A. Mowrey, Youhua Zhang, Shaowei Zhuang, Don W. Wallick, Don G. Hills, Todor N. 
Mazgalev. Cleveland Clinic Foundation, Cleveland, OH 
Background: Atrial fibrillation (AF), the most common clinical arrhythmia, leads to 
increased ventricular rate (VR), which is not always well tolerated. Unfortunately, the res- 
toration and maintenance of sinus rhythm is very difficult, with no highly successful treat- 
ment for AF. In such cases a better therapy target may be to reduce the VR. We have 
previously demonstrated that postganglionic vagal stimulation (PGVS) effectively slows 
the VR during AF. The goal of this study was to determine if varying ths intensity of 
PGVS could maintain the VR at predetermined levels. 
Methods: AF was maintained in 5 mongrel dogs (25.0 kg i 1.2 kg). PGVS (20 1 ms 
pulses 6 ms apart) was applied to the AVN fat pad (3 dogs) and the left cervical vagus (2 
dogs) immediately following each ventricular deflection. The intensity of PGVS was com- 
puter controlled by a feedback algorithm that compared the current ventricular interval 
(Vi) with the target interval (TI). 
Results: The graph shows a typical 500 beat run. The VI during AF prior to the applica- 
tion of PGVS was 254 ms. The TI was 400 ms, close to the normal sinus rate. The thin 
line is the VI (ms). The thick line is the PGVS intensity (mA) applied to the AVN fat pad. 
The table shows the average (n=29) of the % of the target reached and the PGVS feed- 
back (mA) in blocks of 100 VI over the entire 500 VI run in all studied hearts. Overall, 
95.8% of the target was reached over the last 400 beats with a PGVS amplitude of 4.6 ? 
0.6 mA. 
1st 1OOVI 2nd 100 VI 3rd 100 VI 4th 100 VI 5th 100 VI 
% of TI 77.4 91.7 96.1 97.5 97.9 
PGVS (mA) 1.9 + 0.9 3.7 * 0.4 4.5 + 0.2 4.9 f 0.2 5.2 k 0.1 
Conclusion: A target mean VR close to the normal sinus rate can be reached and man- 
tained during AF by computer controlled PGVS applied to the AVN fat pad. This novel 
approach may be clinically feasible. Further optimization of the feedback algorithm will 
be directed toward reduction of the heart rate variabilitv. 
JACC February 2001 
Conclusions: 1. VR slowing by both AVNVS and Ablation + RVP improves hemodynam- 
its during AF. 2. AVNVS, without destroying the AVN and thus maintaining the antegrade 
activation, results in similar hemodynamic responses compared to the AVN Ablation + 
RVP. 
AF AF + AVNVS Ablation + RVP 
RR interval (ms) 337 *54 * 511 587 505 f 86 
Systolic BP (mmHg) 82t8 * 97+18 99+16 
Diastolic BP (mmHg) 66 + 8 73+17 76~17 
LVSP (mmHg) 69i4 * 85+11 98213 # 
LVEDP (mmHg) 10.7 r 5.3 10.3 f 5.0 10.9 I 6.2 
+LV dpidt (mmHg/s) 1639t338 1705 i. 368 1636 + 395 
-LV dpidt (mmHg/s) -1140+197 * -1638 2 344 -1830 + 755 
Stroke volume (ml/beat) 9.7 e 3.8 * 16.9 f 5.2 13.9 + 8.6 
Cardiac output (Limin) 1.7io.5 2.0 r 0.4 1.6 + 0.7 
BP: blood pressure, LV (left ventricle), SP/EDP (systolic/end diastolic pressure) 
( )  .-_ -  -~~ _ 
0 100 200 300 400 500 
1299-124 A Hemodynamic Comparison of 2 Strategies for Control of 
Ventricular Rate During Atrial Fibrillation: Local Vagal 
Stimulation Versus Atrioventricular Nodal Ablation With 
Right Ventricular Pacing 
Youhua Zhang, Shaowei Zhuang, Don W. Wallick, Kent A. Mowrey, Tomotsugu Tab.&, 
Todor N. Mazgalev. The Cleveland Clinic Foundation, Cleveland, OH 
Background: Previous experiments have demonstrated that local atrioventricular nodal 
(AVN) vagal stimulation (AVNVS) reduces ventricular rate (VR) in atrial fibrillation (AF). 
With this technique, the ventricular activation is antegrade but irregular, in contrast to 
AVN ablation plus regular but retrograde right ventricular pacing @VP). Although both 
irregularity and retrograde electrical activation of the ventricles diminish cardiac function, 
it is unknown which strategy is preferable. We tested the hypothesis that, at comparable 
levels of VR slowing, antegrade activation of the ventricles with AVNVS has the benefit of 
providing similar hemodynamics while not destroying the AVN. 
Methods: AF was induced and maintained in 6 dogs by rapid atrial pacing. AVNVS was 
delivered to vagal nerves projecting to the AVN and resulted in anterograde ventricular 
activation with VR that was slowed towards the basic sinus rate. Then the AVN was 
ablated and RVP was initiated that resulted in retrograde activation at a constant rate 
similar to the average VR obtained with AVNVS. Major hemodynamic parameters were 
compared during AF, AF + AVNVS and Ablation + RVP. 
Results: The results are shown in the table. Statistical differences (p<O.O17, paired t-test 
with Bonferroni correction) are indicated for AF versus the 2 other groups (‘) and Ablation 
+ RVP versus AF + AVNVS (#). 
1299-125 The Amount of Atrial Fibrosis Predicts the Occurrence of 
Atrial Fibrillation After Open Heart Surgery 
Andreas Goette, Gina Juenemann, Helmut U. Klein, Albert Roesner, Christof Huth, 
Christoph Roecken. University Hospital Magdeburg, Magdeburg, Germany 
Backgro”nd:Atrial fibrillation (AF) is a frequent complication after open heart surgery. 
Increased atrial fibrosis may characterize the presence of an intrinsic arrhythmogenic 
substrate. Therefore, the ain- of this prospective study was to determine whether atrial 
fibrosis is associated with an increased prevalence of AF after open heart surgery 
(OHS). 
Methods and Results: Right atrlal appendages were obtamed from 145 patients under- 
going OHS. None of the patients had a history of AF. Quantitative analysis of the atrial 
fibrosis was performed using a point counting method. In all patients, the ECG was con- 
tinuously monitored for at least 72 hours after OHS. Postoperative AF was defined as an 
episodes of AF lasting 25min. Quantitation of interstitial fibrosis yielded a mean volume 
percentage of 17% (V%; range 8-32%). Patients with fibrosis were divided into three 
groups: group 1: V% = 5.14%, group 2: V%=15-23%, group 3: V%=24-32%. 32 pts 
(22%) developed AF after surgery. AF occurred least commonly in group 1 (10% of the 
pts) and most commonly in group 3 (45%). 25% of the pts in group 2 developed AF. The 
differences between group 1 and 2, as well as group 1 and 3 were significant (~~0.05). 
The remaining pre- and postoperative patients characteristics (age, gender, heart dis- 
ease, medication) were comparable between patients with and without AF. 
Conclusions: The amount of atrial fibrosis correlates with the prevalence of AF after 
OHS. Thus, atriai fibrosis provides a morphologic substrate which increases the likeli- 
hood of AF in response to proarrhythmic events. 
1299-126 Atrial Ectopy: Determinants of Initiating Mechanisms of 
Atrial Fibrillation 
Taya V. Glotzer, Judy Jin, Stephanie M. Fitts, John Zimmerman. Ha&en&& Universify 
Medical Center, Hackensack, NJ, Medtronic, Inc, Minneapolis, MN 
Background: In order to develop more effective therapy for atrial fibrillation (AF), the 
mechanism of AF initiatmn should be better understood. The Medtronic AT500 pace- 
maker has the unique capability of recording and storing 48 atria and ventricular cycles 
(onset buffer) and 4 seconds of intracardiac electrograms at the onset of AF Methods: 
We reviewed 904 initiations of AF in 38 patients with paroxysmal AF and the AT500 pace- 
maker in order to elucidate the mechanism of AF onset. Atrial premature beat (APC) is 
defined as a premature beat ~75% of the cycle length of the underlying heart rate. 
Results: All episodes of AF were initiated by a single APC. 495 of 904 episodes had at 
least one (range 1-8) additional APC in the onset buffer that did not imtiate sustained AF. 
54% of these APCs triggered one to ten (median 2.0) more beats of non-sustained AF 
(NSAF). The coupling Interval (Cl) of the APCs that Initiated sustained AF was the same 
as that of the APCs which initiated NSAF (476 vs. 478, p=ns). Regression analysis 
showed no relationship between the Cls of APCs and the baseline heart rate (R2=0.16). 
75% of the patients had atrial paced underlying rhythm. Concluiions: In this group of 
patients, AF is initiated by isolated APCs despite underlying paced atrial rhythm. The Cl 
of APCs which initiate sustained AF is the same as that of innocuous APCs. AF is inti- 
ated by presumed unifocal APCs which occur frequently in the seconds before AF onset 
and could be targeted for ablation therapy. 
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1300-127 Randomized Trial of Propafenone, Ibutilide, or Rate Control 
in Post operative Atrial Fibrillation 
&hard J. Saucier. Jr., Neal Lippman, Michael L. Themen, David I. Silverman, Melecio 
Abordo, Kp Madhusoodanan, Honora Dalamagas, Print Jaagosild, Ellison Berns. Sf 
Francis Hospiral and Medical Center, H&ford, CT CT 
5ackground:lt is unclear whether acute conversion of atnal fibrillation (AF) with antiar- 
rhythmic drugs followmg cardiac surgery restores and maintains sinus rhythm and 
reduces length of stay (LOS). Methods: A randomized prospective trial was conducted in 
2 teaching hospitals from 3/28/98 to 812199 to study the effect of the early use of ibutilide 
or propafenone on the duration of AF, rhythm at discharge, and LOS. A total of 42 stable 
patients with new AF after surgery were randomized to oral propafenone (600mg, single 
dose; n=20), ibutilide (lmg X up to 2 doses if necessary; n=lO). or rate control only 
(n=iZ). Agents used for rate control were left to the discretion of the primary physician 
but beta blockers were encouraged. Results: Pre-randomization distribution of diabetes, 
CHF, previous AF, and the use of beta blockers was similar in all groups. The graph 
depicts the Kaplan-Meyer curves according to treatment arm. At 24 hours O%, 65% and 
33% of patients in the ibutilide (p=O.Ol), propafenone (p=ns), and rate control groups 
respectively were stlil in AF. Although ibutilide decreased AF duration, recurrence rates 
were 90%, 41%, and 58% in those groups (p=ns compared to rate control). Of 3 patients 
who did not convert, all received propafenone. There was no difference in LOS or rhythm 
at discharge. Conclusion: lbutilide but not propafenone decreases the duration of AF 
after cardiac surgery and neither appears to affect LOS or rhythm at discharge. It 
appears from this data that a strategy of rate control only is a reasonable one I” the early 
management of post operative AF. 
Time to conversion 
1 v lbutilide p=O.O2 
-1 
3 
Propafenone p=O.l 
Rate control 
Logrank test, 
active drugs were 
compared with 
rate control 
Time, diys 
1300-128 Electrophysiologic Effect of Amiodarone Pretreatment in 
Persistent Atrial Fibrillation Patients 
Giovanni Q. Villani, Maswno F. Ptepoli, Natale Marrazzo, Alessandro Capucci 
Cardiology Division, Piacenza. /f&y 
Background. Persistent atrial fibrillation (PAF) with sustalned rapid atrial rates is associ- 
ated with progressive decrease in atrial refractoriness due to the so-called electrical 
remodallng. which is antagonized in experimental model by verapamil infusion. Amio- 
darone is considered an effective treatment in the cardioversion of PAF but little is known 
on its effect on atrial electrophsiologic properties in PAF. In a placebo controlled study we 
assessed the effect of amiodarone pretreatment on electrical remodeling in PAF patients, 
who underwent to internal electrical cardioversion. Methods. 19 PAF patients (AF dura- 
tion: 3.4 months) were prospectively randomly allocated either to amiodarone (400 mgl 
day: 10 pts. 7 Male, 67yrs) or placebo pretreatment (9 pts, 5 Male, 68yrs). After 30 days 
therapy, a step up synchronized internal cardioversion (6msec/6msec biphasic shock 
waveform) wth increasing energy levels from 0.2 to 20 joules was performed using a dual 
leads defibrlilation system (right atrium-coronary sinus configuration; Rhythm Technolo- 
gies, USA). After sinus rhythm restoration a MAP catheter (EP Technologies, USA) was 
inserted in the right atrium and atrlal ERP and the MAP90 were measured by 4 stimula- 
tion CycleS (from 300 to 600 ms) in 3 atrial sites (hiah and low sedum. lateral wall) in ” 
orderio define the absolute ERP, the ERP disperswn and the presence/absence of phys- 
iological ERP rate-adaptation (ERP-RA) phenomenon. Results 
Placebo Amiodarone P 
Atrial Def Threshold (J) 9.1 t2 8.2~2.3 ns 
Mean ERP (ms) 178ilO 189+10 ns 
Conclusion. Oral amiodarone treatment of pts with persistent AF does not influence ERP 
and dispersion of refractormess. The restoration of ERP-RA however can be an impor- 
tant electrophysiological fmding explaining the clinical positive amiodarone preventive 
effect on early recurrence of AF after electrical cardioversion. 
1300-129 Pharmacologic and Ablative Hybrid-Therapy in Atrial 
Fibrillation: Relevance of Intravenous Propafenone Testing 
Thorsten Lewalter, Lars Lickfett, Christian Wolpert, Alexander Yang, Rainer Schimpf, 
Berndt Luederitz. Depf. of Cardio/ogy, Univerwfy of Bonn, Bonn, Germany 
In 10.15% of patients with recurrent atrial fibrillation (AF) and class IC antiarrhythmic 
drug treatment, typical atrial flutter (AFL) can be observed during follow-up. After catheter 
ablation of the drug-induced AFL and continuation of the drug treatment (hybrid therapy), 
a reduced AF incidence was reported. Since now, identification of patients suitable for 
this approach IS limited to the spontaneous occurrence of AFL. We therefore investi- 
gated, whether it is possible to identify such patients using intravenous (iv) drug testing. 
Twenty-seven symptomatic AF patients (11 women, 16 men, mean age: 56.7k7.8 years; 
hypertensive heart disease 15, coronary artery disease 2, idiopathic AF 10) received an 
iv propafenone bolus (2 mglkg) during ongoing AF. In 9 patients typical AFL could be 
observed within one hour of ECG monitoring. During a 3 months follow-up, all 9 patients 
received an oral propafenone treatment with 6 of them again demonstratmg AFL. In one 
of the 6 patients, the propafenone treatment had to be withdrawn due to extracardiac side 
effects. In the remaining 5 patients the drug-induced AFL was isthmus-dependent with a 
counterclockwise right atrial activation. After catheter ablation with bidirectional conduc- 
tion block in the cavotricuspid isthmus and continuation of the oral propafenone medica- 
tion, 3 patients demonstrated no longer AFL or AF within a 6 months follow-up. In 1 
patient, AF was reduced (9.8 episodes/month vs. 1.3 episodes/month), 1 patient exhib- 
ited an unchanged AF incidence and additional atypical AFL. About 70% of patients who 
developed typical AFL after iv propafenone administration also demonstrated typical AFL 
during oral propafenone treatment. The majority of such patients who were treated with 
the “pharmacologic and ablative hybrid therapy” remained in sinus rhythm. Thus, iv pro- 
pafenone testing allows to identify patients suitable for an hybrid approach in AF. 
1300-130 Single-Day Loading Dose of Oral Amiodarone Does Not 
Prevent Atrial Fibrillation After Coronary Artery Bypass 
Surgery 
Dejan Maras, Srdjan Boskovic, Slobodan Kovacevic, Petal Otasevic, Zoran Popovic, 
Rade Babic, Ljilja Vuk, Tomislav Jovanovic, Milovan Bojic, Aleksandar Neskovic. Dedfnje 
Cardiovascular fnsfifufe, Belgrade, Yugoslawa 
Background: It has been shown that one-week loading dose of oral amiodarone can 
reduce presence and severity of atrial fibrillation (AF) following coronary artery bypass 
surgery (CABS). However, there is no evidence whether single-day loading dose of oral 
amiodarone has beneficial effect in preventing AF after CABS. Methods: In order to 
assess the effect of single-day loading dose of oral amiodarone in prevention of AF after 
CABS, a double-blind, randomized, placebo-controlled study was conducted evaluating 
315 consecutive patients (pts). Pts received either amiodarone (159 pts) or placebo (156 
pts) in a single oral dose of 1200 mg one day before CABS, followed by 200 mg daily dur- 
ing next 7 days, including the day of surgery. All pts were monitored for AF during first 48 
h in the ICU. After that, serial electrocardiograms (twice daily routinely, and if heart rate 
(HR) was >lOO/min, or pt experienced angina, hypotension, dyspnea or sweating) and 
HR measurements (4 times daily routinely) were obtained in order to detect AF. Only epi- 
sodes of AF lasting more than 1 hour, or shorter but associated with symptoms and/or 
hemodynamic disturbances, were taken into consideration. In addition, overall mortality, 
duration of hospital stay, and other rhythm disturbances ware also evaluated. Results: 
Pts with and without postoperative AF were similar regarding age, sax, preoperative EF 
and severity of coronary artery disease, operative data, and electrolyte status. The inci- 
dence and characteristics of AF, as well as mortality and duration of hospital stay are 
shown in the Table. 
Amiodarone (n=l59, Placebo (n=156, P value 
age 58.3 + 9.1) age 57.3 + 8.4) 
AF (pts (%)) 31 (19.5) 33 (21.2) NS 
AF episodes 1.9il.Z 2.3 + 2.2 NS 
AF duration (h) 28.4 t 39.9 21.2 c 29.0 NS 
To&al mortality (pts (%)) 7 (4.4) 5 (3.2) NS 
Hospital stay (days) 10.3 ? 6.2 10.0 i: 3.6 NS 
Other arrhythmias (pts (%)) 48 (30.2) 45 (28.8) NS 
Conclusion: Single-day oral loading dose of amiodarone does not prevent occurrence, 
duration and number of episodes of AF in the unselected population of pts undergoing 
CABS and has no effect on the overall mortality and the duration of hospital stay in such 
pts. 
ERP dispersion (ms) 24tlO 31*10 ns 
ERP-RA + 
Early recurrence AF (n) 1 2 
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892-I Role of P Wave Morphology of Atrial Premature Beats in 
Guiding Maping for Pummonary Vein Ablation in 
Paroxysmal Atrial Fibrillation 
Davendra Mehta, Michael Hoffman, Noelle Langan, Anthony Games. Mount Sinai 
Hospital, New York, NY 
A significant proportion of focal atrial fibrillation originates in the pulmonary veins (PV). 
Mapping of atrial premature beats is used to identify these sights for ablative purposes. In 
order to identify the P wave morphology of atrial premature beats originating from the 4 
Pv’s, 12-&d ECG’s were performed while pacing the ostia of all 4 Pv’s. Methods: 
Tewelve patients undergoing tran-septal punctures for ablation of the left-sided accessory 
pathways were prospectively studied. Following the ablation procedure, a pacing catheter 
was advanced into all 4 PV’s. While pacing at 100 bpm, the catheter was withdrawn until 
atrial capture was obtained. 12 lead ECG’s were continuously performed while pacing. 
Resulting P waves in all 12 leads were identified as predominantly positive or negative. 
Results: Significant differences were ?,een between the ECG’s taken while pacing the left 
and right Pv’s. Left PV pacing (upper and lower) resulted in positive P waves in lead aVR 
(~~0.05) and negative P waves in aVL (p<O.OOl). Additionally, left lower PV pacing 
resulted in negative P waves in leads V3 (p<O.OOl), V4 (pcO.O5), V5 (p<O.O5), V6 
(p<O.O5). Right PV (upper and lower) pacing, resulted in negative P waves in lead aVR 
and positive P waves in lead aVL. There were so signrficant differences in morphology 
when pacing right upper or lower Pv’s when compared to the P waves produced by nor- 
mal sinus rhythm. Conclusions: 1) The morphology of P waves in leads aVR and aVL can 
be used to differentiate between foci originating from the right and left Pv’s. 2) The mor- 
phology of P waves in precordial leads V3-V6 can be used to differentiate between foci 
originating from left upper and lower Pv’s. 3) There are no significant differences in the P 
wave morphology between foci originating from the 2 right Pv’s. 4) The 1Blead ECG is 
useful in determining which pulmonary vein is the origin of impulse formation. Localiza- 
tion of abnormal impulses may aid in therapy of focal atrial fibrillation. 
892-2 
IO:45 a.m. 
Evaluation of Asymptomatic Arrhythmia Detected During 
the Reveal@ Plus Clinical Study 
G. J. Klein, J. M. Hartog, B. J. Hugel, C. Menozzr, 6. 8. Lee. Medtronic Inc., Minneapolis, 
MN 
The REVEALBPLUS insertable loop recorder (ILR) has the capability to automatically 
detect cardiac arrhythmia and store the ECG for up to 14 events. This feature is designed 
to aid in diagnosing patients who suffer from unexplained syncope by capturing arrhyth- 
mia that may be asymptomatic. An international study was conducted in 9 clinical sites. 
We report on the automatically detected events collected during the REVEAL PLUS clin- 
ical study. Methods: REVEAL PLUS was implanted left parasternally in forty patients 
(58% male, average age 64rl3 years) with unexplained syncope (3.5 + 2.1 events) in the 
previous 12 months. Concomitant cardiovascular disease was reported in 40% of 
patientsAfter 36 of the 40 patients were setup and followed for 1 month (39 f 22 days), 
the automatically detected stored events were collected and analyzed. For the remaining 
4 patients, data collection continues. Results: Thirty of the 36 patients (83%) had very 
low rates of inappropriate automatic activation (IAA) (1.5 f 2.2 per week, median 0.32, 
range 0 to 7.7). Of these thirty-six patients, 9 (25%) had no IAA, and the remaining 27 
had a total of 184 IAAs stored in memory (undersensing due to small signal, n=107; 
undersensing believed to be caused by temporary loss of signal due to amplifier satura- 
tion, n=48; oversensing due to large T-waves, n=24; oversensing due to noise, n=5). 
Asymptomatic arrhythmia were detected in 6 of the 36 patients (17%) and 44 events 
were captured in total (asystole, II=‘& bradycardia, n=26; sinus tachycardia, n=lO). The 
final 6 (17%) of the 36 patients exhibited high rates of IAA (87.5 f 68.7 par week, median 
57.2, range 32.3 to 193.3). In these six patients, this high rata significantly reduced the 
monitoring window available for automatically capturing asymptomatic arrhythmia. Con- 
clusion: The majority of patients implanted with the device had vary few inappropriate 
automatic activations. REVEAL PLUS appears to be effective in automatically capturing 
infrequeht, asymptomatic cardiac arrhythmia and storing these events in memory. 
1 I:00 a.m. 
892-3 Holter Analyses Are Inappropriate for Atrial Fibrillation 
Trina A. Buhr, Rupa Bahri, Chad T. Giese, H. Toby Markowitz, Douglas F! Zipes, Richard 
Sutton, David S. Cannom, David G. Benditt. Medtronic Inc., Minneapolis, MN 
Background; Halter monitoring is often used to manage pharmacological heart rate con- 
trol of atria.1 fibrillation (AF). Halter reports typically include daily and hourly maximum, 
mrnimum, and mean heart rate from analyses that use averaged beat values rather than 
actual heart rate. While averaging may reduce the impact of artifact, it may be dysfunc- 
‘tional when used in AF. We hypothesized that use of averaged beat values would under- 
report maximum heart rate in AF. 
Methods: Nine AF patients from 2 centers underwent 24.hour ambulatory Halter moni- 
toring. A core lab created conventronal Halter reports. Recordings were then manually 
edited beat-by-beat to provide ‘True” heart rate data. For comparison, 8 Halter manufac- 
JACC February 2001 
turers provided information on programs used to generate reports. All manufacturers 
reported the use of averaged beat values to report maximum heart rate. Averaging tech- 
niques were of two types: rolling or sequential segments. Segment size was based either 
on a number of beats (e.g. 4) or on a period of time (e.g. 6 seconds). We simulated the 8 
Halter manufacturer programs in our analysis of the 9 Halter monitoring recordings. 
Results: Conventional Halter 
reports under-reported ‘“true” bpm 
maximum heart rate by a 
mean of 81 bpm (range: 34. 
170 bpm), and simulations 
under-reported 
maxim”m 
heart rate by a mea” of 62 
bpm (range: 19-126 bpm). 
1_1 jgf.yI!~, 
Beat averaging obscured 
maximum heart rate both in Halter reports and our simulations. Below are 21 sequential 
beats surrounding a daily heart rate maximum from 1 patient, along with means calcu- 
lated by 2 methods. 
maximum heart rate (bpm) 
true 200 
4.beat rolling avg 155 
4.beat sequential avg 153 
# beats > 155bpm lOOf 
Conclusion: Current Halter reports significantly under-report maximum heart rate of AF 
patients, due to use of averaged beat values in the analyses. Misleading physicians as to 
maxlmum heart rate achieved may severely limit the clinical usefulness of Halters in AF. 
892-4 
11:15 a.m. 
Shortening the Duration of the Head-Up Tilt Table Test: A 
Randomised Controlled Trial of PO-Minute Sublingual 
Glyceryl Trinitrate-Provoked Versus 40-Minute Passive 
Protocols as Initial Investigations in the Diagnosis of 
Vasovagal Syncope 
Steve W. Parry, Janine C. Gray, Diarmuid O’Shea, Mary Baptist, Rose Anne Kenny. 
Cardiovascular hvestigation Unit, University of Newcastle, Newcastle upon Jyne, United 
Kingdom 
Introduction: The head up tilt table test is the initial investigation of choice in the diagno- 
sis of vasovagal syncope, but is time consuming and labour intensive. Second line inves- 
tigations include provocative tests with isoproterenol or nitrates. We compared a 
shortened 20 minute glyceryl trinitrate provoked head up tilt (GTN-HUT) with the stan- 
dard 40 minute tilt (HUT) as first line investigations in patients with unexplained syncope 
and asymptomatic controls in random&d controlled fashion. 
Methods: Consecutive patients with unexplained syncopelpre-syncope referred to our 
syncope facility and asymptomatic controls with a similar age/sex profile were randomly 
assigned GTN-HUT (800mcg metered dose spray) or HUT and then the opposite tilt test 
1 week later at the same time of day. Positive tilt: hypotensionibradycardia with exact 
symptom reproduction in patients, haemodynamic changes in isolation in controls. False 
positive: haemodynamic changes in isolation rn patients. 
Results: 149 patients (mean age 58 yr [sd 19.31, 90 [60.4%] female), 83 controls (mean 
age 55 yr [sd 19.41, 45 [54.2%] female). 
Results of head up tilt tests. Patients and Controls 
Patients 
HUT positive GTN HUT positive Total 
NO Ye?, 
NO 91 41 132 
Yes 4 13 17 
Total 95 54 149 
OR 10.25, 95% Cl 3.7, 39.4. McNemars Chi2=30.42, P<O.OOOOl False positive tilt in 9 
patients, 8 with GTN HUT 
Controls 
HUT positive GTN HUT positive Total 
No YC?S 
No 58 16 74 
Yes 2 7 9 
Total 60 23 83 
OR 8, 95% Cl 1.9, 71.6. McNemars Chi2=10.89, P=O.OOl No order effects (Fishers 
exact test ~~0.7) or significant side-effects (headache in 7 patients and 6 controls wrth 
GTN) 
Conclusion: Patients were 10.25 times more likely to have a diagnostic test with a 20. 
minute GTN-HUT than with prolonged 40-minute passive HUT. The 20.minute GTN-pro- 
vokad tilt test should replace prolonged passive tilt testing as the diagnostic test of choice 
in the diagnosis of vasovagal syndrome in subjects with unexplained syncope. 
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11:30 a.m. 
Prospective, Randomized, Crossover Evaluation of the 
Effect of Propranolol, Nadolol, and Placebo on 
Neurocardiogenic Syncope Recurrence and Patients’ Well- 
Being 
Panagiota Fievari, Efthimios G. Livanis, George N. Theodorakis, Elias Zarvalis, Dimitrios 
T. Kremastinos. Onassis Cardiac Surgery Center Athens, Greece 
The aim of the present study was to test the relative therapeutic efficacy of a nonselectwe 
lipophilic beta-blocker (propranolol), a nonselective hydrophilic beta-blocker (nadolol) and 
placebo on neurocardiogenic syncope (NCS) recurrence and patients’ (pts’) well being. 
Methods: The patient (pt) population consisted of 30 consecutive pts with recurrent neu- 
rocardiogenic syncope (at least 2 episodes in the last 3 months) and positive head-up tilt 
test. All were serially assigned in a random way to propranolol, nadolol and placebo. 
Therapy with each drug lasted 3 months. On the day of drug crossover, pts were asked to 
report the total number of syncopallpresyncopal attacks during the previous 3.month 
period and possible side effects. They were also asked to grade each drug treatment tak- 
ing into account its efficacy and their personal well-being during therapy (scale O-3. 
O=discontinuation, l=bad, 2=good, 3=very good). In case of discontinuing one drug, they 
were randomized to another. 
Results: The mean number of syncopal attacks during the 3.month period before ther- 
apy initiation (2.93i2.52) was reduced by all treatments tested (0.14+0.36 by propranoiol, 
0.01+0.01 by nadolol and 0.44kO.73 by placebo, p<O.OOOl). The same was observed 
regarding presyncopal attacks (p<O.OOOl). No differences were observed II? syncopel 
presyncope recurrence among the three drugs. Two pts discontinued propranolol due to 
fatigue, and 2 discontinued placebo due to continuing syncopal attacks. No difference 
was observed between the 3 medications I” the pts’ drug assessment, though a trend 
(p=O.O9) was observed favoring placebo treatment vs propranolol, mainly due to propra- 
nololis central side effects. 
Conclusion: Propranolol. nadolol as well as placebo drug are equally effective treat- 
ments in NCS, as assessed by reduction of syncopelpresyncope recurrence and pts’ well 
being. This may have important pathophysiologic and clinical Implications. 
892-6 
1 I:45 a.m. 
Recurrent Syncope Following Beta-Blocker Therapy vs. 
Conservative Management in Patients With Vasovagal 
Syncope 
Jorge Alegria, Bernard Gersh, Chris Scott David Hodge, Steven Hamm~ll, Win Shen 
Mayo Clinic, Rochester, MN 
Background: Although beta-blockers are frequently used in the treatment of vasovagal 
syncope, the clinical efficacy remains to be defined. The objective of this study is to com- 
pare the clinical outcome of pts with vasovagal syncope treated wth beta-blockers vs 
conservative management (education and avoidance of volume depletion). Methods: All 
pts with clinically confirmed diagnosis of vasovagal syncope between 1996 and 1998 at 
the Mayo Clinic were included in the study. Clinical follow-up was conducted prospec- 
tively by survey. Recurrence of syncope was estimated by the Kaplan Meier method and 
was compared between the two treatment groups using log rank test. Results: During 
the study period, 463 consecutive patients (F/M 2431220, mean age 53+/-23 yrs) had 
clinically confirmed diagnosis of vasovagal syncope, 449 (97%) had tilt table testing. Of 
the total, 172 (37%) were treated with beta-blockers (mean age 48 +/- 25 yrs, F/M 1021 
70), and 87 (19%) received conservative management ( mean age 55+/-23 yrs, F/M 431 
44). Patients receiving beta blocker were younger (p=O.Ol). The mean follow-up was 20 
+/-13.2 months. The following clinical characteristics were not significantly different 
between the two groups (p z 0.05): number of previous syncope, previous attempts of 
syncope therapy, presence of comorbidities or cardiovascular diseases, EF, abnormali- 
ties on Halter or ECG. One or more episodes of syncope occurred in 47 pts receiving 
beta blockers and 15 pts receiving conservative therapy. The probability of survival free 
from syncope was 77% and 60% at 1 yr, and was 65% and 80% at 2 yrs, for pts receiving 
beta blockers and conservative therapy, respectively (p = 0.056). Conclusions: 1) In a 
consecutive group of pts, recurrent syncope was more frequent in pts treated with beta 
blockers when compared to pts treated with conservative management. 2) Although the 
limitations of the retrospective nature of the study are well recognized, our observations 
challenge the utility of “routine” beta blocker therapy in pts with vasovagal syncope. 
